[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2025026738A1 - 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides - Google Patents

6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides Download PDF

Info

Publication number
WO2025026738A1
WO2025026738A1 PCT/EP2024/070220 EP2024070220W WO2025026738A1 WO 2025026738 A1 WO2025026738 A1 WO 2025026738A1 EP 2024070220 W EP2024070220 W EP 2024070220W WO 2025026738 A1 WO2025026738 A1 WO 2025026738A1
Authority
WO
WIPO (PCT)
Prior art keywords
spp
methyl
cycloalkyl
cyano
compounds
Prior art date
Application number
PCT/EP2024/070220
Other languages
French (fr)
Inventor
Yolanda Cancho Grande
Rüdiger Fischer
Steffen Müller
Yeshua SEMPERE MOLINA
Matthieu WILLOT
Elke Hellwege
Kerstin Ilg
Marc LINKA
Peter Lösel
Manuel SOMMER
Olga Malsam
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of WO2025026738A1 publication Critical patent/WO2025026738A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Definitions

  • BCS233014 FC-Text Gam/lep 2024-05-29 - 1 - Heterocycle derivatives as pesticides
  • the present invention relates to heterocycle derivatives of the formula (I), to their use as acaricides and/or insecticides for controlling animal pests, particularly arthropods and especially insects and arachnids, and to methods and intermediates for their preparation.
  • Heterocycle derivatives having insecticidal properties are already described in the literature, for example in WO 2010/125985, WO 2012/074135, WO 2012/086848, WO 2013/018928, WO 2013/180193, WO 2013/191113, WO 2014/142292, WO 2014/148451, WO 2015/000715, WO 2016/124563, WO 2016/124557, WO 2015/121136, WO 2015/133603, WO 2015/198859, WO 2015/002211, WO 2015/071180, WO 2015/091945, WO 2016/005263, WO 2016/039441, WO 2015/198817, WO 2016/041819, WO 2016/039441, WO 2016/039444, WO 2016/026848, WO 2016/023954, WO 2016/020286, WO 2016/046071, WO 2016/058928, WO 2016/059145, WO 2016/071214, WO 2016/091731
  • Novel heterocycle derivatives have now been found, these having advantages over the compounds already known, examples of which include better biological or environmental properties, a wider range of application methods, better insecticidal or acaricidal action, and good compatibility with crop plants.
  • the heterocycle derivatives can be used in combination with further compositions for improving efficacy, especially against insects that are difficult to control.
  • R 1 represents aryl or 5 to 6 membered hetaryl, each of which is optionally mono- or polysubstituted by identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, acetyl, SCN, SF5, tri(C1-C4)alkylsilyl, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3- C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3- C6)cycloalkyl, cyano(configuration 1-1)
  • R 1 represents aryl or 5 to 6 membered hetaryl, each of which is optionally mono- or polysubsti
  • the compounds of the formula (I) have very good efficacy as pesticides, preferably as insecticides and/or acaricides, and additionally generally have very good plant compatibility, in particular with respect to crop plants.
  • the compounds according to the invention are defined in general terms by the formula (I).
  • R 1 preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, furanyl, pyrazolyl, thiazolyl, oxazolyl or imidazolyl, each of which is optionally mono- or polysubstituted by identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3- C6)cycloalkyl, (C1-C4)
  • R 1 particularly preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl or thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents, where possible substituents in each case are as follows: cyano, halogen, nitro, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1- C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl,
  • R 1 very particularly preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, halogen, (C 3 -C 6 )cycloalkyl, (C 1 -C 4 )haloalkyl-(C 3 - C 6 )cycloalkyl, halo(C 3 -C 6 )cycloalkyl, cyano(C 3 -C 6 )cycloalkyl, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )cyanoalkyl, (C 1 -C
  • R 1 with emphasis represents phenyl, pyridyl (pyridinyl), pyrimidyl (pyrimidinyl), pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, fluorine, bromine, chlorine, methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, 1-cyanocyclopropyl, 1- trifluoromethylcyclopropyl, 1-fluorocyclopropyl, 2-cyanopropan-2-yl, cyano(difluoro)methyl, methoxyimino, ethoxyimino, aminocarbonyl, chlorophenyl or chloropyridy
  • Configuration 5-2 R 1 with emphasis represents phenyl which is optionally mono-, di- or trisubstituted by identical or different substituents where possible substituents in each case are as follows: cyano, fluorine, bromine, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1-fluorocyclopropyl, methoxyimino, ethoxyimino, aminocarbonyl or chlorophenyl, or pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon BCS233014 FC-Text - 5 - atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, fluorine, bromine, chlorine, methyl,
  • Configuration 6-1 R 1 especially represents phenyl, which is mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl, or pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl (-CF 2 CN), methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosub
  • FC-Text - 6 - R 1 especially represents phenyl, which is mono-, di- or trisubstituted identically or differently by fluorine, bromine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl, or pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl (-CF2CN), methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyr
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl.
  • R 1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1-fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl.
  • R 1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, bromine or chlorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is mono-, di- or trisubstituted by fluorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is monosubstituted by fluorine, bromine or chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is disubstituted identically or differently by fluorine, bromine or chlorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is trisubstituted identically or differently by fluorine, bromine or chlorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is monosubstituted by fluorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is disubstituted by fluorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is trisubstituted by fluorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is monosubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is disubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R 1 represents phenyl, which is trisubstituted by chlorine.
  • the invention relates to compounds of the formula (I), in which BCS233014 FC-Text - 8 - R 1 represents pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl, methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl, or pyridazin-3-yl which is monosubstituted by chlorine or cyano, or pyrimidin-2-yl which is mono- or
  • the invention relates to compounds of the formula (I), in which R 1 represents pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl, methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl.
  • the invention relates to compounds of the formula (I), in which R 1 represents pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH 3 ) 2 CN) or chloropyridin-4-yl.
  • the invention relates to compounds of the formula (I), in which R 1 represents pyridazin-3-yl which is monosubstituted by chlorine or cyano.
  • the invention relates to compounds of the formula (I), in which R 1 represents pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy.
  • the invention relates to compounds of the formula (I), in which R 1 represents pyrazin-2-yl which is monosubstituted by chlorine.
  • the invention relates to compounds of the formula (I), in which R 1 represents 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents 1H-pyrazol-3-yl which is monosubstituted by methyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents thien-2-yl which is monosubstituted by 1-cyanocyclopropyl.
  • the invention relates to compounds of the formula (I), in which R 1 represents 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano.
  • R 1 represents 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano.
  • halogen is selected from the group of fluorine, chlorine, bromine and iodine, preferably in turn from the group of fluorine, chlorine and bromine.
  • Aryl (including as part of a larger unit, for example arylalkyl), unless defined differently elsewhere, is selected from the series phenyl, naphthyl, anthryl, phenanthrenyl, and is preferably in turn phenyl.
  • alkyl either on its own or else in combination with further terms, for example haloalkyl, is understood to mean a radical of a saturated, aliphatic hydrocarbon group which has 1 to 12 carbon atoms and may be branched or unbranched.
  • C 1 -C 12 -alkyl radicals are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 1-methylbutyl, 2-methylbutyl, 1- ethylpropyl, 1,2-dimethylpropyl, hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl and n-dodecyl.
  • alkenyl either on its own or else in combination with further terms, is understood to mean a straight-chain or branched C2-C12-alkenyl radical which has at least one double bond, for example vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1,3-pentadienyl, 1- hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl and 1,4-hexadienyl.
  • alkynyl either on its own or else in combination with further terms, is understood to mean a straight-chain or branched C 2 -C 12 -alkynyl radical which has at least one triple bond, for example ethynyl, 1-propynyl and propargyl.
  • the alkynyl radical may also contain at least one double bond.
  • cycloalkyl either on its own or else in combination with further terms, is understood to mean a C 3 -C 8 -cycloalkyl radical, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. Among these, preference is given to C 3 -C 6 -cycloalkyl radicals.
  • alkoxy either on its own or else in combination with further terms, for example haloalkoxy, is understood in the present case to mean an O-alkyl radical, where the term "alkyl" is as defined above.
  • Halogen-substituted radicals for example haloalkyl, are mono- or polyhalogenated, up to the maximum number of possible substituents.
  • the halogen atoms may be identical or different.
  • Halogen here is fluorine, chlorine, bromine or iodine, especially fluorine, chlorine or bromine.
  • optionally substituted radicals may be mono- or polysubstituted, where the substituents in the case of polysubstitutions may be the same or different.
  • the radical definitions or illustrations given above in general terms or listed within ranges of preference apply correspondingly to the end products and to the starting materials and intermediates. These radical definitions can be combined with one another as desired, i.e.
  • Preference according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being preferred. Particular preference according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being particularly preferred. BCS233014 FC-Text - 11 - Very particular preference according to the invention is given to using compounds of the formula (I) which contain a combination of the definitions listed above as being very particularly preferred. Emphasis according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being emphasized. Special emphasis according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being especially emphasized.
  • the compounds of the formula (I) may be in the form of geometric and/or optically active isomers or corresponding isomer mixtures in different compositions. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers. Isotopic variants The present invention also encompasses all suitable isotopic variants of the compounds of the formula (I).
  • An isotopic variant of such a compound is understood to mean a compound of the formula (I) in which at least one atom is replaced by another atom of the same atomic number, but with a different atomic mass than the atomic mass usually or predominantly occurring in nature.
  • isotopes that can be incorporated into a compounds of the formula (I) are those of hydrogen, carbon, nitrogen, oxygen, phosphorus, sulfur, fluorine, chlorine, bromine and iodine, such as 2 H (deuterium), 3 H (tritium), 13 C, 14 C, 15 N, 17 O, 18 O, 32 P, 33 P, 33 S, 34 S, 35 S, 36 S, 18 F, 36 Cl, 82 Br, 123 I, 124 I, 129 I and 131 I.
  • isotopic variants of a compounds of the formula (I), such as in particular those in which one or more radioactive isotopes are incorporated, can be useful, for example, for investigating the mechanism of action or the active ingredient distribution, for example in the body of a pathogen; for this purpose, compounds labeled with 3 H or 14 C isotopes are particularly suitable, because their production and detection which is comparatively easy.
  • isotopes such as, for example, deuterium
  • Isotopic modifications of the compounds of the formula (I) can therefore also represent a preferred embodiment of the invention.
  • Isotopic variants of the compounds of the formula (I) can be prepared by methods known to the person skilled in the art, for example by the methods described below and the instructions given in the exemplary embodiments, by using appropriate isotopic modifications of the respective reagents and/or starting compounds (educts).
  • the inventive compounds of the formula (I) can be obtained by the processes shown in the following schemes: BCS233014 FC-Text - 12 - Process A
  • R 1 is preferably aryl, 6- membered hetaryl or C-connected 5-membered hetaryl (R 1 is bridged via a carbon atom to the rest of the molecule) is described below.
  • the radical R 1 has the meanings described above.
  • Step a) Compound of the formula (IV) can be prepared from starting materials (II) and (III) in the presence of a condensing agent.
  • Compound (II) is either commercially available or can be prepared by known methods, for example analogously to the methods described in WO 2010/125985, WO 2012/074135, WO 2012/086848, WO 2013/018928, WO 2015/000715, WO 2015/121136, WO 2016/039441, WO 2016/059145, WO 2016/071214, WO 2016/169882, WO 2016/169886 or WO 2016/124557.
  • Compound of the formula (III) can be prepared by known methods, for example analogously to the methods described in WO 2018/130437, WO 2018/130443, WO 2020/002082
  • the conversion to compound of the formula (IV) can be effected neat or in a solvent, preference being given to conducting the reaction in a solvent selected from customary solvents that are inert under the prevailing reaction conditions.
  • ethers for example diisopropyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, tert-butyl methyl ether; halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol, ethanol or isopropanol; nitriles, for example acetonitrile or propionitrile; aromatic hydrocarbons, for example toluene or xylene; aprotic polar solvents, for example N,N-dimethylformamide or N-methylpyrrolidone, or nitrogen compounds, for example pyridine.
  • halogenated hydrocarbons for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene
  • alcohols such as methanol, ethanol or isopropan
  • suitable condensing agents are carbodiimides such as 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride (EDCI) or 1,3-dicyclohexylcarbodiimide; anhydrides such as acetic anhydride, trifluoroacetic anhydride; a mixture of triphenylphosphine, a base and carbon tetrachloride, or a mixture of triphenylphosphine and an azo diester, for example diethylazodicarboxylic acid.
  • the reaction can be conducted in the presence of a suitable catalyst, for example 1-hydroxybenzotriazole.
  • the reaction can be carried out in the presence of an acid or a base.
  • an acid which can be used in the reaction described are sulfonic acids such as methanesulfonic acid or para-toluenesulfonic acid; carboxylic acids such as acetic acid, or polyphosphoric acids.
  • suitable bases are nitrogenous heterocycles such as pyridine, picoline, 2,6-lutidine, 1,8- diazabicyclo[5.4.0]-7-undecene (DBU); tertiary amines such as triethylamine and N,N- diisopropylethylamine; inorganic bases such as potassium phosphate, potassium carbonate and sodium hydride.
  • Step b) The compounds of the formulas (V) or (I) can be prepared by oxidation of the corresponding intermediates of the formula (IV) or (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082.
  • the oxidation is generally carried out in a solvent.
  • Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2- dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water.
  • suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid.
  • Step c) Compounds of the formulas (IV) or (V) may be converted to compounds of the corresponding formula (VI) or (I), for example by transition metal-mediated cross-couplings [cf. Chem. Rev. 1995, 95, 2457- 2483; Tetrahedron 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F. Diederich), 2nd ed.,Wiley-VCH, Weinheim, 2004] or by nucleophilic aromatic substitution (cf. the processes described in Bioorganic and Medicinal Chemistry Letters 2007, 17, 5825-5830 or US 4125726).
  • transition metal-mediated cross-couplings cf. Chem. Rev. 1995, 95, 2457- 2483; Tetrahedron 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F.
  • compounds of the formula (IV) or (V) may be reacted with suitable boronic acids [R 1 - B(OH)2] or boronic esters according to known methods (cf. WO 2012/143599, US 2014/094474, US 2014/243316, US 2015/284358 or Journal of Organic Chemistry 2004, 69, 8829-8835) in the presence of suitable catalysts from the series of transition metal salts to give compounds of the formula (VI) or (I).
  • preferred coupling catalysts include palladium catalysts such as [1,1'- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(triphenylphosphine)palladium(II) dichloride or tetrakis(triphenylphosphine)palladium.
  • Suitable basic reaction auxiliaries used to conduct the processes are preferably carbonates of sodium, potassium or caesium.
  • Some of the required boronic acid derivatives [R 1 -B(OH)2] or boronic ester derivatives are known and/or commercially available, or they can be prepared by generally known methods (cf.
  • the reaction is preferably conducted in a mixture of water and an organic solvent selected from customary solvents that are inert under the prevailing reaction conditions.
  • Ethers such as tetrahydrofuran, dioxane or 1,2-dimethoxyethane are frequently used.
  • stannane derivatives [R 1 -Sn(n-Bu) 3 ] as coupling partners (cf. US 2013/281433, WO 2004/099177 or WO 2016/071214).
  • R 1 - Sn(n-Bu) 3 Some of the required stannane derivatives [R 1 - Sn(n-Bu) 3 ] are known and/or commercially available, or they can be prepared by generally known methods (cf. WO 2016/071214 or WO 2007/148093).
  • Process B The general method for the preparation of compounds of the formula (I) in which R 1 is preferably aryl, 6- membered hetaryl or C-connected 5-membered hetaryl hetaryl (R 1 is bridged via a carbon atom to the rest of the molecule) is described below.
  • the radical R 1 has the meanings described above.
  • X is halogen, preferably iodine or bromine.
  • Step a) The conversion of compound of the formula (II) into compound of the formula (VII) is carried out in BCS233014 FC-Text - 15 - acetic acid or triethyl orthoformate at high temperatures, e.g. between 120 °C and 150 °C and eventually assisted by microwaves as described in US 2019/202829 or US 2020/146293.
  • Step b) The compound of the formula (VII) is coupled with compound of the formula (VIII) to give compound of the formula (IX) as described in WO 2020/074558.
  • the deprotonation of compound of the formula (VII) is generally carried out in tetrahydrofurane using 2,2,6,6-tetramethylpiperidinylzinc chloride lithium chloride as a base and the in-situ Negishi coupling is carried out using preferentially tetrakis(triphenylphosphine)palladium(0) or XPhos-G3-palladacycle as a catalyst and at temperatures between 60 °C and 80 °C.
  • the synthesis of compound of the formula (VIII) is described in US 2022/009930.
  • Step c) The compound of the formula (IX) is coupled with halogenated cycles of the formula R 1 -X to give compounds of the formula (VI) as described in WO 2020/074560.
  • the deprotonation of compounds of the formula (IX) is generally carried out in tetrahydrofurane using 2,2,6,6-tetramethylpiperidinylzinc chloride lithium chloride as a base and the in-situ Negishi coupling is carried out using preferentially tetrakis(triphenylphosphine)palladium(0) or XPhos-G3-palladacycle as a catalyst and at temperatures included between 60 °C and 80 °C.
  • the compounds of the formula (I) can be prepared by oxidation of compounds of the formula (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082.
  • the oxidation is generally carried out in a solvent.
  • Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water.
  • suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid.
  • reaction can be carried out under an inert gas atmosphere by catalysis with copper(I) salts, copper(I) iodide for example, in the presence of a suitable ligand, e.g. trans-N,N'- dimethylcyclohexane-1,2-diamine or R-(+)-proline, and a suitable base, e.g. potassium carbonate or potassium phosphate, in a suitable solvent such as 1,4-dioxane or toluene (cf., for example WO 2016/109559).
  • a suitable ligand e.g. trans-N,N'- dimethylcyclohexane-1,2-diamine or R-(+)-proline
  • a suitable base e.g. potassium carbonate or potassium phosphate
  • a suitable solvent such as 1,4-dioxane or toluene (cf., for example WO 2016/109559).
  • Step b) The compounds of the formula (I) can be prepared by oxidation of compounds of the formula (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082.
  • the oxidation is generally carried out in a solvent.
  • Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water.
  • suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid.
  • the invention also relates to methods for controlling animal pests, in which compounds of the formula (I) are allowed to act on animal pests and/or their habitat.
  • the control of the animal pests is preferably conducted in agriculture and forestry, and in material protection.
  • Preferably excluded herefrom are methods for the surgical or therapeutic treatment of the human or animal body and diagnostic methods carried out on the human or animal body.
  • the invention furthermore relates to the use of the compounds of the formula (I) as pesticides, in particular crop protection agents.
  • the term "pesticide” in each case also always comprises the term "crop protection agent".
  • the compounds of the formula (I) having good plant tolerance, favourable homeotherm toxicity and good environmental compatibility, are suitable for protecting plants and plant organs against biotic and abiotic stressors, for increasing harvest yields, for improving the quality of the harvested material and for controlling animal pests, especially insects, arachnids, helminths, in particular nematodes, and molluscs, which are encountered in agriculture, in horticulture, in animal husbandry, in aquatic cultures, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector.
  • the term “hygiene” is understood to mean any and all measures, procedures and practices which aim to prevent disease, in particular infectious disease, and which serve to protect the health of humans and animals and/or to protect the environment, and/or which maintain cleanliness.
  • this especially includes measures for cleaning, disinfection and sterilisation of, for example, textiles or hard surfaces, especially surfaces of glass, wood, concrete, porcelain, ceramics, plastic or also of metal(s), and for ensuring that these are kept free of hygiene pests and/or their excretions.
  • surgical or therapeutic treatment procedures applicable to the human body or to the bodies of animals and diagnostic procedures which are carried out on the human body or on the bodies of animals.
  • honeygiene sector thus covers all areas, technical fields and industrial applications in which these hygiene measures, procedures and practices are important, in relation for example to hygiene in kitchens, bakeries, airports, bathrooms, swimming pools, department stores, hotels, hospitals, stables, animal husbandries, etc.
  • the term “hygiene pest” is therefore understood to mean one or more animal pests whose presence in the hygiene sector is problematic, in particular for health reasons. It is therefore a primary objective to avoid or minimize the presence of hygiene pests, and/or exposure to them, in the hygiene sector. This can be achieved in particular through the application of a pesticide that can be used both to prevent infestation and to tackle an infestation which is already present. Preparations which avoid or reduce exposure to pests can also be used.
  • Hygiene pests include, for example, the organisms mentioned below.
  • the term “hygiene protection” thus covers all actions to maintain and/or improve these hygiene measures, procedures and practices.
  • the compounds of the formula (I) can preferably be used as pesticides. They are active against normally sensitive and resistant species and against all or some stages of development.
  • pests from the phylum of the Arthropoda in particular from the class of the Arachnida, for example Acarus spp., for example Acarus siro, Aceria kuko, Aceria sheldoni, Aculops spp., Aculus spp., for example Aculus fockeui, Aculus Mattendali, Amblyomma spp., Amphitetranychus viennensis, Argas spp., Boophilus spp., Brevipalpus spp., for example Brevipalpus phoenicis, Bryobia graminum, Bryobia BCS233014 FC-Text - 18 - praetiosa, Centruroides spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Dermacent
  • phytoparasitic nematodes in particular Aglenchus spp., for example Aglenchus agricola, Anguina spp., for example Anguina tritici, Aphelenchoides spp., for example Aphelenchoides arachidis, Aphelenchoides fragariae, Belonolaimus spp., for example Belonolaimus gracilis, Belonolaimus longicaudatus, Belonolaimus nortoni, Bursaphelenchus spp., for example Bursaphelenchus cocophilus, Bursaphelenchus eremus, Bursaphelenchus xylophilus, Cacopaurus spp., for example Cacopaurus pestis, Criconemella spp., for example Criconemella curvata, Criconemella onoensis, Criconemella ornata, Criconemella rusium, Criconemella
  • the compounds of the formula (I) can optionally, at certain concentrations or application rates, also be used as herbicides, safeners, growth regulators or agents to improve plant properties, as microbicides or gametocides, for example as fungicides, antimycotics, bactericides, viricides (including agents against viroids) or as agents against MLO (mycoplasma-like organisms) and RLO (rickettsia-like organisms). If appropriate, they can also be used as intermediates or precursors for the synthesis of other active compounds.
  • Formulations/Use forms The present invention further relates to formulations, in particular formulations for controlling unwanted controlling animal pests. The formulation may be applied to the animal pest and/or in their habitat.
  • the formulation of the invention may be provided to the end user as “ready-for-use” use form, i.e. the formulations may be directly applied to the plants or seeds by a suitable device, such as a spraying or dusting device.
  • the formulations may be provided to the end user in the form of concentrates which have to be diluted, preferably with water, prior to use.
  • the wording “formulation” therefore means such concentrate
  • the wording “use form” means the end user as “ready-for-use” solution, i.e. usually such diluted formulation.
  • the formulation of the invention can be prepared in conventional manners, for example by mixing the compound of the invention with one or more suitable auxiliaries, such as disclosed herein.
  • the formulation comprises at least one compound of the invention and at least one agriculturally suitable auxiliary, e.g. carrier(s) and/or surfactant(s).
  • a carrier is a solid or liquid, natural or synthetic, organic or inorganic substance that is generally inert. The carrier generally improves the application of the compounds, for instance, to plants, plants parts or seeds.
  • suitable solid carriers include, but are not limited to, ammonium salts, in particular ammonium sulfates, ammonium phosphates and ammonium nitrates, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, silica gel and synthetic rock flours, such as finely divided silica, alumina and silicates.
  • ammonium salts in particular ammonium sulfates, ammonium phosphates and ammonium nitrates
  • natural rock flours such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth
  • silica gel and synthetic rock flours such as finely divided silica, alumina and silicates.
  • typically useful solid carriers for preparing granules include, but are not limited to crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks.
  • suitable liquid carriers include, but are not limited to, water, organic solvents and combinations thereof.
  • suitable solvents include polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene, tetrahydronaphthalene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as ethanol, propanol, butanol, benzylalcohol, cyclohexanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone, acetophenone, or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted
  • the carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
  • a liquefied gaseous extender i.e. liquid which is gaseous at standard temperature and under standard pressure
  • aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
  • Preferred solid carriers are selected from clays, talc and silica.
  • Preferred liquid carriers are selected from water, fatty acid amides and esters thereof, aromatic and nonaromatic hydrocarbons, lactams, lactones, carbonic acid esters, ketones, (poly)ethers.
  • the amount of carrier typically ranges from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the formulation.
  • Liquid carriers are typically present in a range of from 20 to 90%, for example 30 to 80% by weight of the formulation.
  • Solid carriers are typically present in a range of from 0 to 50%, preferably 5 to 45%, for example 10 to 30% by weight of the formulation. If the formulation comprises two or more carriers, the outlined ranges refer to the total amount of carriers.
  • the surfactant can be an ionic (cationic or anionic), amphoteric or non-ionic surfactant, such as ionic or non-ionic emulsifier(s), foam former(s), dispersant(s), wetting agent(s), penetration enhancer(s) and any mixtures thereof.
  • surfactants include, but are not limited to, salts of polyacrylic acid, ethoxylated polya(alpha-substituted)acrylate derivatives, salts of lignosulfonic acid (such as sodium lignosulfonate), salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and/or propylene oxide with or without alcohols, fatty acids or fatty amines (for example, polyoxyethylene fatty acid esters such as castor oil ethoxylate, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols (such a fatty acid esters of g
  • any reference to salts in this paragraph refers preferably to the respective alkali, alkaline earth and ammonium salts.
  • Preferred surfactants are selected from ethoxylated polya(alpha-substituted)acrylate derivatives, polycondensates of ethylene oxide and/or propylene oxide with alcohols, polyoxyethylene fatty acid esters, alkylbenzene sulfonates, sulfonated polymers of naphthalene/formaldehyde, polyoxyethylene fatty acid esters such as castor oil ethoxylate, sodium lignosulfonate and arylphenol ethoxylate.
  • the amount of surfactants typically ranges from 5 to 40%, for example 10 to 20%, by weight of the formulation.
  • auxiliaries include water repellents, siccatives, binders (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids BCS233014 FC-Text - 27 - such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone and tylose), thickeners and secondary thickeners (such as cellulose ethers, acrylic acid derivatives, xanthan gum, modified clays, e.g.
  • binders adheresive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids BCS233014 FC-Text
  • stabilizers e.g. cold stabilizers, preservatives (e.g. dichlorophene, benzyl alcohol hemiformal, 1,2-Benzisothiazolin-3-on, 2- methyl-4-isothiazolin-3-one), antioxidants, light stabilizers, in particular UV stabilizers, or other agents which improve chemical and/or physical stability
  • dyes or pigments such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g.
  • auxiliaries mineral and vegetable oils, perfumes, waxes, nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers.
  • the choice of the auxiliaries depends on the intended mode of application of the compound of the invention and/or on the physical properties of the compound(s).
  • the auxiliaries may be chosen to impart particular properties (technical, physical and/or biological properties) to the formulations or use forms prepared therefrom. The choice of auxiliaries may allow customizing the formulations to specific needs.
  • the formulation comprises an insecticidal/acaricidal/nematicidal effective amount of the compound(s) of the invention.
  • effective amount denotes an amount, which is sufficient for controlling harmful insects/mites/nematodes on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the insect/mite/nematode species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of the invention used.
  • the formulation according to the invention contains from 0.01 to 99% by weight, preferably from 0.05 to 98% by weight, more preferred from 0.1 to 95% by weight, even more preferably from 0.5 to 90% by weight, most preferably from 1 to 80% by weight of the compound of the invention. It is possible that a formulation comprises two or more compounds of the invention. In such case the outlined ranges refer to the total amount of compounds of the present invention.
  • the formulation of the invention may be in any customary formulation type, such as solutions (e.g aqueous solutions), emulsions, water- and oil-based suspensions, powders (e.g. wettable powders, soluble powders), dusts, pastes, granules (e.g.
  • soluble granules, granules for broadcasting suspoemulsion concentrates, natural or synthetic products impregnated with the compound of the invention, fertilizers and also microencapsulations in polymeric substances.
  • the compound of the invention may be present in a suspended, emulsified or dissolved form.
  • suitable formulation types are solutions, watersoluble concentrates (e.g. SL, LS), dispersible concentrates (DC), suspensions and suspension concentrates (e.g. SC, OD, OF, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME, SE), capsules (e.g.
  • the formulation of the invention is in form of one of the following types: EC, SC, FS, SE, OD, WG, WP, CS, more preferred EC, SC, OD, WG, CS. Further details about examples of formulation types and their preparation are given below. If two or more compounds of the invention are present, the outlined amount of compound of the invention refers to the total amount of compounds of the present invention. This applies mutatis mutandis for any further component of the formulation, if two or more representatives of such component, e.g. wetting agent, binder, are present.
  • Water-soluble concentrates (SL, LS) 10-60 % by weight of at least one compound of the invention and 5-15 % by weight surfactant (e.g. polycondensates of ethylene oxide and/or propylene oxide with alcohols) are dissolved in such amount of water and/or water-soluble solvent (e.g. alcohols such as propylene glycol or carbonates such as propylene carbonate) to result in a total amount of 100 % by weight. Before application the concentrate is diluted with water.
  • Dispersible concentrates (DC) 5-25 % by weight of at least one compound of the invention and 1-10 % by weight surfactant and/or binder (e.g.
  • Emulsifiable concentrates EC 15-70 % by weight of at least one compound of the invention and 5-10 % by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in such amount of water-insoluble organic solvent (e.g. aromatic hydrocarbon or fatty acid amide) and if needed additional water-soluble solvent to result in a total amount of 100 % by weight.
  • surfactant e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate
  • Emulsions EW, EO, ES 5-40 % by weight of at least one compound of the invention and 1-10 % by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate, or polycondensates of ethylene oxide and/or propylene oxide with or without alcohols) are dissolved in 20-40 % by weight water- BCS233014 FC-Text - 29 - insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is added to such amount of water by means of an emulsifying machine to result in a total amount of 100 % by weight.
  • surfactant e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate, or polycondensates of ethylene oxide and/or propylene oxide with or without alcohols
  • surfactant e.g. a mixture of calcium dodecylbenzenesulfonate and cast
  • the resulting formulation is a homogeneous emulsion. Before application the emulsion may be further diluted with water.
  • SC, FS Water-based
  • 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2 % by weight thickener (e.g. xanthan gum) and water to give a fine active substance suspension.
  • surfactant e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether
  • thickener e.g. xanthan gum
  • Dilution with water gives a stable suspension of the active substance.
  • binder e.g. polyvinylalcohol
  • a suitable grinding equipment e.g. an agitated ball mill
  • 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2 % by weight thickener (e.g. modified clay, in particular Bentone, or silica) and an organic carrier to give a fine active substance oil suspension.
  • surfactant e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether
  • thickener e.g. modified clay, in particular Bentone, or silica
  • the organic carrier is added in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion of the active substance.
  • Water-dispersible granules and water-soluble granules (WG, SG) 1-90 % by weight, preferably 20-80%, most preferably 50-80 % by weight of at least one compound of the invention are ground finely with addition of surfactant (e.g. sodium lignosulfonate and sodium alkylnaphthylsulfonates) and potentially carrier material and converted to water-dispersible or water- soluble granules by means of typical technical appliances like e.g. extrusion, spray drying, fluidized bed granulation.
  • surfactant e.g. sodium lignosulfonate and sodium alkylnaphthylsulfonates
  • the surfactant and carrier material are used in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance.
  • Water-dispersible powders and water-soluble powders (WP, SP, WS) 50-80 % by weight of at least one compound of the invention are ground in a rotor-stator mill with addition of 1-20 % by weight surfactant (e.g. sodium lignosulfonate, sodium alkylnaphthylsulfonates) and such amount of solid carrier, e.g. silica gel, to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance.
  • surfactant e.g. sodium lignosulfonate, sodium alkylnaphthylsulfonates
  • solid carrier e.g. silica gel
  • Microcapsules An oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 % by weight acrylic monomers (e.g.
  • methylmethacrylate, methacrylic acid and a di- or triacrylate are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
  • a protective colloid e.g. polyvinyl alcohol
  • Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
  • an oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g.
  • xii) Granules (GR, FG) 0.5-30 % by weight of at least one compound of the invention are ground finely and associated with such amount of solid carrier (e.g. silicate) to result in a total amount of 100 % by weight.
  • solid carrier e.g. silicate
  • Ultra-low volume liquids (UL) 1-50 % by weight of at least one compound of the invention are dissolved in such amount of organic solvent, e.g. aromatic hydrocarbon, to result in a total amount of 100 % by weight.
  • the formulations types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 % by weight preservatives, 0.1-1 % by weight antifoams, 0.1-1 % by weight dyes and/or pigments, and 5-10% by weight antifreezes.
  • the compounds of the formula (I) may also be employed as a mixture with one or more suitable fungicides, bactericides, acaricides, molluscicides, nematicides, insecticides, microbiologicals, beneficial species, herbicides, fertilizers, bird repellents, phytotonics, sterilants, safeners, semiochemicals and/or plant growth regulators, in order thus, for example, to broaden the spectrum of action, to prolong the duration of action, to increase the rate of action, to prevent repulsion or prevent evolution of resistance.
  • active compound combinations may improve plant growth and/or tolerance to abiotic factors, for example high or low temperatures, to drought or to elevated water content or soil salinity.
  • the compounds of the formula (I) can be present in a mixture with other active compounds or semiochemicals such as attractants and/or bird repellants and/or plant activators and/or growth regulators and/or fertilizers.
  • the compounds of the formula (I) can be used to improve plant properties such as, for example, growth, yield and quality of the harvested material.
  • the compounds of the formula (I) are present in formulations or the use forms prepared from these formulations in a mixture with further compounds, preferably those as described below. If one of the compounds mentioned below can occur in different tautomeric forms, these forms are also included even if not explicitly mentioned in each case. Further, all named mixing partners can, if their functional groups enable this, optionally form salts with suitable bases or acids. Insecticides/acaricides/nematicides
  • the active compounds identified here by their common names are known and are described, for example, in the pesticide handbook (“The Pesticide Manual” 16th Ed., British Crop Protection Council 2012) or can be found on the Internet (e.g. http://www.alanwood.net/pesticides).
  • Acetylcholinesterase (AChE) inhibitors preferably carbamates selected from alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, BCS233014 FC-Text - 32 - propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb, or organophosphates selected from acephate, azamethiphos, azinphos-ethyl, azinphos
  • GABA-gated chloride channel blockers preferably cyclodiene-organochlorines selected from chlordane and endosulfan, or phenylpyrazoles (fiproles) selected from ethiprole and fipronil.
  • Sodium channel modulators preferably pyrethroids selected from acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin,
  • Nicotinic acetylcholine receptor (nAChR) competitive modulators preferably neonicotinoids selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam, or nicotine, or sulfoximines selected from sulfoxaflor, or butenolids selected from flupyradifurone, or mesoionics selected from triflumezopyrim, or pyridylidenes selected from Flupyrimin.
  • nAChR Nicotinic acetylcholine receptor
  • Nicotinic acetylcholine receptor (nAChR) allosteric modulators site I
  • nAChR Nicotinic acetylcholine receptor
  • site I preferably spinosyns selected from spinetoram and spinosad.
  • Glutamate-gated chloride channel (GluCl) allosteric modulators preferably avermectins/milbemycins selected from abamectin, emamectin benzoate, lepimectin and milbemectin.
  • Juvenile hormone mimics preferably juvenile hormone analogues selected from hydroprene, kinoprene and methoprene, or fenoxycarb or pyriproxyfen.
  • Miscellaneous non-specific (multi-site) inhibitors preferably alkyl halides selected from methyl bromide and other alkyl halides, or chloropicrine or sulphuryl fluoride or borax or tartar emetic or methyl isocyanate generators selected from diazomet and metam.
  • Mite growth inhibitors affecting CHS1 selected from clofentezine, hexythiazox, diflovidazin and etoxazole.
  • Microbial disruptors of the insect gut membranes selected from Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis, and B.t.
  • Inhibitors of mitochondrial ATP synthase preferably ATP disruptors selected from diafenthiuron, or organotin compounds selected from azocyclotin, cyhexatin and fenbutatin oxide, or propargite or tetradifon.
  • Uncouplers of oxidative phosphorylation via disruption of the proton gradient selected from chlorfenapyr, DNOC and sulfluramid.
  • Nicotinic acetylcholine receptor channel blockers selected from bensultap, cartap hydrochloride, thiocylam and thiosultap-sodium.
  • Moulting disruptors in particular for Diptera, i.e. dipterans selected from cyromazine.
  • Ecdysone receptor agonists preferably diacylhydrazines selected from chromafenozide, halofenozide, methoxyfenozide and tebufenozide.
  • Octopamine receptor agonists selected from amitraz.
  • Mitochondrial complex III electron transport inhibitors selected from hydramethylnone, acequinocyl, fluacrypyrim and bifenazate.
  • Mitochondrial complex I electron transport inhibitors preferably METI acaricides and insecticides selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad, or rotenone (Derris).
  • METI acaricides and insecticides selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad, or rotenone (Derris).
  • Voltage-dependent sodium channel blockers preferably oxadiazines selected from indoxacarb, or semicarbazones selected from metaflumizone.
  • Inhibitors of acetyl CoA carboxylase preferably tetronic and tetramic acid derivatives selected from spirodiclofen, spiromesifen, spiropidion and spirotetramat.
  • Mitochondrial complex IV electron transport inhibitors preferably phosphides selected from aluminium phosphide, calcium phosphide, phosphine and zinc phosphide, or cyanides selected from calcium cyanide, potassium cyanide and sodium cyanide.
  • Mitochondrial complex II electron transport inhibitors preferably beta-ketonitrile derivatives selected from cyenopyrafen and cyflumetofen, or carboxanilides selected from pyflubumide.
  • Ryanodine receptor modulators preferably diamides selected from chlorantraniliprole, cyantraniliprole, cyclaniliprole, flubendiamide and tetraniliprole.
  • Chordotonal organ Modulators (with undefined target site) selected from flonicamid.
  • GABA-gated chlorid channel allosteric modulators preferably meta-diamides selected from broflanilide, or isoxazoles selected from fluxametamide.
  • Baculoviruses preferably Granuloviruses (GVs) selected from Cydia pomonella GV and Thaumatotibia leucotreta (GV), or Nucleopolyhedroviruses (NPVs) selected from Anticarsia gemmatalis MNPV, Flucypyriprole and Helicoverpa armigera NPV.
  • GVs Granuloviruses
  • NPVs Nucleopolyhedroviruses
  • Nicotinic acetylcholine receptor allosteric modulators site II
  • Site II selected from GS-omega/kappa HXTX-Hv1a peptide.
  • Calcium-activated potassium channel KCa2 modulators selected from acynonapyr.
  • Mitochondrial complex III electron transfer inhibitors (non-Qo site), selected from flometoquin.
  • UN Compounds of unknown or uncertain MoA (Target protein responsible for biological activity is unknown, or uncharacterized), selected from azadirachtin, benzoximate, bromopropylate, chinomethionat, dicofol, lime sulfur, mancozeb, pyridalyl, and sulfur.
  • UNB Bacterial agents (non-Bt) of unknown or uncertain MoA (Target protein responsible for biological activity is unknown or uncharacterized), selected from Burkholderia spp., and Wolbachia pipientis (Zap).
  • UNE Botanical essence including synthetic, extracts and unrefined oils with unknown or uncertain MoA (Target protein responsible for biological activity is unknown, or uncharacterized), selected from Chenopodium ambrosioides near ambrosioides extract and fatty acid monoesters with glycerol or propanediol neem oil.
  • Non-specific mechanical and physical disruptors (Target protein responsible for biological activity is unknown, or uncharacterized), selected from Diatomaceous earth, and mineral oil. Further active compounds selected from Afoxolaner, Benbenzaramine, Benzpyrimoxan, Chloroprallethrin, Cryolite, Cyclobutrifluram, Cycloxaprid, Cyetpyrafen, Cyhalodiamide, Cyproflanilide (CAS 2375110-88-4), Dicloromezotiaz, Dimpropyridaz, epsilon-Metofluthrin, epsilon-Momfluthrin, Fenmezoditiaz, Fluazaindolizine, Fluchlordiniliprole, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fufenozide, Flupentiofenox,
  • Nematicides The active compounds identified here by their common names are known and are described, for example, in the pesticide handbook (“The Pesticide Manual” 16th Ed., British Crop Protection Council 2012) or can be found on the Internet (e.g. http://www.alanwood.net/pesticides). The classification is based on the current Nematicide IRAC Mode of Action Classification Groups at the time of filing of this patent application.
  • Acetylcholinesterase (AChE) inhibitors preferably (N-1A) carbamates selected from aldicarb, benfuracarb, carbofuran, carbosulfan and thiodicarb, or (N-1B) organophosphates selected from cadusafos, ethoprofos, fenamiphos, fosthiazate, imicyafos, phorate and terbufos.
  • Group N-2 Glutamate-gated chloride channel (GluCl) allosteric modulators, preferably avermectins selected from abamectin and emamectin benzoate.
  • Group N-UNX Compounds of unknown or uncertain mode of action: Presumed multi-site inhibitors, preferably volatile sulphur generators selected from carbon disulphide and dimethyl disulphide (DMDS), or carbon disulphide liberators selected from sodium tetrathiocarbonate, or alkyl halides selected from methyl bromide and methyl iodide (iodomethane), or halogenated hydrocarbons selected from 1,2- dibromo-3-chloropropane (DBCP) and 1,3-dichloropropene, or chloropicrin, or methyl isothiocyanate generators selected from allyl isothiocyanate, diazomet, metam potassium and metam sodium.
  • DMDS carbon disulphide and dimethyl disulphide
  • iodomethane alkyl halides selected from methyl bromide and methyl iodide (iodomethane)
  • DBCP 1,2- dibromo-3-chloropropane
  • Bacterial agents (non-Bt) of unknown or uncertain mode of action, preferably bacterium or bacterium-derived, selected from Burkholderia spp., e.g. rinojensis A396, Bacillus spp., e.g. firmus, licheniformis, amyloliquefaciens or subtilis, Pasteuria spp., e.g. penetrans or nishizawae, Pseudomonas spp., e.g. chlororaphis or fluorescens, and Streptomyces spp., e.g. lydicus, dicklowii or albogriseolus.
  • Burkholderia spp. e.g. rinojensis A396, Bacillus spp., e.g. firmus, licheniformis, amyloliquefaciens or subtilis, Pasteuria spp
  • BCS233014 FC-Text - 38 - (Group N-UNF) Fungal agents of unknown or uncertain mode of action, preferably fungus or fungus- derived, selected from Actinomyces spp., e.g. streptococcus, Arthrobotrys spp., e.g. oligospora, Aspergillus spp., e.g. niger, Muscodor spp., e.g. albus, Myrothecium spp., e.g. verrucaria, Paecilomyces spp., e.g.
  • Botanical or animal derived agents including synthetic extracts and unrefined oils, with unknown or uncertain mode of action, preferably botanical or animal derived agents selected from azadirachtin, camellia seed cake, essential oils, garlic extract, pongamia oil, terpenes, e.g.
  • Inhibitors of the ergosterol biosynthesis for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenbuconazole, (1.005) fenhexamid, (1.006) fenpropidin, (1.007) fenpropimorph, (1.008) fenpyrazamine, (1.009) Fluoxytioconazole, (1.010) fluquinconazole, (1.011) flutriafol, (1.012) hexaconazole, (1.013) imazalil, (1.014) imazalil sulfate, (1.015) ipconazole, (1.016) ipfentrifluconazole, (1.017) mefentrifluconazole, (1.018) metconazole, (1.019) myclobutanil, (1.020) paclobutrazol, (1.021) penconazole, (1.022) prochloraz,
  • Inhibitors of the respiratory chain at complex I or II for example (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) cyclobutrifluram, (2.006) flubeneteram, (2.007) fluindapyr, (2.008) fluopyram, (2.009) flutolanil, (2.010) fluxapyroxad, (2.011) furametpyr, (2.012) inpyrfluxam, (2.013) Isofetamid, (2.014) isoflucypram, (2.015) isopyrazam, (2.016) penflufen, (2.017) penthiopyrad, (2.018) pydiflumetofen, (2.019) pyrapropoyne, (2.020) pyraziflumid, (2.021) sedaxane, (2.022) Thifluzamide (aka trifluzamide), (2.023) 5,8-difluoro-N-[
  • Inhibitors of the respiratory chain at complex III for example (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) fenpicoxamid, (3.012) florylpicoxamid, (3.013) flufenoxystrobin, (3.014) fluoxastrobin, (3.015) kresoxim-methyl, (3.016) mandestrobin, (3.017) metarylpicoxamid, (3.018) metominostrobin, (3.019) metyltetraprole, (3.020) orysastrobin, (3.021) picoxystrobin, (3.022) pyraclostrobin, (3.021) pic
  • Inhibitors of the mitosis and cell division for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) fluopimomide, (4.006) metrafenone, (4.007) pencycuron, (4.008) pyridachlometyl, (4.009) pyriofenone (chlazafenone), (4.010) thiabendazole, (4.011) thiophanate-methyl, (4.012) zoxamide, (4.013) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6- methylpyridazine, (4.014) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6- trifluorophenyl)pyridazine, (4.015) 4-(2-bromo-4-fluorophenyl)
  • BCS233014 FC-Text - 42 - 5 Compounds capable to have a multisite action, for example (5.001) bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper(2+) sulfate, (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, (5.015) metiram, (5.016) metiram zinc, (5.017) oxine- copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfide, (5.020) thiram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro
  • Compounds capable to induce a host defence for example (6.001) acibenzolar-S-methyl, (6.002) fosetyl-aluminium, (6.003) fosetyl-calcium, (6.004) fosetyl-sodium, (6.005) isotianil, (6.006) phosphorous acid and its salts, (6.007) probenazole, (6.008) tiadinil.
  • Inhibitors of the amino acid and/or protein biosynthesis for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil 8) Inhibitors of the ATP production, for example (8.001) silthiofam.
  • Inhibitors of the cell wall synthesis for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.
  • Inhibitors of the lipid synthesis or transport, or membrane synthesis for example (10.001) fluoxapiprolin, (10.002) natamycin, (10.003) oxathiapiprolin, (10.004) propamocarb, (10.005) propamocarb hydrochloride, (10.006) propamocarb-fosetylate, (10.007) tolclofos-methyl, (10.008) 1-(4- ⁇ 4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl ⁇ piperidin-1-yl)-2-[5- methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (10.009) 1-(4- ⁇ 4-[(5S)-5-(2,6-difluorophenyl)- 4,5-dihydro-1,2-oxazol-3-yl]-1
  • Inhibitors of the melanin biosynthesis for example (11.001) tolprocarb, (11.002) tricyclazole.
  • Inhibitors of the nucleic acid synthesis for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).
  • 13) Inhibitors of the signal transduction for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin.
  • Bio pesticides as mixing components
  • the compounds of the formula (I) can be combined with biological pesticides.
  • Biological pesticides comprise in particular bacteria, fungi, yeasts, plant extracts and products formed by microorganisms, including proteins and secondary metabolites.
  • Biological pesticides comprise bacteria such as spore-forming bacteria, root-colonising bacteria and bacteria which act as biological insecticides, fungicides or nematicides. Examples of such bacteria which are employed or can be used as biological pesticides are: Bacillus amyloliquefaciens, strain FZB42 (DSM 231179), or Bacillus cereus, in particular B.
  • thuringiensis subspecies israelensis (serotype H- 14), strain AM65-52 (Accession No. ATCC 1276), or B. thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372), or B. thuringiensis subsp. kurstaki strain HD-1, or B. thuringiensis subsp. tenebrionis strain NB 176 (SD-5428), Methylorubrum extorquens TS201, Pasteuria penetrans, Pasteuria spp.
  • fungi and yeasts which are employed or can be used as biological pesticides are: Beauveria bassiana, in particular strain ATCC 74040, Coniothyrium minitans, in particular strain BCS233014 FC-Text - 47 - CON/M/91-8 (Accession No.
  • Lecanicillium spp. in particular strain HRO LEC 12, Lecanicillium lecanii, (formerly known as Verticillium lecanii), in particular strain KV01, Metarhizium anisopliae, in particular strain F52 (DSM3884/ ATCC 90448), Metschnikowia fructicola, in particular strain NRRL Y-30752, Paecilomyces fumosoroseus (now: Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (Accesion No. ATCC 20874), Paecilomyces lilacinus, in particular P.
  • viruses which are employed or can be used as biological pesticides are: Adoxophyes orana (summer fruit tortrix) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, Spodoptera littoralis (African cotton leafworm) NPV.
  • Adoxophyes orana sumr fruit tortrix granulosis virus
  • GV Cydia pomonella (codling moth) granulosis virus
  • NPV Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus
  • Spodoptera exigua beet armyworm
  • Spodoptera frugiperda fall armyworm
  • bacteria and fungi which are added as 'inoculant' to plants or plant parts or plant organs and which, by virtue of their particular properties, promote plant growth and plant health.
  • Agrobacterium spp. Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp., or Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp.
  • plant extracts and products formed by microorganisms including proteins and secondary metabolites which are employed or can be used as biological pesticides are: Allium sativum, Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), Pyrethrum/Pyrethrins, Quassia amara, Quercus, Quillaja, Regalia, "Requiem TM Insecticide", rotenone, ryania/ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album
  • BCS233014 FC-Text - 48 - Safener as mixing components The compounds of the formula (I) can be combined with safeners such as, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-( ⁇ 4-[(methylcarbamoyl)amino]phenyl ⁇ sulphonyl)benzamide (CAS 129531- 12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3- (dichloroacet
  • plants and plant parts can be treated in accordance with the invention.
  • plants are to be understood to mean all plants and plant parts such as wanted and unwanted wild plants or crop plants (including naturally occurring crop plants), for example cereals (wheat, rice, triticale, barley, rye, oats), maize, soya bean, potato, sugar beet, sugar cane, tomatoes, pepper, cucumber, melon, carrot, watermelon, onion, lettuce, spinach, leek, beans, Brassica oleracea (e.g. cabbage) and other vegetable species, cotton, tobacco, oilseed rape, and also fruit plants (with the fruits apples, pears, citrus fruits and grapevines).
  • cereals wheat, rice, triticale, barley, rye, oats
  • soya bean potato
  • sugar beet sugar cane
  • tomatoes pepper, cucumber, melon, carrot
  • watermelon onion
  • lettuce spinach
  • leek beans
  • Brassica oleracea e.g. cabbage
  • Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or cannot be protected by varietal property rights.
  • Plants should be understood to mean all developmental stages, such as seeds, seedlings, young (immature) plants up to mature plants.
  • Plant parts should be understood to mean all parts and organs of the plants above and below ground, such as shoot, leaf, flower and root, examples given being leaves, needles, stalks, stems, flowers, fruit bodies, fruits and seeds, and also tubers, roots and rhizomes.
  • Parts of plants also include harvested plants or harvested plant parts and vegetative and generative propagation material, for example seedlings, tubers, rhizomes, cuttings and seeds.
  • Treatment according to the invention of the plants and plant parts with the compounds of the formula (I) is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on, injection and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.
  • wild plant species and plant cultivars or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and also parts thereof, are treated.
  • transgenic plants and plant cultivars obtained by genetic engineering methods if appropriate in combination with conventional methods (genetically modified organisms), and parts thereof are treated.
  • the term “parts” or “parts of plants” or “plant parts” has been explained above.
  • the invention is used with particular preference to treat plants of the respective commercially customary BCS233014 FC-Text - 49 - cultivars or those that are in use. Plant cultivars are to be understood as meaning plants having new properties ("traits”) and which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques.
  • the compounds of formula (I) can be advantageously used to treat transgenic plants, plant cultivars or plant parts that received genetic material which imparts advantageous and/or useful properties (traits) to these plants, plant cultivars or plant parts. Therefore, it is contemplated that the present invention may be combined with one or more recombinant traits or transgenic event(s) or a combination thereof.
  • a transgenic event is created by the insertion of a specific recombinant DNA molecule into a specific position (locus) within the chromosome of the plant genome.
  • the insertion creates a novel DNA sequence referred to as an “event” and is characterized by the inserted recombinant DNA molecule and some amount of genomic DNA immediately adjacent to/flanking both ends of the inserted DNA.
  • trait(s) or transgenic event(s) include, but are not limited to, pest resistance, water use efficiency, yield performance, drought tolerance, seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance, in which the trait is measured with respect to a plant lacking such trait or transgenic event.
  • Such advantageous and/or useful properties are better plant growth, vigor, stress tolerance, standability, lodging resistance, nutrient uptake, plant nutrition, and/or yield, in particular improved growth, increased tolerance to high or low temperatures, increased tolerance to drought or to levels of water or soil salinity, enhanced flowering performance, easier harvesting, accelerated ripening, higher yields, higher quality and/or a higher nutritional value of the harvested products, better storage life and/or processability of the harvested products, and increased resistance or tolerance against animal and microbial pests, such as against insects, arachnids, nematodes, mites, slugs and snails.
  • animal and microbial pests such as against insects, arachnids, nematodes, mites, slugs and snails.
  • Bt Cry or VIP proteins which include the CrylA, CryIAb, CryIAc, CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF proteins or toxic fragments thereof and also hybrids or combinations thereof, especially the CrylF protein or hybrids derived from a CrylF protein (e.g. hybrid CrylA-CrylF proteins or toxic fragments thereof), the CrylA-type proteins or toxic fragments thereof, preferably the CrylAc protein or hybrids derived from the CrylAc protein (e.g.
  • hybrid CrylAb-CrylAc proteins or the CrylAb or Bt2 protein or toxic fragments thereof, the Cry2Ae, Cry2Af or Cry2Ag proteins or toxic fragments thereof, the CrylA.105 protein or a toxic fragment thereof, the VIP3Aa19 protein, the VIP3Aa20 protein, the VIP3A proteins produced in the COT202 or COT203 cotton events, the BCS233014 FC-Text - 50 - VIP3Aa protein or a toxic fragment thereof as described in Estruch et al.
  • any variants or mutants of any one of these proteins differing in some amino acids (1-10, preferably 1-5) from any of the above named sequences, particularly the sequence of their toxic fragment, or which are fused to a transit peptide, such as a plastid transit peptide, or another protein or peptide, is included herein.
  • a transit peptide such as a plastid transit peptide, or another protein or peptide
  • Another and particularly emphasized example of such properties is conferred tolerance to one or more herbicides, for example imidazolinones, sulphonylureas, glyphosate or phosphinothricin.
  • DNA sequences encoding proteins which confer properties of tolerance to certain herbicides on the transformed plant cells and plants mention will be particularly be made to the bar or PAT gene or the Streptomyces coelicolor gene described in WO2009/152359 which confers tolerance to glufosinate herbicides, a gene encoding a suitable EPSPS (5-enolpyruvylshikimat-3-phosphat-synthase) which confers tolerance to herbicides having EPSPS as a target, especially herbicides such as glyphosate and its salts, a gene encoding glyphosate-n-acetyltransferase, or a gene encoding glyphosate oxidoreductase.
  • EPSPS 5-enolpyruvylshikimat-3-phosphat-synthase
  • herbicide tolerance traits include at least one ALS (acetolactate synthase) inhibitor (e.g. WO2007/024782), a mutated Arabidopsis ALS/AHAS gene (e.g. U.S. Patent 6,855,533), genes encoding 2,4-D- monooxygenases conferring tolerance to 2,4-D (2,4- dichlorophenoxyacetic acid) and genes encoding Dicamba monooxygenases conferring tolerance to dicamba (3,6-dichloro-2- methoxybenzoic acid).
  • ALS acetolactate synthase
  • a mutated Arabidopsis ALS/AHAS gene e.g. U.S. Patent 6,855,533
  • Such properties are increased resistance against phytopathogenic fungi, bacteria and/or viruses owing, for example, to systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and also resistance genes and correspondingly expressed proteins and toxins.
  • SAR systemic acquired resistance
  • systemin phytoalexins
  • elicitors resistance genes and correspondingly expressed proteins and toxins.
  • Particularly useful transgenic events in transgenic plants or plant cultivars which can be treated with preference in accordance with the invention include Event 531/ PV-GHBK04 (cotton, insect control, described in WO2002/040677), Event 1143-14A (cotton, insect control, not deposited, described in WO2006/128569); Event 1143-51B (cotton, insect control, not deposited, described in WO2006/128570); Event 1445 (cotton, herbicide tolerance, not deposited, described in US-A 2002- 120964 or WO2002/034946); Event 17053 (rice, herbicide tolerance, deposited as PTA-9843, described in WO2010/117737); Event 17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO2010/117735); Event 281-24-236 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in WO2005/103266 or US-A 2005-216969); Event 3006-210-23 (cotton, insect control - herb
  • Event BLRl (oilseed rape, restoration of male sterility, deposited as NCIMB 41193, described in WO2005/074671), Event CE43-67B (cotton, insect control, deposited as DSM ACC2724, described in US-A 2009-217423 or WO2006/128573); Event CE44-69D (cotton, insect control, not deposited, described in US-A 2010- 0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO2006/128571); Event CE46-02A (cotton, insect control, not deposited, described in WO2006/128572); Event COT102 (cotton, insect control, not deposited, described in US-A 2006-130175 or WO2004/039986); Event COT202 (cotton, insect control, not deposited, described in US-A 2007-067868 or WO2005/054479); Event COT203 (cotton, insect control, not deposited, described, described in US-A 2007-067868 or
  • transgenic event(s) is provided by the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) and can be found on their website at https://www.aphis.usda.gov/. For this application, the status of such list as it is/was on the filing date of this application, is relevant.
  • the genes/events which impart the desired traits in question may also be present in combinations with one another in the transgenic plants.
  • transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soya beans, potatoes, sugar beet, sugar cane, tomatoes, peas and other types of vegetable, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis being given to maize, soya beans, wheat, rice, potatoes, cotton, sugar cane, tobacco and oilseed rape.
  • Traits which are particularly emphasized are the increased resistance of the plants to insects, arachnids, nematodes and slugs and snails, as well as the increased resistance of the plants to one or more herbicides.
  • Crop protection – types of treatment The treatment of the plants and plant parts with the compounds of the formula (I) is carried out directly or by action on their surroundings, habitat or storage space using customary treatment methods, for example by dipping, spraying, atomizing, irrigating, evaporating, dusting, fogging, broadcasting, foaming, painting, spreading-on, injecting, watering (drenching), drip irrigating and, in the case of propagation material, in particular in the case of seed, furthermore as a powder for dry seed treatment, a solution for liquid seed treatment, a water-soluble powder for slurry treatment, by incrusting, by coating with one or more coats, etc.
  • customary treatment methods for example by dipping, spraying, atomizing, irrigating, evaporating, dusting, fogging, broadcasting, foaming, painting, spreading-on, injecting, watering (drenching), drip irrigating and, in the case of propagation material, in particular in the case of seed, furthermore as a powder for
  • the compounds of the formula (I) by the ultra-low volume method or to inject the application form or the compound of the formula (I) itself into the soil.
  • a preferred direct treatment of the plants is foliar application, i.e. the compounds of the formula (I) are applied to the foliage, where treatment frequency and the application rate should be adjusted according to the level of infestation with the pest in question.
  • the compounds of the formula (I) also access the plants via the root system.
  • the plants are then treated by the action of the compounds of the formula (I) on the habitat of the plant. This may be done, for example, by drenching, or by mixing into the soil or the nutrient solution, i.e.
  • the locus of the plant e.g. soil or hydroponic systems
  • a liquid form of the compounds of the formula (I) or by soil application, i.e. the compounds of the formula (I) according to the invention are introduced in solid form (e.g. in the form of granules) into the locus of the plants, or by drip application (often also referred to as "chemigation"), i.e. the liquid application of the compounds of the formula (I) according to the invention from surface or sub-surface driplines over a certain period of time together with varying amounts of water at defined locations in the vicinity of the plants.
  • chemigation i.e. the liquid application of the compounds of the formula (I) according to the invention from surface or sub-surface driplines over a certain period of time together with varying amounts of water at defined locations in the vicinity of the plants.
  • the compounds of the invention can be used in combination with models e.g. embedded in computer programs for site specific crop management, satellite farming, precision farming or precision agriculture.
  • models support the site specific management of agricultural sites with data from various sources such as soils, weather, crops (e.g. type, growth stage, plant health), weeds (e.g. type, growth stage), diseases, pests, nutrients, water, moisture, biomass, satellite data, yield etc. with the purpose to optimize profitability, sustainability and protection of the environment.
  • the compounds of the invention can be applied to a crop plant according to an appropriate dose regime if a model models the development of a pest and calculates that a threshold has been reached for which it is recommendable to apply the compound of the invention to the crop plant.
  • Commercially available systems which include agronomic models are e.g. FieldScriptsTM from The climate Corporation, XarvioTM from BASF, AGLogicTM from John Deere, etc.
  • the compounds of the invention can also be used in combination with smart spraying equipment such as e.g.
  • Such an equipment usually includes input sensors (such as e.g. a camera) and a processing unit configured to analyze the input data and configured to provide a decision based on the analysis of the input data to apply the compound of the invention to the crop plants (respectively the weeds) in a specific and precise manner.
  • input sensors such as e.g. a camera
  • processing unit configured to analyze the input data and configured to provide a decision based on the analysis of the input data to apply the compound of the invention to the crop plants (respectively the weeds) in a specific and precise manner.
  • the use of such smart spraying equipment usually also requires positions systems (e.g. GPS receivers) to localize recorded data and to guide or to control farm vehicles; geographic information systems (GIS) to represent the information on intelligible maps, and appropriate farm vehicles to perform the required farm action such as the spraying.
  • GPS geographic information systems
  • pests can be detected from imagery acquired by a camera.
  • the pests can be identified and/or classified based on that imagery.
  • image processing algorithms can utilize machine learning algorithms, such as trained neutral networks, decision trees and utilize artificial intelligence algorithms. In this manner, the compounds described herein can be applied only where needed.
  • Treatment of seed The control of animal pests by treating the seed of plants has been known for a long time and is the subject of continuous improvements. However, the treatment of seed entails a series of problems which cannot always be solved in a satisfactory manner.
  • the present invention therefore in particular also relates to a method for the protection of seed and germinating plants, from attack by pests, by treating the seed with one of the compounds of the formula (I).
  • the method according to the invention for protecting seed and germinating plants against attack by pests furthermore comprises a method where the seed is treated simultaneously in one operation or sequentially with a compound of the formula (I) and a mixing component. It also comprises a method where the seed is treated at different times with a compound of the formula (I) and a mixing component.
  • the invention likewise relates to the use of the compounds of the formula (I) for the treatment of seed for protecting the seed and the resulting plant from animal pests.
  • the invention relates to seed which has been treated with a compound of the formula (I) according to the invention so as to afford protection from animal pests.
  • the invention also relates to seed which has been treated simultaneously with a compound of the formula (I) and a mixing component.
  • the invention furthermore relates to seed which has been treated at different times with a compound of the formula (I) and a mixing component.
  • the individual substances may be present on the seed in different layers.
  • the layers comprising a compound of the formula (I) and mixing components may optionally be separated by an intermediate layer.
  • the invention also relates to seed where a compound of the formula (I) and a mixing component have been applied as component of a coating or as a further layer or further layers in addition to a coating.
  • the invention relates to seed which, after the treatment with a compound of the formula (I), is subjected to a film-coating process to prevent dust abrasion on the seed.
  • One of the advantages encountered with a systemically acting compound of the formula (I) is the fact that, by treating the seed, not only the seed itself but also the plants resulting therefrom are, after emergence, protected against animal pests. In this manner, the immediate treatment of the crop at the time of sowing or shortly thereafter can be dispensed with.
  • this takes the form of seed of cereals (for example wheat, barley, rye, millet and oats), corn, cotton, soya beans, rice, potatoes, sunflowers, coffee, tobacco, canola, oilseed rape, beets (for example sugarbeets and fodder beets), peanuts, vegetables (for example tomatoes, cucumbers, bean, cruciferous vegetables, onions and lettuce), fruit plants, lawns and ornamental plants.
  • cereals for example wheat, barley, rye and oats
  • transgenic seed with a compound of the formula (I) is also of particular importance.
  • the heterologous genes in transgenic seed can originate from microorganisms such as Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium.
  • the present invention is particularly suitable for the treatment of transgenic seed which comprises at least one heterologous gene originating from Bacillus sp.
  • the compound of the formula (I) is applied to the seed.
  • the seed is treated in a state in which it is stable enough to avoid damage during treatment.
  • the seed may be treated at any point in time between harvest and sowing.
  • the seed usually used has been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seed which has been harvested, cleaned and dried down to a moisture content which allows storage.
  • seed which, after drying, has been treated BCS233014 FC-Text - 58 - with, for example, water and then dried again, for example priming In the case of rice seed, it is also possible to use seed which has been soaked, for example in water to a certain stage of the rice embryo (‘pigeon breast stage’), stimulating the germination and a more uniform emergence.
  • care must generally be taken that the amount of the compound of the formula (I) applied to the seed and/or the amount of further additives is chosen in such a way that the germination of the seed is not adversely affected, or that the resulting plant is not damaged.
  • the compounds of the formula (I) are applied to the seed in a suitable formulation. Suitable formulations and processes for seed treatment are known to the person skilled in the art.
  • the compounds of the formula (I) can be converted to the customary seed dressing formulations, such as solutions, emulsions, suspensions, powders, foams, slurries or other coating compositions for seed, and also ULV formulations.
  • These formulations are prepared in a known manner, by mixing the compounds of the formula (I) with customary additives such as, for example, customary extenders and also solvents or diluents, colorants, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins and also water.
  • Colorants which may be present in the seed-dressing formulations which can be used in accordance with the invention are all colorants which are customary for such purposes. It is possible to use either pigments, which are sparingly soluble in water, or dyes, which are soluble in water. Examples include the dyes known by the names Rhodamine B, C.I. Pigment Red 112 and C.I.
  • Useful wetting agents which may be present in the seed dressing formulations usable in accordance with the invention are all substances which promote wetting, and which are conventionally used for the formulation of agrochemically active compounds. Preference is given to using alkylnaphthalenesulphonates, such as diisopropyl- or diisobutylnaphthalenesulphonates.
  • Useful dispersants and/or emulsifiers which may be present in the seed dressing formulations usable in accordance with the invention are all nonionic, anionic and cationic dispersants conventionally used for the formulation of active agrochemical ingredients. Preference is given to using nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants.
  • Suitable nonionic dispersants include in particular ethylene oxide/propylene oxide block polymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ethers, and the phosphated or sulphated derivatives thereof.
  • Suitable anionic dispersants are in particular lignosulphonates, polyacrylic acid salts and arylsulphonate/formaldehyde condensates.
  • BCS233014 FC-Text - 59 - Antifoams which may be present in the seed dressing formulations usable in accordance with the invention are all foam-inhibiting substances conventionally used for the formulation of active agrochemical ingredients. Preference is given to using silicone antifoams and magnesium stearate.
  • the gibberellins are known (cf. R. Wegler "Chemie der convinced für Schweizer- and Schdlingsbelampfungsstoff", vol.2, Springer Verlag, 1970, pp.401-412).
  • the seed dressing formulations usable in accordance with the invention can be used to treat a wide variety of different kinds of seed either directly or after prior dilution with water.
  • the concentrates or the preparations obtainable therefrom by dilution with water can be used to dress the seed of cereals, such as wheat, barley, rye, oats, and triticale, and also the seed of maize, rice, oilseed rape, peas, beans, cotton, sunflowers, soya beans and beets, or else a wide variety of different vegetable seed.
  • the seed dressing formulations usable in accordance with the invention, or the dilute use forms thereof can also be used to dress seed of transgenic plants.
  • all mixing units usable customarily for the seed dressing are useful.
  • the procedure in the seed dressing is to place the seed into a mixer, operated batch- wise or continously, to add the particular desired amount of seed dressing formulations, either as such or after prior dilution with water, and to mix everything until the formulation is distributed homogeneously on the seed. If appropriate, this is followed by a drying operation.
  • the application rate of the seed dressing formulations usable in accordance with the invention can be varied within a relatively wide range. It is guided by the particular content of the compounds of the formula (I) in the formulations and by the seed.
  • the application rates of the compound of the formula (I) are BCS233014 FC-Text - 60 - generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 15 g per kilogram of seed.
  • the compounds of the formula (I) are active against animal parasites, in particular ectoparasites or endoparasites.
  • the term endoparasite includes in particular helminths and protozoae, such as coccidia.
  • Ectoparasites are typically and preferably arthropods, in particular insects or acarids.
  • the compounds of the formula (I) are suitable, with favourable toxicity in warm blooded animals, for controlling parasites which occur in animal breeding and animal husbandry in livestock, breeding, zoo, laboratory, experimental and domestic animals. They are active against all or specific stages of development of the parasites.
  • Agricultural livestock include, for example, mammals, such as, sheep, goats, horses, donkeys, camels, buffaloes, rabbits, reindeers, fallow deers, and in particular cattle and pigs; or poultry, such as turkeys, ducks, geese, and in particular chickens; or fish or crustaceans, e.g. in aquaculture; or, as the case may be, insects such as bees.
  • domestic animals include, for example, mammals, such as hamsters, guinea pigs, rats, mice, chinchillas, ferrets or in particular dogs, cats; cage birds; reptiles; amphibians or aquarium fish.
  • the compounds of the formula (I) are administered to mammals.
  • the compounds of the formula (I) are administered to birds, namely cage birds or in particular poultry.
  • the compounds of the formula (I) By using the compounds of the formula (I) to control animal parasites, it is intended to reduce or prevent illness, cases of deaths and performance reductions (in the case of meat, milk, wool, hides, eggs, honey and the like), so that more economical and simpler animal keeping is made possible and better animal well-being is achievable.
  • control or "controlling”, as used herein with regard to the animal health field, means that the compounds of the formula (I) are effective in reducing the incidence of the respective parasite in an animal infected with such parasites to innocuous levels.
  • controlling means that the compounds of the formula (I) are effective in killing the respective parasite, inhibiting its growth, or inhibiting its proliferation.
  • arthropods include, without any limitation from the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.; BCS233014 FC-Text - 61 - from the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example Bovicola spp., Damalina spp., Felicola spp., Lepikentron spp., Menopon spp., Trichodectes spp., Trimenopon spp., Trinoton spp., Werneckiella spp.; from the order of the Diptera and the suborders Nemato
  • Siphonapta for example Ceratophyllus spp.; Ctenocephalides spp., Pulex spp., Tunga spp., Xenopsylla spp.; from the order of the Heteropterida, for example Cimex spp., Panstrongylus spp., Rhodnius spp., Triatoma spp.; as well as nuisance and hygiene pests from the order of the Blattarida.
  • acari may be mentioned by way of example, without any limitation: from the subclass of the Acari (Acarina) and the order of the Metastigmata, for example, from the family of argasidae like Argas spp., Ornithodorus spp., Otobius spp., from the family of Ixodidae like Amblyomma spp., Dermacentor spp., Haemaphysalis spp., Hyalomma spp., Ixodes spp., Rhipicephalus (Boophilus) spp , Rhipicephalus spp.
  • Exemplary parasitic protozoa include, without any limitation: Mastigophora (Flagellata) such as: Metamonada: from the order Vaccinonadida, for example, Giardia spp., Spironucleus spp. Parabasala: from the order Trichomonadida, for example, Histomonas spp., Pentatrichomonas spp., Tetratrichomonas spp., Trichomonas spp., Tritrichomonas spp.
  • Euglenozoa from the order Trypanosomatida, for example, Leishmania spp., Trypanosoma spp BCS233014 FC-Text - 62 - Sarcomastigophora (Rhizopoda), such as Entamoebidae, for example, Entamoeba spp., Centramoebidae, for example, Acanthamoeba sp., Euamoebidae, e.g. Hartmanella sp. Alveolata such as Apicomplexa (Sporozoa): e.g.
  • Cryptosporidium spp. from the order Eimeriida, for example, Besnoitia spp., Cystoisospora spp., Eimeria spp., Hammondia spp., Isospora spp., Neospora spp., Sarcocystis spp., Toxoplasma spp.; from the order Adeleida e.g. Hepatozoon spp., Klossiella spp.; from the order Haemosporida e.g. Leucocytozoon spp., Plasmodium spp.; from the order Piroplasmida e.g.
  • helminths include, without any limitation: Monogenea: e.g.: Dactylogyrus spp., Gyrodactylus spp., Microbothrium spp., Polystoma spp., Troglocephalus spp. Cestodes: from the order of the Pseudophyllidea, for example: Bothridium spp., Diphyllobothrium spp., Diplogonoporus spp., Ichthyobothrium spp., Ligula spp., Schistocephalus spp., Spirometra spp.
  • Cyclophyllida for example: Andyra spp., Anoplocephala spp., Avitellina spp., Bertiella spp., Cittotaenia spp., Davainea spp., Diorchis spp., Diplopylidium spp., Dipylidium spp., Echinococcus spp., Echinocotyle spp., Echinolepis spp., Hydatigera spp., Hymenolepis spp., Joyeuxiella spp., Mesocestoides spp., Moniezia spp., Paranoplocephala spp., Raillietina spp., Stilesia spp., Taenia spp., Thysaniezia spp., Thysanosoma spp.
  • Trematodes from the class of the Digenea, for example: Austrobilharzia spp., Brachylaima spp., Calicophoron spp., Catatropis spp., Clonorchis spp.
  • Collyriclum spp. Cotylophoron spp., Cyclocoelum spp., Dicrocoelium spp., Diplostomum spp., Echinochasmus spp., Echinoparyphium spp., Echinostoma spp., Eurytrema spp., Fasciola spp., Fasciolides spp., Fasciolopsis spp., Fischoederius spp., Gastrothylacus spp., Gigantobilharzia spp., Gigantocotyle spp., Heterophyes spp., Hypoderaeum spp., Leucochloridium spp., Metagonimus spp., Metorchis spp., Nanophyetus spp., Notocotylus spp., Opisthorchis spp., Or
  • Nematodes from the order of the Trichinellida, for example: Capillaria spp., Eucoleus spp., Paracapillaria spp., Trichinella spp., Trichomosoides spp., Trichuris spp. BCS233014 FC-Text - 63 - from the order of the Tylenchida, for example: Micronema spp., Parastrongyloides spp., Strongyloides spp.
  • Aelurostrongylus spp. Amidostomum spp., Ancylostoma spp., Angiostrongylus spp., Bronchonema spp., Bunostomum spp., Chabertia spp., Cooperia spp., Cooperioides spp., Crenosoma spp., Cyathostomum spp., Cyclococercus spp., Cyclodontostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylindropharynx spp., Cystocaulus spp., Dictyocaulus spp., Elaphostrongylus spp., Filaroides spp., Globocephalus spp., Graphidium spp., Gyalocephalus s
  • Spirurida from the order of the Spirurida, for example: Acanthocheilonema spp., Anisakis spp., Ascaridia spp.; Ascaris spp., Ascarops spp., Aspiculuris spp., Baylisascaris spp., Brugia spp., Cercopithifilaria spp., Crassicauda spp., Dipetalonema spp., Dirofilaria spp., Dracunculus spp.; Draschia spp., Enterobius spp., Filaria spp., Gnathostoma spp., Gongylonema spp., Habronema spp., Heterakis spp.; Litomosoides spp., Loa spp., Onchocerca spp., Oxyuris spp., Parabronema spp
  • Acantocephala from the order of the Oligacanthorhynchida, for example: Macracanthorhynchus spp., Prosthenorchis spp.; from the order of the Moniliformida, for example: Moniliformis spp. from the order of the Polymorphida, for example: Filicollis spp.; from the order of the Echinorhynchida, for example: Acanthocephalus spp., Echinorhynchus spp., Leptorhynchoides spp. Pentastoma: from the order of the Porocephalida, for example: Linguatula spp.
  • Fish parasites include crustaceans which in turn include the family Caligidae with representative genus Dissonus, Caligus (i.e. C. curtus, C. elongatus, C. clemensi, C.rogercresseyii), and Lepeophtheirus (i.e. L.
  • the administration of the compounds of the formula (I) is carried out by methods generally known in the art, such as enterally, parenterally, dermally or nasally, in the form of suitable preparations. Administration can be carried out prophylactically, methaphylactically or therapeutically.
  • one embodiment of the present invention refers to the compounds of the formula (I) for use as a medicament.
  • Another aspect refers to the compounds of the formula (I) for use as an antiendoparasitical agent.
  • Another particular aspect refers to the compounds of the formula (I) for use as a anthelmintic agent, more particular for use as a nematicidal agent, a platyhelminthicidal agent, an acanthocephalicidal agent, or a pentastomicidal agent.
  • Another particular aspect refers to the compounds of the formula (I) for use as an antiprotozoal agent.
  • Another aspect refers to the compounds of the formula (I) for use as an antiectoparasitical agent, in particular an arthropodicidal agent, more particular an insecticidal agent or acaricidal agent.
  • veterinary formulations comprising an effective amount of at least one compound of the formula (I) and at least one of the following: pharmaceutically acceptable excipient (e.g. solid or liquid diluents), pharmaceutically acceptable auxiliary (e.g. surfactants), in particular a pharmaceutically acceptable excipient and/or pharmaceutically acceptable auxiliary which is normally used in veterinary formulations.
  • pharmaceutically acceptable excipient e.g. solid or liquid diluents
  • pharmaceutically acceptable auxiliary e.g. surfactants
  • a related aspect of the invention is a method for preparing a veterinary formulation as described herein, comprising the step of mixing at least one compound of the formula (I) with pharmaceutically acceptable excipients and/or auxiliaries, in particular with pharmaceutically acceptable excipients and/or auxiliaries which are normally used in veterinary formulations.
  • veterinary formulations selected from the group of ectoparasiticidal and endoparasiticidal formulations, more particular selected from the group of anthelmintic, antiprotozoal, and arthropodicidal formulations, even more particular selected from the group of nematicidal, platyhelminthicidal, acanthocephalicidal, pentastomicidal, insecticidal, and acaricidal formulations, in accordance with the mentioned aspects, as well as their methods for preparation.
  • Another aspect refers to a method for treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying an effective amount of a compound of the formula (I) to an animal, in particular a non-human animal, in need thereof.
  • Another aspect refers to a method for treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying a veterinary formulation as defined herein to an animal, in particular a non-human animal, in need thereof.
  • Another aspect refers to the use of the compounds of the formula (I) in the treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, in an animal, in particular a non-human animal.
  • treatment includes prophylactic, metaphylactic or therapeutical treatment.
  • mixtures of at least one compound of the formula (I) with other active ingredients, particularly with endo- and ectoparasiticides, for the veterinary field are provided herewith.
  • mixture not only means that two (or more) different active ingredients are formulated in a joint formulation and are accordingly applied together but also refers to products which comprise separate formulations for each active compound. Accordingly, if more than two active compounds are to be applied, all active compounds may be formulated in a joint formulation or all active compounds may be formulated in separate formulations; also feasible are mixed forms where some of the active compounds are formulated jointly and some of the active compounds are formulated separately. Separate formulations allow the separate or successive application of the active compounds in question.
  • the active compounds specified herein by their common names are known and described, for example, in the Pesticide Manual (see above) or can be searched in the internet (e.g. http://www.alanwood.net/pesticides).
  • active ingredients from the group of ectoparasiticides, as mixing partners include, without limitation insecticides and acaricides listed in detail above. Further active ingredients which may be used are listed below following the aforementioned classification which is based on the current IRAC Mode of Action Classification Scheme: (1) Acetylcholinesterase (AChE) inhibitors; (2) GABA-gated chloride channel blockers; (3) Sodium channel modulators; (4) Nicotinic acetylcholine receptor (nAChR) competitive modulators; (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators; (6) Glutamate-gated chloride channel (GluCl) allosteric modulators; (7) Juvenile hormone mimics; (8) Miscellaneous non-specific (multi-site) inhibitors; (9) Modulators of chordotonal organs; (10) Mite growth inhibitors; (12) Inhibitors of mitochondrial ATP synthase, such as, ATP disruptors; (13)
  • Active compounds with unknown or non-specific mode of action e.g., fentrifanil, fenoxacrim, cycloprene, chlorobenzilate, chlordimeform, flubenzimine, dicyclanil, amidoflumet, quinomethionate, triarathene, clothiazoben, tetrasul, potassium oleate, petroleum, metoxadiazone, gossyplure, flutenzin, bromopropylate, cryolite; Compounds from other classes: butacarb, dimetilan, cloethocarb, phosphocarb, pirimiphos (-ethyl), parathion (-ethyl), methacrifos, isopropyl o-salicylate, trichlorfon, sulprofos, propaphos, sebufos, pyridathion, prothoate, dichlofenthion, demeton-S-methyls
  • camphechlor lindane, heptachlor
  • phenylpyrazoles e.g. acetoprole, pyrafluprole, pyriprole, vaniliprole, sisapronil
  • isoxazolines e.g. afoxolaner, esafoxolaner, fluralaner, lotilaner, mivorilaner, modoflaner, sarolaner, umifoxolaner
  • pyrazolyl-arylamides e.g. nicofluprole, tigolaner
  • pyrethroids e.g.
  • nithiazine dicloromezotiaz, triflumezopyrim
  • macrocyclic lactones e.g. nemadectin, ivermectin, latidectin, moxidectin, selamectin, eprinomectin, doramectin, emamectin benzoate, milbemycin oxime; triprene, epofenonane, diofenolan; biologicals, hormones or pheromones, for example natural products, e.g. thuringiensin, codlemone or neem components; dinitrophenols, e.g.
  • Anthelmintically active compounds including, without limitation, the following nematicidally, trematicidally and/or cestocidally active compounds: from the class of macrocyclic lactones, for example: eprinomectin, abamectin, nemadectin, moxidectin, doramectin, selamectin, lepimectin, latidectin, milbemectin, ivermectin, emamectin, milbemycin; from the class of benzimidazoles and probenzimidazoles, for example: oxibendazole, mebendazole, triclabendazole, thiophanate, parbendazole, oxfendazole, netobimin, fenbendazole, febantel, thiabendazole, cyclobendazole, cambendazole, albendazole-sulphoxide, albendazole, flu
  • Antiprotozoal active compounds including, without limitation, the following active compounds: from the class of triazines, for example: diclazuril, ponazuril, letrazuril, toltrazuril; from the class of polylether ionophore, for example: monensin, salinomycin, maduramicin, narasin; from the class of macrocyclic lactones, for example: milbemycin, erythromycin; from the class of quinolones, for example: enrofloxacin, pradofloxacin; from the class of quinines, for example: chloroquine; from the class of pyrimidines, for example: pyrimethamine; from the class of sulfonamides, for example: sulfaquinoxaline, trimethoprim, sulfaclozin; from the class of thiamines, for example: amprolium; from the class of lincosamides, for example: clindamycin
  • a vector is an arthropod, in particular an insect or arachnid, capable of transmitting pathogens such as, for example, viruses, worms, single-cell organisms and bacteria from a reservoir (plant, animal, human, etc.) to a host.
  • pathogens can be transmitted either mechanically (for example trachoma by non-stinging flies) to a host, or by injection (for example malaria parasites by mosquitoes) into a host.
  • vectors and the diseases or pathogens they transmit are: 1) Mosquitoes - Anopheles: malaria, filariasis; - Culex: Japanese encephalitis, other viral diseases, filariasis, transmission of other worms; - Aedes: yellow fever, dengue fever, other viral diseases, filariasis; - Simuliidae: transmission of worms, in particular Onchocerca volvulus; - Psychodidae: transmission of leishmaniasis 2) Lice: skin infections, epidemic typhus; 3) Fleas: plague, endemic typhus, cestodes; 4) Flies: sleeping sickness (trypanosomiasis); cholera, other bacterial diseases; 5) Mites: acariosis, epidemic typhus, rickettsialpox, tularaemia, Saint Louis encephalitis, tick-borne encephalitis (TBE), Crimean–Congo haemorrhagic fever, borreliosis;
  • vectors in the sense of the present invention are insects, for example aphids, flies, leafhoppers or thrips, which are capable of transmitting plant viruses to plants.
  • Other vectors capable of transmitting plant viruses are spider mites, lice, beetles and nematodes.
  • Further examples of vectors in the sense of the present invention are insects and arachnids such as mosquitoes, in particular of the genera Aedes, Anopheles, for example A. gambiae, A. arabiensis, A. funestus, A.
  • a further aspect of the present invention is the use of compounds of the formula (I) for vector control, for example in agriculture, in horticulture, in gardens and in leisure facilities, and also in the protection of materials and stored products.
  • the compounds of the formula (I) are suitable for protecting industrial materials against attack or destruction by insects, for example from the orders Coleoptera, Hymenoptera, Isoptera, Lepidoptera, Psocoptera and Zygentoma.
  • Industrial materials in the present context are understood to mean inanimate materials, such as preferably plastics, adhesives, sizes, papers and cards, leather, wood, processed wood products and coating compositions. The use of the invention for protecting wood is particularly preferred.
  • the compounds of the formula (I) are used together with at least one further insecticide and/or at least one fungicide.
  • the compounds of the formula (I) are present as a ready-to-use pesticide, i.e.
  • the compounds of the formula (I) can be employed for protecting objects which come into contact with saltwater or brackish water, in particular hulls, screens, nets, buildings, moorings and signalling systems, against fouling.
  • the compounds of the formula (I) alone or in combinations with other active compounds, can be used as antifouling agents. Control of animal pests in the hygiene sector
  • the compounds of the formula (I) are suitable for controlling animal pests in the hygiene sector.
  • the invention can be applied in the domestic sector, in the hygiene sector and in the protection of stored products, especially for controlling insects, arachnids, ticks and mites encountered in enclosed spaces such as dwellings, factory halls, offices, vehicle cabins, animal husbandries.
  • the compounds of the formula (I) are used alone or in combination with other active compounds and/or auxiliaries. They are preferably used in domestic insecticide products.
  • the compounds of the formula (I) are effective against sensitive and resistant species, and against all developmental stages.
  • pests from the class Arachnida from the orders Scorpiones, Araneae and Opiliones, from the classes Chilopoda and Diplopoda, from the class Insecta the order Blattodea, from the orders Coleoptera, Dermaptera, Diptera, Heteroptera, Hymenoptera, Isoptera, Lepidoptera, Phthiraptera, Psocoptera, Saltatoria or Orthoptera, Siphonaptera and Zygentoma and from the class Malacostraca the order Isopoda.
  • BCS233014 FC-Text - 71 - They are used, for example, in aerosols, pressure-free spray products, for example pump and atomizer sprays, automatic fogging systems, foggers, foams, gels, evaporator products with evaporator tablets made of cellulose or plastic, liquid evaporators, gel and membrane evaporators, propeller-driven evaporators, energy-free, or passive, evaporation systems, moth papers, moth bags and moth gels, as granules or dusts, in baits for spreading or in bait stations.
  • Analytical methods The analytical methods described below refer to all information in the entire document, unless the procedure of the respective analytical determination is described separately at the respective passage.
  • LC-MS6 and LC-MS7 Agilent 1290 LC, Agilent MSD, HTS PAL autosampler. Linear gradient 0.0 to 1.80 minutes from 10 % acetonitrile to 95 % acetonitrile, from 1.80 to 2.50 minutes constant 95 % acetonitrile, flow 1.0 ml/min.
  • LC-MS8 Waters IClass Acquity with QDA mass spectrometer and FTN autosampler (column Waters Acquity 1.7 ⁇ m 50 mm * 2.1 mm, oven temperature 45°C). Linear gradient 0.0 to 2.10 minutes from 10 % acetonitrile to 95 % acetonitrile, from 2.10 to 3.00 minutes constant 95 % acetonitrile, flow 0.7 ml/min.
  • BCS233014 FC-Text - 72 - Retention time indices were calculated in all cases according to a homologue series of straight chain alkan-2-ones with 3 to 16 carbons where the index of the first alkanone was set to 300, the last to 1600, the ones between correspondingly and using linear interpolation between successive alkanones.
  • the determination of 1 H-NMR data was done with a Bruker Avance III 400 MHz spectrometer equipped with a 1.7 mm TCI probehead, with tetramethylsilane as reference (0.00 ppm) and the measurements were recorded usually from solutions in the solvents CD3CN, CDCl3 or d6-DMSO.
  • a Bruker Avance III 600 MHz instrument equipped with a 5 mm CPNMP probehead or a Bruker Avance NEO 600 MHz instrument equipped with a 5 mm TCI probehead were used for the measurements. Usually, the measurements were carried out with a probehead temperature of 298 K. Other measurement temperatures are explicitly noticed.
  • NMR peak lists procedure 1 H-NMR data of selected examples are written in form of 1 H-NMR peak lists. ⁇ -Values in ppm and the signal intensity in round brackets are listed to each signal peak. Semicolons are depicted as delimiters between the ⁇ -value – signal intensity pairs.
  • the peak list of an example has the form: ⁇ 1 (intensity1); ⁇ 2 (intensity2);........; ⁇ i (intensityi); hence; ⁇ n (intensityn)
  • the intensity of sharp signals correlates with the height of the signals in a printed view of a 1 H-NMR spectrum in cm and shows the real relations of signal intensities.
  • Several peaks from broad signals or the middle of the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown. Tetramethylsilane or the chemical shift of the solvent in cases where the sample does not contain tetramethylsilane is used for a calibration of the chemical shift for 1 H spectra.
  • the tetramethylsilane peak can occur in 1 H-NMR peak lists, but not necessarily.
  • 1 H-NMR peak lists are equivalent to classical 1 H-NMR prints and contain usually all peaks, which are also listed at classical 1 H-NMR-interpretations. In addition, they can show signals of solvents, stereoisomers of the compounds which are optionally object of the invention, and/or peaks of impurities, like classical 1 H-NMR prints.
  • 1 H-NMR solvent signals, the tetramethylsilane signal and the water signal in the corresponding solvent are excluded from the relative intensity calibration as they have very high intensity values.
  • the peaks of stereoisomers of the compounds according to the invention and/or peaks of impurities have usually a lower intensity than the peaks of compounds according to the invention (for example with a purity >90%).
  • Such stereoisomers and/or impurities can be typical for the specific preparation process.
  • the corresponding peaks can help to recognize the reproduction of the preparation process via “side-products- fingerprints”.
  • An expert who calculates the peaks of the target compounds with known methods (MestreC, ACD- simulation, but also with empirically evaluated expectation values), can assign the peaks of the target compounds as needed, optionally using additional intensity filters. This assignment would be similar to the usual peak picking at classical 1 H-NMR interpretations.
  • the used solvent can be extracted from the JCAMP file with the parameter “solvent”, the spectrometer frequency with “observe frequency” and the spectrometer type with “spectrometer/data system”.
  • 13 C-NMR data are displayed analogous to 1 H-NMR data as peak lists from broadband decoupled 13 C- NMR spectra.
  • 13 C-NMR solvent signals and tetramethylsilane are excluded from the relative intensity calibration as these signals can have very high intensities. Further details of NMR-data description with peak lists are disclosed in the publication “Citation of NMR Peaklist Data within Patent Applications” of the Research Disclosure Database Number 564025.
  • logP value is determined by measurement of LC-UV, in a neutral range, with 0.001 molar ammonium acetate solution in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile). Calibration was done with straight-chain alkan-2-ones (with 3 to 16 carbon atoms) with known logP values. The values between successive alkanones are determined by linear regression.
  • Step 2 6-[5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine (INT-04/compound of the formula (IX)) This reaction was carried out under argon atmosphere using a Schlenk tube.
  • Step 4 1-(6- ⁇ 5-(ethylsulfanyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6- yl]-1H-imidazol-2-yl ⁇ pyridin-3-yl)cyclopropanecarbonitrile (INT-06) This reaction was carried out under argon atmosphere using a Schlenk tube.
  • Step 5 18 ⁇ L (0.468 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.113 mL, 1.31 mmol) were added dropwise to a solution of 50 mg (0.094 mmol) of 1-(6- ⁇ 5-(ethylsulfanyl)-1-methyl-4- [7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl ⁇ pyridin-3- yl)cyclopropanecarbonitrile (INT-06) in dichloromethane (2.0 mL) and the resulting solution was stirred at RT overnight.
  • INT-06 1-(6- ⁇ 5-(ethylsulfanyl)-1-methyl-4- [7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1
  • the resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3.
  • the organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, dried with Na2SO4, filtered and concentrated under reduced pressure.
  • Step 2 1-(5-iodo-2-thienyl)cyclopropanecarbonitrile (INT-08)
  • a solution (2.5 M) of n-butyl lithium in hexanes (0.84 mL, 2.1 mmol) was added dropwise to a solution of 300 mg (2.01 mmol) of 1-(2-thienyl)cyclopropanecarbonitrile (INT-07) in tetrahydrofurane (12 mL) and the reaction mixture was stirred at -78 °C for 5 minutes.
  • Step 4 54.5 ⁇ L (1.32 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.318 mL, 3.71 mmol) were added dropwise to a solution of 143 mg (0.265 mmol) of 1-(5- ⁇ 5-(ethylsulfanyl)-1-methyl- 4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl ⁇ -2- thienyl)cyclopropanecarbonitrile (INT-09) in dichloromethane (5.7 mL) and the resulting solution was stirred at RT overnight.
  • the resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3.
  • the organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, dried with Na2SO4, filtered and concentrated under reduced pressure.
  • Step 2 33 ⁇ L (0.89 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.106 mL, 1.24 mmol) were added dropwise to a solution of 98.2 mg (0.177 mmol) of 6-[2-(4-bromo-1,3-thiazol-2-yl)-5- (ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-10) in dichloromethane (4.4 mL) and the resulting solution was stirred at RT overnight.
  • the resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO 3 .
  • the organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO 3 solution, BCS233014 FC-Text - 84 - dried with Na2SO4, filtered and concentrated under reduced pressure.
  • Step 2 19 ⁇ L (0.503 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.121 mL, 1.41 mmol) were added dropwise to a solution of 54.1 mg (0.101 mmol) of 6-[2-(3-bromo-1H-pyrazol-1-yl)- 5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine (INT-11) in dichloromethane (4.3 mL) and the resulting solution was stirred at RT overnight.
  • the resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO 3 .
  • the organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO 3 solution, dried with Na 2 SO 4 , filtered and concentrated under reduced pressure.
  • test concentrations are prepared by dilution with emulsifier containing water. Soaked wheat seeds (Triticum aestivum) are placed in a multiple well plate filled with agar and some water and are incubated for 1 day to germinate (5 seeds per well). The germinated wheat seeds are sprayed with a test solution containing the desired concentration of the active ingredient. Afterwards each unit is infected with 10-20 larvae of the banded cucumber beetle (Diabrotica balteata). After 7 days efficacy in % is determined. 100 % means all the seedlings have grown up like in the untreated, uninfected control; 0 % means none of the seedlings have grown.
  • Common bean (Phaseolus vulgaris) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration and infected with all instars of the western flower thrips (Frankliniella occidentalis) afterwards. After 7 days leaf protection efficacy is determined in %.100 % means no visible leaf damage (very good protection) and 0 % means a complete damaged leaf disk (no protection). In this test, for example, the following compounds from the preparation examples showed a very good leaf protection of 90 % at an application rate of 500 g/ha: I-13, I-84.
  • the plates are sealed with parafilm through which a mixed population of the green peach aphid (Myzus persicae) can suck on the compound preparation.
  • a mixed population of the green peach aphid Myzus persicae
  • mortality in % is determined.100 % means all aphids have been killed and 0 % means none of the aphids have been killed.
  • test concentrations are prepared by dilution with emulsifier containing water.
  • Chinese cabbage (Brassica pekinensis) leaf disks infected with all instars of the green peach aphid (Myzus persicae) are sprayed with a preparation of the active ingredient of the desired concentration. After 5 days mortality in % is determined.100 % means all aphids have been killed and 0 % means none of the aphids have been killed.
  • the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-6, I-9, I-10, I-53, I-57, I-79, I-95, I-96, I-98, I-103.
  • the following compounds from the preparation examples showed good activity of 95 % at an application rate of 100 g/ha: I-84.
  • the following compounds from the preparation examples showed good activity of 90 % at an application rate of 100 g/ha: I-8, I-11, I-20, I-22, I-23, I-24, I-26, I-28, I-30, I-38, I-45, I-48, I-49, I-50, I-51, I-55, I-59, I-62, I-63, I-69, I-71, I-72, I-76, I-80, I-92, I-93, I-97, I-99, I-101, I-104, I-106.
  • the following compounds from the preparation examples showed good activity of 85 % at an application rate of 100 g/ha: I-14, I-89.
  • the following compounds from the preparation examples showed good activity of 80 % at an application rate of 100 g/ha: I-83.
  • the following compounds from the preparation examples showed good activity of 70 % at an application rate of 100 g/ha: I-4, I-27, I-37, I-40, I-54, I-58, I-61, I-70, I-78, I-94, I-102.
  • Nezara viridula – spray test Solvent 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide
  • Emulsifier alkylarylpolyglycol ether
  • To produce a suitable preparation of active compound 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Barley plants (Hordeum vulgare) are sprayed with a test solution containing the desired concentration of the active ingredient and are infested with larvae of the southern green stink bug (Nezara viridula). After 4 days mortality in % is determined.
  • Rice plants (Oryza sativa) are sprayed with a preparation of the active ingredient of the desired concentration and the plants are infested with the brown planthopper (Nilaparvata lugens). After 4 days mortality in % is determined.100 % means all planthoppers have been killed and 0 % means none of the planthoppers have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 500 g/ha: I-10, I-27, I-28, I-30, I-36, I-40, I-41, I-48, I-49, I-51, I-70, I- 72, I-73, I-74, I-76.
  • BCS233014 FC-Text - 110 - Chinese cabbage (Brassica pekinensis) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf disks are infested with mustard beetle larvae (Phaedon cochleariae). After 7 days mortality in % is determined.100 % means all beetle larvae have been killed and 0 % means none of the beetle larvae have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-53.
  • Spodoptera frugiperda – spray test Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide
  • Emulsifier alkylarylpolyglycol ether
  • To produce a suitable preparation of active compound 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water.
  • Maize (Zea mays) leaf sections are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf sections are infested with fall armyworm larvae (Spodoptera frugiperda). After 7 days mortality in % is determined.
  • Nezara viridula – spray test Solvent: 52.5 parts by weight of acetone 7 parts by weight of dimethylformamide
  • Emulsifier alkylaryl polyglycolether BCS233014 FC-Text - 111 -
  • To produce a suitable preparation of active compound 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration if necessary.
  • Barley plants (Hordeum vulgare) are sprayed with a test solution containing the desired concentration of the active ingredient and are infested with larvae of the southern green stink bug (Nezara viridula). After 4 days mortality in % is determined. 100 % means all the stink bugs have been killed; 0 % means none of the stink bugs have been killed.
  • the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-1, I-2, I-3, I-6, I-7, I-17, I-19, I-20, I-23, I-24, I-53, I-54, I- 55, I-57, I-58, I-62, I-63, I-78, I-79, I-92, I-93, I-94, I-95, I-97, I-98, I-99, I-100, I-101, I-102, I-103, I- 104, I-105, I-106.
  • test concentrations are prepared by dilution with emulsifier containing water.
  • Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration if necessary.
  • Rice plants (Oryza sativa) are treated by being sprayed with the desired concentration of the active compound and are infested with larvae of the brown planthopper (Nilaparvata lugens). After 4 days mortality in % is determined.100 % means all planthoppers have been killed and 0 % means none of the planthoppers have been killed.
  • the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-1, I-4, I-6, I-7, I-19, I-22, I-24, I-53, I-54, I-55, I-57, I-58, I- BCS233014 FC-Text - 112 - 59, I-61, I-62, I-63, I-71, I-78, I-79, I-92, I-93, I-94, I-95, I-96, I-97, I-98, I-99, I-100, I-101, I-102, I-103, I-104, I-106.
  • Chinese cabbage (Brassica pekinensis) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf disks are infested with mustard beetle larvae (Phaedon cochleariae). After the specified period of time mortality in % is determined. 100 % means all beetle larvae have been killed and 0 % means none of the beetle larvae have been killed.
  • Vessels are filled with sand, a solution of the active ingredient, a suspension containing eggs and larvae of the southern root-knot nematode (Meloidogyne incognita) and lettuce seeds.
  • the lettuce seeds germinate and the seedlings grow. Galls develop in the roots. After 14 days the nematicidal effect in percent is determined by the formation of galls.100 % means no galls were found and 0 % means the number of galls found on the roots of the treated plants was equal to that in untreated control plants.
  • Cabbage leaves (Brassica oleracea) are treated by being sprayed with the preparation of the active compound of the desired concentration and are infested with larvae of the diamondback moth (Plutella xylostella). After the specified period of time mortality in % is determined.100 % means all the caterpillars have been killed and 0 % means none of the caterpillars have been killed.
  • Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration.
  • Cotton plants (Gossypium hirsutum), which are heavily infested with the cotton aphid (Aphis gossypii), are treated by being sprayed with the preparation of the active compound of the desired concentration. After the specicifed period of time mortality in % is determined. 100 % means all the aphids have been killed and 0 % means none of the aphids have been killed.
  • Corn plant leaves (Zea mays) in pots filled with soil, are treated by being drenched with the preparation of the active compound of the desired concentration and are infested with caterpillars of the fall army worm (Spodoptera frugiperda). After the specicifed period of time mortality in % is determined. 100 % means all the caterpillars have been killed and 0 % means none of the caterpillars have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table BCS233014 FC-Text - 115 - Table: Substance Structure Object Concentration % Efficacy dat* Example No. I-063 o ,0_ , . .

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to novel compounds of the formula (I), to the compounds of formula (I) for use as acaricides and/or insecticides for controlling animal pests, and to methods and intermediates for the preparation thereof.

Description

BCS233014 FC-Text Gam/lep 2024-05-29 - 1 - Heterocycle derivatives as pesticides The present invention relates to heterocycle derivatives of the formula (I), to their use as acaricides and/or insecticides for controlling animal pests, particularly arthropods and especially insects and arachnids, and to methods and intermediates for their preparation. Heterocycle derivatives having insecticidal properties are already described in the literature, for example in WO 2010/125985, WO 2012/074135, WO 2012/086848, WO 2013/018928, WO 2013/180193, WO 2013/191113, WO 2014/142292, WO 2014/148451, WO 2015/000715, WO 2016/124563, WO 2016/124557, WO 2015/121136, WO 2015/133603, WO 2015/198859, WO 2015/002211, WO 2015/071180, WO 2015/091945, WO 2016/005263, WO 2016/039441, WO 2015/198817, WO 2016/041819, WO 2016/039441, WO 2016/039444, WO 2016/026848, WO 2016/023954, WO 2016/020286, WO 2016/046071, WO 2016/058928, WO 2016/059145, WO 2016/071214, WO 2016/091731, WO 2016/096584, WO 2016/107742, WO 2016/107831, WO 2016/113155, WO 2016/116338, WO 2016/121997, WO 2016/125621, WO 2016/125622, WO 2016/129684, WO 2016/142326, WO 2016/142327, WO 2016/169882, WO 2016/169886, WO 2018/130437, WO 2018/130443, WO 2020/002082, WO 2022/002818. Modern crop protection compositions have to meet many demands, for example in relation to extent, persistence and spectrum of their action and possible use. Questions of toxicity, sparing of beneficial species and pollinators, environmental properties, application rates, combinability with other active ingredients or formulation auxiliaries play a role, as does the question of the complexity involved in the synthesis of an active ingredient, and resistances can also occur, to mention just a few parameters. For all these reasons alone, the search for novel crop protection compositions cannot be considered complete, and there is a constant need for novel compounds having improved properties compared to the known compounds, at least in relation to individual aspects. It was an object of the present invention to provide compounds which broaden the spectrum of the pesticides in various aspects and/or improve their activity. Novel heterocycle derivatives have now been found, these having advantages over the compounds already known, examples of which include better biological or environmental properties, a wider range of application methods, better insecticidal or acaricidal action, and good compatibility with crop plants. The heterocycle derivatives can be used in combination with further compositions for improving efficacy, especially against insects that are difficult to control. The subject matter of the present invention is therefore novel compounds of the formula (I) BCS233014 FC-Text - 2 -
Figure imgf000003_0001
in which (configuration 1-1) R1 represents aryl or 5 to 6 membered hetaryl, each of which is optionally mono- or polysubstituted by identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, acetyl, SCN, SF5, tri(C1-C4)alkylsilyl, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3- C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3- C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1- C4)cyanohaloalkyl, (C1-C4)hydroxyalkyl, hydroxycarbonyl-(C1-C4)alkoxy, (C1- C4)alkoxycarbonyl-(C1-C4)alkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C2-C4)alkenyl, (C2- C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3-C6)cycloalkyl-(C2)alkenyl, (C2-C4)alkynyl, (C2- C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkoxy, (C1-C4)alkoxy-(C1-C4)alkoxy, (C1-C4)alkoxyimino, (C1- C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkoxy-(C1-C4)alkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkoxy-(C1- C4)alkylsulfinyl, (C1-C4)alkylsulfinyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyl, (C1- C4)haloalkylsulfonyl, (C1-C4)alkoxy-(C1-C4)alkylsulfonyl, (C1-C4)alkylsulfonyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyloxy, (C1-C4)haloalkylsulfonyloxy, (C1-C4)alkylcarbonyl, (C1- C4)haloalkylcarbonyl, (C1-C4)alkylcarbonyloxy, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di(C1-C4)alkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1-C4)alkylsulfonylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1- C4)alkylsulfoximino, aminothiocarbonyl, (C1-C4)alkylaminothiocarbonyl, di(C1- C4)alkylaminothiocarbonyl, (C1-C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3- C6)cycloalkylcarbonylamino, aryl, haloaryl, cyanoaryl, (C1-C6)haloalkylaryl or hetaryl, oxohetaryl, halohetaryl, halooxohetaryl, cyanohetaryl, cyanooxohetaryl, (C1-C4)haloalkylhetaryl or (C1-C4)haloalkyloxohetaryl. It has additionally been found that the compounds of the formula (I) have very good efficacy as pesticides, preferably as insecticides and/or acaricides, and additionally generally have very good plant compatibility, in particular with respect to crop plants. The compounds according to the invention are defined in general terms by the formula (I). Preferred substituents or ranges of the radicals given in the formulae mentioned above and below are illustrated BCS233014 FC-Text - 3 - hereinafter: Configuration 2-1 R1 preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, furanyl, pyrazolyl, thiazolyl, oxazolyl or imidazolyl, each of which is optionally mono- or polysubstituted by identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3- C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3- C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C1- C4)hydroxyalkyl, hydroxycarbonyl-(C1-C4)alkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkyl, (C1- C4)alkoxy-(C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3- C6)cycloalkyl-(C2)alkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C1- C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkoxy, (C1- C4)alkoxy-(C1-C4)alkoxy, (C1-C4)alkoxyimino, (C1-C4)haloalkoxyimino, (C1-C4)alkylthio, (C1- C4)haloalkylthio, (C1-C4)alkoxy-(C1-C4)alkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1- C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkoxy-(C1-C4)alkylsulfinyl, (C1- C4)alkylsulfinyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl, (C1- C4)alkylcarbonyl, (C1-C4)haloalkylcarbonyl, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di(C1- C4)alkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1-C4)alkylsulfonylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1- C4)alkylsulfoximino, aminothiocarbonyl, (C1-C4)alkylaminothiocarbonyl, di(C1- C4)alkylaminothiocarbonyl, (C1-C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3- C6)cycloalkylcarbonylamino, phenyl which is optionally substituted by halogen, cyano or (C1- C6)haloalkyl or 5 to 6 membered hetaryl which is optionally substituted by halogen, cyano or (C1- C6)haloalkyl. Configuration 3-1 R1 particularly preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl or thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents, where possible substituents in each case are as follows: cyano, halogen, nitro, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1- C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C2-C4)alkenyl, (C2- C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3-C6)cycloalkyl-(C2)alkenyl, (C2-C4)alkynyl, (C2- C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxyimino, (C1-C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1- C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkylsulfonyl, BCS233014 FC-Text - 4 - (C1-C4)haloalkylsulfonyl, (C1-C4)alkylcarbonyl, (C1-C4)haloalkylcarbonyl, aminocarbonyl, (C1- C4)alkylaminocarbonyl, di(C1-C4)alkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1- C4)alkylsulfonylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1-C4)alkylsulfoximino, (C1-C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3- C6)cycloalkylcarbonylamino, phenyl, halophenyl, pyridyl or halopyridyl. Configuration 4-1 R1 very particularly preferably represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, halogen, (C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3- C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1- C4)alkoxyimino, aminocarbonyl, phenyl which is optionally monosubstituted by chlorine or pyridyl which is optionally monosubstituted by chlorine, or very particularly preferably represents pyrazolyl which is optionally monosubstituted by cyano, halogen or (C1-C4)haloalkyl – bridged via a nitrogen atom to the rest of the molecule. Configuration 5-1 R1 with emphasis represents phenyl, pyridyl (pyridinyl), pyrimidyl (pyrimidinyl), pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, fluorine, bromine, chlorine, methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, 1-cyanocyclopropyl, 1- trifluoromethylcyclopropyl, 1-fluorocyclopropyl, 2-cyanopropan-2-yl, cyano(difluoro)methyl, methoxyimino, ethoxyimino, aminocarbonyl, chlorophenyl or chloropyridyl, or pyrazolyl which is optionally monosubstituted by cyano, bromine, chlorine, iodine or trifluoromethyl – bridged via a nitrogen atom to the rest of the molecule. Configuration 5-2 R1 with emphasis represents phenyl which is optionally mono-, di- or trisubstituted by identical or different substituents where possible substituents in each case are as follows: cyano, fluorine, bromine, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1-fluorocyclopropyl, methoxyimino, ethoxyimino, aminocarbonyl or chlorophenyl, or pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon BCS233014 FC-Text - 5 - atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, fluorine, bromine, chlorine, methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, 1- cyanocyclopropyl, 1-fluorocyclopropyl, 2-cyanopropan-2-yl, cyano(difluoro)methyl, aminocarbonyl or chloropyridyl, or pyrazolyl which is optionally monosubstituted by cyano, bromine, chlorine, iodine or trifluoromethyl – bridged via a nitrogen atom to the rest of the molecule. Configuration 6-1 R1 especially represents phenyl, which is mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl, or pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl (-CF2CN), methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl, or pyridazin-3-yl which is monosubstituted by chlorine or cyano, or pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy, or pyrazin-2-yl which is monosubstituted by chlorine, or 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl, or 1H-pyrazol-3-yl which is monosubstituted by methyl, or 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl, or thien-2-yl which is monosubstituted by 1-cyanocyclopropyl, or 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano. Configuration 6-2 BCS233014 FC-Text - 6 - R1 especially represents phenyl, which is mono-, di- or trisubstituted identically or differently by fluorine, bromine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl, or pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl (-CF2CN), methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl, or pyridazin-3-yl which is monosubstituted by chlorine or cyano, or pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy, or pyrazin-2-yl which is monosubstituted by chlorine, or 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl, or 1H-pyrazol-3-yl which is monosubstituted by methyl, or 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl, or thien-2-yl which is monosubstituted by 1-cyanocyclopropyl, or 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1-fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl. BCS233014 FC-Text - 7 - In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is optionally mono-, di- or trisubstituted identically or differently by fluorine, bromine or chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is mono-, di- or trisubstituted by fluorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is monosubstituted by fluorine, bromine or chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is disubstituted identically or differently by fluorine, bromine or chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is trisubstituted identically or differently by fluorine, bromine or chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is monosubstituted by fluorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is disubstituted by fluorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is trisubstituted by fluorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is monosubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is disubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents phenyl, which is trisubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which BCS233014 FC-Text - 8 - R1 represents pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl, methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl, or pyridazin-3-yl which is monosubstituted by chlorine or cyano, or pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy, or pyrazin-2-yl which is monosubstituted by chlorine, or 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl, or 1H-pyrazol-3-yl which is monosubstituted by methyl, or 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl, or thien-2-yl which is monosubstituted by 1-cyanocyclopropyl, or 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl, methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyridazin-3-yl which is monosubstituted by chlorine or cyano. BCS233014 FC-Text - 9 - In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents pyrazin-2-yl which is monosubstituted by chlorine. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents 1H-pyrazol-3-yl which is monosubstituted by methyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents thien-2-yl which is monosubstituted by 1-cyanocyclopropyl. In a preferred embodiment, the invention relates to compounds of the formula (I), in which R1 represents 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano. In the definitions listed in general or within areas of preference, unless stated otherwise, halogen is selected from the group of fluorine, chlorine, bromine and iodine, preferably in turn from the group of fluorine, chlorine and bromine. Aryl (including as part of a larger unit, for example arylalkyl), unless defined differently elsewhere, is selected from the series phenyl, naphthyl, anthryl, phenanthrenyl, and is preferably in turn phenyl. In the context of the present invention, unless defined differently elsewhere, the term "alkyl", either on its own or else in combination with further terms, for example haloalkyl, is understood to mean a radical of a saturated, aliphatic hydrocarbon group which has 1 to 12 carbon atoms and may be branched or unbranched. Examples of C1-C12-alkyl radicals are methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, 1-methylbutyl, 2-methylbutyl, 1- ethylpropyl, 1,2-dimethylpropyl, hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl and n-dodecyl. BCS233014 FC-Text - 10 - Among these alkyl radicals, particular preference is given to C1-C6-alkyl radicals. Special preference is given to C1-C4-alkyl radicals. According to the invention, unless defined differently elsewhere, the term "alkenyl", either on its own or else in combination with further terms, is understood to mean a straight-chain or branched C2-C12-alkenyl radical which has at least one double bond, for example vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1,3-butadienyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1,3-pentadienyl, 1- hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl and 1,4-hexadienyl. Among these, preference is given to C2-C6-alkenyl radicals and particular preference to C2-C4-alkenyl radicals. According to the invention, unless defined differently elsewhere, the term "alkynyl", either on its own or else in combination with further terms, is understood to mean a straight-chain or branched C2-C12-alkynyl radical which has at least one triple bond, for example ethynyl, 1-propynyl and propargyl. Among these, preference is given to C3-C6-alkynyl radicals and particular preference to C3-C4-alkynyl radicals. The alkynyl radical may also contain at least one double bond. According to the invention, unless defined differently elsewhere, the term "cycloalkyl", either on its own or else in combination with further terms, is understood to mean a C3-C8-cycloalkyl radical, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. Among these, preference is given to C3-C6-cycloalkyl radicals. The term "alkoxy", either on its own or else in combination with further terms, for example haloalkoxy, is understood in the present case to mean an O-alkyl radical, where the term "alkyl" is as defined above. Halogen-substituted radicals, for example haloalkyl, are mono- or polyhalogenated, up to the maximum number of possible substituents. In the case of polyhalogenation, the halogen atoms may be identical or different. Halogen here is fluorine, chlorine, bromine or iodine, especially fluorine, chlorine or bromine. Unless stated otherwise, optionally substituted radicals may be mono- or polysubstituted, where the substituents in the case of polysubstitutions may be the same or different. The radical definitions or illustrations given above in general terms or listed within ranges of preference apply correspondingly to the end products and to the starting materials and intermediates. These radical definitions can be combined with one another as desired, i.e. including combinations between the respective preferred ranges. Preference according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being preferred. Particular preference according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being particularly preferred. BCS233014 FC-Text - 11 - Very particular preference according to the invention is given to using compounds of the formula (I) which contain a combination of the definitions listed above as being very particularly preferred. Emphasis according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being emphasized. Special emphasis according to the invention is given to using compounds of the formula (I) which contain a combination of the meanings listed above as being especially emphasized. Isomers Depending on the nature of the substituents, the compounds of the formula (I) may be in the form of geometric and/or optically active isomers or corresponding isomer mixtures in different compositions. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Accordingly, the invention encompasses both pure stereoisomers and any mixture of these isomers. Isotopic variants The present invention also encompasses all suitable isotopic variants of the compounds of the formula (I). An isotopic variant of such a compound is understood to mean a compound of the formula (I) in which at least one atom is replaced by another atom of the same atomic number, but with a different atomic mass than the atomic mass usually or predominantly occurring in nature. Examples of isotopes that can be incorporated into a compounds of the formula (I) are those of hydrogen, carbon, nitrogen, oxygen, phosphorus, sulfur, fluorine, chlorine, bromine and iodine, such as 2H (deuterium), 3H (tritium), 13C, 14C, 15N, 17O, 18O, 32P, 33P, 33S, 34S, 35S, 36S, 18F, 36Cl, 82Br, 123I, 124I, 129I and 131I. Certain isotopic variants of a compounds of the formula (I), such as in particular those in which one or more radioactive isotopes are incorporated, can be useful, for example, for investigating the mechanism of action or the active ingredient distribution, for example in the body of a pathogen; for this purpose, compounds labeled with 3H or 14C isotopes are particularly suitable, because their production and detection which is comparatively easy. In addition, the incorporation of isotopes, such as, for example, deuterium, can lead to advantages, for example as a result of greater metabolic stability of the compound, such as, for example, an extension of the half-life or a reduction in the required effective dose. Isotopic modifications of the compounds of the formula (I) can therefore also represent a preferred embodiment of the invention. Isotopic variants of the compounds of the formula (I) can be prepared by methods known to the person skilled in the art, for example by the methods described below and the instructions given in the exemplary embodiments, by using appropriate isotopic modifications of the respective reagents and/or starting compounds (educts). The inventive compounds of the formula (I) can be obtained by the processes shown in the following schemes: BCS233014 FC-Text - 12 - Process A The general method for the preparation of compounds of the formula (I) in which R1 is preferably aryl, 6- membered hetaryl or C-connected 5-membered hetaryl (R1 is bridged via a carbon atom to the rest of the molecule) is described below.
Figure imgf000013_0001
The radical R1 has the meanings described above. Step a) Compound of the formula (IV) can be prepared from starting materials (II) and (III) in the presence of a condensing agent. Compound (II) is either commercially available or can be prepared by known methods, for example analogously to the methods described in WO 2010/125985, WO 2012/074135, WO 2012/086848, WO 2013/018928, WO 2015/000715, WO 2015/121136, WO 2016/039441, WO 2016/059145, WO 2016/071214, WO 2016/169882, WO 2016/169886 or WO 2016/124557. Compound of the formula (III) can be prepared by known methods, for example analogously to the methods described in WO 2018/130437, WO 2018/130443, WO 2020/002082 The conversion to compound of the formula (IV) can be effected neat or in a solvent, preference being given to conducting the reaction in a solvent selected from customary solvents that are inert under the prevailing reaction conditions. Preference is given to ethers, for example diisopropyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, tert-butyl methyl ether; halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol, ethanol or isopropanol; nitriles, for example acetonitrile or propionitrile; aromatic hydrocarbons, for example toluene or xylene; aprotic polar solvents, for example N,N-dimethylformamide or N-methylpyrrolidone, or nitrogen compounds, for example pyridine. BCS233014 FC-Text - 13 - Examples of suitable condensing agents are carbodiimides such as 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide hydrochloride (EDCI) or 1,3-dicyclohexylcarbodiimide; anhydrides such as acetic anhydride, trifluoroacetic anhydride; a mixture of triphenylphosphine, a base and carbon tetrachloride, or a mixture of triphenylphosphine and an azo diester, for example diethylazodicarboxylic acid. The reaction can be conducted in the presence of a suitable catalyst, for example 1-hydroxybenzotriazole. The reaction can be carried out in the presence of an acid or a base. Examples of an acid which can be used in the reaction described are sulfonic acids such as methanesulfonic acid or para-toluenesulfonic acid; carboxylic acids such as acetic acid, or polyphosphoric acids. Examples of suitable bases are nitrogenous heterocycles such as pyridine, picoline, 2,6-lutidine, 1,8- diazabicyclo[5.4.0]-7-undecene (DBU); tertiary amines such as triethylamine and N,N- diisopropylethylamine; inorganic bases such as potassium phosphate, potassium carbonate and sodium hydride. Step b) The compounds of the formulas (V) or (I) can be prepared by oxidation of the corresponding intermediates of the formula (IV) or (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082. The oxidation is generally carried out in a solvent. Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2- dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water. Examples of suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid. Step c) Compounds of the formulas (IV) or (V) may be converted to compounds of the corresponding formula (VI) or (I), for example by transition metal-mediated cross-couplings [cf. Chem. Rev. 1995, 95, 2457- 2483; Tetrahedron 2002, 58, 9633-9695; Metal-Catalyzed Cross-Coupling Reactions (Eds.: A. de Meijere, F. Diederich), 2nd ed.,Wiley-VCH, Weinheim, 2004] or by nucleophilic aromatic substitution (cf. the processes described in Bioorganic and Medicinal Chemistry Letters 2007, 17, 5825-5830 or US 4125726). For example, compounds of the formula (IV) or (V) may be reacted with suitable boronic acids [R1- B(OH)2] or boronic esters according to known methods (cf. WO 2012/143599, US 2014/094474, US 2014/243316, US 2015/284358 or Journal of Organic Chemistry 2004, 69, 8829-8835) in the presence of suitable catalysts from the series of transition metal salts to give compounds of the formula (VI) or (I). BCS233014 FC-Text - 14 - Examples of preferred coupling catalysts include palladium catalysts such as [1,1'- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(triphenylphosphine)palladium(II) dichloride or tetrakis(triphenylphosphine)palladium. Suitable basic reaction auxiliaries used to conduct the processes are preferably carbonates of sodium, potassium or caesium. Some of the required boronic acid derivatives [R1-B(OH)2] or boronic ester derivatives are known and/or commercially available, or they can be prepared by generally known methods (cf. Boronic Acids (eds.: D. G. Hall), 2nd ed., Wiley-VCH, Weinheim, 2011). In this case, the reaction is preferably conducted in a mixture of water and an organic solvent selected from customary solvents that are inert under the prevailing reaction conditions. Ethers such as tetrahydrofuran, dioxane or 1,2-dimethoxyethane are frequently used. Alternatively, it is possible to use stannane derivatives [R1-Sn(n-Bu)3] as coupling partners (cf. US 2013/281433, WO 2004/099177 or WO 2016/071214). Some of the required stannane derivatives [R1- Sn(n-Bu)3] are known and/or commercially available, or they can be prepared by generally known methods (cf. WO 2016/071214 or WO 2007/148093). Process B The general method for the preparation of compounds of the formula (I) in which R1 is preferably aryl, 6- membered hetaryl or C-connected 5-membered hetaryl hetaryl (R1 is bridged via a carbon atom to the rest of the molecule) is described below.
Figure imgf000015_0001
The radical R1 has the meanings described above. X is halogen, preferably iodine or bromine. Step a) The conversion of compound of the formula (II) into compound of the formula (VII) is carried out in BCS233014 FC-Text - 15 - acetic acid or triethyl orthoformate at high temperatures, e.g. between 120 °C and 150 °C and eventually assisted by microwaves as described in US 2019/202829 or US 2020/146293. Step b) The compound of the formula (VII) is coupled with compound of the formula (VIII) to give compound of the formula (IX) as described in WO 2020/074558. The deprotonation of compound of the formula (VII) is generally carried out in tetrahydrofurane using 2,2,6,6-tetramethylpiperidinylzinc chloride lithium chloride as a base and the in-situ Negishi coupling is carried out using preferentially tetrakis(triphenylphosphine)palladium(0) or XPhos-G3-palladacycle as a catalyst and at temperatures between 60 °C and 80 °C. The synthesis of compound of the formula (VIII) is described in US 2022/009930. Step c) The compound of the formula (IX) is coupled with halogenated cycles of the formula R1-X to give compounds of the formula (VI) as described in WO 2020/074560. The deprotonation of compounds of the formula (IX) is generally carried out in tetrahydrofurane using 2,2,6,6-tetramethylpiperidinylzinc chloride lithium chloride as a base and the in-situ Negishi coupling is carried out using preferentially tetrakis(triphenylphosphine)palladium(0) or XPhos-G3-palladacycle as a catalyst and at temperatures included between 60 °C and 80 °C. Step d) The compounds of the formula (I) can be prepared by oxidation of compounds of the formula (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082. The oxidation is generally carried out in a solvent. Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water. Examples of suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid. Process C The general method for the preparation of compounds of the formula (I) in which R1 is N-connected 5- membered hetaryl (R1 is bridged via a nitrogen atom to the rest of the molecule) is described below. BCS233014 FC-Text - 16 -
Figure imgf000017_0001
Step a) Coupling of the compound of the formula (IV) with N-connected 5-membered hetaryl (such as pyrazoles), optionally substituted as described above, to give compounds of the formula (VI) can be conducted by reaction under basic conditions (e.g. with sodium hydride in dimethylformamide, cf., for example WO 2005/058898). Alternatively, the reaction can be carried out under an inert gas atmosphere by catalysis with copper(I) salts, copper(I) iodide for example, in the presence of a suitable ligand, e.g. trans-N,N'- dimethylcyclohexane-1,2-diamine or R-(+)-proline, and a suitable base, e.g. potassium carbonate or potassium phosphate, in a suitable solvent such as 1,4-dioxane or toluene (cf., for example WO 2016/109559). Step b) The compounds of the formula (I) can be prepared by oxidation of compounds of the formula (VI), for example analogously to the methods described in WO 2018/130437, WO 2018/130443 or WO 2020/002082. The oxidation is generally carried out in a solvent. Preference is given to halogenated hydrocarbons, for example dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or chlorobenzene; alcohols such as methanol or ethanol; formic acid, acetic acid, propionic acid or water. Examples of suitable oxidizing compositions is hydrogen peroxide and meta-chloroperbenzoic acid. Methods and uses The invention also relates to methods for controlling animal pests, in which compounds of the formula (I) are allowed to act on animal pests and/or their habitat. The control of the animal pests is preferably conducted in agriculture and forestry, and in material protection. Preferably excluded herefrom are methods for the surgical or therapeutic treatment of the human or animal body and diagnostic methods carried out on the human or animal body. The invention furthermore relates to the use of the compounds of the formula (I) as pesticides, in particular crop protection agents. In the context of the present application, the term "pesticide" in each case also always comprises the term "crop protection agent". BCS233014 FC-Text - 17 - The compounds of the formula (I), having good plant tolerance, favourable homeotherm toxicity and good environmental compatibility, are suitable for protecting plants and plant organs against biotic and abiotic stressors, for increasing harvest yields, for improving the quality of the harvested material and for controlling animal pests, especially insects, arachnids, helminths, in particular nematodes, and molluscs, which are encountered in agriculture, in horticulture, in animal husbandry, in aquatic cultures, in forests, in gardens and leisure facilities, in the protection of stored products and of materials, and in the hygiene sector. Within the context of the present patent application, the term “hygiene” is understood to mean any and all measures, procedures and practices which aim to prevent disease, in particular infectious disease, and which serve to protect the health of humans and animals and/or to protect the environment, and/or which maintain cleanliness. In accordance with the invention, this especially includes measures for cleaning, disinfection and sterilisation of, for example, textiles or hard surfaces, especially surfaces of glass, wood, concrete, porcelain, ceramics, plastic or also of metal(s), and for ensuring that these are kept free of hygiene pests and/or their excretions. Preferably excluded from the scope of the invention in this regard are surgical or therapeutic treatment procedures applicable to the human body or to the bodies of animals and diagnostic procedures which are carried out on the human body or on the bodies of animals. The term “hygiene sector” thus covers all areas, technical fields and industrial applications in which these hygiene measures, procedures and practices are important, in relation for example to hygiene in kitchens, bakeries, airports, bathrooms, swimming pools, department stores, hotels, hospitals, stables, animal husbandries, etc. The term “hygiene pest” is therefore understood to mean one or more animal pests whose presence in the hygiene sector is problematic, in particular for health reasons. It is therefore a primary objective to avoid or minimize the presence of hygiene pests, and/or exposure to them, in the hygiene sector. This can be achieved in particular through the application of a pesticide that can be used both to prevent infestation and to tackle an infestation which is already present. Preparations which avoid or reduce exposure to pests can also be used. Hygiene pests include, for example, the organisms mentioned below. The term “hygiene protection” thus covers all actions to maintain and/or improve these hygiene measures, procedures and practices. The compounds of the formula (I) can preferably be used as pesticides. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned pests include: pests from the phylum of the Arthropoda, in particular from the class of the Arachnida, for example Acarus spp., for example Acarus siro, Aceria kuko, Aceria sheldoni, Aculops spp., Aculus spp., for example Aculus fockeui, Aculus schlechtendali, Amblyomma spp., Amphitetranychus viennensis, Argas spp., Boophilus spp., Brevipalpus spp., for example Brevipalpus phoenicis, Bryobia graminum, Bryobia BCS233014 FC-Text - 18 - praetiosa, Centruroides spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Dermacentor spp., Eotetranychus spp., for example Eotetranychus hicoriae, Epitrimerus pyri, Eutetranychus spp., for example Eutetranychus banksi, Eriophyes spp., for example Eriophyes pyri, Glycyphagus domesticus, Halotydeus destructor, Hemitarsonemus spp., for example Hemitarsonemus latus (=Polyphagotarsonemus latus), Hyalomma spp., Ixodes spp., Latrodectus spp., Loxosceles spp., Neutrombicula autumnalis, Nuphersa spp., Oligonychus spp., for example Oligonychus coffeae, Oligonychus coniferarum, Oligonychus ilicis, Oligonychus indicus, Oligonychus mangiferus, Oligonychus pratensis, Oligonychus punicae, Oligonychus yothersi, Ornithodorus spp., Ornithonyssus spp., Panonychus spp., for example Panonychus citri (=Metatetranychus citri), Panonychus ulmi (=Metatetranychus ulmi), Phyllocoptruta oleivora, Platytetranychus multidigituli, Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Scorpio maurus, Steneotarsonemus spp., Steneotarsonemus spinki, Tarsonemus spp., for example Tarsonemus confusus, Tarsonemus pallidus, Tetranychus spp., for example Tetranychus canadensis, Tetranychus cinnabarinus, Tetranychus turkestani, Tetranychus urticae, Trombicula alfreddugesi, Vaejovis spp., Vasates lycopersici; from the class of the Chilopoda, for example Geophilus spp., Scutigera spp.; from the order or the class of the Collembola, for example Onychiurus armatus; Sminthurus viridis; from the class of the Diplopoda, for example Blaniulus guttulatus; from the class of the Insecta, for example from the order of the Blattodea, for example Blatta orientalis, Blattella asahinai, Blattella germanica, Leucophaea maderae, Loboptera decipiens, Neostylopyga rhombifolia, Panchlora spp., Parcoblatta spp., Periplaneta spp., for example Periplaneta americana, Periplaneta australasiae, Pycnoscelus surinamensis, Supella longipalpa; from the order of the Coleoptera, for example Acalymma vittatum, Acanthoscelides obtectus, Adoretus spp., Aethina tumida, Agelastica alni, Agrilus spp., for example Agrilus planipennis, Agrilus coxalis, Agrilus bilineatus, Agrilus anxius, Agriotes spp., for example Agriotes linneatus, Agriotes mancus, Agriotes obscurus, Alphitobius diaperinus, Amphimallon solstitialis, Anobium punctatum, Anomala dubia, Anoplophora spp., for example Anoplophora glabripennis, Anthonomus spp., for example Anthonomus grandis, Anthrenus spp., Apion spp., Apogonia spp., Athous haemorrhoidales, Atomaria spp., for example Atomaria linearis, Attagenus spp., Baris caerulescens, Bruchidius obtectus, Bruchus spp., for example Bruchus pisorum, Bruchus rufimanus, Cassida spp., Cerotoma trifurcata, Ceutorrhynchus spp., for example Ceutorrhynchus assimilis, Ceutorrhynchus quadridens, Ceutorrhynchus rapae, Chaetocnema spp., for example Chaetocnema confinis, Chaetocnema denticulata, Chaetocnema ectypa, Cleonus mendicus, Conoderus spp., Cosmopolites spp., for example Cosmopolites sordidus, Costelytra zealandica, Ctenicera spp., Curculio spp., for example Curculio caryae, Curculio caryatrypes,Curculio obtusus, Curculio sayi, Cryptolestes ferrugineus, Cryptolestes pusillus, Cryptorhynchus lapathi, Cryptorhynchus mangiferae, Cylindrocopturus spp., Cylindrocopturus adspersus, BCS233014 FC-Text - 19 - Cylindrocopturus furnissi, Dendroctonus spp., for example Dendroctonus ponderosae, Dermestes spp., Diabrotica spp., for example Diabrotica balteata, Diabrotica barberi, Diabrotica undecimpunctata howardi, Diabrotica undecimpunctata undecimpunctata, Diabrotica virgifera virgifera, Diabrotica virgifera zeae, Dichocrocis spp., Dicladispa armigera, Diloboderus spp., Epicaerus spp., Epilachna spp., for example Epilachna borealis, Epilachna varivestis, Epitrix spp., for example Epitrix cucumeris, Epitrix fuscula, Epitrix hirtipennis, Epitrix subcrinita, Epitrix tuberis, Faustinus spp., Gibbium psylloides, Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Heteronyx spp., Hoplia argentea, Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypomeces squamosus, Hypothenemus spp., for example Hypothenemus hampei, Hypothenemus obscurus, Hypothenemus pubescens, Lachnosterna consanguinea, Lasioderma serricorne, Latheticus oryzae, Lathridius spp., Lema spp., Leptinotarsa decemlineata, Leucoptera spp., for example Leucoptera coffeella, Limonius ectypus, Lissorhoptrus oryzophilus, Listronotus (= Hyperodes) spp., Lixus spp., Luperodes spp., Luperomorpha xanthodera, Lyctus spp., Megacyllene spp., for example Megacyllene robiniae, Megascelis spp., Melanotus spp., for example Melanotus longulus oregonensis, Meligethes aeneus, Melolontha spp., for example Melolontha melolontha, Migdolus spp., Monochamus spp., Naupactus xanthographus, Necrobia spp., Neogalerucella spp., Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorhynchus spp., for example Otiorhynchus cribricollis, Otiorhynchus ligustici, Otiorhynchus ovatus, Otiorhynchus rugosostriarus, Otiorhynchus sulcatus, Oulema spp., for example Oulema melanopus, Oulema oryzae, Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga spp., Phyllophaga helleri, Phyllotreta spp., for example Phyllotreta armoraciae, Phyllotreta pusilla, Phyllotreta ramosa, Phyllotreta striolata, Popillia japonica, Premnotrypes spp., Prostephanus truncatus, Psylliodes spp., for example Psylliodes affinis, Psylliodes chrysocephala, Psylliodes punctulata, Ptinus spp., Rhizobius ventralis, Rhizopertha dominica, Rhynchophorus spp., Rhynchophorus ferrugineus, Rhynchophorus palmarum, Scolytus spp., for example Scolytus multistriatus, Sinoxylon perforans, Sitophilus spp., for example Sitophilus granarius, Sitophilus linearis, Sitophilus oryzae, Sitophilus zeamais, Sphenophorus spp., Stegobium paniceum, Sternechus spp., for example Sternechus paludatus, Symphyletes spp., Tanymecus spp., for example Tanymecus dilaticollis, Tanymecus indicus, Tanymecus palliatus, Tenebrio molitor, Tenebrioides mauretanicus, Tribolium spp., for example Tribolium audax, Tribolium castaneum, Tribolium confusum, Trogoderma spp., Tychius spp., Xylotrechus spp., Zabrus spp., for example Zabrus tenebrioides; from the order of the Dermaptera, for example Anisolabis maritime, Forficula auricularia, Labidura riparia; from the order of the Diptera, for example Aedes spp., for example Aedes aegypti, Aedes albopictus, Aedes sticticus, Aedes vexans, Agromyza spp., for example Agromyza frontella, Agromyza parvicornis, Anastrepha spp., Anopheles spp., for example Anopheles quadrimaculatus, Anopheles gambiae, Asphondylia spp., Bactrocera spp., for example Bactrocera cucurbitae, Bactrocera dorsalis, Bactrocera oleae, Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina, Ceratitis capitata, Chironomus spp., BCS233014 FC-Text - 20 - Chrysomya spp., Chrysops spp., Chrysozona pluvialis, Cochliomya spp., Contarinia spp., for example Contarinia johnsoni, Contarinia nasturtii, Contarinia pyrivora, Contarinia schulzi, Contarinia sorghicola, Contarinia tritici,Cordylobia anthropophaga, Cricotopus sylvestris, Culex spp., for example Culex pipiens, Culex quinquefasciatus, Culicoides spp., Culiseta spp., Cuterebra spp., Dacus oleae, Dasineura spp., for example Dasineura brassicae, Delia spp., for example Delia antiqua, Delia coarctata, Delia florilega, Delia platura, Delia radicum, Dermatobia hominis, Drosophila spp., for example Drosphila melanogaster, Drosophila suzukii, Echinocnemus spp., Euleia heraclei, Fannia spp., Gasterophilus spp., Glossina spp., Haematopota spp., Hydrellia spp., Hydrellia griseola, Hylemya spp., Hippobosca spp., Hypoderma spp., Liriomyza spp., for example Liriomyza brassicae, Liriomyza huidobrensis, Liriomyza sativae, Lucilia spp., for example Lucilia cuprina, Lutzomyia spp., Mansonia spp., Musca spp., for example Musca domestica, Musca domestica vicina, Oestrus spp., Oscinella frit, Paratanytarsus spp., Paralauterborniella subcincta, Pegomya or Pegomyia spp., for example Pegomya betae, Pegomya hyoscyami, Pegomya rubivora, Phlebotomus spp., Phorbia spp., Phormia spp., Piophila casei, Platyparea poeciloptera, Prodiplosis spp., Psila rosae, Rhagoletis spp., for example Rhagoletis cingulata, Rhagoletis completa, Rhagoletis fausta, Rhagoletis indifferens, Rhagoletis mendax, Rhagoletis pomonella, Sarcophaga spp., Simulium spp., for example Simulium meridionale, Stomoxys spp., Tabanus spp., Tetanops spp., Tipula spp., for example Tipula paludosa, Tipula simplex, Toxotrypana curvicauda; from the order of the Hemiptera, for example Acizzia acaciaebaileyanae, Acizzia dodonaeae, Acizzia uncatoides, Acrida turrita, Acyrthosipon spp., for example Acyrthosiphon pisum, Acrogonia spp., Aeneolamia spp., Agonoscena spp., Aleurocanthus spp., Aleyrodes proletella, Aleurolobus barodensis, Aleurothrixus floccosus, Allocaridara malayensis, Amrasca spp., for example Amrasca bigutulla, Amrasca devastans, Anuraphis cardui, Aonidiella spp., for example Aonidiella aurantii, Aonidiella citrina, Aonidiella inornata, Aphanostigma piri, Aphis spp., for example Aphis citricola, Aphis craccivora, Aphis fabae, Aphis forbesi, Aphis glycines, Aphis gossypii, Aphis hederae, Aphis illinoisensis, Aphis middletoni, Aphis nasturtii, Aphis nerii, Aphis pomi, Aphis spiraecola, Aphis viburniphila, Arboridia apicalis, Arytainilla spp., Aspidiella spp., Aspidiotus spp., for example Aspidiotus nerii, Atanus spp., Aulacorthum solani, Bemisia tabaci, Blastopsylla occidentalis, Boreioglycaspis melaleucae, Brachycaudus helichrysi, Brachycolus spp., Brevicoryne brassicae, Cacopsylla spp., for example Cacopsylla pyricola, Calligypona marginata, Capulinia spp., Carneocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes spp., Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chondracris rosea, Chromaphis juglandicola, Chrysomphalus aonidum, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp., for example Coccus hesperidum, Coccus longulus, Coccus pseudomagnoliarum, Coccus viridis, Cryptomyzus ribis, Cryptoneossa spp., Ctenarytaina spp., Dalbulus spp., Dialeurodes chittendeni, Dialeurodes citri, Diaphorina citri, Diaspis spp., Diuraphis spp., Doralis spp., Drosicha spp., Dysaphis spp., for example Dysaphis apiifolia, Dysaphis plantaginea, Dysaphis tulipae, Dysmicoccus spp., Empoasca spp., for example Empoasca abrupta, Empoasca fabae, Empoasca maligna, Empoasca solana, Empoasca stevensi, Eriosoma spp., for example Eriosoma americanum, Eriosoma lanigerum, Eriosoma pyricola, Erythroneura spp., Eucalyptolyma spp., Euphyllura spp., BCS233014 FC-Text - 21 - Euscelis bilobatus, Ferrisia spp., Fiorinia spp., Furcaspis oceanica, Geococcus coffeae, Glycaspis spp., Heteropsylla cubana, Heteropsylla spinulosa, Homalodisca coagulata, Hyalopterus arundinis, Hyalopterus pruni, Icerya spp., for example Icerya purchasi, Idiocerus spp., Idioscopus spp., Laodelphax striatellus, Lecanium spp., for example Lecanium corni (=Parthenolecanium corni), Lepidosaphes spp., for example Lepidosaphes ulmi, Lipaphis erysimi, Lopholeucaspis japonica, Lycorma delicatula, Macrosiphum spp., for example Macrosiphum euphorbiae, Macrosiphum lilii, Macrosiphum rosae, Macrosteles facifrons, Mahanarva spp., Melanaphis sacchari, Metcalfiella spp., Metcalfa pruinosa, Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzus spp., for example Myzus ascalonicus, Myzus cerasi, Myzus ligustri, Myzus ornatus, Myzus persicae, Myzus nicotianae, Nasonovia ribisnigri, Neomaskellia spp., Nephotettix spp., for example Nephotettix cincticeps,, Nephotettix nigropictus, Nettigoniclla spectra, Nilaparvata lugens, Oncometopia spp., Orthezia praelonga, Oxya chinensis, Pachypsylla spp., Parabemisia myricae, Paratrioza spp., for example Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., for example Pemphigus bursarius, Pemphigus populivenae, Peregrinus maidis, Perkinsiella spp., Phenacoccus spp., for example Phenacoccus madeirensis, Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp., for example Phylloxera devastatrix, Phylloxera notabilis, Pinnaspis aspidistrae, Planococcus spp., for example Planococcus citri, Prosopidopsylla flava, Protopulvinaria pyriformis, Pseudaulacaspis pentagona, Pseudococcus spp., for example Pseudococcus calceolariae, Pseudococcus comstocki, Pseudococcus longispinus, Pseudococcus maritimus, Pseudococcus viburni, Psyllopsis spp., Psylla spp., for example Psylla buxi, Psylla mali, Psylla pyri, Pteromalus spp., Pulvinaria spp., Pyrilla spp., Quadraspidiotus spp., for example Quadraspidiotus juglansregiae, Quadraspidiotus ostreaeformis, Quadraspidiotus perniciosus, Quesada gigas, Rastrococcus spp., Rhopalosiphum spp., for example Rhopalosiphum maidis, Rhopalosiphum oxyacanthae, Rhopalosiphum padi, Rhopalosiphum rufiabdominale, Saissetia spp., for example Saissetia coffeae, Saissetia miranda, Saissetia neglecta, Saissetia oleae, Scaphoideus titanus, Schizaphis graminum, Selenaspidus articulatus, Sipha flava, Sitobion avenae, Sogata spp., Sogatella furcifera, Sogatodes spp., Stictocephala festina, Siphoninus phillyreae, Tenalaphara malayensis,Tetragonocephela spp., Tinocallis caryaefoliae, Tomaspis spp., Toxoptera spp., for example Toxoptera aurantii, Toxoptera citricidus, Trialeurodes vaporariorum, Trioza spp., for example Trioza diospyri, Typhlocyba spp., Unaspis spp., Viteus vitifolii, Zygina spp.; from the suborder of the Heteroptera, for example Aelia spp., Anasa tristis, Antestiopsis spp., Boisea spp., Blissus spp., Calocoris spp., Campylomma livida, Cavelerius spp., Cimex spp., for example Cimex adjunctus, Cimex hemipterus, Cimex lectularius, Cimex pilosellus, Collaria spp., Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp., Euschistus spp., for example Euschistus heros, Euschistus servus, Euschistus tristigmus, Euschistus variolarius, Eurydema spp., Eurygaster spp., Halyomorpha halys, Heliopeltis spp., Horcias nobilellus, Leptocorisa spp., Leptocorisa varicornis, Leptoglossus occidentalis, Leptoglossus phyllopus, Lygocoris spp., for example Lygocoris pabulinus, Lygus spp., for example Lygus elisus, Lygus hesperus, Lygus lineolaris, Macropes excavatus, Megacopta cribraria, Miridae, Monalonion atratum, Nezara spp., for example Nezara viridula, Nysius spp., Oebalus spp., Pentomidae, Piesma quadrata, Piezodorus spp., for example Piezodorus guildinii, BCS233014 FC-Text - 22 - Psallus spp., Pseudacysta persea, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophora spp., Stephanitis nashi, Tibraca spp., Triatoma spp.; from the order of the Hymenoptera, for example Acromyrmex spp., Athalia spp., for example Athalia rosae, Atta spp., Camponotus spp., Dolichovespula spp., Diprion spp., for example Diprion similis, Hoplocampa spp., for example Hoplocampa cookei, Hoplocampa testudinea, Lasius spp., Linepithema (Iridiomyrmex) humile, Monomorium pharaonis, Paratrechina spp., Paravespula spp., Plagiolepis spp., Sirex spp., for example Sirex noctilio, Solenopsis invicta, Tapinoma spp., Technomyrmex albipes, Urocerus spp., Vespa spp., for example Vespa crabro, Wasmannia auropunctata, Xeris spp.; from the order of the Isopoda, for example Armadillidium vulgare, Oniscus asellus, Porcellio scaber; from the order of the Isoptera, for example Coptotermes spp., for example Coptotermes formosanus, Cornitermes cumulans, Cryptotermes spp., Incisitermes spp., Kalotermes spp., Microtermes obesi, Nasutitermes spp., Odontotermes spp., Porotermes spp., Reticulitermes spp., for example Reticulitermes flavipes, Reticulitermes hesperus; from the order of the Lepidoptera, for example Achroia grisella, Acronicta major, Adoxophyes spp., for example Adoxophyes orana, Aedia leucomelas, Agrotis spp., for example Agrotis segetum, Agrotis ipsilon, Alabama spp., for example Alabama argillacea, Amyelois transitella, Anarsia spp., Anticarsia spp., for example Anticarsia gemmatalis, Argyroploce spp., Autographa spp., Barathra brassicae, Blastodacna atra, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius, Busseola spp., Cacoecia spp., Caloptilia theivora, Capua reticulana, Carpocapsa pomonella, Carposina niponensis, Cheimatobia brumata, Chilo spp., for example Chilo plejadellus, Chilo suppressalis, Choreutis pariana, Choristoneura spp., Chrysodeixis chalcites, Clysia ambiguella, Cnaphalocerus spp., Cnaphalocrocis medinalis, Cnephasia spp., Conopomorpha spp., Conotrachelus spp., Copitarsia spp., Cydia spp., for example Cydia nigricana, Cydia pomonella, Dalaca noctuides, Diaphania spp., Diparopsis spp., Diatraea saccharalis, Dioryctria spp., for example Dioryctria zimmermani, Earias spp., Ecdytolopha aurantium, Elasmopalpus lignosellus, Eldana saccharina, Ephestia spp., for example Ephestia elutella, Ephestia kuehniella, Epinotia spp., Epiphyas postvittana, Erannis spp., Erschoviella musculana, Etiella spp., Eudocima spp., Eulia spp., Eupoecilia ambiguella, Euproctis spp., for example Euproctis chrysorrhoea, Euxoa spp., Feltia spp., Galleria mellonella, Gracillaria spp., Grapholitha spp., for example Grapholita molesta, Grapholita prunivora, Hedylepta spp., Helicoverpa spp., for example Helicoverpa armigera, Helicoverpa zea, Heliothis spp., for example Heliothis virescens, Hepialus spp., for example Hepialus humuli, Hofmannophila pseudospretella, Homoeosoma spp., Homona spp., Hyponomeuta padella, Kakivoria flavofasciata, Lampides spp., Laphygma spp., Laspeyresia molesta, Leucinodes orbonalis, Leucoptera spp., for example Leucoptera coffeella, Lithocolletis spp., for example Lithocolletis blancardella, Lithophane antennata, Lobesia spp., for example Lobesia botrana, Loxagrotis albicosta, Lymantria spp., for example Lymantria dispar, Lyonetia spp., for example Lyonetia clerkella, Malacosoma neustria, Maruca testulalis, Mamestra brassicae, Melanitis leda, Mocis spp., Monopis obviella, Mythimna separata, BCS233014 FC-Text - 23 - Nemapogon cloacellus, Nymphula spp., Oiketicus spp., Omphisa spp., Operophtera spp., Oria spp., Orthaga spp., Ostrinia spp., for example Ostrinia nubilalis, Panolis flammea, Parnara spp., Pectinophora spp., for example Pectinophora gossypiella, Perileucoptera spp., Phthorimaea spp., for example Phthorimaea operculella, Phyllocnistis citrella, Phyllonorycter spp., for example Phyllonorycter blancardella, Phyllonorycter crataegella, Pieris spp., for example Pieris rapae, Platynota stultana, Plodia interpunctella, Plusia spp., Plutella xylostella (=Plutella maculipennis), Podesia spp., for example Podesia syringae, Prays spp., Prodenia spp., Protoparce spp., Pseudaletia spp., for example Pseudaletia unipuncta, Pseudoplusia includens, Pyrausta nubilalis, Rachiplusia nu, Schoenobius spp., for example Schoenobius bipunctifer, Scirpophaga spp., for example Scirpophaga innotata, Scotia segetum, Sesamia spp., for example Sesamia inferens, Sparganothis spp., Spodoptera spp., for example Spodoptera eradiana, Spodoptera exigua, Spodoptera frugiperda, Spodoptera praefica, Stathmopoda spp., Stenoma spp., Stomopteryx subsecivella, Synanthedon spp., Tecia solanivora, Thaumetopoea spp., Thermesia gemmatalis, Tinea cloacella, Tinea pellionella, Tineola bisselliella, Tortrix spp., Trichophaga tapetzella, Trichoplusia spp., for example Trichoplusia ni, Tryporyza incertulas, Tuta absoluta, Virachola spp.; from the order of the Orthoptera or Saltatoria, for example Acheta domesticus, Dichroplus spp., Gryllotalpa spp., for example Gryllotalpa gryllotalpa, Hieroglyphus spp., Locusta spp., for example Locusta migratoria, Melanoplus spp., for example Melanoplus devastator, Paratlanticus ussuriensis, Schistocerca gregaria; from the order of the Phthiraptera, for example Damalinia spp., Haematopinus spp., Linognathus spp., Pediculus spp., Phylloxera vastatrix, Phthirus pubis, Trichodectes spp.; from the order of the Psocoptera, for example Lepinotus spp., Liposcelis spp.; from the order of the Siphonaptera, for example, Ceratophyllus spp., Ctenocephalides spp., for example Ctenocephalides canis, Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsylla cheopis; from the order of the Thysanoptera, for example Anaphothrips obscurus, Baliothrips biformis, Chaetanaphothrips leeuweni, Drepanothrips reuteri, Enneothrips flavens, Frankliniella spp., for example Frankliniella fusca, Frankliniella occidentalis, Frankliniella schultzei, Frankliniella tritici, Frankliniella vaccinii, Frankliniella williamsi, Haplothrips spp., Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Rhipiphorothrips cruentatus, Scirtothrips spp., Taeniothrips cardamomi, Thrips spp., for example Thrips palmi, Thrips tabaci; from the order of the Zygentoma (= Thysanura), for example Ctenolepisma spp., Lepisma saccharina, Lepismodes inquilinus, Thermobia domestica; from the class of the Symphyla, for example Scutigerella spp., for example Scutigerella immaculata; BCS233014 FC-Text - 24 - pests from the phylum of the Mollusca, for example from the class of the Bivalvia, for example Dreissena spp., and also from the class of the Gastropoda, for example Arion spp., for example Arion ater rufus, Biomphalaria spp., Bulinus spp., Deroceras spp., for example Deroceras laeve, Galba spp., Lymnaea spp., Oncomelania spp., Pomacea spp., Succinea spp.; plant pests from the phylum of the Nematoda, i.e. phytoparasitic nematodes, in particular Aglenchus spp., for example Aglenchus agricola, Anguina spp., for example Anguina tritici, Aphelenchoides spp., for example Aphelenchoides arachidis, Aphelenchoides fragariae, Belonolaimus spp., for example Belonolaimus gracilis, Belonolaimus longicaudatus, Belonolaimus nortoni, Bursaphelenchus spp., for example Bursaphelenchus cocophilus, Bursaphelenchus eremus, Bursaphelenchus xylophilus, Cacopaurus spp., for example Cacopaurus pestis, Criconemella spp., for example Criconemella curvata, Criconemella onoensis, Criconemella ornata, Criconemella rusium, Criconemella xenoplax (= Mesocriconema xenoplax), Criconemoides spp., for example Criconemoides ferniae, Criconemoides onoense, Criconemoides ornatum, Ditylenchus spp., for example Ditylenchus dipsaci, Dolichodorus spp., Globodera spp., for example Globodera pallida, Globodera rostochiensis, Helicotylenchus spp., for example Helicotylenchus dihystera, Hemicriconemoides spp., Hemicycliophora spp., Heterodera spp., for example Heterodera avenae, Heterodera glycines, Heterodera schachtii, Hirschmaniella spp., Hoplolaimus spp., Longidorus spp., for example Longidorus africanus, Meloidogyne spp., for example Meloidogyne chitwoodi, Meloidogyne fallax, Meloidogyne hapla, Meloidogyne incognita, Meloinema spp., Nacobbus spp., Neotylenchus spp., Paralongidorus spp., Paraphelenchus spp., Paratrichodorus spp., for example Paratrichodorus minor, Paratylenchus spp., Pratylenchus spp., for example Pratylenchus penetrans, Pseudohalenchus spp., Psilenchus spp., Punctodera spp., Quinisulcius spp., Radopholus spp., for example Radopholus citrophilus, Radopholus similis, Rotylenchulus spp., Rotylenchus spp., Scutellonema spp., Subanguina spp., Trichodorus spp., for example Trichodorus obtusus, Trichodorus primitivus, Tylenchorhynchus spp., for example Tylenchorhynchus annulatus, Tylenchulus spp., for example Tylenchulus semipenetrans, Xiphinema spp., for example Xiphinema index. The compounds of the formula (I) can optionally, at certain concentrations or application rates, also be used as herbicides, safeners, growth regulators or agents to improve plant properties, as microbicides or gametocides, for example as fungicides, antimycotics, bactericides, viricides (including agents against viroids) or as agents against MLO (mycoplasma-like organisms) and RLO (rickettsia-like organisms). If appropriate, they can also be used as intermediates or precursors for the synthesis of other active compounds. Formulations/Use forms The present invention further relates to formulations, in particular formulations for controlling unwanted controlling animal pests. The formulation may be applied to the animal pest and/or in their habitat. BCS233014 FC-Text - 25 - The formulation of the invention may be provided to the end user as “ready-for-use” use form, i.e. the formulations may be directly applied to the plants or seeds by a suitable device, such as a spraying or dusting device. Alternatively, the formulations may be provided to the end user in the form of concentrates which have to be diluted, preferably with water, prior to use. Unless otherwise indicated, the wording “formulation” therefore means such concentrate, whereas the wording “use form” means the end user as “ready-for-use” solution, i.e. usually such diluted formulation. The formulation of the invention can be prepared in conventional manners, for example by mixing the compound of the invention with one or more suitable auxiliaries, such as disclosed herein. The formulation comprises at least one compound of the invention and at least one agriculturally suitable auxiliary, e.g. carrier(s) and/or surfactant(s). A carrier is a solid or liquid, natural or synthetic, organic or inorganic substance that is generally inert. The carrier generally improves the application of the compounds, for instance, to plants, plants parts or seeds. Examples of suitable solid carriers include, but are not limited to, ammonium salts, in particular ammonium sulfates, ammonium phosphates and ammonium nitrates, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, silica gel and synthetic rock flours, such as finely divided silica, alumina and silicates. Examples of typically useful solid carriers for preparing granules include, but are not limited to crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks. Examples of suitable liquid carriers include, but are not limited to, water, organic solvents and combinations thereof. Examples of suitable solvents include polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene, tetrahydronaphthalene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as ethanol, propanol, butanol, benzylalcohol, cyclohexanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone, acetophenone, or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide or fatty acid amides) and esters thereof, lactams (such as N-alkylpyrrolidones, in particular N-methylpyrrolidone) and lactones, sulfones and sulfoxides (such as dimethyl sulfoxide), oils of vegetable or animal origin, nitriles (alkyl nitriles such as acetonitrile, propionotrilie, butyronitrile, or aromatic nitriles, such as benzonitrile), carbonic acid esters (cyclic carbonic acid esters, such as ethylene carbonate, propylene carbonate, butylene carbonate, or dialkyl carbonic acid esters, such as dimethyl carbonate, diethyl carbonate, dipropyl carbonate, dibutyl carbonate, dioctyl carbonate). The carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide. BCS233014 FC-Text - 26 - Preferred solid carriers are selected from clays, talc and silica. Preferred liquid carriers are selected from water, fatty acid amides and esters thereof, aromatic and nonaromatic hydrocarbons, lactams, lactones, carbonic acid esters, ketones, (poly)ethers. The amount of carrier typically ranges from 1 to 99.99%, preferably from 5 to 99.9%, more preferably from 10 to 99.5%, and most preferably from 20 to 99% by weight of the formulation. Liquid carriers are typically present in a range of from 20 to 90%, for example 30 to 80% by weight of the formulation. Solid carriers are typically present in a range of from 0 to 50%, preferably 5 to 45%, for example 10 to 30% by weight of the formulation. If the formulation comprises two or more carriers, the outlined ranges refer to the total amount of carriers. The surfactant can be an ionic (cationic or anionic), amphoteric or non-ionic surfactant, such as ionic or non-ionic emulsifier(s), foam former(s), dispersant(s), wetting agent(s), penetration enhancer(s) and any mixtures thereof. Examples of suitable surfactants include, but are not limited to, salts of polyacrylic acid, ethoxylated polya(alpha-substituted)acrylate derivatives, salts of lignosulfonic acid (such as sodium lignosulfonate), salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and/or propylene oxide with or without alcohols, fatty acids or fatty amines (for example, polyoxyethylene fatty acid esters such as castor oil ethoxylate, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols (such a fatty acid esters of glycerol, sorbitol or sucrose), sulfates (such as alkyl sulfates and alkyl ether sulfates), sulfonates (for example, alkylsulfonates, arylsulfonates and alkylbenzene sulfonates), sulfonated polymers of naphthalene/formaldehyde, phosphate esters, protein hydrolysates, lignosulfite waste liquors and methylcellulose. Any reference to salts in this paragraph refers preferably to the respective alkali, alkaline earth and ammonium salts. Preferred surfactants are selected from ethoxylated polya(alpha-substituted)acrylate derivatives, polycondensates of ethylene oxide and/or propylene oxide with alcohols, polyoxyethylene fatty acid esters, alkylbenzene sulfonates, sulfonated polymers of naphthalene/formaldehyde, polyoxyethylene fatty acid esters such as castor oil ethoxylate, sodium lignosulfonate and arylphenol ethoxylate. The amount of surfactants typically ranges from 5 to 40%, for example 10 to 20%, by weight of the formulation. Further examples of suitable auxiliaries include water repellents, siccatives, binders (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids BCS233014 FC-Text - 27 - such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone and tylose), thickeners and secondary thickeners (such as cellulose ethers, acrylic acid derivatives, xanthan gum, modified clays, e.g. the products available under the name Bentone, and finely divided silica), stabilizers (e.g. cold stabilizers, preservatives (e.g. dichlorophene, benzyl alcohol hemiformal, 1,2-Benzisothiazolin-3-on, 2- methyl-4-isothiazolin-3-one), antioxidants, light stabilizers, in particular UV stabilizers, or other agents which improve chemical and/or physical stability), dyes or pigments (such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g. silicone antifoams and magnesium stearate), antifreezes, stickers, gibberellins and processing auxiliaries, mineral and vegetable oils, perfumes, waxes, nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers. The choice of the auxiliaries depends on the intended mode of application of the compound of the invention and/or on the physical properties of the compound(s). Furthermore, the auxiliaries may be chosen to impart particular properties (technical, physical and/or biological properties) to the formulations or use forms prepared therefrom. The choice of auxiliaries may allow customizing the formulations to specific needs. The formulation comprises an insecticidal/acaricidal/nematicidal effective amount of the compound(s) of the invention. The term "effective amount" denotes an amount, which is sufficient for controlling harmful insects/mites/nematodes on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the insect/mite/nematode species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound of the invention used. Usually, the formulation according to the invention contains from 0.01 to 99% by weight, preferably from 0.05 to 98% by weight, more preferred from 0.1 to 95% by weight, even more preferably from 0.5 to 90% by weight, most preferably from 1 to 80% by weight of the compound of the invention. It is possible that a formulation comprises two or more compounds of the invention. In such case the outlined ranges refer to the total amount of compounds of the present invention. The formulation of the invention may be in any customary formulation type, such as solutions (e.g aqueous solutions), emulsions, water- and oil-based suspensions, powders (e.g. wettable powders, soluble powders), dusts, pastes, granules (e.g. soluble granules, granules for broadcasting), suspoemulsion concentrates, natural or synthetic products impregnated with the compound of the invention, fertilizers and also microencapsulations in polymeric substances. The compound of the invention may be present in a suspended, emulsified or dissolved form. Examples of particular suitable formulation types are solutions, watersoluble concentrates (e.g. SL, LS), dispersible concentrates (DC), suspensions and suspension concentrates (e.g. SC, OD, OF, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME, SE), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), BCS233014 FC-Text - 28 - pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GW, GF). These and further formulation types are defined by the Food and Agriculture Organization of the United Nations (FAO). An overview is given in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No.2, 6th Ed. May 2008, Croplife International. Preferably, the formulation of the invention is in form of one of the following types: EC, SC, FS, SE, OD, WG, WP, CS, more preferred EC, SC, OD, WG, CS. Further details about examples of formulation types and their preparation are given below. If two or more compounds of the invention are present, the outlined amount of compound of the invention refers to the total amount of compounds of the present invention. This applies mutatis mutandis for any further component of the formulation, if two or more representatives of such component, e.g. wetting agent, binder, are present. i) Water-soluble concentrates (SL, LS) 10-60 % by weight of at least one compound of the invention and 5-15 % by weight surfactant (e.g. polycondensates of ethylene oxide and/or propylene oxide with alcohols) are dissolved in such amount of water and/or water-soluble solvent (e.g. alcohols such as propylene glycol or carbonates such as propylene carbonate) to result in a total amount of 100 % by weight. Before application the concentrate is diluted with water. ii) Dispersible concentrates (DC) 5-25 % by weight of at least one compound of the invention and 1-10 % by weight surfactant and/or binder (e.g. polyvinylpyrrolidone) are dissolved in such amount of organic solvent (e.g. cyclohexanone) to result in a total amount of 100 % by weight. Dilution with water gives a dispersion. iii) Emulsifiable concentrates (EC) 15-70 % by weight of at least one compound of the invention and 5-10 % by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in such amount of water-insoluble organic solvent (e.g. aromatic hydrocarbon or fatty acid amide) and if needed additional water-soluble solvent to result in a total amount of 100 % by weight. Dilution with water gives an emulsion. iv) Emulsions (EW, EO, ES) 5-40 % by weight of at least one compound of the invention and 1-10 % by weight surfactant (e.g. a mixture of calcium dodecylbenzenesulfonate and castor oil ethoxylate, or polycondensates of ethylene oxide and/or propylene oxide with or without alcohols) are dissolved in 20-40 % by weight water- BCS233014 FC-Text - 29 - insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is added to such amount of water by means of an emulsifying machine to result in a total amount of 100 % by weight. The resulting formulation is a homogeneous emulsion. Before application the emulsion may be further diluted with water. v) Suspensions and suspension concentrates v-1) Water-based (SC, FS) In a suitable grinding equipment, e.g. an agitated ball mill, 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2 % by weight thickener (e.g. xanthan gum) and water to give a fine active substance suspension. The water is added in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable suspension of the active substance. For FS type formulations up to 40 % by weight binder (e.g. polyvinylalcohol) is added. v-2) Oil-based (OD, OF) In a suitable grinding equipment, e.g. an agitated ball mill, 20-60 % by weight of at least one compound of the invention are comminuted with addition of 2-10 % by weight surfactant (e.g. sodium lignosulfonate and polyoxyethylene fatty alcohol ether), 0.1-2 % by weight thickener (e.g. modified clay, in particular Bentone, or silica) and an organic carrier to give a fine active substance oil suspension. The organic carrier is added in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion of the active substance. vi) Water-dispersible granules and water-soluble granules (WG, SG) 1-90 % by weight, preferably 20-80%, most preferably 50-80 % by weight of at least one compound of the invention are ground finely with addition of surfactant (e.g. sodium lignosulfonate and sodium alkylnaphthylsulfonates) and potentially carrier material and converted to water-dispersible or water- soluble granules by means of typical technical appliances like e.g. extrusion, spray drying, fluidized bed granulation. The surfactant and carrier material are used in such amount to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance. vii) Water-dispersible powders and water-soluble powders (WP, SP, WS) 50-80 % by weight of at least one compound of the invention are ground in a rotor-stator mill with addition of 1-20 % by weight surfactant (e.g. sodium lignosulfonate, sodium alkylnaphthylsulfonates) and such amount of solid carrier, e.g. silica gel, to result in a total amount of 100 % by weight. Dilution with water gives a stable dispersion or solution of the active substance. viii) Gel (GW, GF) BCS233014 FC-Text - 30 - In an agitated ball mill, 5-25 % by weight of at least one compound of the invention are comminuted with addition of 3-10 % by weight surfactant (e.g. sodium lignosulfonate), 1-5 % by weight binder (e.g. carboxymethylcellulose) and such amount of water to result in a total amount of 100 % by weight. This results in a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance. ix) Microemulsion (ME) 5-20 % by weight of at least one compound of the invention are added to 5-30 % by weight organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 % by weight surfactant blend (e.g. polyoxyethylene fatty alcohol ether and arylphenol ethoxylate), and such amount of water to result in a total amount of 100 % by weight. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion. x) Microcapsules (CS) An oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 % by weight acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 % by weight of at least one compound of the invention, 0-40 % by weight water-insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol), this resulting in the formation of polyurea microcapsules. Optionally, the addition of a polyamine (e.g. hexamethylenediamine) is also used to result in the formation of polyurea microcapsules. The monomers amount to 1-10 % by weight of the total CS formulation. xi) Dustable powders (DP, DS) 1-10 % by weight of at least one compound of the invention are ground finely and mixed intimately with such amount of solid carrier, e.g. finely divided kaolin, to result in a total amount of 100 % by weight. xii) Granules (GR, FG) 0.5-30 % by weight of at least one compound of the invention are ground finely and associated with such amount of solid carrier (e.g. silicate) to result in a total amount of 100 % by weight. xiii) Ultra-low volume liquids (UL) 1-50 % by weight of at least one compound of the invention are dissolved in such amount of organic solvent, e.g. aromatic hydrocarbon, to result in a total amount of 100 % by weight. BCS233014 FC-Text - 31 - The formulations types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 % by weight preservatives, 0.1-1 % by weight antifoams, 0.1-1 % by weight dyes and/or pigments, and 5-10% by weight antifreezes. Mixtures The compounds of the formula (I) may also be employed as a mixture with one or more suitable fungicides, bactericides, acaricides, molluscicides, nematicides, insecticides, microbiologicals, beneficial species, herbicides, fertilizers, bird repellents, phytotonics, sterilants, safeners, semiochemicals and/or plant growth regulators, in order thus, for example, to broaden the spectrum of action, to prolong the duration of action, to increase the rate of action, to prevent repulsion or prevent evolution of resistance. In addition, such active compound combinations may improve plant growth and/or tolerance to abiotic factors, for example high or low temperatures, to drought or to elevated water content or soil salinity. It is also possible to improve flowering and fruiting performance, optimize germination capacity and root development, facilitate harvesting and improve yields, influence maturation, improve the quality and/or the nutritional value of the harvested products, prolong storage life and/or improve the processability of the harvested products. Furthermore, the compounds of the formula (I) can be present in a mixture with other active compounds or semiochemicals such as attractants and/or bird repellants and/or plant activators and/or growth regulators and/or fertilizers. Likewise, the compounds of the formula (I) can be used to improve plant properties such as, for example, growth, yield and quality of the harvested material. In a particular embodiment according to the invention, the compounds of the formula (I) are present in formulations or the use forms prepared from these formulations in a mixture with further compounds, preferably those as described below. If one of the compounds mentioned below can occur in different tautomeric forms, these forms are also included even if not explicitly mentioned in each case. Further, all named mixing partners can, if their functional groups enable this, optionally form salts with suitable bases or acids. Insecticides/acaricides/nematicides The active compounds identified here by their common names are known and are described, for example, in the pesticide handbook (“The Pesticide Manual” 16th Ed., British Crop Protection Council 2012) or can be found on the Internet (e.g. http://www.alanwood.net/pesticides). The classification is based on the current IRAC Mode of Action Classification Scheme at the time of filing of this patent application. (1) Acetylcholinesterase (AChE) inhibitors, preferably carbamates selected from alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, BCS233014 FC-Text - 32 - propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb, or organophosphates selected from acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triclorfon and vamidothion. (2) GABA-gated chloride channel blockers, preferably cyclodiene-organochlorines selected from chlordane and endosulfan, or phenylpyrazoles (fiproles) selected from ethiprole and fipronil. (3) Sodium channel modulators, preferably pyrethroids selected from acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans-isomer], deltamethrin, empenthrin [(EZ)-(1R)-isomer], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, momfluorothrin, permethrin, phenothrin [(1R)-trans-isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)- isomer)], tralomethrin and transfluthrin, or DDT or methoxychlor. (4) Nicotinic acetylcholine receptor (nAChR) competitive modulators, preferably neonicotinoids selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam, or nicotine, or sulfoximines selected from sulfoxaflor, or butenolids selected from flupyradifurone, or mesoionics selected from triflumezopyrim, or pyridylidenes selected from Flupyrimin. (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators (site I), preferably spinosyns selected from spinetoram and spinosad. (6) Glutamate-gated chloride channel (GluCl) allosteric modulators, preferably avermectins/milbemycins selected from abamectin, emamectin benzoate, lepimectin and milbemectin. (7) Juvenile hormone mimics, preferably juvenile hormone analogues selected from hydroprene, kinoprene and methoprene, or fenoxycarb or pyriproxyfen. (8) Miscellaneous non-specific (multi-site) inhibitors, preferably alkyl halides selected from methyl bromide and other alkyl halides, or chloropicrine or sulphuryl fluoride or borax or tartar emetic or methyl isocyanate generators selected from diazomet and metam. BCS233014 FC-Text - 33 - (9) Chordotonal organ TRPV channel modulators, preferably pyridine azomethanes selected from pymetrozine and pyrifluquinazon, or pyropenes selected from afidopyropen. (10) Mite growth inhibitors affecting CHS1 selected from clofentezine, hexythiazox, diflovidazin and etoxazole. (11) Microbial disruptors of the insect gut membranes selected from Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis, and B.t. plant proteins selected from Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb and Cry34Ab1/35Ab1. (12) Inhibitors of mitochondrial ATP synthase, preferably ATP disruptors selected from diafenthiuron, or organotin compounds selected from azocyclotin, cyhexatin and fenbutatin oxide, or propargite or tetradifon. (13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient selected from chlorfenapyr, DNOC and sulfluramid. (14) Nicotinic acetylcholine receptor channel blockers selected from bensultap, cartap hydrochloride, thiocylam and thiosultap-sodium. (15) Inhibitors of chitin biosynthesis affecting CHS1, preferably benzoylureas selected from bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron. (16) Inhibitors of chitin biosynthesis, type 1 selected from buprofezin. (17) Moulting disruptors (in particular for Diptera, i.e. dipterans) selected from cyromazine. (18) Ecdysone receptor agonists, preferably diacylhydrazines selected from chromafenozide, halofenozide, methoxyfenozide and tebufenozide. (19) Octopamine receptor agonists selected from amitraz. (20) Mitochondrial complex III electron transport inhibitors selected from hydramethylnone, acequinocyl, fluacrypyrim and bifenazate. (21) Mitochondrial complex I electron transport inhibitors, preferably METI acaricides and insecticides selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad, or rotenone (Derris). BCS233014 FC-Text - 34 - (22) Voltage-dependent sodium channel blockers, preferably oxadiazines selected from indoxacarb, or semicarbazones selected from metaflumizone. (23) Inhibitors of acetyl CoA carboxylase, preferably tetronic and tetramic acid derivatives selected from spirodiclofen, spiromesifen, spiropidion and spirotetramat. (24) Mitochondrial complex IV electron transport inhibitors, preferably phosphides selected from aluminium phosphide, calcium phosphide, phosphine and zinc phosphide, or cyanides selected from calcium cyanide, potassium cyanide and sodium cyanide. (25) Mitochondrial complex II electron transport inhibitors, preferably beta-ketonitrile derivatives selected from cyenopyrafen and cyflumetofen, or carboxanilides selected from pyflubumide. (28) Ryanodine receptor modulators, preferably diamides selected from chlorantraniliprole, cyantraniliprole, cyclaniliprole, flubendiamide and tetraniliprole. (29) Chordotonal organ Modulators (with undefined target site) selected from flonicamid. (30) GABA-gated chlorid channel allosteric modulators, preferably meta-diamides selected from broflanilide, or isoxazoles selected from fluxametamide. (31) Baculoviruses, preferably Granuloviruses (GVs) selected from Cydia pomonella GV and Thaumatotibia leucotreta (GV), or Nucleopolyhedroviruses (NPVs) selected from Anticarsia gemmatalis MNPV, Flucypyriprole and Helicoverpa armigera NPV. (32) Nicotinic acetylcholine receptor allosteric modulators (site II) selected from GS-omega/kappa HXTX-Hv1a peptide. (33) Calcium-activated potassium channel KCa2 modulators, selected from acynonapyr. (34) Mitochondrial complex III electron transfer inhibitors (non-Qo site), selected from flometoquin. (UN) Compounds of unknown or uncertain MoA (Target protein responsible for biological activity is unknown, or uncharacterized), selected from azadirachtin, benzoximate, bromopropylate, chinomethionat, dicofol, lime sulfur, mancozeb, pyridalyl, and sulfur. (UNB) Bacterial agents (non-Bt) of unknown or uncertain MoA (Target protein responsible for biological activity is unknown or uncharacterized), selected from Burkholderia spp., and Wolbachia pipientis (Zap). (UNE) Botanical essence including synthetic, extracts and unrefined oils with unknown or uncertain MoA (Target protein responsible for biological activity is unknown, or uncharacterized), selected from Chenopodium ambrosioides near ambrosioides extract and fatty acid monoesters with glycerol or propanediol neem oil. BCS233014 FC-Text - 35 - (UNF) Fungal agents of unknown or uncertain MoA (Target protein responsible for biological activity is unknown, or uncharacterized), selected from Beauveria bassiana strains, Metarhizium anisopliae strain F52, and Paecilomyces fumosoroseus Apopka strain 97. (UNM) Non-specific mechanical and physical disruptors (Target protein responsible for biological activity is unknown, or uncharacterized), selected from Diatomaceous earth, and mineral oil. Further active compounds selected from Afoxolaner, Benbenzaramine, Benzpyrimoxan, Chloroprallethrin, Cryolite, Cyclobutrifluram, Cycloxaprid, Cyetpyrafen, Cyhalodiamide, Cyproflanilide (CAS 2375110-88-4), Dicloromezotiaz, Dimpropyridaz, epsilon-Metofluthrin, epsilon-Momfluthrin, Fenmezoditiaz, Fluazaindolizine, Fluchlordiniliprole, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Fluralaner, Fufenozide, Flupentiofenox, Flupyroxypyrim, Guadipyr, Heptafluthrin, Imidaclothiz, Indazapyroxamet, Iprodione, Isocycloseram, kappa-Bifenthrin, kappa- Tefluthrin, Lotilaner, Meperfluthrin, Mivorilaner, Modoflaner, Nicofluprole (CAS 1771741-86-6), Oxazosulfyl, Paichongding, Pyriminostrobin, Sarolaner, Spidoxamat, Spirobudifen, Tetramethylfluthrin, Tetrachlorantraniliprole, Tigolaner, Tiorantraniliprole, Tioxazafen, Thiofluoximate, Trifluenfuronate (CAS 2074661-82-6), Tyclopyrazoflor, Iodomethane; furthermore preparations based on Bacillus firmus (I-1582, Votivo), azadirachtin (BioNeem), and Ledprona (Calantha®), and also the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulphinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazole-5- amine (known from WO2006/043635) (CAS 885026-50-6), 2-chloro-N-[2-{1-[(2E)-3-(4- chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006/003494) (CAS 872999-66-1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8- diazaspiro[4.5]dec-3-en-2-one (known from WO 2010052161) (CAS 1225292-17-0), 3-(4-chloro-2,6- dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl ethyl carbonate (known from EP2647626) (CAS 1440516-42-6), PF1364 (known from JP2010/018586) (CAS 1204776-60-2), (3E)-3- [1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO2013/144213) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3- (pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010/051926) (CAS 1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3- chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN103232431) (CAS 1449220-44-3), 4-[5-(3,5- dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)- benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans- 1-oxido-3-thietanyl)-benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3- isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)benzamide (known from WO 2013/050317 A1) (CAS 1332628-83-7), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl] -propanamide, (+)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl) sulfinyl]-propanamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3- trifluoropropyl)sulfinyl]-propanamide (known from WO 2013/162715 A2, WO 2013/162716 A2, US 2014/0213448 A1) (CAS 1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4- BCS233014 FC-Text - 36 - (trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from CN 101337937 A) (CAS 1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino) thioxomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from CN 103109816 A) (CAS 1232543-85-9); N-[4-chloro-2-[[(1,1-dimethylethyl)amino] carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO 2012/034403 A1) (CAS 1268277-22-0), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4- chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO 2011/085575 A1) (CAS 1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy] phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (known from CN 101337940 A) (CAS 1108184-52-6); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4- (difluoromethoxy)phenyl]-hydrazinecarboxamide (known from CN 101715774 A) (CAS 1232543-85-9); 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropanecarboxylic acid ester (known from CN 103524422 A) (CAS 1542271-46-4); (4aS)-7-chloro-2,5-dihydro-2- [[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine- 4a(3H)-carboxylic acid methyl ester (known from CN 102391261 A) (CAS 1370358-69-2); 6-deoxy-3- O-ethyl-2,4-di-O-methyl-, 1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H-1,2,4-triazol-3-yl] phenyl]carbamate]-α-L-mannopyranose (known from US 2014/0275503 A1) (CAS 1181213-14-8); 8-(2- cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza- bicyclo[3.2.1 ]octane (CAS 1253850-56-4), (8-anti)-8-(2-cyclopropylmethoxy-4-trifluoromethyl- phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1 ]octane (CAS 933798-27-7), (8-syn)- 8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza- bicyclo[3.2.1]octane (known from WO 2007040280 A1, WO 2007040282 A1) (CAS 934001-66-8), N- [4-(aminothioxomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2- pyridinyl)-1H-pyrazole-5-carboxamide (known from CN 103265527 A) (CAS 1452877-50-7), 3-(4- chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO 2014/187846 A1) (CAS 1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1, 8-diazaspiro[4.5]dec-3-en-4-yl-carbonic acid ethyl ester (known from WO 2010/066780 A1, WO 2011151146 A1) (CAS 1229023-00-0), N-[1-(2,6-difluorophenyl)-1H-pyrazol-3-yl]-2-(trifluoromethyl) benzamide (known from WO 2014/053450 A1) (CAS 1594624-87-9), N-[2-(2,6-difluorophenyl)-2H-1,2, 3-triazol-4-yl]-2-(trifluoromethyl)benzamide (known from WO 2014/053450 A1) (CAS 1594637-65-6), N-[1-(3,5-difluoro-2-pyridinyl)-1H-pyrazol-3-yl]-2-(trifluoromethyl)benzamide (known from WO 2014/053450 A1) (CAS 1594626-19-3), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-2- (methylsulfonyl)-propanamide (known from WO 2019/236274 A1) (CAS 2396747-83-2), N-[2-bromo- 4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-2-fluoro-3-[(4-fluorobenzoyl) amino]-benzamide (known from WO 2019059412 A1) (CAS 1207977-87-4), 2-(5-cyclopropyl-3- ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfinyl)-1,3-benzoxazole (known from WO 2017146226 A1) (CAS 2128706-04-5), 6-(5-cyclopropyl-3-ethylsulfonyl-2-pyridyl)-2,2-difluoro-7-methyl- [1,3]dioxolo[4,5-f]benzimidazole (known from WO 2020013147 A1) (CAS 2408220-91-5), 1-[6-(2,2- BCS233014 FC-Text - 37 - difluoro-7-methyl-[1,3]dioxolo[4,5-f]benzimidazole-6-yl)-5-ethylsulfonyl-3- pyridyl]cyclopropanecarbonitrile (known from WO 2020013147 A1) (CAS 2408220-94-8), 2-(3- ethylsulfonyl-2-pyridyl)-5-(2,2,3,3,3-pentafluoropropoxy)pyrazine (known from WO 2017065228 A1) (CAS 2095470-94-1). Nematicides The active compounds identified here by their common names are known and are described, for example, in the pesticide handbook (“The Pesticide Manual” 16th Ed., British Crop Protection Council 2012) or can be found on the Internet (e.g. http://www.alanwood.net/pesticides). The classification is based on the current Nematicide IRAC Mode of Action Classification Groups at the time of filing of this patent application. (Group N-1) Acetylcholinesterase (AChE) inhibitors, preferably (N-1A) carbamates selected from aldicarb, benfuracarb, carbofuran, carbosulfan and thiodicarb, or (N-1B) organophosphates selected from cadusafos, ethoprofos, fenamiphos, fosthiazate, imicyafos, phorate and terbufos. (Group N-2) Glutamate-gated chloride channel (GluCl) allosteric modulators, preferably avermectins selected from abamectin and emamectin benzoate. (Group N-3) Mitochondrial complex II electron transport inhibitors, especially inhibitors of succinate- coenzyme Q reductase, preferably pyridinylmethyl-benzamides selected from fluopyram. (Group N-4) Lipid synthesis/growth regulation modulators, especially inhibitors of acetyl CoA carboxylase, preferably tetronic and tetramic acid derivatives selected from spirotetramat. (Group N-UN) Compounds of unknown or uncertain mode of action with various chemistries, selected from fluensulfone, fluazaindolizine, furfural, iprodione, tioxazafen and trifluenfuronate. (Group N-UNX) Compounds of unknown or uncertain mode of action: Presumed multi-site inhibitors, preferably volatile sulphur generators selected from carbon disulphide and dimethyl disulphide (DMDS), or carbon disulphide liberators selected from sodium tetrathiocarbonate, or alkyl halides selected from methyl bromide and methyl iodide (iodomethane), or halogenated hydrocarbons selected from 1,2- dibromo-3-chloropropane (DBCP) and 1,3-dichloropropene, or chloropicrin, or methyl isothiocyanate generators selected from allyl isothiocyanate, diazomet, metam potassium and metam sodium. (Group N-UNB) Bacterial agents (non-Bt) of unknown or uncertain mode of action, preferably bacterium or bacterium-derived, selected from Burkholderia spp., e.g. rinojensis A396, Bacillus spp., e.g. firmus, licheniformis, amyloliquefaciens or subtilis, Pasteuria spp., e.g. penetrans or nishizawae, Pseudomonas spp., e.g. chlororaphis or fluorescens, and Streptomyces spp., e.g. lydicus, dicklowii or albogriseolus. BCS233014 FC-Text - 38 - (Group N-UNF) Fungal agents of unknown or uncertain mode of action, preferably fungus or fungus- derived, selected from Actinomyces spp., e.g. streptococcus, Arthrobotrys spp., e.g. oligospora, Aspergillus spp., e.g. niger, Muscodor spp., e.g. albus, Myrothecium spp., e.g. verrucaria, Paecilomyces spp., e.g. lilacinus (Purpureocillium lilacinum), carneus or fumosoroseus, Pochonia spp., e.g. chlamydosporia, and Trichoderma spp., e.g. harzianum, virens, atroviride or viride. (Group N-UNE) Botanical or animal derived agents, including synthetic extracts and unrefined oils, with unknown or uncertain mode of action, preferably botanical or animal derived agents selected from azadirachtin, camellia seed cake, essential oils, garlic extract, pongamia oil, terpenes, e.g. carvacrol, geraniol and thymol, and Quillaja saponaria extract. Fungicides The active ingredients specified herein by their Common Name are known and described, for example, in The Pesticide Manual (16th Ed. British Crop Protection Council) or can be searched in the internet (e.g. www.alanwood.net/pesticides). All named fungicidal mixing partners of the classes (1) to (15) can, if their functional groups enable this, optionally form salts with suitable bases or acids. Where a mixing partner can be present in tautomeric form, such a compound is understood herein above and herein below also to include corresponding tautomeric forms. 1) Inhibitors of the ergosterol biosynthesis, for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenbuconazole, (1.005) fenhexamid, (1.006) fenpropidin, (1.007) fenpropimorph, (1.008) fenpyrazamine, (1.009) Fluoxytioconazole, (1.010) fluquinconazole, (1.011) flutriafol, (1.012) hexaconazole, (1.013) imazalil, (1.014) imazalil sulfate, (1.015) ipconazole, (1.016) ipfentrifluconazole, (1.017) mefentrifluconazole, (1.018) metconazole, (1.019) myclobutanil, (1.020) paclobutrazol, (1.021) penconazole, (1.022) prochloraz, (1.023) propiconazole, (1.024) prothioconazole, (1.025) pyrisoxazole, (1.026) spiroxamine, (1.027) tebuconazole, (1.028) tetraconazole, (1.029) triadimenol, (1.030) tridemorph, (1.031) triticonazole, (1.032) 4-[[6-[(2R)-2-(2,4-difluorophenyl)-1,1- difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, (1.033) 4-[[6- [(2S)-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3- pyridyl]oxy]benzonitrile, (1.034) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4- triazol-1-yl)propan-2-ol, (1.035) (2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4- triazol-1-yl)propan-2-ol, (1.036) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3- dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.037) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]- 4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.038) 2-[6-(4-bromophenoxy)-2- (trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.039) 2-[6-(4-chlorophenoxy)-2- (trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.040) 3-[2-(1-chlorocyclopropyl)-3-(3- chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, (1.041) methyl 2-[2-chloro-4-(4- BCS233014 FC-Text - 39 - chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate, (1.042) methyl (2R)-2-[2- chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1,2,4-triazol-1-yl)propanoate, (1.043) methyl (S)-2-[2- chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1,2,4-triazol-1-yl)propanoate, (1.044) N'-(2,5- dimethyl-4-(2-methylbenzyl)phenyl)-N-ethyl-N-methylformimidamide, (1.045) N'-(2-chloro-4-(4- cyanobenzyl)-5-methylphenyl)-N-ethyl-N-methylformimidamide, (1.046) N'-(2-chloro-4-(4- methoxybenzyl)-5-methylphenyl)-N-ethyl-N-methylformimidamide, (1.047) N'-(2-chloro-5-methyl-4- phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (1.048) N'-(4-benzyl-2-chloro-5-methylphenyl)-N- ethyl-N-methylformimidamide, (1.049) N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N- methylimidoformamide, (1.050) N'-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]- N-ethyl-N-methylimidoformamide, (1.051) N'-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5- dimethylphenyl}-N-ethyl-N-methylimidoformamide, (1.052) N'-{5-bromo-2-methyl-6-[(1- propoxypropan-2-yl)oxy]pyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.053) N'-{5-bromo-6- [(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.054) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N- methylimidoformamide, (1.055) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3- yl}-N-ethyl-N-methylimidoformamide, (1.056) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2- methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.057) N'-{5-bromo-6-[1-(3,5- difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide, (1.058) N-isopropyl- N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methylimidoformamide, (1.059) p-tolylmethyl 4-[(E)-[ethyl(methyl)amino]methyleneamino]-2,5-dimethyl-benzoate, (1.060) N'- (2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine. 2) Inhibitors of the respiratory chain at complex I or II, for example (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) cyclobutrifluram, (2.006) flubeneteram, (2.007) fluindapyr, (2.008) fluopyram, (2.009) flutolanil, (2.010) fluxapyroxad, (2.011) furametpyr, (2.012) inpyrfluxam, (2.013) Isofetamid, (2.014) isoflucypram, (2.015) isopyrazam, (2.016) penflufen, (2.017) penthiopyrad, (2.018) pydiflumetofen, (2.019) pyrapropoyne, (2.020) pyraziflumid, (2.021) sedaxane, (2.022) Thifluzamide (aka trifluzamide), (2.023) 5,8-difluoro-N-[2-(2-fluoro-4-{[4- (trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (2.024) 5-chloro-N-[2-[1-(4- chlorophenyl)pyrazol-3-yl]oxyethyl]-6-ethyl-pyrimidin-4-amine, (2.025) N-[2-[1-(4- chlorophenyl)pyrazol-3-yl]oxyethyl]quinazolin-4-amine, (2.026) 1-methyl-3-(trifluoromethyl)-N-[2'- (trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.027) 2-fluoro-6-(trifluoromethyl)-N- (1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.028) 3-(difluoromethyl)-1-methyl-N-(1,1,3- trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.029) 3-(difluoromethyl)-1- methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) 3- (difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole- 4-carboxamide, (2.031) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4- yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro- 1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.033) N- BCS233014 FC-Text - 40 - [(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1- methyl-1H-pyrazole-4-carboxamide, (2.034) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3- (difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.035) 5-chloro-1,3-dimethyl-N-[(3S)-1,1,3- trimethyl-3H-isobenzofuran-4-yl]pyrazole-4-carboxamide, (2.036) 5-chloro-1,3-dimethyl-N-[(3R)-1,1,3- trimethyl-3H-isobenzofuran-4-yl]pyrazole-4-carboxamide, (2.037) N-[2-[(1S)-1,3- dimethylbutyl]phenyl]-5-fluoro-1,3-dimethyl-pyrazole-4-carboxamide, (2.038) N-[2-[(1R)-1,3- dimethylbutyl]phenyl]-5-fluoro-1,3-dimethyl-pyrazole-4-carboxamide, (2.039) 3-(difluoromethyl)-N- methoxy-1-methyl-N-[(1S)-1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, (2.040) 3- (difluoromethyl)-N-methoxy-1-methyl-N-[(1R)-1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4- carboxamide, (2.041) N-[2-[(1S)-1,3-dimethylbutyl]-3-thienyl]-1-methyl-3-(trifluoromethyl)pyrazole-4- carboxamide, (2.042) N-[2-[(1R)-1,3-dimethylbutyl]-3-thienyl]-1-methyl-3-(trifluoromethyl)pyrazole-4- carboxamide, (2.043) N-[rac-(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2- (trifluoromethyl)nicotinamide, (2.044) 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine- 3-carboxamide. 3) Inhibitors of the respiratory chain at complex III, for example (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) fenpicoxamid, (3.012) florylpicoxamid, (3.013) flufenoxystrobin, (3.014) fluoxastrobin, (3.015) kresoxim-methyl, (3.016) mandestrobin, (3.017) metarylpicoxamid, (3.018) metominostrobin, (3.019) metyltetraprole, (3.020) orysastrobin, (3.021) picoxystrobin, (3.022) pyraclostrobin, (3.023) pyrametostrobin, (3.024) pyraoxystrobin, (3.025) pyribencarb, (3.026) trifloxystrobin, (3.027) (2E)-2-{2- [({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2- (methoxyimino)-N-methylacetamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3- yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H- pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.030) (2R)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.031) (2S)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.032) (Z,2E)-5-[1-(2,4- dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, (3.033) methyl (Z)-2- (5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, (3.034) methyl (Z)-2-(5-cyclopentyl-2- methyl-phenoxy)-3-methoxy-prop-2-enoate, (3.035) methyl (Z)-3-methoxy-2-[2-methyl-5-(3- propylpyrazol-1-yl)phenoxy]prop-2-enoate, (3.036) methyl (Z)-3-methoxy-2-[2-methyl-5-[3- (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, (3.037) methyl {5-[3-(2,4-dimethylphenyl)-1H- pyrazol-1-yl]-2-methylbenzyl}carbamate, (3.038) (2E)-2-methoxyimino-N-methyl-2-[3-methyl-2-[[(E)- 1-[3-(trifluoromethyl)phenyl]ethylideneamino]oxymethyl]phenyl]acetamide, (3.039) (2E)-2-[2-[[(E)-1- (3,5-difluorophenyl)ethylideneamino]oxymethyl]-3-methyl-phenyl]-2-methoxyimino-N-methyl- acetamide, (3.040) [rac-2-(4-bromo-7-fluoro-indol-1-yl)-1-methyl-propyl] (2S)-2-[(3-hydroxy-4- methoxy-pyridine-2-carbonyl)amino]propanoate, (3.041) [rac-2-(7-bromo-4-fluoro-indol-1-yl)-1- methyl-propyl] (2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate, (3.042) [rac-2-(7- BCS233014 FC-Text - 41 - bromoindol-1-yl)-1-methyl-propyl] (2S)-2-[(3-hydroxy-4-methoxy-pyridine-2- carbonyl)amino]propanoate, (3.043) [rac-2-(3,5-dichloro-2-pyridyl)-1-methyl-propyl] (2S)-2-[(3- hydroxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate, (3.044) [(1S)-1-[1-(1- naphthyl)cyclopropyl]ethyl] (2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate, (3.045) [(1S)-1-[1-(1-naphthyl)cyclopropyl]ethyl] (2S)-2-[(3-hydroxy-4-methoxy-pyridine-2- carbonyl)amino]propanoate, (3.046) [(1S)-1-[1-(1-naphthyl)cyclopropyl]ethyl] (2S)-2-[[3- (acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]propanoate, (3.047) [2-[[(1S)-2-[(1RS,2SR)-2- (3,5-dichloro-2-pyridyl)-1-methyl-propoxy]-1-methyl-2-oxo-ethyl]carbamoyl]-4-methoxy-3- pyridyl]oxymethyl 2-methylpropanoate, (3.048) 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2- dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide, (3.049) 2-[cyano-(2,6-difluoro-4-pyridyl)amino]- 5-methyl-N-spiro[3.4]octan-3-yl-thiazole-4-carboxamide, (3.050) 2-[cyano-(2,6-difluoro-4- pyridyl)amino]-N-hexyl-5-methyl-thiazole-4-carboxamide, (3.051) 2-[acetyl-(2,6-difluoro-4- pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide, (3.052) 2-[(2,6-difluoro- 4-pyridyl)-(2-methylpropanoyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide, (3.053) 2-[(2,6-difluoro-4-pyridyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl- thiazole-4-carboxamide, (3.054) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2- hydroxybenzamide. 4) Inhibitors of the mitosis and cell division, for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) fluopimomide, (4.006) metrafenone, (4.007) pencycuron, (4.008) pyridachlometyl, (4.009) pyriofenone (chlazafenone), (4.010) thiabendazole, (4.011) thiophanate-methyl, (4.012) zoxamide, (4.013) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6- methylpyridazine, (4.014) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6- trifluorophenyl)pyridazine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl- 1H-pyrazol-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl- 1H-pyrazol-5-amine, (4.017) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol- 5-amine, (4.018) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5- amine, (4.019) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.020) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.021) 4-(2- chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(2-chloro- 4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.023) 4-(2-chloro-4- fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) 4-(2-chloro-4- fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) 4-(4-chlorophenyl)-5-(2,6- difluorophenyl)-3,6-dimethylpyridazine, (4.026) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4- fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.027) N-(2-bromophenyl)-4-(2-chloro-4- fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.028) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro- 4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine. BCS233014 FC-Text - 42 - 5) Compounds capable to have a multisite action, for example (5.001) bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper(2+) sulfate, (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, (5.015) metiram, (5.016) metiram zinc, (5.017) oxine- copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfide, (5.020) thiram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro-5H- pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile. 6) Compounds capable to induce a host defence, for example (6.001) acibenzolar-S-methyl, (6.002) fosetyl-aluminium, (6.003) fosetyl-calcium, (6.004) fosetyl-sodium, (6.005) isotianil, (6.006) phosphorous acid and its salts, (6.007) probenazole, (6.008) tiadinil. 7) Inhibitors of the amino acid and/or protein biosynthesis, for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil 8) Inhibitors of the ATP production, for example (8.001) silthiofam. 9) Inhibitors of the cell wall synthesis, for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one. 10) Inhibitors of the lipid synthesis or transport, or membrane synthesis, for example (10.001) fluoxapiprolin, (10.002) natamycin, (10.003) oxathiapiprolin, (10.004) propamocarb, (10.005) propamocarb hydrochloride, (10.006) propamocarb-fosetylate, (10.007) tolclofos-methyl, (10.008) 1-(4- {4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5- methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (10.009) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)- 4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H- pyrazol-1-yl]ethanone, (10.010) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn- 1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (10.011) 2-[3,5- bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro- 1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (10.012) 2-[3,5-bis(difluoromethyl)-1H- pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3- thiazol-2-yl)piperidin-1-yl]ethanone, (10.013) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1- yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (10.014) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin- 4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (10.015) 2-{3-[2- (1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2- oxazol-5-yl}phenyl methanesulfonate, (10.016) 3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1- yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (10.017) 9-fluoro-3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3- BCS233014 FC-Text - 43 - thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (10.018) 3-[2-(1-{[3,5- bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4- benzodioxepin-6-yl methanesulfonate, (10.019) 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1- yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-9-fluoro-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate. 11) Inhibitors of the melanin biosynthesis, for example (11.001) tolprocarb, (11.002) tricyclazole. 12) Inhibitors of the nucleic acid synthesis, for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam). 13) Inhibitors of the signal transduction, for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin. 14) Compounds capable to act as an uncoupler, for example (14.001) fluazinam, (14.002) meptyldinocap. 15) Further compounds, for example (15.001) abscisic acid, (15.002) aminopyrifen, (15.003) benthiazole, (15.004) bethoxazin, (15.005) capsimycin, (15.006) carvone, (15.007) chinomethionat, (15.008) chloroinconazide, (15.009) cufraneb, (15.010) cyflufenamid, (15.011) cymoxanil, (15.012) cyprosulfamide, (15.013) dipymetitrone, (15.014) D-tagatose, (15.015) flufenoxadiazam, (15.016) flumetylsulforim, (15.017) flutianil, (15.018) ipflufenoquin, (15.019) methyl isothiocyanate, (15.020) mildiomycin, (15.021) nickel dimethyldithiocarbamate, (15.022) nitrothal-isopropyl, (15.023) oxyfenthiin, (15.024) pentachlorophenol and salts, (15.025) picarbutrazox, (15.026) quinofumelin, (15.027) tebufloquin, (15.028) tecloftalam, (15.029) tolnifanide, (15.030) 2-(6-benzylpyridin-2- yl)quinazoline, (15.031) 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15.032) 2- phenylphenol and salts, (15.033) 4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5- fluoropyrimidin-2(1H)-one), (15.034) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, (15.035) 5-amino- 1,3,4-thiadiazole-2-thiol, (15.036) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide, (15.037) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.038) 5-fluoro-2-[(4- methylbenzyl)oxy]pyrimidin-4-amine, (15.039) but-3-yn-1-yl {6-[({[(Z)-(1-methyl-1H-tetrazol-5- yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.040) ethyl (2Z)-3-amino-2-cyano- 3-phenylacrylate, (15.041) methyl 2-[acetyl-[2-ethylsulfonyl-4-(trifluoromethyl)benzoyl]amino]-5- (trifluoromethoxy)benzoate, (15.042) N-acetyl-N-[2-bromo-4-(trifluoromethoxy)phenyl]-2- ethylsulfonyl-4-(trifluoromethyl)benzamide, (15.043) phenazine-1-carboxylic acid, (15.044) propyl 3,4,5-trihydroxybenzoate, (15.045) quinolin-8-ol, (15.046) quinolin-8-ol sulfate (2:1), (15.047) (2R)-2- benzyl-N-(8-fluoro-2-methyl-3-quinolyl)-2,4-dimethyl-pentanamide, (15.048) (2S)-2-benzyl-N-(8- fluoro-2-methyl-3-quinolyl)-2,4-dimethyl-pentanamide, (15.049) 1-(4,5-dimethyl-1H-benzimidazol-1- yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.050) 1-(4,5-dimethylbenzimidazol-1-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, (15.051) 1-(5-(fluoromethyl)-6-methyl-pyridin-3-yl)-4,4- difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.052) 1-(5,6-dimethylpyridin-3-yl)-4,4-difluoro-3,3- dimethyl-3,4-dihydroisoquinoline, (15.053) 1-(6-(difluoromethyl)-5-methoxy-pyridin-3-yl)-4,4-difluoro- BCS233014 FC-Text - 44 - 3,3-dimethyl-3,4-dihydroisoquinoline, (15.054) 1-(6-(difluoromethyl)-5-methyl-pyridin-3-yl)-4,4- difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.055) 4,4-difluoro-3,3-dimethyl-1-(7- methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, (15.056) 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, (15.057) 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4- difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.058) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3- yl)oxy]phenyl}propan-2-ol, (15.059) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1- yl)quinoline, (15.060) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-8-fluoroquinoline, (15.061) 3-(4,4-difluoro-5,5-dimethyl-4,5-dihydrothieno[2,3-c]pyridin-7-yl)quinoline, (15.062) 3-(5- fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.063) 4,4-difluoro-3,3-dimethyl-1- (4-methylbenzimidazol-1-yl)isoquinoline, (15.064) 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1,5- a]pyridin-3-yl)isoquinoline, (15.065) 5-bromo-1-(5,6-dimethylpyridin-3-yl)-3,3-dimethyl-3,4- dihydroisoquinoline, (15.066) 7,8-difluoro-N-[rac-1-benzyl-1,3-dimethyl-butyl]quinoline-3- carboxamide, (15.067) 8-fluoro-3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)-quinoline, (15.068) 8-fluoro-3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-quinoline, (15.069) 8-fluoro-N- (4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl)quinoline-3-carboxamide, (15.070) 8-fluoro-N-[(1R)-1-[(3- fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, (15.071) 8-fluoro-N-[(1S)-1-[(3- fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, (15.072) 8-fluoro-N-[(2S)-4,4,4- trifluoro-2-methyl-1-phenylbutan-2-yl]quinoline-3-carboxamide, (15.073) 8-fluoro-N-[rac-1-[(3- fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, (15.074) 9-fluoro-2,2-dimethyl-5- (quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.075) N-(2,4-dimethyl-1-phenylpentan-2-yl)-8- fluoroquinoline-3-carboxamide, (15.076) N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline- 3-carboxamide, (15.077) N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, (15.078) N-[(2R)-2,4-dimethyl-1-phenylpentan-2-yl]-8-fluoroquinoline-3-carboxamide, (15.079) rac-2- benzyl-N-(8-fluoro-2-methyl-3-quinolyl)-2,4-dimethyl-pentanamide, (15.080) (5RS)-3-[3-(3- cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4- oxadiazine, (15.081) (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2,4- dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine, (15.082) (5RS)-5-(4-bromo-2-methylbenzyl)-3-[3-(3- chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine, (15.083) (5RS)-3- [3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H- 1,2,4-oxadiazine, (15.084) (5S)-5-(4-bromo-2-methylbenzyl)-3-[3-(3-chloro-2-fluorophenoxy)-6- methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine, (15.085) (5R)-3-[3-(3-chloro-2- fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine, (15.086) (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)- 5,6-dihydro-4H-1,2,4-oxadiazine, (15.087) 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4- dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide, (15.088) 3-(3-bromo-2- fluoro-phenoxy)-6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4- carbox-amide, (15.089) 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2- fluoro-phenoxy)-5-methylpyridazine-4-carboxamide, (15.090) 6-chloro-3-(3-cyclopropyl-2- BCS233014 FC-Text - 45 - fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide, (15.091) 6-chloro-3-(3-chloro-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5- methylpyridazine-4-carbox-amide, (15.092) N-[2-(2-bromo-4-methylphenyl)-2,2-difluoroethyl]-6- chloro-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methylpyridazine-4-carboxamide, (15.093) 1,1-diethyl-3- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.094) 1,3-dimethoxy-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.095) 1-[[3-fluoro-4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)phenyl]methyl]azepan-2-one, (15.096) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]piperidin-2-one, (15.097) 1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]urea, (15.098) 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]urea, (15.099) 2-(difluoromethyl)-5-[2-[1-(2,6- difluorophenyl)cyclopropoxy]pyrimidin-5-yl]-1,3,4-oxadiazole, (15.100) 2,2-difluoro-N-methyl-2-[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, (15.101) 3,3-dimethyl-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.102) 3-ethyl-1-methoxy-1- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.103) 4,4-dimethyl-1-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.104) 4,4-dimethyl-2-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.105) 4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl dimethylcarbamate, (15.106) 5,5-dimethyl-2-[[4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.107) 5-[5- (difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(1R)-1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine, (15.108) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(1R)-1-(2,6-difluorophenyl)propyl]pyrimidin- 2-amine, (15.109) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(1R)-1-(2- fluorophenyl)ethyl]pyrimidin-2-amine, (15.110) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(1R)-1- (2-fluorophenyl)ethyl]pyrimidin-2-amine, (15.111) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(1R)- 1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine, (15.112) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N- [(1R)-1-phenylethyl]pyrimidin-2-amine, (15.113) 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2- fluorophenyl)cyclopropyl]pyrimidin-2-amine, (15.114) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.115) ethyl 1-{4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzyl}-1H-pyrazole-4-carboxylate, (15.116) methyl {4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl}carbamate, (15.117) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzamide, (15.118) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzamide, (15.119) N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, (15.120) N,N-dimethyl-1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzyl}-1H-1,2,4-triazol-3-amine, (15.121) N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]benzamide, (15.122) N-[(E)-N-methoxy-C-methyl-carbonimidoyl]-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.123) N-[(Z)-methoxyiminomethyl]-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.124) N-[(Z)-N-methoxy-C-methyl- carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.125) N-[[2,3-difluoro-4-[5- (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide, (15.126) N-[[4-[5- BCS233014 FC-Text - 46 - (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.127) N-[4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide, (15.128) N-{2,3-difluoro-4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]benzyl}butanamide, (15.129) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]benzyl}cyclopropanecarboxamide, (15.130) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl}propanamide, (15.131) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]acetamide, (15.132) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, (15.133) N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]phenyl]methyl]propanamide, (15.134) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide, (15.135) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol- 3-yl]benzamide, (15.136) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide, (15.137) N-methyl-N-phenyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.138) 2,2- difluoro-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetic acid. Biological pesticides as mixing components The compounds of the formula (I) can be combined with biological pesticides. Biological pesticides comprise in particular bacteria, fungi, yeasts, plant extracts and products formed by microorganisms, including proteins and secondary metabolites. Biological pesticides comprise bacteria such as spore-forming bacteria, root-colonising bacteria and bacteria which act as biological insecticides, fungicides or nematicides. Examples of such bacteria which are employed or can be used as biological pesticides are: Bacillus amyloliquefaciens, strain FZB42 (DSM 231179), or Bacillus cereus, in particular B. cereus strain CNCM I-1562 or Bacillus firmus, strain I-1582 (Accession number CNCM I-1582) or Bacillus pumilus, in particular strain GB34 (Accession No. ATCC 700814) and strain QST2808 (Accession No. NRRL B- 30087), or Bacillus subtilis, in particular strain GB03 (Accession No. ATCC SD-1397), or Bacillus subtilis strain QST713 (Accession No. NRRL B-21661) or Bacillus subtilis strain OST 30002 (Accession No. NRRL B-50421) Bacillus thuringiensis, in particular B. thuringiensis subspecies israelensis (serotype H- 14), strain AM65-52 (Accession No. ATCC 1276), or B. thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372), or B. thuringiensis subsp. kurstaki strain HD-1, or B. thuringiensis subsp. tenebrionis strain NB 176 (SD-5428), Methylorubrum extorquens TS201, Pasteuria penetrans, Pasteuria spp. (Rotylenchulus reniformis nematode)-PR3 (Accession Number ATCC SD-5834), Streptomyces microflavus strain AQ6121 (= QRD 31.013, NRRL B-50550), Streptomyces galbus strain AQ 6047 (Acession Number NRRL 30232). Examples of fungi and yeasts which are employed or can be used as biological pesticides are: Beauveria bassiana, in particular strain ATCC 74040, Coniothyrium minitans, in particular strain BCS233014 FC-Text - 47 - CON/M/91-8 (Accession No. DSM-9660), Lecanicillium spp., in particular strain HRO LEC 12, Lecanicillium lecanii, (formerly known as Verticillium lecanii), in particular strain KV01, Metarhizium anisopliae, in particular strain F52 (DSM3884/ ATCC 90448), Metschnikowia fructicola, in particular strain NRRL Y-30752, Paecilomyces fumosoroseus (now: Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (Accesion No. ATCC 20874), Paecilomyces lilacinus, in particular P. lilacinus strain 251 (AGAL 89/030550), Talaromyces flavus, in particular strain V117b, Trichoderma atroviride, in particular strain SC1 (Accession Number CBS 122089), Trichoderma harzianum, in particular T. harzianum rifai T39. (Accession Number CNCM I-952). Examples of viruses which are employed or can be used as biological pesticides are: Adoxophyes orana (summer fruit tortrix) granulosis virus (GV), Cydia pomonella (codling moth) granulosis virus (GV), Helicoverpa armigera (cotton bollworm) nuclear polyhedrosis virus (NPV), Spodoptera exigua (beet armyworm) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, Spodoptera littoralis (African cotton leafworm) NPV. Also included are bacteria and fungi which are added as 'inoculant' to plants or plant parts or plant organs and which, by virtue of their particular properties, promote plant growth and plant health. Examples which may be mentioned are: Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia), Gigaspora spp., or Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp., Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., in particular Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suillus spp., Streptomyces spp. Examples of plant extracts and products formed by microorganisms including proteins and secondary metabolites which are employed or can be used as biological pesticides are: Allium sativum, Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), Pyrethrum/Pyrethrins, Quassia amara, Quercus, Quillaja, Regalia, "Requiem ™ Insecticide", rotenone, ryania/ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, Brassicaceae extract, in particular oilseed rape powder or mustard powder, as well as bioinsecticidal / acaricidal active substances obtained from olive oil, in particular unsaturated fatty/carboxylic acids having carbon chain lengths C16-C20 as active ingredients, such as, for example, contained in the product with the trade name FLiPPER®. BCS233014 FC-Text - 48 - Safener as mixing components The compounds of the formula (I) can be combined with safeners such as, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole, isoxadifen (-ethyl), mefenpyr (-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulphonyl)benzamide (CAS 129531- 12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS 71526-07-3), 2,2,5-trimethyl-3- (dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4). Plants and plant parts All plants and plant parts can be treated in accordance with the invention. Here, plants are to be understood to mean all plants and plant parts such as wanted and unwanted wild plants or crop plants (including naturally occurring crop plants), for example cereals (wheat, rice, triticale, barley, rye, oats), maize, soya bean, potato, sugar beet, sugar cane, tomatoes, pepper, cucumber, melon, carrot, watermelon, onion, lettuce, spinach, leek, beans, Brassica oleracea (e.g. cabbage) and other vegetable species, cotton, tobacco, oilseed rape, and also fruit plants (with the fruits apples, pears, citrus fruits and grapevines). Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or cannot be protected by varietal property rights. Plants should be understood to mean all developmental stages, such as seeds, seedlings, young (immature) plants up to mature plants. Plant parts should be understood to mean all parts and organs of the plants above and below ground, such as shoot, leaf, flower and root, examples given being leaves, needles, stalks, stems, flowers, fruit bodies, fruits and seeds, and also tubers, roots and rhizomes. Parts of plants also include harvested plants or harvested plant parts and vegetative and generative propagation material, for example seedlings, tubers, rhizomes, cuttings and seeds. Treatment according to the invention of the plants and plant parts with the compounds of the formula (I) is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on, injection and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats. As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and also parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (genetically modified organisms), and parts thereof are treated. The term “parts” or “parts of plants” or “plant parts” has been explained above. The invention is used with particular preference to treat plants of the respective commercially customary BCS233014 FC-Text - 49 - cultivars or those that are in use. Plant cultivars are to be understood as meaning plants having new properties ("traits") and which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes. Transgenic plant, seed treatment and integration events According to the invention, the compounds of formula (I) can be advantageously used to treat transgenic plants, plant cultivars or plant parts that received genetic material which imparts advantageous and/or useful properties (traits) to these plants, plant cultivars or plant parts. Therefore, it is contemplated that the present invention may be combined with one or more recombinant traits or transgenic event(s) or a combination thereof. For the purposes of this application, a transgenic event is created by the insertion of a specific recombinant DNA molecule into a specific position (locus) within the chromosome of the plant genome. The insertion creates a novel DNA sequence referred to as an “event” and is characterized by the inserted recombinant DNA molecule and some amount of genomic DNA immediately adjacent to/flanking both ends of the inserted DNA. Such trait(s) or transgenic event(s) include, but are not limited to, pest resistance, water use efficiency, yield performance, drought tolerance, seed quality, improved nutritional quality, hybrid seed production, and herbicide tolerance, in which the trait is measured with respect to a plant lacking such trait or transgenic event. Concrete examples of such advantageous and/or useful properties (traits) are better plant growth, vigor, stress tolerance, standability, lodging resistance, nutrient uptake, plant nutrition, and/or yield, in particular improved growth, increased tolerance to high or low temperatures, increased tolerance to drought or to levels of water or soil salinity, enhanced flowering performance, easier harvesting, accelerated ripening, higher yields, higher quality and/or a higher nutritional value of the harvested products, better storage life and/or processability of the harvested products, and increased resistance or tolerance against animal and microbial pests, such as against insects, arachnids, nematodes, mites, slugs and snails. Among DNA sequences encoding proteins which confer properties of resistance or tolerance to such animal and microbial pests, in particular insects, mention will particularly be made of the genetic material from Bacillus thuringiensis encoding the Bt proteins widely described in the literature and well known to those skilled in the art. Mention will also be made of proteins extracted from bacteria such as Photorhabdus (WO97/17432 and WO98/08932). In particular, mention will be made of the Bt Cry or VIP proteins which include the CrylA, CryIAb, CryIAc, CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF proteins or toxic fragments thereof and also hybrids or combinations thereof, especially the CrylF protein or hybrids derived from a CrylF protein (e.g. hybrid CrylA-CrylF proteins or toxic fragments thereof), the CrylA-type proteins or toxic fragments thereof, preferably the CrylAc protein or hybrids derived from the CrylAc protein (e.g. hybrid CrylAb-CrylAc proteins) or the CrylAb or Bt2 protein or toxic fragments thereof, the Cry2Ae, Cry2Af or Cry2Ag proteins or toxic fragments thereof, the CrylA.105 protein or a toxic fragment thereof, the VIP3Aa19 protein, the VIP3Aa20 protein, the VIP3A proteins produced in the COT202 or COT203 cotton events, the BCS233014 FC-Text - 50 - VIP3Aa protein or a toxic fragment thereof as described in Estruch et al. (1996), Proc Natl Acad Sci US A.28;93(11):5389-94, the Cry proteins as described in WO2001/47952, the insecticidal proteins from Xenorhabdus (as described in WO98/50427), Serratia (particularly from S. entomophila) or Photorhabdus species strains, such as Tc-proteins from Photorhabdus as described in WO98/08932. Also any variants or mutants of any one of these proteins differing in some amino acids (1-10, preferably 1-5) from any of the above named sequences, particularly the sequence of their toxic fragment, or which are fused to a transit peptide, such as a plastid transit peptide, or another protein or peptide, is included herein. Another and particularly emphasized example of such properties is conferred tolerance to one or more herbicides, for example imidazolinones, sulphonylureas, glyphosate or phosphinothricin. Among DNA sequences encoding proteins which confer properties of tolerance to certain herbicides on the transformed plant cells and plants, mention will be particularly be made to the bar or PAT gene or the Streptomyces coelicolor gene described in WO2009/152359 which confers tolerance to glufosinate herbicides, a gene encoding a suitable EPSPS (5-enolpyruvylshikimat-3-phosphat-synthase) which confers tolerance to herbicides having EPSPS as a target, especially herbicides such as glyphosate and its salts, a gene encoding glyphosate-n-acetyltransferase, or a gene encoding glyphosate oxidoreductase. Further suitable herbicide tolerance traits include at least one ALS (acetolactate synthase) inhibitor (e.g. WO2007/024782), a mutated Arabidopsis ALS/AHAS gene (e.g. U.S. Patent 6,855,533), genes encoding 2,4-D- monooxygenases conferring tolerance to 2,4-D (2,4- dichlorophenoxyacetic acid) and genes encoding Dicamba monooxygenases conferring tolerance to dicamba (3,6-dichloro-2- methoxybenzoic acid). Further and particularly emphasized examples of such properties are increased resistance against phytopathogenic fungi, bacteria and/or viruses owing, for example, to systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and also resistance genes and correspondingly expressed proteins and toxins. Particularly useful transgenic events in transgenic plants or plant cultivars which can be treated with preference in accordance with the invention include Event 531/ PV-GHBK04 (cotton, insect control, described in WO2002/040677), Event 1143-14A (cotton, insect control, not deposited, described in WO2006/128569); Event 1143-51B (cotton, insect control, not deposited, described in WO2006/128570); Event 1445 (cotton, herbicide tolerance, not deposited, described in US-A 2002- 120964 or WO2002/034946); Event 17053 (rice, herbicide tolerance, deposited as PTA-9843, described in WO2010/117737); Event 17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO2010/117735); Event 281-24-236 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in WO2005/103266 or US-A 2005-216969); Event 3006-210-23 (cotton, insect control - herbicide tolerance, deposited as PTA-6233, described in US-A 2007-143876 orWO2005/103266); Event 3272 (corn, quality trait, deposited as PTA-9972, described in WO2006/098952 or US-A 2006-230473); Event 33391 (wheat, herbicide tolerance, deposited as BCS233014 FC-Text - 51 - PTA-2347, described in WO2002/027004), Event 40416 (corn, insect control - herbicide tolerance, deposited as ATCC PTA-11508, described in WO 11/075593); Event 43A47 (corn, insect control - herbicide tolerance, deposited as ATCC PTA-11509, described in WO2011/075595); Event 5307 (corn, insect control, deposited as ATCC PTA-9561, described in WO2010/077816); Event ASR- 368 (bent grass, herbicide tolerance, deposited as ATCC PTA-4816, described in US-A 2006-162007 or WO2004/053062); Event B16 (corn, herbicide tolerance, not deposited, described in US-A 2003- 126634); Event BPS-CV127- 9 (soybean, herbicide tolerance, deposited as NCIMB No. 41603, described in WO2010/080829); Event BLRl (oilseed rape, restoration of male sterility, deposited as NCIMB 41193, described in WO2005/074671), Event CE43-67B (cotton, insect control, deposited as DSM ACC2724, described in US-A 2009-217423 or WO2006/128573); Event CE44-69D (cotton, insect control, not deposited, described in US-A 2010- 0024077); Event CE44-69D (cotton, insect control, not deposited, described in WO2006/128571); Event CE46-02A (cotton, insect control, not deposited, described in WO2006/128572); Event COT102 (cotton, insect control, not deposited, described in US-A 2006-130175 or WO2004/039986); Event COT202 (cotton, insect control, not deposited, described in US-A 2007-067868 or WO2005/054479); Event COT203 (cotton, insect control, not deposited, described in WO2005/054480); ); Event DAS21606-3 / 1606 (soybean, herbicide tolerance, deposited as PTA-11028, described in WO2012/033794), Event DAS40278 (corn, herbicide tolerance, deposited as ATCC PTA-10244, described in WO2011/022469); Event DAS-44406-6 / pDAB8264.44.06.l (soybean, herbicide tolerance, deposited as PTA-11336, described in WO2012/075426), Event DAS-14536-7 /pDAB8291.45.36.2 (soybean, herbicide tolerance, deposited as PTA-11335, described in WO2012/075429), Event DAS-59122-7 (corn, insect control - herbicide tolerance, deposited as ATCC PTA 11384, described in US-A 2006- 070139); Event DAS-59132 (corn, insect control - herbicide tolerance, not deposited, described in WO2009/100188); Event DAS68416 (soybean, herbicide tolerance, deposited as ATCC PTA-10442, described in WO2011/066384 or WO2011/066360); Event DP-098140-6 (corn, herbicide tolerance, deposited as ATCC PTA-8296, described in US-A 2009- 137395 or WO 08/112019); Event DP- 305423-1 (soybean, quality trait, not deposited, described in US-A 2008-312082 or WO2008/054747); Event DP-32138-1 (corn, hybridization system, deposited as ATCC PTA-9158, described in US-A 2009-0210970 or WO2009/103049); Event DP-356043-5 (soybean, herbicide tolerance, deposited as ATCC PTA-8287, described in US-A 2010-0184079 or WO2008/002872); Event EE-I (brinjal, insect control, not deposited, described in WO 07/091277); Event Fil 17 (corn, herbicide tolerance, deposited as ATCC 209031, described in US-A 2006-059581 or WO 98/044140); Event FG72 (soybean, herbicide tolerance, deposited as PTA-11041, described in WO2011/063413), Event GA21 (corn, herbicide tolerance, deposited as ATCC 209033, described in US-A 2005-086719 or WO 98/044140); Event GG25 (corn, herbicide tolerance, deposited as ATCC 209032, described in US-A 2005-188434 or WO98/044140); Event GHB119 (cotton, insect control - herbicide tolerance, deposited as ATCC PTA-8398, described in WO2008/151780); Event GHB614 (cotton, herbicide tolerance, deposited as ATCC PTA-6878, described in US-A 2010-050282 or W02007/017186); BCS233014 FC-Text - 52 - Event GJ11 (corn, herbicide tolerance, deposited as ATCC 209030, described in US-A 2005-188434 or WO98/044140); Event GM RZ13 (sugar beet, virus resistance, deposited as NCIMB-41601, described in WO2010/076212); Event H7-l (sugar beet, herbicide tolerance, deposited as NCIMB 41158 or NCIMB 41159, described in US-A 2004-172669 or WO 2004/074492); Event JOPLINl (wheat, disease tolerance, not deposited, described in US-A 2008-064032); Event LL27 (soybean, herbicide tolerance, deposited as NCIMB41658, described in WO2006/108674 or US-A 2008- 320616); Event LL55 (soybean, herbicide tolerance, deposited as NCIMB 41660, described in WO 2006/108675 or US-A 2008-196127); Event LLcotton25 (cotton, herbicide tolerance, deposited as ATCC PTA-3343, described in WO2003/013224 or US- A 2003-097687); Event LLRICE06 (rice, herbicide tolerance, deposited as ATCC 203353, described in US 6,468,747 or WO2000/026345); Event LLRice62 (rice, herbicide tolerance, deposited as ATCC 203352, described in WO2000/026345), Event LLRICE601 (rice, herbicide tolerance, deposited as ATCC PTA-2600, described in US-A 2008-2289060 or WO2000/026356); Event LY038 (corn, quality trait, deposited as ATCC PTA-5623, described in US-A 2007-028322 or WO2005/061720); Event MIR162 (corn, insect control, deposited as PTA-8166, described in US-A 2009-300784 or WO2007/142840); Event MIR604 (corn, insect control, not deposited, described in US-A 2008-167456 or WO2005/103301); Event MON15985 (cotton, insect control, deposited as ATCC PTA-2516, described in US-A 2004- 250317 or WO2002/100163); Event MON810 (corn, insect control, not deposited, described in US- A 2002-102582); Event MON863 (corn, insect control, deposited as ATCC PTA-2605, described in WO2004/011601 or US-A 2006-095986); Event MON87427 (corn, pollination control, deposited as ATCC PTA-7899, described in WO2011/062904); Event MON87460 (corn, stress tolerance, deposited as ATCC PTA-8910, described in WO2009/111263 or US-A 2011-0138504); Event MON87701 (soybean, insect control, deposited as ATCC PTA- 8194, described in US-A 2009- 130071 or WO2009/064652); Event MON87705 (soybean, quality trait - herbicide tolerance, deposited as ATCC PTA-9241, described in US-A 2010-0080887 or WO2010/037016); Event MON87708 (soybean, herbicide tolerance, deposited as ATCC PTA-9670, described in WO2011/034704); Event MON87712 (soybean, yield, deposited as PTA-10296, described in WO2012/051199), Event MON87754 (soybean, quality trait, deposited as ATCC PTA-9385, described in WO2010/024976); Event MON87769 (soybean, quality trait, deposited as ATCC PTA- 8911, described in US-A 2011-0067141 or WO2009/102873); Event MON88017 (corn, insect control - herbicide tolerance, deposited as ATCC PTA-5582, described in US-A 2008-028482 or WO2005/059103); Event MON88913 (cotton, herbicide tolerance, deposited as ATCC PTA-4854, described in WO2004/072235 or US-A 2006-059590); Event MON88302 (oilseed rape, herbicide tolerance, deposited as PTA-10955, described in WO2011/153186), Event MON88701 (cotton, herbicide tolerance, deposited as PTA-11754, described in WO2012/134808), Event MON89034 (corn, insect control, deposited as ATCC PTA-7455, described in WO 07/140256 or US-A 2008- 260932); Event MON89788 (soybean, herbicide tolerance, deposited as ATCC PTA-6708, described in US-A 2006-282915 or WO2006/130436); Event MSl 1 (oilseed rape, pollination control - herbicide BCS233014 FC-Text - 53 - tolerance, deposited as ATCC PTA-850 or PTA-2485, described in WO2001/031042); Event MS8 (oilseed rape, pollination control - herbicide tolerance, deposited as ATCC PTA-730, described in WO2001/041558 or US-A 2003-188347); Event NK603 (corn, herbicide tolerance, deposited as ATCC PTA-2478, described in US-A 2007-292854); Event PE-7 (rice, insect control, not deposited, described in WO2008/114282); Event RF3 (oilseed rape, pollination control - herbicide tolerance, deposited as ATCC PTA-730, described in WO2001/041558 or US-A 2003-188347); Event RT73 (oilseed rape, herbicide tolerance, not deposited, described in WO2002/036831 or US-A 2008- 070260); Event SYHT0H2 / SYN-000H2-5 (soybean, herbicide tolerance, deposited as PTA-11226, described in WO2012/082548), Event T227-1 (sugar beet, herbicide tolerance, not deposited, described in WO2002/44407 or US-A 2009-265817); Event T25 (corn, herbicide tolerance, not deposited, described in US-A 2001-029014 or WO2001/051654); Event T304-40 (cotton, insect control - herbicide tolerance, deposited as ATCC PTA-8171, described in US-A 2010-077501 or WO2008/122406); Event T342-142 (cotton, insect control, not deposited, described in WO2006/128568); Event TC1507 (corn, insect control - herbicide tolerance, not deposited, described in US-A 2005-039226 or WO2004/099447); Event VIP1034 (corn, insect control - herbicide tolerance, deposited as ATCC PTA-3925, described in WO2003/052073), Event 32316 (corn, insect control-herbicide tolerance, deposited as PTA-11507, described in WO2011/084632), Event 4114 (corn, insect control-herbicide tolerance, deposited as PTA-11506, described in W02011/084621), event EE-GM3 / FG72 (soybean, herbicide tolerance, ATCC Accession N° PTA-11041) optionally stacked with event EE-GM1/LL27 or event EE-GM2/LL55 (WO2011/063413A2), event DAS- 68416-4 (soybean, herbicide tolerance, ATCC Accession N° PTA-10442, WO2011/066360Al), event DAS-68416-4 (soybean, herbicide tolerance, ATCC Accession N° PTA-10442, WO2011/066384Al), event DP-040416-8 (corn, insect control, ATCC Accession N° PTA-11508, WO2011/075593Al), event DP-043A47-3 (corn, insect control, ATCC Accession N° PTA-11509, WO2011/075595Al), event DP- 004114-3 (corn, insect control, ATCC Accession N° PTA-11506, WO2011/084621Al), event DP-032316-8 (corn, insect control, ATCC Accession N° PTA-11507, WO2011/084632Al), event MON-88302-9 (oilseed rape, herbicide tolerance, ATCC Accession N° PTA-10955, WO2011/153186Al), event DAS-21606-3 (soybean, herbicide tolerance, ATCC Accession No. PTA-11028, WO2012/033794A2), event MON-87712-4 (soybean, quality trait, ATCC Accession N°. PTA-10296, WO2012/051199A2), event DAS-44406-6 (soybean, stacked herbicide tolerance, ATCC Accession N°. PTA-11336, WO2012/075426Al), event DAS-14536-7 (soybean, stacked herbicide tolerance, ATCC Accession N°. PTA-11335, WO2012/075429Al), event SYN-000H2-5 (soybean, herbicide tolerance, ATCC Accession N°. PTA-11226, WO2012/082548A2), event DP-061061-7 (oilseed rape, herbicide tolerance, no deposit N° available, WO2012071039Al), event DP-073496-4 (oilseed rape, herbicide tolerance, no deposit N° available, US2012131692), event 8264.44.06.1 (soybean, stacked herbicide tolerance, Accession N° PTA- 11336, WO2012075426A2), event 8291.45.36.2 (soybean, stacked herbicide tolerance, Accession N°. PTA-11335, WO2012075429A2), event SYHT0H2 (soybean, ATCC Accession N°. PTA-11226, BCS233014 FC-Text - 54 - WO2012/082548A2), event MON88701 (cotton, ATCC Accession N° PTA-11754, WO2012/134808Al), event KK179-2 (alfalfa, ATCC Accession N° PTA-11833, WO2013/003558Al), event pDAB8264.42.32.1 (soybean, stacked herbicide tolerance, ATCC Accession N° PTA-11993, WO2013/010094Al), event MZDT09Y (corn, ATCC Accession N° PTA- 13025, WO2013/012775Al). Further, a list of such transgenic event(s) is provided by the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) and can be found on their website at https://www.aphis.usda.gov/. For this application, the status of such list as it is/was on the filing date of this application, is relevant. The genes/events which impart the desired traits in question may also be present in combinations with one another in the transgenic plants. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice, triticale, barley, rye, oats), maize, soya beans, potatoes, sugar beet, sugar cane, tomatoes, peas and other types of vegetable, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis being given to maize, soya beans, wheat, rice, potatoes, cotton, sugar cane, tobacco and oilseed rape. Traits which are particularly emphasized are the increased resistance of the plants to insects, arachnids, nematodes and slugs and snails, as well as the increased resistance of the plants to one or more herbicides. Commercially available examples of such plants, plant parts or plant seeds that may be treated with preference in accordance with the invention include commercial products, such as plant seeds, sold or distributed under the GENUITY®, DROUGHTGARD®, SMARTSTAX®, RIB COMPLETE®, ROUNDUP READY®, VT DOUBLE PRO®, VT TRIPLE PRO®, BOLLGARD II®, ROUNDUP READY 2 YIELD®, YIELDGARD®, ROUNDUP READY® 2 XTENDTM, INTACTA RR2 PRO®, VISTIVE GOLD®, and/or XTENDFLEX™ trade names. Crop protection – types of treatment The treatment of the plants and plant parts with the compounds of the formula (I) is carried out directly or by action on their surroundings, habitat or storage space using customary treatment methods, for example by dipping, spraying, atomizing, irrigating, evaporating, dusting, fogging, broadcasting, foaming, painting, spreading-on, injecting, watering (drenching), drip irrigating and, in the case of propagation material, in particular in the case of seed, furthermore as a powder for dry seed treatment, a solution for liquid seed treatment, a water-soluble powder for slurry treatment, by incrusting, by coating with one or more coats, etc. It is furthermore possible to apply the compounds of the formula (I) by the ultra-low volume method or to inject the application form or the compound of the formula (I) itself into the soil. A preferred direct treatment of the plants is foliar application, i.e. the compounds of the formula (I) are applied to the foliage, where treatment frequency and the application rate should be adjusted according to the level of infestation with the pest in question. BCS233014 FC-Text - 55 - In the case of systemically active compounds, the compounds of the formula (I) also access the plants via the root system. The plants are then treated by the action of the compounds of the formula (I) on the habitat of the plant. This may be done, for example, by drenching, or by mixing into the soil or the nutrient solution, i.e. the locus of the plant (e.g. soil or hydroponic systems) is impregnated with a liquid form of the compounds of the formula (I), or by soil application, i.e. the compounds of the formula (I) according to the invention are introduced in solid form (e.g. in the form of granules) into the locus of the plants, or by drip application (often also referred to as "chemigation"), i.e. the liquid application of the compounds of the formula (I) according to the invention from surface or sub-surface driplines over a certain period of time together with varying amounts of water at defined locations in the vicinity of the plants. In the case of paddy rice crops, this can also be done by metering the compound of the formula (I) in a solid application form (for example as granules) into a flooded paddy field. Digital Technologies The compounds of the invention can be used in combination with models e.g. embedded in computer programs for site specific crop management, satellite farming, precision farming or precision agriculture. Such models support the site specific management of agricultural sites with data from various sources such as soils, weather, crops (e.g. type, growth stage, plant health), weeds (e.g. type, growth stage), diseases, pests, nutrients, water, moisture, biomass, satellite data, yield etc. with the purpose to optimize profitability, sustainability and protection of the environment. In particular, such models can help to optimize agronomical decisions, control the precision of pesticide applications and record the work performed. As an example, the compounds of the invention can be applied to a crop plant according to an appropriate dose regime if a model models the development of a pest and calculates that a threshold has been reached for which it is recommendable to apply the compound of the invention to the crop plant. Commercially available systems which include agronomic models are e.g. FieldScriptsTM from The Climate Corporation, XarvioTM from BASF, AGLogicTM from John Deere, etc. The compounds of the invention can also be used in combination with smart spraying equipment such as e.g. spot spraying or precision spraying equipment attached to or housed within a farm vehicle such as a tractor, robot, helicopter, airplane, unmanned aerial vehicle (UAV) such as a drone, etc. Such an equipment usually includes input sensors (such as e.g. a camera) and a processing unit configured to analyze the input data and configured to provide a decision based on the analysis of the input data to apply the compound of the invention to the crop plants (respectively the weeds) in a specific and precise manner. The use of such smart spraying equipment usually also requires positions systems (e.g. GPS receivers) to localize recorded data and to guide or to control farm vehicles; geographic information systems (GIS) to represent the information on intelligible maps, and appropriate farm vehicles to perform the required farm action such as the spraying. BCS233014 FC-Text - 56 - In an example, pests can be detected from imagery acquired by a camera. In an example the pests can be identified and/or classified based on that imagery. Such identification and/ classification can make use of image processing algorithms. Such image processing algorithms can utilize machine learning algorithms, such as trained neutral networks, decision trees and utilize artificial intelligence algorithms. In this manner, the compounds described herein can be applied only where needed. Treatment of seed The control of animal pests by treating the seed of plants has been known for a long time and is the subject of continuous improvements. However, the treatment of seed entails a series of problems which cannot always be solved in a satisfactory manner. Thus, it is desirable to develop methods for protecting the seed and the germinating plant which dispense with, or at least reduce considerably, the additional application of pesticides during storage, after sowing or after emergence of the plants. It is furthermore desirable to optimize the amount of active compound employed in such a way as to provide optimum protection for the seed and the germinating plant from attack by animal pests, but without damaging the plant itself by the active compound employed. In particular, methods for the treatment of seed should also take into consideration the intrinsic insecticidal or nematicidal properties of pest-resistant or -tolerant transgenic plants in order to achieve optimum protection of the seed and also the germinating plant with a minimum of pesticides being employed. The present invention therefore in particular also relates to a method for the protection of seed and germinating plants, from attack by pests, by treating the seed with one of the compounds of the formula (I). The method according to the invention for protecting seed and germinating plants against attack by pests furthermore comprises a method where the seed is treated simultaneously in one operation or sequentially with a compound of the formula (I) and a mixing component. It also comprises a method where the seed is treated at different times with a compound of the formula (I) and a mixing component. The invention likewise relates to the use of the compounds of the formula (I) for the treatment of seed for protecting the seed and the resulting plant from animal pests. Furthermore, the invention relates to seed which has been treated with a compound of the formula (I) according to the invention so as to afford protection from animal pests. The invention also relates to seed which has been treated simultaneously with a compound of the formula (I) and a mixing component. The invention furthermore relates to seed which has been treated at different times with a compound of the formula (I) and a mixing component. In the case of seed which has been treated at different points in time with a compound of the formula (I) and a mixing component, the individual substances may be present on the seed in different layers. Here, the layers comprising a compound of the formula (I) and mixing components may optionally be separated by an intermediate layer. The invention also relates to seed where a compound of the formula (I) and a mixing component have been applied as component of a coating or as a further layer or further layers in addition to a coating. BCS233014 FC-Text - 57 - Furthermore, the invention relates to seed which, after the treatment with a compound of the formula (I), is subjected to a film-coating process to prevent dust abrasion on the seed. One of the advantages encountered with a systemically acting compound of the formula (I) is the fact that, by treating the seed, not only the seed itself but also the plants resulting therefrom are, after emergence, protected against animal pests. In this manner, the immediate treatment of the crop at the time of sowing or shortly thereafter can be dispensed with. It has to be considered a further advantage that by treatment of the seed with a compound of the formula (I), germination and emergence of the treated seed may be enhanced. It is likewise to be considered advantageous that compounds of the formula (I) can be used in particular also for transgenic seed. Furthermore, compounds of the formula (I) can be employed in combination with compositions or compounds of signalling technology, leading to better colonization by symbionts such as, for example, rhizobia, mycorrhizae and/or endophytic bacteria or fungi, and/or to optimized nitrogen fixation. The compounds of the formula (I) are suitable for protection of seed of any plant variety which is used in agriculture, in the greenhouse, in forests or in horticulture. In particular, this takes the form of seed of cereals (for example wheat, barley, rye, millet and oats), corn, cotton, soya beans, rice, potatoes, sunflowers, coffee, tobacco, canola, oilseed rape, beets (for example sugarbeets and fodder beets), peanuts, vegetables (for example tomatoes, cucumbers, bean, cruciferous vegetables, onions and lettuce), fruit plants, lawns and ornamental plants. The treatment of the seed of cereals (such as wheat, barley, rye and oats), maize, soya beans, cotton, canola, oilseed rape, vegetables and rice is of particular importance. As already mentioned above, the treatment of transgenic seed with a compound of the formula (I) is also of particular importance. This takes the form of seed of plants which, as a rule, comprise at least one heterologous gene which governs the expression of a polypeptide with in particular insecticidal and/or nematicidal properties. The heterologous genes in transgenic seed can originate from microorganisms such as Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus or Gliocladium. The present invention is particularly suitable for the treatment of transgenic seed which comprises at least one heterologous gene originating from Bacillus sp. It is particularly preferably a heterologous gene derived from Bacillus thuringiensis. In the context of the present invention, the compound of the formula (I) is applied to the seed. Preferably, the seed is treated in a state in which it is stable enough to avoid damage during treatment. In general, the seed may be treated at any point in time between harvest and sowing. The seed usually used has been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seed which has been harvested, cleaned and dried down to a moisture content which allows storage. Alternatively, it is also possible to use seed which, after drying, has been treated BCS233014 FC-Text - 58 - with, for example, water and then dried again, for example priming. In the case of rice seed, it is also possible to use seed which has been soaked, for example in water to a certain stage of the rice embryo (‘pigeon breast stage’), stimulating the germination and a more uniform emergence. When treating the seed, care must generally be taken that the amount of the compound of the formula (I) applied to the seed and/or the amount of further additives is chosen in such a way that the germination of the seed is not adversely affected, or that the resulting plant is not damaged. This must be ensured particularly in the case of active compounds which can exhibit phytotoxic effects at certain application rates. In general, the compounds of the formula (I) are applied to the seed in a suitable formulation. Suitable formulations and processes for seed treatment are known to the person skilled in the art. The compounds of the formula (I) can be converted to the customary seed dressing formulations, such as solutions, emulsions, suspensions, powders, foams, slurries or other coating compositions for seed, and also ULV formulations. These formulations are prepared in a known manner, by mixing the compounds of the formula (I) with customary additives such as, for example, customary extenders and also solvents or diluents, colorants, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins and also water. Colorants which may be present in the seed-dressing formulations which can be used in accordance with the invention are all colorants which are customary for such purposes. It is possible to use either pigments, which are sparingly soluble in water, or dyes, which are soluble in water. Examples include the dyes known by the names Rhodamine B, C.I. Pigment Red 112 and C.I. Solvent Red 1. Useful wetting agents which may be present in the seed dressing formulations usable in accordance with the invention are all substances which promote wetting, and which are conventionally used for the formulation of agrochemically active compounds. Preference is given to using alkylnaphthalenesulphonates, such as diisopropyl- or diisobutylnaphthalenesulphonates. Useful dispersants and/or emulsifiers which may be present in the seed dressing formulations usable in accordance with the invention are all nonionic, anionic and cationic dispersants conventionally used for the formulation of active agrochemical ingredients. Preference is given to using nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Suitable nonionic dispersants include in particular ethylene oxide/propylene oxide block polymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ethers, and the phosphated or sulphated derivatives thereof. Suitable anionic dispersants are in particular lignosulphonates, polyacrylic acid salts and arylsulphonate/formaldehyde condensates. BCS233014 FC-Text - 59 - Antifoams which may be present in the seed dressing formulations usable in accordance with the invention are all foam-inhibiting substances conventionally used for the formulation of active agrochemical ingredients. Preference is given to using silicone antifoams and magnesium stearate. Preservatives which may be present in the seed dressing formulations usable in accordance with the invention are all substances usable for such purposes in agrochemical compositions. Examples include dichlorophene and benzyl alcohol hemiformal. Secondary thickeners which may be present in the seed dressing formulations usable in accordance with the invention are all substances which can be used for such purposes in agrochemical compositions. Cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica are preferred. Adhesives which may be present in the seed dressing formulations usable in accordance with the invention are all customary binders usable in seed dressing products. Polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose may be mentioned as being preferred. Gibberellins which can be present in the seed-dressing formulations which can be used in accordance with the invention are preferably the gibberellins A1, A3 (= gibberellic acid), A4 and A7; gibberellic acid is especially preferably used. The gibberellins are known (cf. R. Wegler "Chemie der Pflanzenschutz- and Schädlingsbekämpfungsmittel", vol.2, Springer Verlag, 1970, pp.401-412). The seed dressing formulations usable in accordance with the invention can be used to treat a wide variety of different kinds of seed either directly or after prior dilution with water. For instance, the concentrates or the preparations obtainable therefrom by dilution with water can be used to dress the seed of cereals, such as wheat, barley, rye, oats, and triticale, and also the seed of maize, rice, oilseed rape, peas, beans, cotton, sunflowers, soya beans and beets, or else a wide variety of different vegetable seed. The seed dressing formulations usable in accordance with the invention, or the dilute use forms thereof, can also be used to dress seed of transgenic plants. For treatment of seed with the seed dressing formulations usable in accordance with the invention, or the use forms prepared therefrom by adding water, all mixing units usable customarily for the seed dressing are useful. Specifically, the procedure in the seed dressing is to place the seed into a mixer, operated batch- wise or continously, to add the particular desired amount of seed dressing formulations, either as such or after prior dilution with water, and to mix everything until the formulation is distributed homogeneously on the seed. If appropriate, this is followed by a drying operation. The application rate of the seed dressing formulations usable in accordance with the invention can be varied within a relatively wide range. It is guided by the particular content of the compounds of the formula (I) in the formulations and by the seed. The application rates of the compound of the formula (I) are BCS233014 FC-Text - 60 - generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 15 g per kilogram of seed. Animal health In the animal health field, i.e. in the field of veterinary medicine, the compounds of the formula (I) are active against animal parasites, in particular ectoparasites or endoparasites. The term endoparasite includes in particular helminths and protozoae, such as coccidia. Ectoparasites are typically and preferably arthropods, in particular insects or acarids. In the field of veterinary medicine, the compounds of the formula (I) are suitable, with favourable toxicity in warm blooded animals, for controlling parasites which occur in animal breeding and animal husbandry in livestock, breeding, zoo, laboratory, experimental and domestic animals. They are active against all or specific stages of development of the parasites. Agricultural livestock include, for example, mammals, such as, sheep, goats, horses, donkeys, camels, buffaloes, rabbits, reindeers, fallow deers, and in particular cattle and pigs; or poultry, such as turkeys, ducks, geese, and in particular chickens; or fish or crustaceans, e.g. in aquaculture; or, as the case may be, insects such as bees. Domestic animals include, for example, mammals, such as hamsters, guinea pigs, rats, mice, chinchillas, ferrets or in particular dogs, cats; cage birds; reptiles; amphibians or aquarium fish. According to a particular embodiment, the compounds of the formula (I) are administered to mammals. According to another particular embodiment, the compounds of the formula (I) are administered to birds, namely cage birds or in particular poultry. By using the compounds of the formula (I) to control animal parasites, it is intended to reduce or prevent illness, cases of deaths and performance reductions (in the case of meat, milk, wool, hides, eggs, honey and the like), so that more economical and simpler animal keeping is made possible and better animal well-being is achievable. The term “control” or "controlling", as used herein with regard to the animal health field, means that the compounds of the formula (I) are effective in reducing the incidence of the respective parasite in an animal infected with such parasites to innocuous levels. More specifically, "controlling", as used herein, means that the compounds of the formula (I) are effective in killing the respective parasite, inhibiting its growth, or inhibiting its proliferation. Exemplary arthropods include, without any limitation from the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.; BCS233014 FC-Text - 61 - from the order of the Mallophagida and the suborders Amblycerina and Ischnocerina, for example Bovicola spp., Damalina spp., Felicola spp., Lepikentron spp., Menopon spp., Trichodectes spp., Trimenopon spp., Trinoton spp., Werneckiella spp.; from the order of the Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Atylotus spp., Braula spp., Calliphora spp., Chrysomyia spp., Chrysops spp., Culex spp., Culicoides spp., Eusimulium spp., Fannia spp., Gasterophilus spp., Glossina spp., Haematobia spp., Haematopota spp., Hippobosca spp., Hybomitra spp., Hydrotaea spp., Hypoderma spp., Lipoptena spp., Lucilia spp., Lutzomyia spp., Melophagus spp., Morellia spp., Musca spp., Odagmia spp., Oestrus spp., Philipomyia spp., Phlebotomus spp., Rhinoestrus spp., Sarcophaga spp., Simulium spp., Stomoxys spp., Tabanus spp., Tipula spp., Wilhelmia spp., Wohlfahrtia spp. from the order of the Siphonapterida, for example Ceratophyllus spp.; Ctenocephalides spp., Pulex spp., Tunga spp., Xenopsylla spp.; from the order of the Heteropterida, for example Cimex spp., Panstrongylus spp., Rhodnius spp., Triatoma spp.; as well as nuisance and hygiene pests from the order of the Blattarida. Further, among the arthropods, the following acari may be mentioned by way of example, without any limitation: from the subclass of the Acari (Acarina) and the order of the Metastigmata, for example, from the family of argasidae like Argas spp., Ornithodorus spp., Otobius spp., from the family of Ixodidae like Amblyomma spp., Dermacentor spp., Haemaphysalis spp., Hyalomma spp., Ixodes spp., Rhipicephalus (Boophilus) spp , Rhipicephalus spp. (the original genus of multi host ticks); from the order of mesostigmata like Dermanyssus spp., Ornithonyssus spp., Pneumonyssus spp., Raillietia spp., Sternostoma spp., Tropilaelaps spp., Varroa spp.; from the order of the Actinedida (Prostigmata), for example Acarapis spp., Cheyletiella spp., Demodex spp., Listrophorus spp., Myobia spp., Neotrombicula spp., Ornithocheyletia spp., Psorergates spp., Trombicula spp.; and from the order of the Acaridida (Astigmata), for example Acarus spp., Caloglyphus spp., Chorioptes spp., Cytodites spp., Hypodectes spp., Knemidocoptes spp., Laminosioptes spp., Notoedres spp., Otodectes spp., Psoroptes spp., Pterolichus spp., Sarcoptes spp., Trixacarus spp., Tyrophagus spp. Exemplary parasitic protozoa include, without any limitation: Mastigophora (Flagellata) such as: Metamonada: from the order Diplomonadida, for example, Giardia spp., Spironucleus spp. Parabasala: from the order Trichomonadida, for example, Histomonas spp., Pentatrichomonas spp., Tetratrichomonas spp., Trichomonas spp., Tritrichomonas spp. Euglenozoa: from the order Trypanosomatida, for example, Leishmania spp., Trypanosoma spp BCS233014 FC-Text - 62 - Sarcomastigophora (Rhizopoda), such as Entamoebidae, for example, Entamoeba spp., Centramoebidae, for example, Acanthamoeba sp., Euamoebidae, e.g. Hartmanella sp. Alveolata such as Apicomplexa (Sporozoa): e.g. Cryptosporidium spp.; from the order Eimeriida, for example, Besnoitia spp., Cystoisospora spp., Eimeria spp., Hammondia spp., Isospora spp., Neospora spp., Sarcocystis spp., Toxoplasma spp.; from the order Adeleida e.g. Hepatozoon spp., Klossiella spp.; from the order Haemosporida e.g. Leucocytozoon spp., Plasmodium spp.; from the order Piroplasmida e.g. Babesia spp., Ciliophora spp., Echinozoon spp., Theileria spp.; from the order Vesibuliferida e.g. Balantidium spp., Buxtonella spp. Microspora such as Encephalitozoon spp., Enterocytozoon spp., Globidium spp., Nosema spp., and furthermore, e.g. Myxozoa spp. Helminths pathogenic for humans or animals include, for example, acanthocephala, nematodes, pentastoma and platyhelmintha (e.g. monogenea, cestodes and trematodes). Exemplary helminths include, without any limitation: Monogenea: e.g.: Dactylogyrus spp., Gyrodactylus spp., Microbothrium spp., Polystoma spp., Troglocephalus spp. Cestodes: from the order of the Pseudophyllidea, for example: Bothridium spp., Diphyllobothrium spp., Diplogonoporus spp., Ichthyobothrium spp., Ligula spp., Schistocephalus spp., Spirometra spp. from the order of the Cyclophyllida, for example: Andyra spp., Anoplocephala spp., Avitellina spp., Bertiella spp., Cittotaenia spp., Davainea spp., Diorchis spp., Diplopylidium spp., Dipylidium spp., Echinococcus spp., Echinocotyle spp., Echinolepis spp., Hydatigera spp., Hymenolepis spp., Joyeuxiella spp., Mesocestoides spp., Moniezia spp., Paranoplocephala spp., Raillietina spp., Stilesia spp., Taenia spp., Thysaniezia spp., Thysanosoma spp. Trematodes: from the class of the Digenea, for example: Austrobilharzia spp., Brachylaima spp., Calicophoron spp., Catatropis spp., Clonorchis spp. Collyriclum spp., Cotylophoron spp., Cyclocoelum spp., Dicrocoelium spp., Diplostomum spp., Echinochasmus spp., Echinoparyphium spp., Echinostoma spp., Eurytrema spp., Fasciola spp., Fasciolides spp., Fasciolopsis spp., Fischoederius spp., Gastrothylacus spp., Gigantobilharzia spp., Gigantocotyle spp., Heterophyes spp., Hypoderaeum spp., Leucochloridium spp., Metagonimus spp., Metorchis spp., Nanophyetus spp., Notocotylus spp., Opisthorchis spp., Ornithobilharzia spp., Paragonimus spp., Paramphistomum spp., Plagiorchis spp., Posthodiplostomum spp., Prosthogonimus spp., Schistosoma spp., Trichobilharzia spp., Troglotrema spp., Typhlocoelum spp. Nematodes: from the order of the Trichinellida, for example: Capillaria spp., Eucoleus spp., Paracapillaria spp., Trichinella spp., Trichomosoides spp., Trichuris spp. BCS233014 FC-Text - 63 - from the order of the Tylenchida, for example: Micronema spp., Parastrongyloides spp., Strongyloides spp. from the order of the Rhabditina, for example: Aelurostrongylus spp., Amidostomum spp., Ancylostoma spp., Angiostrongylus spp., Bronchonema spp., Bunostomum spp., Chabertia spp., Cooperia spp., Cooperioides spp., Crenosoma spp., Cyathostomum spp., Cyclococercus spp., Cyclodontostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylindropharynx spp., Cystocaulus spp., Dictyocaulus spp., Elaphostrongylus spp., Filaroides spp., Globocephalus spp., Graphidium spp., Gyalocephalus spp., Haemonchus spp., Heligmosomoides spp., Hyostrongylus spp., Marshallagia spp., Metastrongylus spp., Muellerius spp., Necator spp., Nematodirus spp., Neostrongylus spp., Nippostrongylus spp., Obeliscoides spp., Oesophagodontus spp., Oesophagostomum spp., Ollulanus spp.; Ornithostrongylus spp., Oslerus spp., Ostertagia spp., Paracooperia spp., Paracrenosoma spp., Parafilaroides spp., Parelaphostrongylus spp., Pneumocaulus spp., Pneumostrongylus spp., Poteriostomum spp., Protostrongylus spp., Spicocaulus spp., Stephanurus spp., Strongylus spp., Syngamus spp., Teladorsagia spp., Trichonema spp., Trichostrongylus spp., Triodontophorus spp., Troglostrongylus spp., Uncinaria spp. from the order of the Spirurida, for example: Acanthocheilonema spp., Anisakis spp., Ascaridia spp.; Ascaris spp., Ascarops spp., Aspiculuris spp., Baylisascaris spp., Brugia spp., Cercopithifilaria spp., Crassicauda spp., Dipetalonema spp., Dirofilaria spp., Dracunculus spp.; Draschia spp., Enterobius spp., Filaria spp., Gnathostoma spp., Gongylonema spp., Habronema spp., Heterakis spp.; Litomosoides spp., Loa spp., Onchocerca spp., Oxyuris spp., Parabronema spp., Parafilaria spp., Parascaris spp., Passalurus spp., Physaloptera spp., Probstmayria spp., Pseudofilaria spp., Setaria spp., Skjrabinema spp., Spirocerca spp., Stephanofilaria spp., Strongyluris spp., Syphacia spp., Thelazia spp., Toxascaris spp., Toxocara spp., Wuchereria spp. Acantocephala: from the order of the Oligacanthorhynchida, for example: Macracanthorhynchus spp., Prosthenorchis spp.; from the order of the Moniliformida, for example: Moniliformis spp. from the order of the Polymorphida, for example: Filicollis spp.; from the order of the Echinorhynchida, for example: Acanthocephalus spp., Echinorhynchus spp., Leptorhynchoides spp. Pentastoma: from the order of the Porocephalida, for example: Linguatula spp. Fish parasites include crustaceans which in turn include the family Caligidae with representative genus Dissonus, Caligus (i.e. C. curtus, C. elongatus, C. clemensi, C.rogercresseyii), and Lepeophtheirus (i.e. L. salmonis); families Cecropidae, Dichelesthiidae, Lernaeopodidae with representative genus Salmincola; families Pandaridae, Pennellidae with representative genus Lernaeocera and Pennella; and family Sphyriidae; family Lernaeidae with representative genus Lernaea; families Bomolochidae, Chondracanthidae, Ergasilidae and Philichthyidae; family Argulidae with representative genus Argulus (I..e. A. foliaceus). BCS233014 FC-Text - 64 - In the veterinary field and in animal keeping, the administration of the compounds of the formula (I) is carried out by methods generally known in the art, such as enterally, parenterally, dermally or nasally, in the form of suitable preparations. Administration can be carried out prophylactically, methaphylactically or therapeutically. Thus, one embodiment of the present invention refers to the compounds of the formula (I) for use as a medicament. Another aspect refers to the compounds of the formula (I) for use as an antiendoparasitical agent. Another particular aspect refers to the compounds of the formula (I) for use as a anthelmintic agent, more particular for use as a nematicidal agent, a platyhelminthicidal agent, an acanthocephalicidal agent, or a pentastomicidal agent. Another particular aspect refers to the compounds of the formula (I) for use as an antiprotozoal agent. Another aspect refers to the compounds of the formula (I) for use as an antiectoparasitical agent, in particular an arthropodicidal agent, more particular an insecticidal agent or acaricidal agent. Further aspects of the invention are veterinary formulations, comprising an effective amount of at least one compound of the formula (I) and at least one of the following: pharmaceutically acceptable excipient (e.g. solid or liquid diluents), pharmaceutically acceptable auxiliary (e.g. surfactants), in particular a pharmaceutically acceptable excipient and/or pharmaceutically acceptable auxiliary which is normally used in veterinary formulations. A related aspect of the invention is a method for preparing a veterinary formulation as described herein, comprising the step of mixing at least one compound of the formula (I) with pharmaceutically acceptable excipients and/or auxiliaries, in particular with pharmaceutically acceptable excipients and/or auxiliaries which are normally used in veterinary formulations. Another particular aspect of the invention are veterinary formulations, selected from the group of ectoparasiticidal and endoparasiticidal formulations, more particular selected from the group of anthelmintic, antiprotozoal, and arthropodicidal formulations, even more particular selected from the group of nematicidal, platyhelminthicidal, acanthocephalicidal, pentastomicidal, insecticidal, and acaricidal formulations, in accordance with the mentioned aspects, as well as their methods for preparation. Another aspect refers to a method for treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying an effective amount of a compound of the formula (I) to an animal, in particular a non-human animal, in need thereof. BCS233014 FC-Text - 65 - Another aspect refers to a method for treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, by applying a veterinary formulation as defined herein to an animal, in particular a non-human animal, in need thereof. Another aspect refers to the use of the compounds of the formula (I) in the treatment of a parasitic infection, in particular an infection by a parasite selected from the group of ectoparasites and endoparasites mentioned herein, in an animal, in particular a non-human animal. In the present context of the animal health or veterinary field, the term "treatment" includes prophylactic, metaphylactic or therapeutical treatment. In a particular embodiment, mixtures of at least one compound of the formula (I) with other active ingredients, particularly with endo- and ectoparasiticides, for the veterinary field are provided herewith. In the field of animal health “mixture” not only means that two (or more) different active ingredients are formulated in a joint formulation and are accordingly applied together but also refers to products which comprise separate formulations for each active compound. Accordingly, if more than two active compounds are to be applied, all active compounds may be formulated in a joint formulation or all active compounds may be formulated in separate formulations; also feasible are mixed forms where some of the active compounds are formulated jointly and some of the active compounds are formulated separately. Separate formulations allow the separate or successive application of the active compounds in question. The active compounds specified herein by their common names are known and described, for example, in the Pesticide Manual (see above) or can be searched in the internet (e.g. http://www.alanwood.net/pesticides). Exemplary active ingredients from the group of ectoparasiticides, as mixing partners, include, without limitation insecticides and acaricides listed in detail above. Further active ingredients which may be used are listed below following the aforementioned classification which is based on the current IRAC Mode of Action Classification Scheme: (1) Acetylcholinesterase (AChE) inhibitors; (2) GABA-gated chloride channel blockers; (3) Sodium channel modulators; (4) Nicotinic acetylcholine receptor (nAChR) competitive modulators; (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators; (6) Glutamate-gated chloride channel (GluCl) allosteric modulators; (7) Juvenile hormone mimics; (8) Miscellaneous non-specific (multi-site) inhibitors; (9) Modulators of chordotonal organs; (10) Mite growth inhibitors; (12) Inhibitors of mitochondrial ATP synthase, such as, ATP disruptors; (13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient; (14) Nicotinic acetylcholine receptor channel blockers; (15) Inhibitors of chitin biosynthesis, type 0; (16) Inhibitors of chitin biosynthesis, type 1; (17) Moulting disruptor (in particular for Diptera, i.e. dipterans); (18) Ecdysone receptor agonists; (19) Octopamine receptor agonists; (21) Mitochondrial complex I electron transport inhibitors; (25) Mitochondrial complex II electron transport inhibitors; (20) Mitochondrial complex III electron transport inhibitors; (22) Voltage-dependent sodium channel blockers; (23) Inhibitors of acetyl BCS233014 FC-Text - 66 - CoA carboxylase; (28) Ryanodine receptor modulators; (30) GABA-gated chloride channel allosteric modulators; (33) Calcium-activated potassium channel KCa2 modulators; (34) Mitochondrial complex III electron transfer inhibitors, non-Qo site. Active compounds with unknown or non-specific mode of action, e.g., fentrifanil, fenoxacrim, cycloprene, chlorobenzilate, chlordimeform, flubenzimine, dicyclanil, amidoflumet, quinomethionate, triarathene, clothiazoben, tetrasul, potassium oleate, petroleum, metoxadiazone, gossyplure, flutenzin, bromopropylate, cryolite; Compounds from other classes: butacarb, dimetilan, cloethocarb, phosphocarb, pirimiphos (-ethyl), parathion (-ethyl), methacrifos, isopropyl o-salicylate, trichlorfon, sulprofos, propaphos, sebufos, pyridathion, prothoate, dichlofenthion, demeton-S-methylsulphone, isazofos, cyanofenphos, dialifos, carbophenothion, autathiofos, aromfenvinfos (-methyl), azinphos (-ethyl), chlorpyrifos (-ethyl), fosmethilan, iodofenphos, dioxabenzofos, formothion, fonofos, flupyrazofos, fensulfothion, etrimfos, atelocantel; organochlorines, e.g. camphechlor, lindane, heptachlor; phenylpyrazoles, e.g. acetoprole, pyrafluprole, pyriprole, vaniliprole, sisapronil; isoxazolines, e.g. afoxolaner, esafoxolaner, fluralaner, lotilaner, mivorilaner, modoflaner, sarolaner, umifoxolaner; pyrazolyl-arylamides, e.g. nicofluprole, tigolaner; pyrethroids, e.g. (cis-, trans-)metofluthrin, profluthrin, flufenprox, flubrocythrinate, fubfenprox, fenfluthrin, protrifenbute, pyresmethrin, RU15525, terallethrin, cis-resmethrin, heptafluthrin, , bioethanomethrin, biopermethrin, fenpyrithrin, cis-cypermethrin, cis-permethrin, clocythrin, cyhalothrin (lambda-), chlovaporthrin, or halogenated carbonhydrogen compounds (HCHs); neonicotinoids, e.g. nithiazine; dicloromezotiaz, triflumezopyrim; macrocyclic lactones, e.g. nemadectin, ivermectin, latidectin, moxidectin, selamectin, eprinomectin, doramectin, emamectin benzoate, milbemycin oxime; triprene, epofenonane, diofenolan; biologicals, hormones or pheromones, for example natural products, e.g. thuringiensin, codlemone or neem components; dinitrophenols, e.g. dinocap, dinobuton, binapacryl; BCS233014 FC-Text - 67 - benzoylureas, e.g. fluazuron, penfluron; amidine derivatives, e.g. chlormebuform, cymiazole, demiditraz; tetronic or tetramic acid derivatives, e.g. spidoxamat, spirobudiclofen; beehive varroa acaricides, for example organic acids, e.g. formic acid, oxalic acid. Exemplary active ingredients from the group of endoparasiticides, as mixing partners, include, without limitation, anthelmintically active compounds and antiprotozoal active compounds. Anthelmintically active compounds, including, without limitation, the following nematicidally, trematicidally and/or cestocidally active compounds: from the class of macrocyclic lactones, for example: eprinomectin, abamectin, nemadectin, moxidectin, doramectin, selamectin, lepimectin, latidectin, milbemectin, ivermectin, emamectin, milbemycin; from the class of benzimidazoles and probenzimidazoles, for example: oxibendazole, mebendazole, triclabendazole, thiophanate, parbendazole, oxfendazole, netobimin, fenbendazole, febantel, thiabendazole, cyclobendazole, cambendazole, albendazole-sulphoxide, albendazole, flubendazole; from the class of depsipeptides, preferably cyclic depsipetides, in particular 24-membered cyclic depsipeptides, for example: emodepside, PF1022A; from the class of tetrahydropyrimidines, for example: morantel, pyrantel, oxantel; from the class of imidazothiazoles, for example: butamisole, levamisole, tetramisole; from the class of aminophenylamidines, for example: amidantel, deacylated amidantel (dAMD), tribendimidine; from the class of aminoacetonitriles, for example: monepantel; from the class of paraherquamides, for example: paraherquamide, derquantel; from the class of salicylanilides, for example: tribromsalan, bromoxanide, brotianide, clioxanide, closantel, niclosamide, oxyclozanide, rafoxanide; from the class of substituted phenols, for example: nitroxynil, bithionol, disophenol, hexachlorophene, niclofolan, meniclopholan; from the class of organophosphates, for example: trichlorfon, naphthalofos, dichlorvos/DDVP, crufomate, coumaphos, haloxon; from the class of piperazinones / quinolines, for example: praziquantel, arpraziquantel, epsiprantel; BCS233014 FC-Text - 68 - from the class of piperazines, for example: piperazine, hydroxyzine; from the class of tetracyclines, for example: tetracyclin, chlorotetracycline, doxycyclin, oxytetracyclin, rolitetracyclin; from diverse other classes, for example: bunamidine, niridazole, resorantel, omphalotin, oltipraz, nitroscanate, nitroxynile, oxamniquine, mirasan, miracil, lucanthone, hycanthone, hetolin, emetine, diethylcarbamazine, dichlorophen, diamfenetide, clonazepam, bephenium, amoscanate, clorsulon. Antiprotozoal active compounds, including, without limitation, the following active compounds: from the class of triazines, for example: diclazuril, ponazuril, letrazuril, toltrazuril; from the class of polylether ionophore, for example: monensin, salinomycin, maduramicin, narasin; from the class of macrocyclic lactones, for example: milbemycin, erythromycin; from the class of quinolones, for example: enrofloxacin, pradofloxacin; from the class of quinines, for example: chloroquine; from the class of pyrimidines, for example: pyrimethamine; from the class of sulfonamides, for example: sulfaquinoxaline, trimethoprim, sulfaclozin; from the class of thiamines, for example: amprolium; from the class of lincosamides, for example: clindamycin; from the class of carbanilides, for example: imidocarb; from the class of nitrofuranes, for example: nifurtimox; from the class of quinazolinone alkaloids, for example: halofuginon; from diverse other classes, for example: oxamniquin, paromomycin; from the class of vaccines or antigenes from microorganisms, for example: Babesia canis rossi, Eimeria tenella, Eimeria praecox, Eimeria necatrix, Eimeria mitis, Eimeria maxima, Eimeria brunetti, Eimeria acervulina, Babesia canis vogeli, Leishmania infantum, Babesia canis canis, Dictyocaulus viviparus. All named mixing partners can, if their functional groups enable this, optionally form salts with suitable bases or acids. BCS233014 FC-Text - 69 - Vector control The compounds of the formula (I) can also be used in vector control. For the purpose of the present invention, a vector is an arthropod, in particular an insect or arachnid, capable of transmitting pathogens such as, for example, viruses, worms, single-cell organisms and bacteria from a reservoir (plant, animal, human, etc.) to a host. The pathogens can be transmitted either mechanically (for example trachoma by non-stinging flies) to a host, or by injection (for example malaria parasites by mosquitoes) into a host. Examples of vectors and the diseases or pathogens they transmit are: 1) Mosquitoes - Anopheles: malaria, filariasis; - Culex: Japanese encephalitis, other viral diseases, filariasis, transmission of other worms; - Aedes: yellow fever, dengue fever, other viral diseases, filariasis; - Simuliidae: transmission of worms, in particular Onchocerca volvulus; - Psychodidae: transmission of leishmaniasis 2) Lice: skin infections, epidemic typhus; 3) Fleas: plague, endemic typhus, cestodes; 4) Flies: sleeping sickness (trypanosomiasis); cholera, other bacterial diseases; 5) Mites: acariosis, epidemic typhus, rickettsialpox, tularaemia, Saint Louis encephalitis, tick-borne encephalitis (TBE), Crimean–Congo haemorrhagic fever, borreliosis; 6) Ticks: borellioses such as Borrelia burgdorferi sensu lato., Borrelia duttoni, tick-borne encephalitis, Q fever (Coxiella burnetii), babesioses (Babesia canis canis), ehrlichiosis. Examples of vectors in the sense of the present invention are insects, for example aphids, flies, leafhoppers or thrips, which are capable of transmitting plant viruses to plants. Other vectors capable of transmitting plant viruses are spider mites, lice, beetles and nematodes. Further examples of vectors in the sense of the present invention are insects and arachnids such as mosquitoes, in particular of the genera Aedes, Anopheles, for example A. gambiae, A. arabiensis, A. funestus, A. dirus (malaria) and Culex, psychodids such as Phlebotomus, Lutzomyia, lice, fleas, flies, mites and ticks capable of transmitting pathogens to animals and/or humans. Vector control is also possible if the compounds of the formula (I) are resistance breaking. BCS233014 FC-Text - 70 - Compounds of the formula (I) are suitable for use in the prevention of diseases and/or pathogens transmitted by vectors. Thus, a further aspect of the present invention is the use of compounds of the formula (I) for vector control, for example in agriculture, in horticulture, in gardens and in leisure facilities, and also in the protection of materials and stored products. Protection of industrial materials The compounds of the formula (I) are suitable for protecting industrial materials against attack or destruction by insects, for example from the orders Coleoptera, Hymenoptera, Isoptera, Lepidoptera, Psocoptera and Zygentoma. Industrial materials in the present context are understood to mean inanimate materials, such as preferably plastics, adhesives, sizes, papers and cards, leather, wood, processed wood products and coating compositions. The use of the invention for protecting wood is particularly preferred. In a further embodiment, the compounds of the formula (I) are used together with at least one further insecticide and/or at least one fungicide. In a further embodiment, the compounds of the formula (I) are present as a ready-to-use pesticide, i.e. they can be applied to the material in question without further modifications. Suitable further insecticides or fungicides are in particular those mentioned above. Surprisingly, it has also been found that the compounds of the formula (I) can be employed for protecting objects which come into contact with saltwater or brackish water, in particular hulls, screens, nets, buildings, moorings and signalling systems, against fouling. Likewise, the compounds of the formula (I), alone or in combinations with other active compounds, can be used as antifouling agents. Control of animal pests in the hygiene sector The compounds of the formula (I) are suitable for controlling animal pests in the hygiene sector. In particular, the invention can be applied in the domestic sector, in the hygiene sector and in the protection of stored products, especially for controlling insects, arachnids, ticks and mites encountered in enclosed spaces such as dwellings, factory halls, offices, vehicle cabins, animal husbandries. For controlling animal pests, the compounds of the formula (I) are used alone or in combination with other active compounds and/or auxiliaries. They are preferably used in domestic insecticide products. The compounds of the formula (I) are effective against sensitive and resistant species, and against all developmental stages. These pests include, for example, pests from the class Arachnida, from the orders Scorpiones, Araneae and Opiliones, from the classes Chilopoda and Diplopoda, from the class Insecta the order Blattodea, from the orders Coleoptera, Dermaptera, Diptera, Heteroptera, Hymenoptera, Isoptera, Lepidoptera, Phthiraptera, Psocoptera, Saltatoria or Orthoptera, Siphonaptera and Zygentoma and from the class Malacostraca the order Isopoda. BCS233014 FC-Text - 71 - They are used, for example, in aerosols, pressure-free spray products, for example pump and atomizer sprays, automatic fogging systems, foggers, foams, gels, evaporator products with evaporator tablets made of cellulose or plastic, liquid evaporators, gel and membrane evaporators, propeller-driven evaporators, energy-free, or passive, evaporation systems, moth papers, moth bags and moth gels, as granules or dusts, in baits for spreading or in bait stations. Analytical methods The analytical methods described below refer to all information in the entire document, unless the procedure of the respective analytical determination is described separately at the respective passage. Mass Spectrometry The determination of [M+H]+ or M- by LC-MS under acidic chromatographic conditions was done with 1 ml formic acid per liter acetonitrile and 0.9 ml formic acid per liter Millipore water as eluents. The column Zorbax Eclipse Plus C1850 mm * 2.1 mm was used. The temperature of the column oven was 55°C. Instruments: LC-MS3: Waters UPLC with SQD2 mass spectrometer and SampleManager autosampler. Linear gradient 0.0 to 1.70 minutes from 10 % acetonitrile to 95 % acetonitrile, from 1.70 to 2.40 minutes constant 95 % acetonitrile, flow 0.85 ml/min. LC-MS6 and LC-MS7: Agilent 1290 LC, Agilent MSD, HTS PAL autosampler. Linear gradient 0.0 to 1.80 minutes from 10 % acetonitrile to 95 % acetonitrile, from 1.80 to 2.50 minutes constant 95 % acetonitrile, flow 1.0 ml/min. The determination of [M+H]+ by LC-MS under neutral chromatographic conditions was done with acetonitrile and Millipore water containing 79 mg/l ammonia carbonate as eluents. Instruments: LC-MS4: Waters IClass Acquity with QDA mass spectrometer and FTN autosampler (column Waters Acquity 1.7 µm 50 mm * 2.1 mm, oven temperature 45°C). Linear gradient 0.0 to 2.10 minutes from 10 % acetonitrile to 95 % acetonitrile, from 2.10 to 3.00 minutes constant 95 % acetonitrile, flow 0.7 ml/min. LC-MS8: Waters IClass Acquity with QDA mass spectrometer and FTN autosampler (column Waters Acquity 1.7 µm 50 mm * 2.1 mm, oven temperature 45°C). Linear gradient 0.0 to 2.10 minutes from 10 % acetonitrile to 95 % acetonitrile, from 2.10 to 3.00 minutes constant 95 % acetonitrile, flow 0.7 ml/min. BCS233014 FC-Text - 72 - Retention time indices were calculated in all cases according to a homologue series of straight chain alkan-2-ones with 3 to 16 carbons where the index of the first alkanone was set to 300, the last to 1600, the ones between correspondingly and using linear interpolation between successive alkanones. The determination of 1H-NMR data was done with a Bruker Avance III 400 MHz spectrometer equipped with a 1.7 mm TCI probehead, with tetramethylsilane as reference (0.00 ppm) and the measurements were recorded usually from solutions in the solvents CD3CN, CDCl3 or d6-DMSO. Alternatively, a Bruker Avance III 600 MHz instrument equipped with a 5 mm CPNMP probehead or a Bruker Avance NEO 600 MHz instrument equipped with a 5 mm TCI probehead were used for the measurements. Usually, the measurements were carried out with a probehead temperature of 298 K. Other measurement temperatures are explicitly noticed. NMR peak lists procedure 1H-NMR data of selected examples are written in form of 1H-NMR peak lists. δ-Values in ppm and the signal intensity in round brackets are listed to each signal peak. Semicolons are depicted as delimiters between the δ-value – signal intensity pairs. Therefore the peak list of an example has the form: δ1 (intensity1); δ2 (intensity2);……..; δi (intensityi);……; δn (intensityn) The intensity of sharp signals correlates with the height of the signals in a printed view of a 1H-NMR spectrum in cm and shows the real relations of signal intensities. Several peaks from broad signals or the middle of the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown. Tetramethylsilane or the chemical shift of the solvent in cases where the sample does not contain tetramethylsilane is used for a calibration of the chemical shift for 1H spectra. Therefore, the tetramethylsilane peak can occur in 1H-NMR peak lists, but not necessarily. 1H-NMR peak lists are equivalent to classical 1H-NMR prints and contain usually all peaks, which are also listed at classical 1H-NMR-interpretations. In addition, they can show signals of solvents, stereoisomers of the compounds which are optionally object of the invention, and/or peaks of impurities, like classical 1H-NMR prints. 1H-NMR solvent signals, the tetramethylsilane signal and the water signal in the corresponding solvent are excluded from the relative intensity calibration as they have very high intensity values. BCS233014 FC-Text - 73 - On average, the peaks of stereoisomers of the compounds according to the invention and/or peaks of impurities have usually a lower intensity than the peaks of compounds according to the invention (for example with a purity >90%). Such stereoisomers and/or impurities can be typical for the specific preparation process. Thus, the corresponding peaks can help to recognize the reproduction of the preparation process via “side-products- fingerprints”. An expert, who calculates the peaks of the target compounds with known methods (MestreC, ACD- simulation, but also with empirically evaluated expectation values), can assign the peaks of the target compounds as needed, optionally using additional intensity filters. This assignment would be similar to the usual peak picking at classical 1H-NMR interpretations. The used solvent can be extracted from the JCAMP file with the parameter “solvent”, the spectrometer frequency with “observe frequency” and the spectrometer type with “spectrometer/data system”. 13C-NMR data are displayed analogous to 1H-NMR data as peak lists from broadband decoupled 13C- NMR spectra. 13C-NMR solvent signals and tetramethylsilane are excluded from the relative intensity calibration as these signals can have very high intensities. Further details of NMR-data description with peak lists are disclosed in the publication “Citation of NMR Peaklist Data within Patent Applications” of the Research Disclosure Database Number 564025. logP values Measurement of logP values was performed according to EEC directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on reversed phase columns with the following methods: [a] logP value is determined by measurement of LC-UV, in an acidic range, with 0.9 ml/l formic acid in water and 1.0 ml/l formic acid in acetonitrile as eluents (linear gradient from 10% acetonitrile to 95% acetonitrile). [b] logP value is determined by measurement of LC-UV, in a neutral range, with 0.001 molar ammonium acetate solution in water and acetonitrile as eluent (linear gradient from 10% acetonitrile to 95% acetonitrile). Calibration was done with straight-chain alkan-2-ones (with 3 to 16 carbon atoms) with known logP values. The values between successive alkanones are determined by linear regression. BCS233014 FC-Text - 74 - Preparation examples Synthesis of 6-[2-(3-chlorophenyl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example (Ex.) I-30) Step 1 6-[2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H- imidazo[4,5-c]pyridazine (INT-01/compound of the formula (IV))
Figure imgf000075_0001
A solution of 600 mg (2.48 mmol) of N3-methyl-6-(pentafluoroethyl)pyridazine-3,4-diamine, 657 mg (2.48 mmol) 2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazole-4-carboxylic acid and 570 mg (2.97 mmol) 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI in pyridine (2.4 ml) was stirred at room temperature overnight. Subsequently, the solvent was distilled off under reduced pressure and the residue was taken up in acetic acid. The mixture was stirred at 100°C for 8 h, cooled to room temperature, slurried with water, then filtered over a Nutsche filter, dried. The target compound was used in the next step without further purification (700 mg, 21 % yield, 43% purity). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.5897 (5.7); 4.2782 (16.0); 3.7832 (14.7); 3.7736 (0.6); 3.3209 (36.4); 3.3120 (0.4); 3.3082 (0.1); 3.0786 (1.3); 3.0733 (0.3); 3.0663 (4.0); 3.0540 (4.0); 3.0418 (1.3); 2.6182 (0.1); 2.6152 (0.2); 2.6124 (0.1); 2.5242 (0.3); 2.5210 (0.4); 2.5179 (0.5); 2.5090 (9.9); 2.5061 (20.9); 2.5031 (28.7); 2.5001 (21.0); 2.4972 (10.0); 2.3898 (0.1); 2.3869 (0.2); 2.3839 (0.1); 2.0759 (0.2); 1.1538 (0.2); 1.1466 (4.2); 1.1418 (0.6); 1.1344 (8.8); 1.1221 (4.1); 0.0967 (0.1); 0.0107 (0.1); 0.0053 (1.0); -0.0001 (27.2); -0.0056 (1.2); -0.0123 (0.1); -0.1004 (0.1) Step 2 6-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H- imidazo[4,5-c]pyridazine (INT-02/compound of the formula (V))
Figure imgf000075_0002
BCS233014 FC-Text - 75 - To a solution of 2.87 g (6.1 mmol) of 6-[2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-01) in dichloromethane (100 mL) were added 2.30 mL (61.0 mmol) of formic acid and 5.34 mL (61.0 mmol, 35% in water) of hydrogen peroxide. The mixture was stirred at room temperature overnight and the reaction was terminated by adding saturated sodium thiosulfate solution. The organic phase was separated off, dried over sodium sulfate, filtered, and the target compound thus obtained (3.04 g, 78% yield) and used in the next step without further purification. 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.7459 (6.7); 4.0630 (16.0); 3.9401 (14.6); 3.8067 (1.0); 3.7883 (3.5); 3.7698 (3.5); 3.7514 (1.1); 3.3314 (108.4); 2.6765 (0.3); 2.6720 (0.4); 2.6676 (0.3); 2.5253 (1.1); 2.5205 (1.6); 2.5119 (23.8); 2.5075 (50.6); 2.5030 (68.6); 2.4985 (49.2); 2.4941 (23.1); 2.3298 (0.4); 1.3082 (3.6); 1.3001 (0.5); 1.2898 (8.2); 1.2713 (3.6); -0.0002 (1.3) Step 3
Figure imgf000076_0001
To a solution of 120 mg (0.24 mmol) of 6-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-02) and 48 mg (0.31 mmol) of (3- chlorophenyl)boronic acid in 1.5 ml dioxane was added 0.3 ml of 0.5 M cesium carbonate aq. solution. The solution was purged with argon for 2 minutes, at which time 19 mg (0.02 mmol) of PdCl2(dppf).CH2Cl2 were added. The reaction mixture was purged again with argon for 3 minutes, then placed in the microwave and heated for 75 minutes at 110 °C. In order to achieve full consumption of startings materials 48 mg (0.31 mmol) (3-chlorophenyl)boronic acid and 19 mg (0.02 mmol) of PdCl2(dppf).CH2Cl2 were added to the reaction mixture which was stirred in the microwave further for 75 minutes at 120 °C. The mixture was diluted with water and extracted with dichloromethane. The combined organic phase was dried over anhydrous sodium sulfate and concentrated under vacuo. The crude was directly purified by column chromatography (cyclohexane/ ethylacetate as eluent mixture) to isolate a fraction which was purified a second time by prep. HPLC to yield desired product I-30 (42 mg, 42% yield) and 4 mg of 6-[2-(3’-chloro[biphenyl]-3-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example I-34). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.7474 (6.2); 8.3180 (0.4); 7.9278 (1.7); 7.9238 (2.8); 7.9194 (1.8); 7.8239 (1.0); 7.8206 (1.5); 7.8168 (1.0); 7.8052 (1.2); 7.8018 (1.9); 7.7982 (1.1); 7.7181 (0.6); 7.7150 (0.9); 7.7097 (0.7); 7.6978 (1.6); 7.6945 (1.7); 7.6929 (1.8); 7.6896 (1.3); 7.6691 (2.1); 7.6498 (2.3); 7.6300 (0.9); 4.1235 (16.0); 3.9849 (14.1); 3.8704 (0.9); 3.8520 (3.2); 3.8335 (3.2); 3.8151 (1.0); BCS233014 FC-Text - 76 - 3.3309 (108.7); 2.6760 (0.9); 2.6716 (1.2); 2.6671 (0.9); 2.5249 (3.7); 2.5114 (72.1); 2.5071 (141.0); 2.5026 (183.1); 2.4980 (135.1); 2.4937 (66.9); 2.3340 (0.8); 2.3294 (1.1); 2.3248 (0.8); 1.3640 (3.4); 1.3456 (7.9); 1.3271 (3.4); 0.1459 (0.5); 0.0080 (5.0); -0.0002 (121.2); -0.0084 (5.0); -0.1496 (0.5) Synthesis of 6-[2-(2-chloropyridin-4-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example I-79)
Figure imgf000077_0001
To a solution of 120 mg (0.24 mmol) of 6-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-02) and 48 mg (0.31 mmol) of ((2- chloropyridin-4-yl)boronic acid in 3 ml dioxane under argon was added 0.44 ml of 0.5 M cesium carbonate aq. solution and 19 mg (0.02 mmol) of PdCl2(dppf).CH2Cl2. The reaction mixture was purged with argon then placed in the microwave and heated for 60 minutes at 120 °C. The mixture was diluted with water and extracted with dichloromethane. The combined organic phase was dried over anhydrous sodium sulfate and concentrated under vacuo. The crude was directly purified by prep. HPLC to isolate desired product (135 mg) and 42 mg of 2’-chloro-4-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]76yridazine-6-yl]-1H-imidazol-2-yl}-2,4’-bipyridine (Example I- 82). 1H-NMR (400 MHz, d6-DMSO) δ ppm: δ= 8.7550 (5.9); 8.6844 (2.4); 8.6715 (2.5); 7.9987 (3.0); 7.8990 (2.0); 7.8954 (1.8); 7.8862 (1.9); 7.8826 (1.8); 4.1226 (16.0); 4.0473 (14.2); 3.8796 (0.9); 3.8613 (3.2); 3.8428 (3.3); 3.8243 (1.0); 3.3260 (46.4); 2.6720 (0.4); 2.5253 (1.2); 2.5119 (24.5); 2.5075 (49.2); 2.5029 (64.9); 2.4984 (47.6); 2.4939 (23.2); 2.3298 (0.4); 2.0867 (2.5); 1.3675 (3.5); 1.3491 (8.0); 1.3306 (3.4); 0.1459 (0.4); 0.0078 (2.9); -0.0002 (75.8); -0.0086 (2.7); -0.1495 (0.4) Synthesis of 3-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine-6-yl]-1H-imidazol-2-yl}benzamide (Example I-26)
Figure imgf000077_0002
38 mg (0.033 mmol) of tetrakis(triphenylphosphine)palladium(0) were added to a degassed solution of BCS233014 FC-Text - 77 - 167 mg (0.331 mmol) of 6-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-02), 114 mg (0.496 mmol) of 3-(4,4,5,5- tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and 324 mg (0.993 mmol) of caesium carbonate in wet 1,4-dioxane (18 mL) and the reaction mixture was stirred at 150 °C in the microwave for 1h. The resulting solution was cooled down to RT (room temperature), diluted with water and extracted with dichloromethane. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 21 mg (0.040 mmol, 11%) of 3-{5-(ethylsulfonyl)-1-methyl- 4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine-6-yl]-1H-imidazol-2-yl}benzamide (I- 26). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.75 (s, 1H), 8.29 (s, 1H), 8.16 (brs, 1H), 8.10 (d, 1H), 7.99 (d, 1H), 7.71 (t, 1H), 7.58 (brs, 1H), 4.13 (s, 3H), 4.00 (s, 3H), 3.85 (q, 2H), 1.35 (t, 3H). Synthesis of 6-[2-(6-chloropyridin-2-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example I-3)
Figure imgf000078_0001
46 mg (0.040 mmol) of tetrakis(triphenylphosphine)palladium(0) were added to a degassed solution of 100 mg (0.199 mmol) of 6-[2-bromo-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-02), 200 mg (0.298 mmol) of 2-chloro-6- (tributylstannyl)pyridine, 25 mg (0.596 mmol) of lithium chloride and 4 mg (0.02 mmol) of copper(I) chloride in 1,4-dioxane (8.0 mL) and the reaction mixture was stirred at 150 °C in the microwave for 1h. The resulting solution was cooled down to RT and concentrated under reduced pressure. The residue was dissolved in dichloromethane / triethylamine (95:5), filtered on silica gel and concentrated under reduced pressure: The crude product was purified by preparative HPLC using a water / acetonitrile gradient as eluent to give 27 mg (0.051 mmol, 25%) of 6-[2-(6-chloropyridin-2-yl)-5-(ethylsulfonyl)-1-methyl-1H- imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (I-3). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.76 (s, 1H), 8.20 (d, 1H), 8.12 (t, 1H), 7.75 (d, 1H), 4.33 (s, 3H), 4.11 (s, 3H), 3.81 (q, 2H), 1.32 (t, 3H). Synthesis of 1-(6-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazin-6-yl]-1H-imidazol-2-yl}pyridin-3-yl)cyclopropanecarbonitrile (Example I-6) Step 1 BCS233014 FC-Text - 78 - 7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-03/compound of the formula (VII))
Figure imgf000079_0001
A solution of 2.00 g (8.26 mmol) of N3-methyl-6-(pentafluoroethyl)pyridazine-3,4-diamine in triethyl orthoformiate (15 mL) was stirred at 120 °C for 4h. The reaction mixture was cooled down to RT and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 1.81 g (7.18 mmol, 87%) of 7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-03). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.99 (s, 1H), 8.66 (s, 1H), 4.08 (s, 3H). Step 2 6-[5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine (INT-04/compound of the formula (IX))
Figure imgf000079_0002
This reaction was carried out under argon atmosphere using a Schlenk tube. A solution (1.31 M) of 2,2,6,6- tetramethylpiperidinylzinc chloride lithium chloride in tetrahydrofurane (16.7 mL, 21.8 mmol) was added dropwise to a degassed solution of 5.00 g (19.8 mmol) of 7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine (INT-03) in tetrahydrofurane (75 mL) and the resulting solution was stirred at RT for 10 min. 5.32 g (19.8 mmol) of 5-(ethylsulfanyl)-4-iodo-1-methyl-1H-imidazole and 2.29 g (1.98 mmol) of tetrakis(triphenylphosphine)palladium(0) were then added and the reaction mixture was stirred at 80 °C for 4h. The resulting solution was cooled down to RT, quenched with a saturated aqueous NH4Cl solution and extracted with ethyl acetate. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 5.98 g (15.2 mmol, 77%) of 6-[5- (ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-04). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.55 (s, 1H), 8.24 (s, 1H), 4.33 (s, 3H), 3.80 (s, 3H), 3.07 (q, 2H), 1.11 (t, 3H). BCS233014 FC-Text - 79 - Step 3 1-(6-bromopyridin-3-yl)cyclopropanecarbonitrile (INT-05)
Figure imgf000080_0001
An aqueous solution (45%) of sodium hydroxide (26.0 mL, 445 mmol) was added to a solution of 1.17 g (5.94 mmol) of (6-bromopyridin-3-yl)acetonitrile, 0.62 mL (7.13 mmol) of 1,2-dibromoethane and 2.04 g (6.53 mmol) of benzyltri-n-butylammonium chloride in acetonitrile (17 mL) and the reaction mixture was stirred at RT for 2h. The resulting solution was diluted with water and extracted with ethyl acetate. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 1.29 g (5.78 mmol, 97%) of 1-(6-bromopyridin-3-yl)cyclopropanecarbonitrile (INT- 05). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.40 (d, 1H), 7.72 (dd, 1H), 7.67 (dm, 1H), 1.82 (m, 2H), 1.62 (m, 2H). Step 4 1-(6-{5-(ethylsulfanyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6- yl]-1H-imidazol-2-yl}pyridin-3-yl)cyclopropanecarbonitrile (INT-06)
Figure imgf000080_0002
This reaction was carried out under argon atmosphere using a Schlenk tube. A solution (1.22 M) of 2,2,6,6- tetramethylpiperidinylzinc chloride lithium chloride in tetrahydrofurane (0.31 mL, 0.38 mmol) was added dropwise to a degassed solution of 150 mg (0.38 mmol) of 6-[5-(ethylsulfanyl)-1-methyl-1H-imidazol-4- yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-04) in tetrahydrofurane (6.5 mL) and the resulting solution was stirred at RT for 20 min. 85 mg (0.38 mmol) of 1-(6-bromopyridin-3- yl)cyclopropanecarbonitrile (INT-05) and 44 mg (0.038 mmol) of tetrakis(triphenylphosphine)palladium(0) were then added and the reaction mixture was stirred at 80 °C for 4h. The resulting solution was cooled down to RT, quenched with a saturated aqueous NH4Cl solution and extracted with ethyl acetate. The organic layer was dried with Na2SO4, filtered and concentrated under BCS233014 FC-Text - 80 - reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 50 mg (0.094 mmol, 24%) of 1-(6-{5- (ethylsulfanyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H- imidazol-2-yl}pyridin-3-yl)cyclopropanecarbonitrile (INT-06). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.73 (d, 1H), 8.60 (s, 1H), 8.26 (d, 1H), 7.97 (dd, 1H), 4.41 (s, 3H), 4.23 (s, 3H), 3.11 (q, 2H), 1.90 (m, 2H), 1.72 (m, 2H), 1.17 (t, 3H). Step 5
Figure imgf000081_0001
18 µL (0.468 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.113 mL, 1.31 mmol) were added dropwise to a solution of 50 mg (0.094 mmol) of 1-(6-{5-(ethylsulfanyl)-1-methyl-4- [7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl}pyridin-3- yl)cyclopropanecarbonitrile (INT-06) in dichloromethane (2.0 mL) and the resulting solution was stirred at RT overnight. The resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3. The organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC using a water / acetonitrile gradient as eluent to give 42 mg (0.074 mmol, 78%) of 1-(6-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H- imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl}pyridin-3-yl)cyclopropanecarbonitrile (Example I-6). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.77 (d, 1H), 8.75 (s, 1H), 8.19 (d, 1H), 8.00 (dd, 1H), 4.36 (s, 3H), 4.11 (s, 3H), 3.82 (q, 2H), 1.92 (m, 2H), 1.75 (m, 2H), 1.32 (t, 3H). Synthesis of 1-(5-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazin-6-yl]-1H-imidazol-2-yl}-2-thienyl)cyclopropanecarbonitrile (Example I-105) Step 1 1-(2-thienyl)cyclopropanecarbonitrile (INT-07)
Figure imgf000081_0002
BCS233014 FC-Text - 81 - 8.12 g (203 mmol) of sodium hydride (60% dispersion in mineral oil) were added to a solution of 10.0 g (81.2 mmol) of 2-thienylacetonitrile in dimethyl sulfoxide (320 mL) and the reaction mixture was stirred at RT for 30 minutes. 14.0 mL (162 mmol) of 1,2-dibromoethane were then added dropwise and the reaction mixture was stirred further at RT for 2h. The resulting solution was diluted with water and extracted with diethyl ether. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 8.57 g (57.4 mmol, 70%) of 1-(2- thienyl)cyclopropanecarbonitrile (INT-07). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 7.48 (dd, 1H), 7.09 (dd, 1H), 7.00 (dd, 1H), 1.79 (m, 2H), 1.49 (m, 2H). Step 2 1-(5-iodo-2-thienyl)cyclopropanecarbonitrile (INT-08)
Figure imgf000082_0001
At -78 °C, a solution (2.5 M) of n-butyl lithium in hexanes (0.84 mL, 2.1 mmol) was added dropwise to a solution of 300 mg (2.01 mmol) of 1-(2-thienyl)cyclopropanecarbonitrile (INT-07) in tetrahydrofurane (12 mL) and the reaction mixture was stirred at -78 °C for 5 minutes. A solution of 1.53 g (6.03 mmol) of iodine in tetrahydrofurane (5.0 mL) was then added dropwise and the reaction mixture was stirred further at -78 °C for 30 minutes and allowed to come to RT for 1h. The resulting solution was quenched with a saturated aqueous solution of Na2S2O3 and extracted 3 times with dichloromethane. The organic layers were combined, dried with Na2SO4, filtered and concentrated under reduced pressure to give 518 mg (1.88 mmol, 91%) of 1-(5-iodo-2-thienyl)cyclopropanecarbonitrile (INT-08). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 7.22 (d, 1H), 6.84 (d, 1H), 1.79 (m, 2H), 1.50 (m, 2H). Step 3 1-(5-{5-(ethylsulfanyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]- 1H-imidazol-2-yl}-2-thienyl)cyclopropanecarbonitrile (INT-09)
Figure imgf000082_0002
BCS233014 FC-Text - 82 - This reaction was carried out under argon atmosphere using a Schlenk tube. A solution (1.22 M) of 2,2,6,6- tetramethylpiperidinylzinc chloride lithium chloride in tetrahydrofurane (0.31 mL, 0.38 mmol) was added dropwise to a degassed solution of 150 mg (0.38 mmol) of 6-[5-(ethylsulfanyl)-1-methyl-1H-imidazol-4- yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-04) in tetrahydrofurane (6.6 mL) and the resulting solution was stirred at RT for 20 min. 105 mg (0.38 mmol) of 1-(5-iodo-2- thienyl)cyclopropanecarbonitrile (INT-08) and 44 mg (0.038 mmol) of tetrakis(triphenylphosphine)palladium(0) were then added and the reaction mixture was stirred at 80 °C for 4h. The resulting solution was cooled down to RT, quenched with a saturated aqueous NH4Cl solution and extracted with ethyl acetate. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 143 mg (0.265 mmol, 68%) of 1-(5-{5- (ethylsulfanyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H- imidazol-2-yl}-2-thienyl)cyclopropanecarbonitrile (INT-09). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.58 (s, 1H), 7.62 (d, 1H), 7.23 (d, 1H), 4.36 (s, 3H), 4.00 (s, 3H), 3.08 (q, 2H), 1.91 (m, 2H), 1.63 (m, 2H), 1.15 (t, 3H). Step 4
Figure imgf000083_0001
54.5 µL (1.32 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.318 mL, 3.71 mmol) were added dropwise to a solution of 143 mg (0.265 mmol) of 1-(5-{5-(ethylsulfanyl)-1-methyl- 4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl}-2- thienyl)cyclopropanecarbonitrile (INT-09) in dichloromethane (5.7 mL) and the resulting solution was stirred at RT overnight. The resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3. The organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC using a water / acetonitrile gradient as eluent to give 94.0 mg (0.164 mmol, 62%) of 1-(5-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H- imidazo[4,5-c]pyridazin-6-yl]-1H-imidazol-2-yl}-2-thienyl)cyclopropanecarbonitrile (I-105). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.74 (s, 1H), 7.68 (d, 1H), 7.28 (d, 1H), 4.11 (s, 3H), 4.08 (s, 3H), 3.79 (q, 2H), 1.92 (m, 2H), 1.64 (m, 2H), 1.31 (t, 3H). Synthesis of 6-[2-(4-bromo-1,3-thiazol-2-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example I-108) BCS233014 FC-Text - 83 - Step 1 6-[2-(4-bromo-1,3-thiazol-2-yl)-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-10)
Figure imgf000084_0001
This reaction was carried out under argon atmosphere using a Schlenk tube. A solution (1.31 M) of 2,2,6,6- tetramethylpiperidinylzinc chloride lithium chloride in THF (0.31 mL, 0.40 mmol) was added dropwise to a degassed solution of 144 mg (0.367 mmol) of 6-[5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-04) in THF (4.0 mL) and the resulting solution was stirred at RT for 20 min. 89.2 mg (0.367 mmol) of 2,4-dibromo-1,3-thiazole and 42 mg (0.037 mmol) of tetrakis(triphenylphosphine)palladium(0) were then added and the reaction mixture was stirred at 80 °C for 4h. The resulting solution was cooled down to RT, quenched with a saturated aqueous NH4Cl solution and extracted with ethyl acetate. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 98.2 mg (0.177 mmol, 43%) of 6-[2-(4-bromo-1,3-thiazol-2-yl)-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-10). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.63 (s, 1H), 8.08 (s, 1H), 4.36 (s, 3H), 4.21 (s, 3H), 3.12 (q, 2H), 1.16 (t, 3H). Step 2
Figure imgf000084_0002
33 µL (0.89 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.106 mL, 1.24 mmol) were added dropwise to a solution of 98.2 mg (0.177 mmol) of 6-[2-(4-bromo-1,3-thiazol-2-yl)-5- (ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-10) in dichloromethane (4.4 mL) and the resulting solution was stirred at RT overnight. The resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3. The organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, BCS233014 FC-Text - 84 - dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC using a water / acetonitrile gradient as eluent to give 96.0 mg (0.164 mmol, 92%) of 6- [2-(4-bromo-1,3-thiazol-2-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (I-108). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.75 (s, 1H), 8.17 (s, 1H), 4.39 (s, 3H), 4.08 (s, 3H), 3.78 (q, 2H), 1.30 (t, 3H). Synthesis of 2-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazin-6-yl]-1H-imidazol-2-yl}-1,3-thiazole-4-carbonitrile (Example I-109)
Figure imgf000085_0001
17 mg of [Pd(allyl)Cl]2 (0.046 mmol) were added to a degassed solution of 84.9 mg (0.145 mmol) of 6- [2-(4-bromo-1,3-thiazol-2-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (I-108), 122 mg (0.290 mmol) of potassium hexacyanoferrate(III) trihydrate and 29 mg (0.061 mmol) of Xphos in cyclopentyl methyl ether (7.6 mL) and water (2.9 mL) and the reaction mixture was stirred at 100 °C overnight. The resulting solution was cooled down to RT, diluted with water and extracted with EtOAc. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 40 mg (0.075 mmol, 52%) of 2-{5-(ethylsulfonyl)-1-methyl-4-[7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazin-6-yl]-1H-imidazol-2-yl}-1,3-thiazole-4-carbonitrile (I-109). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 9.13 (s, 1H), 8.77 (s, 1H), 4.40 (s, 3H), 4.09 (s, 3H), 3.80 (q, 2H), 1.31 (t, 3H). Synthesis of 6-[2-(3-bromo-1H-pyrazol-1-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (Example I-97) Step 1 6-[2-(3-bromo-1H-pyrazol-1-yl)-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3- (pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-11) BCS233014 FC-Text - 85 -
Figure imgf000086_0001
A solution of 100 mg (0.212 mmol) of 6-[2-bromo-5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-02), 31.2 mg (0.212 mmol) of 3-bromo- 1H-pyrazole and 29.3 mg (0.212 mmol) of potassium carbonate in DMF (2.3 mL) wasstirred at 90 °C overnight. The resulting solution was cooled down to RT, diluted with water and extracted with DCM. The organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography purification using a cyclohexane / ethyl acetate gradient as mobile phase to give 54.1 mg (0.101 mmol, 47%) of 6-[2-(3-bromo-1H-pyrazol-1-yl)-5-(ethylsulfanyl)- 1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (INT-11). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.62 (s, 1H), 8.49 (d, 1H), 6.87 (d, 1H), 4.31 (s, 3H), 3.85 (s, 3H), 3.11 (q, 2H), 1.18 (t, 3H). Step 2
Figure imgf000086_0002
19 µL (0.503 mmol) of formic acid and an aqueous solution (35%) of hydrogen peroxide (0.121 mL, 1.41 mmol) were added dropwise to a solution of 54.1 mg (0.101 mmol) of 6-[2-(3-bromo-1H-pyrazol-1-yl)- 5-(ethylsulfanyl)-1-methyl-1H-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7H-imidazo[4,5- c]pyridazine (INT-11) in dichloromethane (4.3 mL) and the resulting solution was stirred at RT overnight. The resulting solution was cooled down to 0 °C, diluted with water and a saturated aqueous solution of NaHSO3. The organic layer was washed with a saturated aqueous NaCl solution and a 20% aqueous NaHCO3 solution, dried with Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC using a water / acetonitrile gradient as eluent to give 51 mg (0.089 mmol, 86%) of 6-[2-(3-bromo-1H-pyrazol-1-yl)-5-(ethylsulfonyl)-1-methyl-1H-imidazol-4-yl]-7- methyl-3-(pentafluoroethyl)-7H-imidazo[4,5-c]pyridazine (I-97). 1H-NMR (400 MHz, d6-DMSO) δ ppm: 8.77 (s, 1H), 8.46 (d, 1H), 6.90 (d, 1H), 4.10 (s, 3H), 3.99 (s, 3H), 3.84 (q, 2H), 1.33 (t, 3H). In analogy to the examples and according to the above described preparation processes, the following BCS233014 FC-Text - 86 - compounds of the formula (I) can be obtained: Ex. Structure NMR-data I-1 1 F O H-NMR(400.2 MHz, d6-DMSO): F F , \,\ O δ= 8.8736 (1.9); 8.8713 (2.2); 8.8681 (2.1); 8.8658 (2.0); 8.7563 \-- S-- F (6.0); 8.2359 (0.6); 8.2336 (0.7); 8.2145 (3.5); 8.2122 (3.6); N NZ 8.2075 (3.3); 8.2019 (2.8); 8.1861 (0.5); 8.1805 (0.6); 7.3080 F (0.3); 4.3444 (14.6); 4.1146 (16.0); 3.8492 (0.9); 3.8308 (3.1); N N N t N N 3.8123 (3.2); 3.7939 (1.0); 3.3245 (110.5); 2.6802 (0.3); 2.6757 (0.7); 2.6712 (1.0); 2.6665 (0.8); 2.6619 (0.4); 2.5247 (3.0); 2.5199 (4.8); 2.5112 (60.7); 2.5068 (123.8); 2.5023 (162.4); Cl 2.4977 (116.2); 2.4932 (56.1); 2.3376 (0.3); 2.3337 (0.7); 2.3290 (1.0); 2.3245 (0.7); 1.9889 (0.7); 1.3978 (0.4); 1.3361 (3.6); 1.3177 (8.1); 1.2993 (3.4); 1.2350 (0.3); 1.1751 (0.4); 0.1459 (0.9); 0.0079 (7.6); -0.0002 (212.3); -0.0086 (7.7); -0.1497 (0.9) I-2 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7388 (6.4); 7.8665 (4.0); 7.8455 (4.8); 7.5661 (4.6); 7.5451 (4.1); 5.7558 (1.0); 4.1158 (16.0); 3.9784 (14.5); 3.8702 (1.0); 3.8517 (3.4); 3.8332 (3.5); 3.8148 (1.0); 3.3267 (111.8); 2.6761 (0.5); 2.6715 (0.7); 2.6672 (0.6); 2.5248 (2.2); 2.5070 (83.5); ) 2.5026 (108.9); 2.4981 (81.2); 2.3339 (0.5); 2.3295 (0.7); 2.3253 (0.5); 1.8846 (1.2); 1.8715 (3.4); 1.8643 (3.7); 1.8529 (1.5); 1.6645 (1.4); 1.6521 (3.5); 1.6451 (3.6); 1.6314 (1.1); 1.3599 (3.7); 1.3415 (8.3); 1.3230 (3.6); 0.1458 (0.4); 0.0079 (3.3); - 0.0002 (88.6); -0.0082 (3.9); -0.1497 (0.4) I-3 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7580 (6.4); 8.3152 (0.5); 8.2059 (1.4); 8.2037 (1.6); 8.1866 \.... (2.7); 8.1844 (2.6); 8.1411 (2.1); 8.1215 (3.3); 8.1020 (1.5); 7.7622 (2.1); 7.7600 (2.3); 7.7424 (2.0); 7.7403 (2.0); 4.3354 (14.4); 4.1049 (16.0); 3.8418 (0.9); 3.8234 (3.1); 3.8049 (3.2); 3.7865 (0.9); 3.3272 (332.4); 3.2980 (0.4); 2.6802 (0.4); 2.6757 (0.9); 2.6711 (1.2); 2.6667 (0.9); 2.6620 (0.4); 2.5247 (3.4); 2.5199 (5.3); 2.5112 (72.4); 2.5068 (149.8); 2.5022 (198.1); 2.4976 (140.9); 2.4930 (66.5); 2.3384 (0.4); 2.3336 (0.9); 2.3291 (1.2); 2.3244 (0.9); 2.3199 (0.4); 1.3338 (3.4); 1.3155 (8.0); 1.2970 (3.4); 1.2346 (0.6); 0.1458 (0.8); 0.0079 (7.3); -0.0002 (217.1); -0.0086 (7.5); -0.0199 (0.4); -0.1497 (0.8) I-4 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.2584 (2.0); 9.2566 (2.2); 9.2533 (2.2); 9.2513 (2.0); 8.7646 (5.8); 8.5641 (1.6); 8.5587 (1.5); 8.5433 (2.0); 8.5379 (2.0); / 8.3934 (2.4); 8.3915 (2.3); 8.3726 (1.9); 8.3706 (1.9); 8.3154 (0.6); 4.3874 (14.6); 4.1184 (16.0); 3.8635 (0.9); 3.8451 (3.1); 3.8267 (3.1); 3.8084 (0.9); 3.3244 (276.1); 2.6797 (0.6); 2.6754 (1.3); 2.6708 (1.8); 2.6663 (1.3); 2.6618 (0.6); 2.5243 (5.1); 2.5196 (7.6); 2.5109 (106.8); 2.5064 (220.1); 2.5019 (290.7); 2.4973 (205.0); 2.4928 (95.6); 2.3375 (0.6); 2.3332 (1.2); 2.3287 (1.7); 2.3242 (1.2); 2.3196 (0.6); 1.3404 (3.5); 1.3220 (8.2); 1.3035 (3.4); 0.0079 (1.5); -0.0002 (51.1); -0.0086 (1.6) I-5 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.2135 (2.7); 8.8511 (2.6); 8.7604 (5.7); 8.3154 (2.1); 4.3945 (1.3); 4.1420 (16.0); 4.1243 (1.5); 3.9885 (15.2); 3.9681 (3.3); 3.9501 (3.2); 3.9314 (1.0); 3.8472 (0.3); 3.8311 (0.4); 3.5048 (0.4); 3.4779 (0.4); 3.4585 (0.4); 3.4458 (0.5); 3.4260 (0.5); 3.3239 (1107.2); 2.7729 (0.3); 2.7653 (0.3); 2.7366 (0.4); 2.6750 (6.2); 2.6708 (8.3); 2.6664 (6.2); 2.5239 (24.7); 2.5062 (1031.6); 2.5018 (1340.6); 2.4974 (968.6); 2.3329 (5.7); 2.3285 (7.8); 2.3243 (5.8); 1.5341 (0.4); 1.4948 (0.4); 1.3981 (8.1); 1.3737 (4.0); 1.3554 (8.5); 1.3371 (3.9); 1.3276 (1.1); 1.3092 (0.7); 1.2353 (1.0); 1.1869 (0.4); 1.1271 (0.4); 1.0835 (0.3); 1.0593 (0.3); 0.8552 (0.3); 0.1459 (0.7); 0.0080 (7.0); 0.0000 (188.1); - 0.0082 (7.1); -0.1494 (0.9) BCS233014 FC-Text - 87 - I-6 . u_ u_ . „ / _- . 1H-NMR(400.2 MHz, d6-DMSO): -u\\ δ= 8.7735 (2.1); 8.7718 (2.3); 8.7674 (2.3); 8.7656 (2.3); 8.7526 „ z k \ (6.5); 8.3154 (0.3); 8.2040 (1.9); 8.2024 (2.0); 8.1831 (2.4); „ \ z - / 7 8.1814 (2.4); 8.0127 (1.9); 8.0064 ; _ ( N.. , . (1.8); 7.9917 (1.5); 7.9854 z- z z (1.6); 4.3555 (14.4); 4.1082 (16.0); 3.8465 (0.9); _ \ 3.8281 (3.1); ___ z _ \ 3.8096 (3.2); 3.7913 (0.9); 3.3214 (56.0); 2.6755 (0.7); 2.6709 \ \ , (1.0); 2.6664 (0.7); 2.6618 (0.3); 2.5244 (3.4); 2.5196 (5.4); 4 2.5110 (58.6); 2.5065 (119.6); 2.5019 (158.2); 2.4974 (114.2); 2.4928 (55.2); 2.3379 (0.3); 2.3334 (0.7); 2.3288 (1.0); 2.3242 (0.7); 2.3197 (0.3); 2.0743 (2.9); 1.9373 (1.1); 1.9243 (2.7); 1.9166 (3.1); 1.9055 (1.4); 1.7670 (1.4); 1.7544 (3.0); 1.7474 (2.9); 1.7332 (1.0); 1.3357 (3.5); 1.3173 (8.1); 1.2988 (3.4); 0.1459 (0.8); 0.0079 (7.7); -0.0002 (206.2); -0.0086 (7.8); -0.1497 (0.8) I-7 u 0- 1H-NMR(400.2 MHz, d6-DMSO): _u_ _u - \0 δ= 8.7718 (2.4); 8.7584 (2.8); 8.7535 (6.0); 8.3149 (1.7); 8.1072 _u „ \ z \ (2.6); 8.1034 (2.6); 7.4540 (1.6); 7.4490 (1.7); 7.4407 (1.6); z 7.4356 (1.7); 5.7551 (1.1); 4.3406 (14.6); 4.0949 (16.0); 3.8175 zil (1.0); 3.7994 (3.2); 3.7810 (3.2); 3.7627 (1.0); 3.3219 (227.4); z z \ z/ 2.6751 (2.6); 2.6707 (3.6); 2.6661 (2.6); 2.5241 (10.0); 2.5193 (15.8); 2.5106 (219.8); 2.5062 (453.0); 2.5017 (599.2); 2.4972 (428.7); 2.4928 (205.9); 2.3329 (2.5); 2.3285 (3.5); 2.3240 (2.6); 2.0077 (1.1); 1.9940 (3.1); 1.9862 (3.2); 1.9742 (1.4); 1.7865 i i (1.4); 1.7740 (3.1); 1.7666 (3.2); 1.7527 (1.0); 1.3230 (3.5); 1.3046 (8.1); 1.2862 (3.5); 1.2356 (0.4); 0.1459 (1.3); 0.0079 (10.1); -0.0002 (305.9); -0.0085 (10.4); -0.1497 (1.3) I-8 , _u_u 0.. _ . 1H-N —...,0 _, . MR(600.1 MHz, d6-DMSO): δ= 8.7410 (3.6); 8.21 „ u 21 (0.8); 8.2086 (0.8); 8.2011 (0.8); 8.1974 _ \ , , _c. o \ (0.8); 7.9162 (0.5); 7.9126 (0.6); 7.9087 (0.5); 7.9021 (0.6); z u / _ .. 7.8982 (0.5); 7.8941 (0.5); 7.6557 (0.8); 7.6412 (1.6); 7.6267 , /z( ,. . N (0.7); 7.1930 (0.6); 7.1784 (0.4); 7.1628 (0.4); 6.6507 (0.6); .. 5.8638 (0.4); 5.3328 (0.9); 5.3249 (1.7); 5.3155 (0.7); 4.1759 -- (0.3); 4.1172 (9.3); 3.9673 (8.5); 3.8476 (0.5); 3.8349 (1.8); u_ 3.8228 (1.9); 3.8105 (0.6); 3.4303 (0.3); 3.4051 (0.4); 3.3966 _, (0.4); 3.3942 (0.4); 3.3898 (0.6); 3.3857 (0.5); 3.3751 (1.0); 3.3648 (0.9); 3.3574 (1.4); 3.3481 (3.9); 3.3220 (4885.7); 3.3012 (3.6); 3.2926 (1.8); 3.2826 (1.3); 3.2773 (1.1); 3.2661 (0.8); 3.2562 (0.4); 3.2519 (0.4); 3.2441 (0.5); 3.2358 (0.4); 2.6190 (2.9); 2.6162 (6.8); 2.6132 (9.5); 2.6101 (6.7); 2.6071 (2.8); 2.5222 (16.5); 2.5191 (20.3); 2.5160 (19.1); 2.5072 (504.1); 2.5042 (1114.9); 2.5011 (1563.0); 2.4981 (1119.8); 2.4951 (510.0); 2.4531 (1.1); 2.4420 (0.8); 2.4214 (0.7); 2.3911 (3.3); 2.3881 (7.0); 2.3850 (9.6); 2.3819 (6.9); 2.3790 (3.4); 2.3650 (0.5); 2.3307 (0.4); 2.2976 (0.4); 2.2905 (0.3); 2.2411 (0.4); 2.2014 (0.3); 2.1289 (0.3); 2.0207 (1.9); 2.0085 (3.0); 1.9958 (2.4); 1.9861 (1.7); 1.9762 (1.6); 1.9641 (0.9); 1.4675 (1.0); 1.4557 (1.2); 1.4447 (0.9); 1.3545 (2.2); 1.3423 (4.7); 1.3299 (2.2); 1.2940 (1.4); 1.2838 (1.4); 1.2352 (16.0); 1.1839 (0.3); 0.8652 (2.0); 0.8541 (6.0); 0.8424 (2.7); 0.8215 (0.4); 0.0970 (1.0); 0.0054 (6.7); -0.0001 (256.6); -0.0057 (8.2); -0.0169 (0.7); - 0.0289 (0.4); -0.1001 (1.0) I-9 , ..-0. 1H-NMR(600.1 MHz, d6-DMSO): LL „ - - .0 δ= 8.7441 (6.0); 8.0137 (0.6); 8.0112 (0.7); 8.0022 (0.7); 7.999 „ -, -/0 1 ._ \ , 3 \ . • (0.8); 7.9936 (0.7); 7.9848 (0.6); 7.9823 (0.6); 7.9610 (1.3); 7.9510 (1.2); 5.7555 (2.0); 4 z/ . .2826 (0.1); 4.1792 (0.1); 4.1230 /, ,N . , a (16.0); 4.0008 (0.1); 3.9837 (15.3); 3.8616 (1.1); 3.8494 (3.3); -- 3.8370 (3.4); 3.8247 (1.1); 3.3305 (19.6); 3.3266 (35.4); 3.3244 - (44.3); 3.3212 (29.7); 2.6155 (0.3); 2.6122 (0.2); 2.5243 (0.5); u_ 2.5212 (0.6); 2.5181 (0.6); 2.5062 (34.7); 2.5032 (47.9); 2.5003 „ (36.1); 2.3871 (0.3); 2.0749 (0.2); 2.0101 (0.1); 1.3603 (3.7); 1.3480 (8.2); 1.3357 (3.7); 1.2344 (0.8); 0.8649 (0.1); 0.8537 (0.2); 0.8418 (0.1); 0.0052 (0.2); -0.0001 (6.4) BCS233014 FC-Text - 88 - I-10 u u_ _ u_ 1H-NMR(600.1 MHz, d6-DMSO): δ= 8.7422 (6.7); 7.8620 (0.1); 7.8483 (0.1); 7.7776 (1.5); 7.7648 u_ (1.9); 7. ., 7398 (3.0); 7.6539 (1.1); 7.6411 (2.5); 7.6283 (1.6); , 7.5970 (1.8); 7.5829 (1.1); 7.5621 (0.1); 5.7553 (0.9); 5.3241 (0.2); 4.1104 (16.0); 4.0810 (0.1); 4.0609 (0.2); 4.0470 (0.6); 4.0351 (2.0); 4.0232 (2.0); 4.0114 (0.6); 3.9888 (0.1); 3.9772 (0.4); 3.9638 (14.7); 3.9399 (0.2); 3.8502 (1.0); 3.8379 (3.5); 3.8256 (3.5); 3.8133 (1.1); 3.3678 (0.1); 3.3578 (0.2); 3.3448 (0.2); 3.3177 (345.4); 2.6131 (1.5); 2.6103 (1.2); 2.5221 (2.2); 2.5191 (3.2); 2.5161 (3.2); 2.5041 (170.1); 2.5011 (250.2); 2.4982 (208.1); 2.4462 (0.2); 2.4253 (0.1); 2.4059 (0.1); 2.3879 (1.1); 2.3849 (1.6); 2.3823 (1.3); 2.0735 (0.3); 2.0201 (0.2); 2.0084 (0.3); 1.9884 (8.6); 1.9648 (0.1); 1.8696 (0.1); 1.8446 (1.2); 1.8361 (3.6); 1.8315 (4.1); 1.8236 (1.5); 1.7968 (0.2); 1.6687 (0.1); 1.6433 (1.4); 1.6350 (3.7); 1.6305 (4.1); 1.6213 (1.2); 1.4568 (0.2); 1.3559 (3.7); 1.3437 (8.0); 1.3314 (3.8); 1.3164 (0.2); 1.2982 (0.6); 1.2886 (0.3); 1.2690 (0.3); 1.2585 (0.9); 1.2350 (2.3); 1.1997 (0.1); 1.1973 (0.1); 1.1865 (2.3); 1.1747 (4.5); 1.1628 (2.2); 0.8648 (0.2); 0.8539 (0.6); 0.8420 (0.3); 0.0971 (0.1); 0.0054 (0.8); -0.0001 (29.2); -0.1004 (0.2) I-11 u 1H-NMR(600.1 MHz, d6-DMSO): δ= 8.7439 (6.4); 8.1048 (5.1); 8.0941 (5.1); 5.7560 (0 u_ _ u_ u_ , .3); 5.3241 (0.1); 4.2823 (0.1); 4.1788 (0.2); 4.1236 (16.0); 3.9782 (14.4); ., 3.8554 (0.9); 3.8430 (3.1); 3.8307 (3.1); 3.8184 (0.9); 3.5683 (0.8); 3.3204 (80.1); 3.2995 (0.1); 2.6176 (0.2); 2.6145 (0.3); 2.6115 (0.2); 2.5235 (0.5); 2.5204 (0.6); 2.5173 (0.6); 2.5086 (15.1); 2.5055 (33.7); 2.5025 (47.5); 2.4994 (34.3); 2.4964 (15.8); 2.3925 (0.1); 2.3895 (0.2); 2.3864 (0.3); 2.3833 (0.2); 2.0748 (1.4); 2.0219 (0.1); 2.0099 (0.2); 1.9971 (0.2); 1.9852 (0.1); 1.9756 (0.1); 1.4550 (0.1); 1.3606 (3.4); 1.3483 (7.7); 1.3360 (3.3); 1.2928 (0.1); 1.2823 (0.1); 1.2693 (0.1); 1.2341 (1.2); 0.8646 (0.2); 0.8535 (0.4); 0.8417 (0.2); 0.0054 (0.2); -0.0001 (8.3); -0.0057 (0.3) I-12 „„,_ u_ 1H-NMR(600.4 MHz, d6-DMSO): δ= 8.7419 (5.2); 7.7234 (0.7); 7.7199 (0.8); 7.7145 (1.1); 7.7062 (0.8); 7.7013 (0.7); 7.6009 (1.8); 7.5921 (2.0); 7.5876 (2.0); „z _ ,k 7.5805 (1.2); 5.7532 (0.5); 4.1285 (16.0); 3.9202 (0.9); 3.9080 (2.9); 3.8957 (3.0); 3.8832 (1.3); 3.8742 (12.3); 3.3996 (13.6); 3.3704 (33.4); 3.3695 (33.4); 3.3664 (35.4); 3.3620 (37.0); 3.3566 (37.1); 3.3538 (38.5); 3.3524 (38.4); 3.3491 (39.8); 3.3433 (42.1); 3.3413 (40.2); 3.3391 (39.8); 3.3347 (47.0); 3.3334 (45.3); 3.3305 (45.7); 3.3284 (63.5); 3.3271 (64.8); 3.3247 (63.3); 2.6179 (0.5); 2.6147 (0.7); 2.6117 (0.5); 2.5238 (1.3); 2.5207 (1.6); 2.5176 (1.5); 2.5089 (32.6); 2.5058 (73.4); 2.5028 (104.2); 2.4997 (74.6); 2.4967 (34.2); 2.3898 (0.5); 2.3867 (0.7); 2.3836 (0.5); 1.3576 (4.1); 1.3455 (9.1); 1.3331 (4.2) I-13 , __ u u „ 1H-NMR(600.4 MHz, d6-DMSO): δ= 8.7375 (4.2); 8.7330 (1.8); 8.7279 (0.9); 7.9864 (0.7); 7.9679 _ (1.0); 7.9544 (0.7); 7.7180 (2.3); 7.7095 ( u z_ , / 2.2); 7.7062 (2.6); k 7.6943 (0.8); 5.7532 (0.3); 4.1188 (13.8); 3.9798 (16.0); 3.8572 (0.9); 3.8448 (2.6); 3.8325 (2.8); 3.8204 (1.0); 3.3995 (13.7); 3.3693 (34.8); 3.3646 (37.3); 3.3633 (37.7); 3.3618 (37.7); 3.3557 (40.6); 3.3494 (47.8); 3.3452 (41.7); 3.3437 (40.6); 3.3387 (47.2); 3.3374 (47.8); 3.3362 (47.9); 3.3344 (44.5); 3.3300 (71.9); 3.3282 (65.1); 2.6176 (0.4); 2.6145 (0.6); 2.6114 (0.5); 2.5235 (1.3); 2.5204 (1.6); 2.5173 (1.4); 2.5086 (32.3); 2.5056 (72.0); 2.5025 (101.9); 2.4994 (72.4); 2.4964 (33.1); 2.3895 (0.4); 2.3864 (0.6); 2.3834 (0.5); 1.3559 (3.6); 1.3437 (7.8); 1.3314 (3.7) I-14 , 1H-NMR(600.4 MHz, d6-DMSO): ,u_ u_ „ z_,/ δ= 8.7438 (5.8); 7.9257 (0.6); 7.9232 (0.7); 7.9113 (1.2); 7.9002 (0.7); 7.8977 (0.8); 7.7972 (0.6); 7.7947 (0.7); 7.7842 (1.4); k 7.7821 (1.0); 7.7738 (0.8); 7.7712 (0.7); 7.5104 (1.2); 7.4973 (2.2); 7.4840 (1.1); 5.7544 (6.7); 4.1268 (16.0); 3.9226 (0.9); 3.9104 (2.9); 3.8981 (3.0); 3.8857 (1.1); 3.8773 (8.3); 3.8756 (8.6); 3.5684 (0.6); 3.3456 (8.5); 3.3367 (11.4); 3.3308 (15.9); 3.3228 (15.4); 3.3191 (21.1); 3.3169 (26.4); 2.5237 (0.6); 2.5206 (0.8); 2.5175 (0.7); 2.5087 (15.8); 2.5057 (36.0); 2.5026 (51.5); 2.4995 (36.9); 2.4965 (17.0); 2.3865 (0.3); 2.0742 (1.5); 1.9889 (1.3); 1.3616 (3.8); 1.3494 (8.5); 1.3370 (3.8); 1.2343 (0.8); 1.1874 (0.4); 1.1754 (0.7); 1.1636 (0.3); -0.0002 (0.6) BCS233014 FC-Text - 89 - I-15 u_ u__ : ._ _ . 0 1H-NMR(600.1 MHz, d6-DMSO): u z \ /, , z „ , δ= 8.7446 (6.5); 7.9141 (2.7); 4.1177 (16.0); 3.9876 (14.5); \ 3.8396 (3.0); 3.8273 (3.0); 3.3206 (4080.0); 2.6161 (6.4); 2.6131 (9.0); 2.6101 (6.2); 2.5221 (15.8); 2.5190 (19.4); 2.5159 (17.9); .. 2.5072 (494.4); 2.5041 (1105.2); 2.5011 (1552.1); 2.4980 -. (1110.1); 2.4950 (502.5); 2.3880 (7.1); 2.3849 (9.8); 2.3819 (7.1); 2.0083 (1.7); 1.3561 (3.6); 1.3438 (8.0); 1.3315 (3.5); 1.2350 (10.0); 0.8540 (3.8); 0.0053 (5.4); -0.0001 (248.7); -0.0057 (8.6) I-16 ,__ , ,_ u_ ::: „ 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7349 (6.2); 8.3095 (0.8); 7.9221 (1.2); 7.9152 (1.5); 7.9069 \ (1.3); 7.9001 (1.4); 7.8165 (0.7); 7.8096 (0.7); 7.8054 (0.9); ,_ z-. _ , / \ 7.7984 (0.8); 7.7941 (0.9); 7.7872 (0.9); 7. ( z z. , , u_ 7832 (0.9); 7.7762 * (0.8); 7.6048 (1.5); 7.5817 (2.4); 7.5588 (1.2); 5.7496 (2.9); __ z 4.1291 (16.0); 4.0273 (0.4); 3.9228 (1.0); 3.9044 (3.3); 3.8859 _ (3.4); 3.8699 (8.2); 3.8669 (9.0); 3.8501 (0.3); 3.3204 (204.7); 3.3160 (233.9); 2.6796 (0.6); 2.6752 (1.2); 2.6706 (1.8); 2.6660 (1.3); 2.6615 (0.6); 2.5241 (4.9); 2.5194 (7.2); 2.5106 (95.4); (7 2.5062 (200.3); 2.5016 (271.0); 2.4970 (197.7); 2.4925 (96.1); ) 2.3376 (0.5); 2.3330 (1.2); 2.3284 (1.7); 2.3239 (1.2); 2.3195 (0.6); 2.0718 (0.6); 1.3633 (3.5); 1.3449 (8.2); 1.3264 (3.5); 0.0080 (1.4); -0.0002 (46.0); -0.0085 (1.5) I-17 ,_ ,_ ,_ ,_ _ u 07. ). ... ..\ 1 \0 H-NMR(400.2 MHz, d6-DMSO): δ= 8.7478 (6.0); 8.3127 (0.4); 8.1295 (1.4); 8.1125 (3.0); 8.1099 \ (3.3); 8.0969 (2.2); 8.0778 (2 z,, ._.( z.„ z....- z\ .7); 8.0583 (1.0); 7.6940 (2.4); 7.6749 (2.2); 5.7527 (4.5); 4.3449 (14.7); 4.0999 (16.0); 3.8358 (1.1); 3.8170 (3.5); 3.7986 (3.6); 3.7803 (1.2); 3.3161 (146.9); 2.6705 (2.0); 2.6665 (1.8); 2.5058 (250.9); 2.5016 (336.5); 2.4975 (284.4); 2.4452 (0.6); 2.3284 (2.0); 2.3241 (1.8); 1.9565 (1.0); 1.9427 (2.8); 1.9345 (4.1); 1.9258 (2.2); 1.9001 (0.5); 1.8888 (0.5); 1.8641 (1.8); 1.8545 (3.8); 1.8467 (3.2); 1.8326 (1.2); 1.3361 (3.8); 1.3177 (8.3); 1.2992 (3.8); 1.2339 (0.7); 0.1460 u_ u_u u __ u_ . , 0 _ (0.5); -0.0002 (105.3); -0.1494 (0.5) I-19 \ 1 o H-NMR(400.2 MHz, d6-DMSO): δ= 8.7601 (6.1); 8.4948 (1.7); 8.4919 (1.8) z, .z- \ ; 8.4749 (2.2); 8.4720 \ (2.1); 8.3304 (1.4); 8.3109 (3.1); 8.2911 (2.2); 8.2594 (2.4); \ 8.2565 (2.6); 8.2401 (1.4); 8.2372 (1.2); 4.3472 (14.4); 4.1114 \\ (16.0); 3.8535 (0.9); 3.8352 (3.1); 3.8167 (3.2); 3.7983 (0.9); 3.3164 (82.2); 2.6794 (0.5); 2.6751 (1.1); 2.6705 (1.5); 2.6660 (1.1); 2.6617 (0.5); 2.5241 (4.3); 2.5193 (6.3); 2.5106 (89.5); 2.5062 (186.9); 2.5016 (247.6); 2.4970 (174.1); 2.4924 (81.2); 2.3374 (0.5); 2.3330 (1.0); 2.3284 (1.4); 2.3238 (1.0); 2.3194 (0.5); 2.0735 (1.6); 1.3398 (3.4); 1.3214 (8.0); 1.3029 (3.4); 0.0081 (0.5); -0.0001 (17.1); -0.0085 (0.6) I-20 O 1H-NMR(400.2 MHz, d6-DMSO): F F F . ... „ . . .\ O δ= 8.7565 (6.1); 8.2288 (1.9); 8.2271 (2.0); 8.2096 (2.4); 8.2078 S (2.3); 8.0307 (1.6); 8.0110 (3.1); 7.9915 ( F \ _ \-- \ 1.8); 7.8870 (2.5); N N 7.8852 (2.5); 7.8670 (2.0); 7.8653 (1.8); 5.7557 (2.4); 4.3290 F . (14.4); 4.3130 (0.9); 4.1036 (1 N_. N.. .. c 6.0); 3.8416 (0.9); 3.8231 (3.2); N//( „.._ N N Br 3.8047 (3.3); 3.7862 (1.0); 3.3261 (72.1); 2.6766 (0.4); 2.6720 (0.5); 2.6674 (0.4); 2.5254 (1.7); 2.5206 (2.6); 2.5120 (34.9); 2.5076 (71.5); 2.5030 (93.6); 2.4984 (66.1); 2.4940 (30.9); 2.3344 (0.4); 2.3299 (0.6); 2.3253 (0.4); 1.3346 (3.6); 1.3162 (8.3); 1.2977 (3.5); 0.0080 (2.3); -0.0002 (70.0); -0.0085 (2.4) I-21 1 u_ u_ , u_,_ , _ , 0ri, H-NMR(400.2 MHz, d6-DMSO): ( δ= 8.7912 (2.8); 8.7778 (2.9); 8.7599 (6.3); 8.3153 (1.0); 8.2557 , (3.0); 8.2508 (3. z/ / z _ ( z )• 1); 7.7869 (2.0); 7.7818 (1.9); 7.7735 (1.9); •• \ • z • 7.7682 (1.9); 4.3601 (14.7); 4.1264 (16.0); 3.8604 (1.0); 3.8422 • _ - (3.3); 3.8239 (3.4); 3.8057 (1.0); 3.3239 (458.8); 2.6753 (3.1); _ c z 2.6708 (4.3); 2.6665 (3.1); 2.5241 (12.2); 2.5063 (570.4); 2.5019 _ (727.2); 2.4975 (523.8); 2.3331 (3.2); 2.3286 (4.2); 2.3243 (3.2); 1.3407 (3.6); 1.3222 (8.0); 1.3038 (3.5); 1.2368 (0.4); 0.1460 (2.0); 0.0078 (16.0); -0.0002 (447.1); -0.0081 (18.5); -0.0206 (1.1); -0.0382 (0.4); -0.1495 (2.1) BCS233014 FC-Text - 90 - I-22 1H-NMR(600.1 MHz, d6-DMSO): δ= 9.0503 (1.9); 9.0489 (1.9); 9.0419 (1.9); 9.0405 (2.0); 8.7605 (5.2); 8.6064 (1.6); 8.6046 (2.2); 8.6027 (1.7); 8.0844 (1.6); 8.0819 (1.6); 8.0760 (1.5); 8.0734 (1.5); 5.7541 (4.0); 4.3593 (15.0); 4.1509 (16.0); 3.8751 (0.9); 3.8628 (3.0); 3.8505 (3.0); 3.8382 (0.9); 3.3244 (12.8); 3.3225 (12.5); 3.3204 (20.2); 3.3185 (25.5); 2.5241 (0.7); 2.5210 (0.8); 2.5179 (0.8); 2.5092 (14.3); 2.5061 (32.4); 2.5030 (45.8); 2.4999 (32.4); 2.4969 (14.3); 1.3455 (3.5); 1.3332 (8.2); 1.3209 (3.5); 0.0054 (1.2); -0.0001 (46.7); - 0.0057 (1.3) I-23 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.0608 (1.7); 9.0568 (1.9); 9.0487 (1.9); 9.0446 (1.9); 8.7598 (6.2); 8.6366 (1.8); 8.6325 (1.8); 8.6167 (1.9); 8.6125 (1.8); 7.8552 (1.8); 7.8430 (1.7); 7.8353 (1.7); 7.8230 (1.7); 7.5703 (0.3); 7.5533 (0.4); 5.7564 (4.4); 4.2191 (16.0); 4.2117 (14.9); 4.0049 (0.9); 3.9865 (3.2); 3.9680 (3.3); 3.9496 (1.0); 3.3266 (70.0); 2.6761 (0.6); 2.6717 (0.8); 2.6672 (0.6); 2.5251 (2.9); 2.5115 (45.4); 2.5073 (89.1); 2.5027 (119.2); 2.4982 (91.6); 2.4940 (47.8); 2.3341 (0.6); 2.3297 (0.8); 2.3251 (0.6); 1.3976 (3.5); 1.3792 (7.9); 1.3607 (3.4); 0.0079 (1.8); -0.0002 (49.0); - 0.0085 (2.1) I-24 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7550 (6.7); 8.7025 (1.0); 8.6989 (1.7); 8.6957 (1.2); 8.6911 (1.1); 8.6874 (1.8); 8.6844 (1.1); 8.0887 (0.8); 8.0857 (0.9); 8.0672 (1.1); 8.0637 (1.6); 8.0602 (1.1); 8.0418 (1.0); 8.0388 (1.0); 7.7992 (1.0); 7.7883 (1.6); 7.7776 (1.6); 7.7668 (1.2); 7.7561 (0.8); 5.7572 (3.4); 4.1214 (16.0); 4.0850 (14.0); 3.9333 (1.0); 3.9149 (3.4); 3.8964 (3.5); 3.8779 (1.0); 3.3296 (33.9); 2.5265 (1.1); 2.5131 (17.4); 2.5087 (34.5); 2.5042 (46.3); 2.4996 (35.5); 2.4953 (18.2); 2.0764 (1.3); 1.3632 (3.6); 1.3448 (8.2); 1.3263 (3.6); 0.0080 (0.6); -0.0002 (17.1); -0.0085 (0.6) I-25 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7451 (5.7); 7.8746 (3.8); 7.8537 (5.0); 7.7100 (4.1); 7.6895 (3.3); 5.7600 (3.6); 4.1250 (16.0); 3.9894 (14.6); 3.8943 (1.0); 3.8759 (3.3); 3.8575 (3.3); 3.8391 (1.0); 3.3382 (31.8); 2.5087 (39.8); 2.5042 (51.2); 2.4998 (39.0); 1.4376 (1.1); 1.4203 (3.8); 1.4078 (1.4); 1.3667 (3.8); 1.3483 (8.2); 1.3298 (3.6); 1.2353 (3.2) I-26 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7526 (5.6); 8.3189 (0.3); 8.2956 (1.8); 8.2920 (2.9); 8.2883 (1.8); 8.1646 (1.4); 8.1150 (1.4); 8.1112 (1.0); 8.0953 (1.6); 7.9976 (1.4); 7.9813 (1.3); 7.9775 (1.6); 7.7278 (1.4); 7.7084 (2.6); 7.6890 (1.2); 7.5773 (1.5); 5.7590 (5.2); 4.4467 (0.4); 4.1302 (16.0); 3.9988 (14.0); 3.8774 (0.9); 3.8590 (3.1); 3.8405 (3.1); 3.8222 (1.0); 3.6538 (0.4); 3.3420 (30.4); 2.6767 (0.7); 2.6722 (0.9); 2.6677 (0.7); 2.5257 (2.9); 2.5122 (54.0); 2.5078 (105.5); 2.5032 (137.7); 2.4987 (102.7); 2.4943 (50.8); 2.3346 (0.6); 2.3301 (0.8); 2.3256 (0.6); 1.3663 (3.5); 1.3479 (8.0); 1.3294 (3.4); 1.2346 (1.6); 0.8541 (0.4); 0.0080 (2.5); -0.0002 (67.4); -0.0084 (2.7) I-27 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7446 (6.2); 8.3178 (0.4); 7.8455 (2.1); 7.8400 (1.0); 7.8236 (7.1); 7.8053 (6.9); 7.7889 (1.0); 7.7834 (2.0); 5.7580 (2.6); 4.1172 (16.0); 3.9783 (14.4); 3.8649 (1.0); 3.8467 (3.3); 3.8282 (3.3); 3.8097 (1.0); 3.3312 (110.6); 2.6762 (0.9); 2.6716 (1.2); 2.6671 (0.9); 2.5071 (154.7); 2.5026 (197.5); 2.4982 (146.6); 2.4942 (73.7); 2.3339 (0.9); 2.3295 (1.2); 2.3250 (0.9); 1.3591 (3.6); 1.3407 (8.1); 1.3222 (3.5); 0.0079 (3.8); -0.0001 (77.0); - 0.0083 (3.3); -0.1496 (0.3) BCS233014 FC-Text - 91 - I-28 1H-NMR(400.2 MHz, d6-DMSO): iL _ Li_ u_ / δ= 8.7443 (5.9); 8.3178 (0.4); 7.9201 (2.1); 7.9065 (2.4); 7.8981 \ (2.5); 7.8898 (1.1); 7.8845 (2.3); 7.4886 (2.3); 7.4665 (4.3); ( . . 7.4443 (2.1); 5.7583 (2.4); 4.1206 (16.0); 3.9677 (14.4); 3.8700 _ z ( (1.0); 3.8515 (3.3); 3.8330 (3.4); 3.8146 (1.0); 3.3331 (252.0); 7 z - 2.6761 (1.2); 2.6717 (1.6); 2.6675 (1.2); 2.5070 (206.8); 2.5027 - (265.7); 2.4983 (199.4); 2.3339 (1.2); 2.3295 (1.6); 2.3253 (1.2); 1.3609 (3.6); 1.3425 (8.1); 1.3241 (3.6); 0.1459 (0.7); 0.0078 (7.2); -0.0001 (146.6); -0.0082 (6.8); -0.1495 (0.7) I-29 ._ 1H-NMR(400.2 MHz, d6-DMSO): ._ δ= 8.7405 (6.3); 7.7340 (3.6); 7.7138 (4.2); 7.4343 (3.4); 7.4144 \ z (3.0); 5.7586 (4.6); 4.1177 (16.0); 3.9748 (14.3); 3.8625 (0.9); ._ 3.8441 (3.2); 3.8256 (3.3); 3.8073 (1.0); 3.3313 (49.1); z z 2.6762 /i z (0.5); 2.6718 (0.6); 2.6672 (0.5); 2.5250 (2.4); 2.5117 (42.0); 2.5073 (81.1); 2.5028 (105.0); 2.4983 (77.7); 2.4939 (38.6); 2.4240 (10.2); 2.3342 (0.5); 2.3298 (0.6); 2.3250 (0.5); 1.3549 (3.5); 1.3364 (8.0); 1.3180 (3.4); 0.1460 (0.3); 0.0079 (3.4); - 0.0002 (79.4); -0.0085 (3.2); -0.1496 (0.4) I-30 u_ 1H-NMR(400.2 MHz, d6-DMSO): ._ δ= 8.7474 (6.2); 8.3180 (0.4); 7.9278 (1.7); 7.9238 (2.8); 7.9194 \ z (1.8); 7.8239 (1.0); 7.8206 (1.5); 7.8168 (1.0); 7.8052 (1.2); u z _ _ 7.8018 (1.9); 7.7982 (1.1); 7.7181 (0.6); 7.7150 (0.9); 7.7097 z /z/ z (0.7); 7.6978 (1.6); 7.6945 (1.7); 7.6929 (1.8); 7.6896 (1.3); 7.6691 (2.1); 7.6498 (2.3); 7.6300 (0.9); 4.1235 (16.0); 3.9849 (14.1); 3.8704 (0.9); 3.8520 (3.2); 3.8335 (3.2); 3.8151 (1.0); 3.3309 (108.7); 2.6760 (0.9); 2.6716 (1.2); 2.6671 (0.9); 2.5249 (3.7); 2.5114 (72.1); 2.5071 (141.0); 2.5026 (183.1); 2.4980 (135.1); 2.4937 (66.9); 2.3340 (0.8); 2.3294 (1.1); 2.3248 (0.8); 1.3640 (3.4); 1.3456 (7.9); 1.3271 (3.4); 0.1459 (0.5); 0.0080 (5.0); -0.0002 (121.2); -0.0084 (5.0); -0.1496 I-31 L, L 0 (0.5) , \\ 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7434 (5.3); 8.3648 (4.5); 7.9077 (2.2); 7.8868 (4.6); 7.8454 L, \ zz (4.5); 7.8244 (2.2); 4.1197 (13.0); 4.0060 (11.8); 3.9468 (16.0); z z 3.8635 (0.8); 3.8451 (2.8); 3.8266 (2.9); 3.8082 (0.9); 3.3228 (103.4); 2.6752 (0.7); 2.6710 (1.0); 2.6663 (0.7); 2.5063 (114.9); \ \ 2.5019 (148.5); 2.4974 (109.8); 2.3331 (0.7); 2.3288 (1.0); 2.3243 (0.7); 1.9888 (0.4); 1.3591 (3.1); 1.3408 (6.8); 1.3223 (3.0); 0.8640 (0.4); 0.0079 (0.5); -0.0002 (12.0); -0.0084 (0.6) I-32 L, Li_ / 0-----\\ 1 \ H-NMR(400.2 MHz, d6-DMSO): δ= 8.7435 (6.4); 8.3582 (5.2); 8.3152 (0.8); 7.9031 (2.5); 7.8820 ,L \ (5.5); 7.8444 (5.3); 7.8231 (2.5); 4.2355 (1.5); 4.2180 zi - (4.9); ;K Nz- - z 4.2004 (5.0); 4.1828 (1.7); 4.1188 (16.0); 4.0376 (0.3); 4.0197 - (0.5); 4.0045 (14.2); 3.8623 (0.9); 3.8442 (3.3); 3.8257 (3.3); 3.8074 (1.0); 3.3218 (269.2); 2.6896 (1.6); 2.6795 (1.2); 2.6750 (2.3); 2.6706 (3.2); 2.6660 (2.4); 2.6615 (1.2); 2.5239 (9.4); 2.5105 (187.1); 2.5061 (368.0); 2.5016 (478.3); 2.4970 (348.1); 2.4926 (172.3); 2.3376 (1.1); 2.3329 (2.2); 2.3284 (3.0); 2.3240 (2.2); 2.3194 (1.1); 1.9886 (1.1); 1.3978 (0.4); 1.3586 (3.6); 1.3402 (8.3); 1.3217 (3.5); 1.2992 (5.3); 1.2816 (10.9); 1.2640 (5.1); 1.1927 (0.4); 1.1749 (0.7); 1.1572 (0.3); 0.0079 (1.0); - 0.0002 (25.0); -0.0084 (1.0) I-33 F O- y 1H-NMR(400.2 MHz, d6-DMSO): F F / \ O S δ= 8.8652 (0.8); 8.7405 (5.0); 8.6477 (0.8); 8.3060 (0.7); 8.1362 F - N (16.0); 7.9596 (0.7); 7.9375 (7.5); 7.9323 (7.0); 7.9169 (0.5); N F . /- ,../ .- N N, 7.9101 (0.8); 7.8666 (1.3); 7.8534 (1.4); 7.8397 (3.3); 7.8182 N/( -- N (4.0); 7.5955 (3.8); 7.5742 (3.3); 7.4976 (0.4); 7.4252 (1.2); - 7.4118 (1.2); 5.7487 (3.5); 4.7603 (0.3); 4.7057 (0.3); 4.6940 (0.4); 4.6569 (0.3); 4.6303 (0.4); 4.6154 (0.3); 4.5922 (0.4); 4.5818 (0.4); 4.5560 (0.4); 4.5367 (0.4); 4.5247 (0.4); 4.5188 Cl (0.4); 4.5132 (0.4); 4.4869 (0.5); 4.4710 (0.4); 4.4539 (0.5); 4.4390 (0.5); 4.3802 (0.5); 4.3438 (0.6); 4.3153 (0.6); 4.2842 (0.7); 4.2755 (0.6); 4.2357 (0.7); 4.2140 (0.8); 4.1980 (0.8); 4.1850 (0.8); 4.1725 (0.9); 4.1395 (13.6); 4.1174 (1.1); 4.0872 (1.0); 4.0768 (1.1); 4.0377 (12.5); 4.0174 (1.4); 3.9902 (1.4); 3.9702 (1.5); 3.9412 (7.4); 3.9267 (1.7); 3.8814 (4.2); 3.8638 (4.8); 3.8455 (4.9); 3.8265 (3.3); 3.7604 (3.6); 3.4074 (155.0); 3.0069 (2.6); 2.9944 (2.4); 2.9176 (1.8); 2.8888 (1.6); 2.8705 (1.8); 2.8522 (1.7); 2.8332 (1.4); 2.7818 (1.1); 2.7648 (1.0); BCS233014 FC-Text - 92 - 2.7556 (1.0); 2.7426 (0.9); 2.7107 (0.9); 2.6799 (2.3); 2.6754 (2.8); 2.6714 (2.2); 2.6312 (0.7); 2.6167 (0.7); 2.5992 (0.6); 2.5770 (0.6); 2.5567 (0.7); 2.5281 (7.2); 2.5151 (140.6); 2.5108 (271.4); 2.5063 (347.5); 2.5018 (249.5); 2.4975 (121.8); 2.4467 (1.0); 2.3839 (0.6); 2.3639 (0.6); 2.3377 (1.9); 2.3329 (2.5); 2.3285 (2.0); 2.3120 (0.5); 2.2824 (0.4); 2.2616 (0.4); 2.2575 (0.4); 2.2412 (0.4); 2.2332 (0.4); 2.2252 (0.4); 2.2158 (0.4); 2.1959 (0.4); 2.1768 (0.3); 2.1334 (0.4); 2.0936 (0.3); 2.0722 (5.4); 1.3746 (3.0); 1.3561 (6.8); 1.3377 (3.0); 1.0450 (0.5); 0 1.0266 (1.0); 1.0076 (0.5); -0.0002 (1.5) I-34 1H-NMR(400.2 MHz, d6-DMSO): • * δ= 8.7426 (0.5); 8.1364 (16.0); 7.8466 (0.4); 4.1361 (1.5); 4.0305 (1.3); 3.8625 (0.5); 3.8437 (0.5); 3.6378 (0.6); 3.3621 (24.3); 3.0690 (0.5); 2.6772 (0.5); 2.6728 (0.6); 2.6682 (0.5); 2.5124 (7) (37.9); 2.5082 (71.6); 2.5037 (90.8); 2.4992 (64.5); 2.4948 (30.7); 2.3348 (0.4); 2.3304 (0.6); 2.3261 (0.4); 1.3588 (0.7); 1.3402 (0.3); -0.0002 (0.4) I-35 .....0 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.8108 (3.2); 8.7896 (4.1); 8.7794 (0.5); 8.7720 (6.6); 8.6411 (4.0); 8.6200 (3.3); 8.3152 (0.5); 5.7554 (1.1); 4.4854 (0.4); , 4.3478 (14.5); 4.1688 (0.5); 4.1155 ( , z 16.0); 4.0556 (0.3); 4.0378 \ \ (1.0); 4.0200 (1.0); 4.0022 (0.4); 3.8733 (1.0); 3.8550 (3.3); 3.8366 (3.4); 3.8183 (1.0); 3.3224 (187.0); 2.8910 (0.5); 2.7315 (0.4); 2.6798 (0.6); 2.6754 (1.3); 2.6708 (1.8); 2.6663 (1.3); 2.6618 (0.6); 2.5241 (5.9); 2.5108 (105.6); 2.5064 (209.7); 2.5019 z (273.8); 2.4973 (198.7); 2.4929 (97.9); 2.3332 (1.2); 2.3287 (1.7); 2.3241 (1.3); 2.2535 (0.3); 2.0113 (0.6); 1.9887 (4.4); 1.3427 (3.7); 1.3243 (8.2); 1.3058 (3.6); 1.2982 (1.2); 1.2589 (1.3); 1.2352 (0.9); 1.1929 (1.2); 1.1751 (2.4); 1.1573 (1.2); 0.8887 (0.7); 0.8718 (0.7); 0.1458 (0.4); 0.0080 (3.9); -0.0001 (94.5); - 0.0083 (4.0); -0.1497 (0.4) I-36 . 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.8087 (1.3); 8.8068 (1.3); 8.7965 (1.3); 8.7529 (6.0); z..z- z„. . . . . . . . . .... n 8.3151 (0.9); 8.2822 (0.4); 8.2055 (1.6); 8.1858 (2.2); 8.0832 (1.0); 8.0787 (1.0); 8.0637 (1.6); 8.0594 (1.5); 8.0443 (0.8); 8.0398 (0.8); 7.6243 (1.0); 7.6215 (1.0); 7.6122 (1.0); 7.6093 (1.1); 7.6054 (1.0); 7.6026 (0.9); 7.5932 (0.9); 7.5904 (0.9); 4.8016 (0.3); 4.3716 (14.7); 4.1176 (16.0); 3.8486 (1.0); 3.8299 (3.3); 3.8115 (3.3); 3.7930 (1.0); 3.3255 (247.6); 2.6755 (2.0); 2.6710 (2.7); 2.6665 (2.0); 2.5243 (9.2); 2.5109 (165.2); 2.5065 (325.5); 2.5020 (420.3); 2.4974 (297.6); 2.4930 (141.5); 2.3333 (1.9); 2.3289 (2.6); 2.3243 (1.8); 1.3380 (3.6); 1.3197 (8.2); 1.3012 (3.5); 0.1459 (2.6); 0.0295 (0.4); 0.0273 (0.5); 0.0207 (1.0); 0.0080 (24.8); -0.0001 (602.4); -0.0085 (22.0); -0.1496 (2.6) I-37 0 1H-NMR(400.2 MHz, d6-DMSO): z • δ= 8.7401 (6.4); 8.3156 (0.9); 7.8615 (3.1); 7.8412 (3.5); 7.4952 (4.0); 7.4741 (3.6); 4.1223 (16.0); 4.0816 (0.6); 3.9902 (14.3); 3.9464 (0.6); 3.8708 (1.0); 3.8522 (3.2); 3.8338 (3.3); 3.8153 (1.0); 3.3252 (310.9); 2.6755 (2.1); 2.6710 (3.0); 2.6665 (2.2); 2.5244 (9.0); 2.5196 (14.7); 2.5109 (176.5); 2.5066 (357.0); 2.5021 (466.5); 2.4975 (336.4); 2.4931 (164.1); 2.3334 (2.1); 2.3288 (2.9); 2.3244 (2.1); 1.6239 (0.4); 1.6084 (1.6); 1.6039 (1.5); 1.5895 (0.6); 1.5754 (0.5); 1.5595 (1.5); 1.5551 (1.6); 1.5409 (0.6); 1.3617 (3.6); 1.3433 (8.2); 1.3248 (3.7); 1.3011 (1.7); 1.2955 (2.0); 1.2784 (2.0); 1.2731 (1.6); 1.2562 (0.5); - 0, . 0.0002 (3.5) I-38 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7553 (6.7); 8.1383 (3.4); 8.1334 (3.4); 7.9196 (2.3); 7.8987 (4.2); 7.8543 (2.4); 7.8493 (2.2); 7.8334 (1.4); 7.8284 (1.3); 5.7623 (0.8); 4.1222 (16.0); 3.9914 (14.3); 3.8661 (1.0); 3.8475 (3.2); 3.8290 (3.3); 3.8106 (1.0); 3.3530 (1109.8); 2.6813 (1.7); 2.6768 (2.3); 2.6723 (1.6); 2.5302 (7.9); 2.5252 (12.2); 2.5166 (145.9); 2.5123 (280.4); 2.5078 (358.1); 2.5033 (260.1); 2.4989 5 (125.5); 2.3437 (0.8); 2.3392 (1.7); 2.3347 (2.2); 2.3301 (1.6); 7 2.3257 (0.7); 1.3661 (3.5); 1.3477 (8.0); 1.3292 (3.5) BCS233014 FC-Text - 93 - I-39 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7575 (6.4); 7.9267 (13.4); 5.7640 (1.4); 4.1256 (16.0); 3.9889 (14.2); 3.8687 (1.0); 3.8502 (3.2); 3.8317 (3.3); 3.8133 (1.0); 3.3423 (387.6); 2.6809 (1.1); 2.6765 (1.5); 2.6720 (1.0); 2.5299 (5.2); 2.5162 (92.2); 2.5120 (176.1); 2.5075 (224.4); 2.5030 (163.6); 2.4989 (79.8); 2.3388 (1.0); 2.3343 (1.4); 2.3300 (1.0); 1.3693 (3.5); 1.3508 (8.0); 1.3324 (3.4) I-40 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7384 (5.7); 7.6250 (2.4); 7.6100 (2.2); 7.6050 (1.8); 7.5918 (0.8); 7.5859 (0.8); 7.5682 (0.9); 7.5624 (1.3); 7.5568 (0.6); 7.5448 (0.5); 7.5390 (0.7); 4.1240 (16.0); 4.0046 (14.6); 3.8745 (1.0); 3.8561 (3.3); 3.8377 (3.4); 3.8192 (1.0); 3.3209 (42.9); 2.6719 (0.4); 2.5252 (1.1); 2.5204 (1.6); 2.5116 (21.2); 2.5073 (44.2); 2.5029 (59.3); 2.4984 (43.0); 2.4941 (21.0); 2.3295 (0.4); 1.3664 (3.7); 1.3480 (8.3); 1.3295 (3.6); -0.0002 (5.8) I-41 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7679 (0.3); 8.7511 (6.4); 8.0001 (1.4); 7.9809 (2.1); 7.9612 (1.6); 7.9072 (1.6); 7.9025 (1.6); 7.8832 (1.6); 7.8787 (1.6); 7.6579 (1.7); 7.6531 (1.6); 7.6364 (1.4); 7.6323 (1.4); 5.7587 (0.6); 4.1570 (0.5); 4.1176 (16.0); 4.0842 (0.3); 3.9957 (14.3); 3.8682 (1.1); 3.8500 (3.5); 3.8315 (3.5); 3.8129 (1.1); 3.4172 (0.4); 3.3360 (881.1); 2.6760 (2.8); 2.6715 (3.6); 2.6671 (2.6); 2.5069 (455.0); 2.5025 (567.6); 2.4981 (417.0); 2.3335 (2.7); 2.3294 (3.6); 2.3250 (2.6); 1.3611 (3.7); 1.3426 (8.1); 1.3241 (3.5); 1.2335 (0.5); -0.0002 (6.3) I-42 1H-NMR(600.4 MHz, d6-DMSO): δ= 9.2592 (0.8); 9.2402 (0.6); 8.7748 (0.4); 8.7533 (6.3); 8.3858 (3.3); 8.3720 (4.1); 8.3571 (1.0); 8.2808 (1.0); 8.2792 (1.0); 8.2648 (0.7); 8.2632 (0.7); 8.2117 (3.8); 8.1979 (3.5); 8.1936 (1.0); 8.1798 (0.9); 5.7522 (4.3); 4.3222 (14.8); 4.3070 (4.0); 4.2810 (1.0); 4.2637 (0.4); 4.1764 (1.1); 4.1033 (16.0); 3.9971 (4.1); 3.9609 (3.1); 3.9230 (3.0); 3.8316 (0.9); 3.8194 (3.0); 3.8071 (3.1); 3.7994 (0.4); 3.7948 (1.0); 3.7872 (0.8); 3.7749 (0.8); 3.7621 (0.4); 3.7492 (0.6); 3.7369 (0.6); 3.3040 (118.4); 2.6183 (0.6); 2.6152 (1.5); 2.6121 (2.0); 2.6091 (1.4); 2.6059 (0.6); 2.5212 (4.0); 2.5181 (5.1); 2.5150 (5.0); 2.5063 (108.6); 2.5032 (238.5); 2.5001 (335.9); 2.4970 (244.8); 2.4940 (113.8); 2.4806 (1.3); 2.4680 (0.4); 2.4630 (0.5); 2.3902 (0.8); 2.3872 (1.5); 2.3841 (2.0); 2.3810 (1.4); 2.3780 (0.7); 2.0719 (2.2); 1.3506 (0.6); 1.3269 (3.5); 1.3147 (8.2); 1.3023 (3.8); 1.3007 (3.0); 1.2879 (1.6); 1.2754 (1.6); 1.2630 (0.8); 1.2351 (0.5); 0.0968 (0.6); 0.0054 (5.0); -0.0001 (182.0); -0.0057 (5.4); -0.1002 (0.7) I-43 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.0145 (5.4); 8.7664 (6.8); 8.4270 (5.7); 8.3168 (0.7); 4.3344 (14.6); 4.1247 (16.0); 3.8624 (1.0); 3.8439 (3.3); 3.8255 (3.4); 3.8072 (1.0); 3.3650 (0.4); 3.3249 (434.8); 2.6797 (1.3); 2.6752 (2.7); 2.6706 (3.8); 2.6661 (2.8); 2.6618 (1.3); 2.5622 (0.4); 2.5242 (9.5); 2.5195 (13.2); 2.5107 (179.3); 2.5062 (381.0); 2.5017 (517.5); 2.4971 (374.0); 2.4927 (176.9); 2.4595 (0.6); 2.3376 (1.2); 2.3331 (2.5); 2.3285 (3.6); 2.3240 (2.6); 2.3197 (1.2); 1.3387 (3.7); 1.3203 (8.4); 1.3019 (3.6); 1.2353 (0.6); 0.1459 (1.3); 0.0178 (0.4); 0.0080 (9.0); -0.0002 (312.3); -0.0085 (10.4); -0.1496 (1.4) BCS233014 FC-Text - 94 - I-45 1H-NMR(400.2 MHz, d6-DMSO): δ= 20.0036 (0.5); 8.7634 (3.3); 8.3176 (3.4); 8.0919 (0.5); 8.0702 (1.4); 8.0482 (1.3); 8.0308 (1.2); 8.0218 (1.2); 8.0094 (0.6); 7.9993 (0.6); 5.9229 (0.5); 5.9044 (0.5); 5.7575 (1.0); 4.1038 (8.4); 4.0858 (7.3); 3.9212 (0.8); 3.9021 (1.7); 3.8837 (1.9); L 3.8644 (0.6); 3.7511 (0.5); 3.4574 (0.6); 3.4299 (0.7); 3.4050 (0.9); 3.3856 (0.8); 3.3737 (1.3); 3.3278 (1797.1); 3.2865 (1.2); u 3.2721 (0.9); 2.8908 (0.5); 2.8559 (0.6); 2.8017 (0.5); 2.7856 _ (0.6); 2.7474 (0.6); 2.6751 (11.6); 2.6709 (16.0); 2.6667 (12.1); 2.6408 (0.9); 2.5829 (1.7); 2.5242 (39.2); 2.5063 (1833.8); 2.5020 (2442.4); 2.4977 (1771.5); 2.3828 (0.5); 2.3329 (11.0); 2.3287 (15.2); 2.3244 (11.2); 2.3012 (0.7); 1.3561 (2.2); 1.3380 (4.4); 1.3194 (2.0); 1.2350 (1.4); 0.8446 (0.5); 0.1457 (2.5); 0.0080 (16.1); -0.0002 (519.6); -0.0082 (17.7); -0.0386 (0.5); -0.1492 (2.5); -2.9391 (0.5) I-46 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7657 (6.5); 8.5048 (3.3); 8.4841 (3.7); 8.3179 (0.7); 8.1093 (3.6); 8.0886 (3.3); 7.8835 (0.5); 5.7585 (0.5); 5.3242 (0.4); 4.3199 (14.6); 4.1027 (16.0); 3.8444 (1.0); 3.8259 (3.4); 3.8074 (3.4); 3.7891 (1.0); 3.6880 (1.9); 3.3756 (0.4); 3.3326 (425.0); 5 3.2972 (0.4); 2.6864 (0.6); 2.6760 (2.2); 2.6713 (3.1); 2.6675 (2.7); 2.5555 (0.4); 2.5248 (7.9); 2.5201 (11.5); 2.5111 (164.1); 2.5069 (350.6); 2.5025 (474.1); 2.4981 (347.0); 2.4406 (0.3); 'i c3 2.4303 (0.4); 2.3337 (2.1); 2.3293 (3.0); 2.3250 (2.2); 2.0255 (0.5); 2.0079 (0.9); 1.9885 (0.8); 1.9729 (0.4); 1.4551 (0.4); 1.3316 (3.8); 1.3132 (8.5); 1.2948 (4.0); 1.2347 (6.2); 1.1176 (0.6); 1.0992 (1.1); 1.0809 (0.6); 0.8695 (0.5); 0.8540 (1.4); 0.8368 (0.6); -0.0002 (2.5) I-47 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7701 (6.3); 8.3187 (0.5); 8.2818 (3.6); 8.2777 (4.0); 8.1818 (3.7); 8.1777 (3.5); 5.3238 (0.4); 4.3144 (14.6); 4.1120 (16.0); 3.8561 (1.0); 3.8376 (3.3); 3.8192 (3.4); 3.8009 (1.0); 3.3314 (179.1); 2.6758 (1.3); 2.6713 (1.8); 2.6668 (1.4); 2.5248 (4.2); 2.5200 (6.3); 2.5109 (100.2); 2.5068 (213.1); 2.5023 (289.4); 2.4979 (210.9); 2.4936 (101.1); 2.3337 (1.4); 2.3292 (1.9); 2.3248 (1.4); 2.0265 (0.5); 2.0073 (0.9); 1.9888 (0.8); 1.9745 (0.4); 1.3355 (3.7); 1.3171 (8.3); 1.2986 (3.8); 1.2343 (6.1); 0.8696 (0.5); 0.8539 (1.3); 0.8361 (0.6); 0.0079 (1.1); -0.0002 (39.0); - 0.0084 (1.3) I-48 1H-NMR(600.1 MHz, d6-DMSO): δ= 8.7365 (4.8); 8.1338 (0.1); 8.1088 (1.3); 8.1052 (1.3); 8.0970 (1.3); 8.0934 (1.3); 7.8841 (0.7); 7.8804 (0.7); 7.8763 (0.8); 7.8727 (0.8); 7.8698 (0.9); 7.8661 (0.8); 7.8620 (0.8); 7.8584 (7 (0.8); 7.6974 (1.4); 7.6824 (2.1); 7.6676 (1.2); 5.7536 (5.0); .) 4.2836 (0.1); 4.1805 (0.1); 4.1227 (16.0); 3.9883 (0.1); 3.9753 (15.1); 3.8551 (1.0); 3.8428 (3.3); 3.8305 (3.4); 3.8181 (1.0); u_ 3.5689 (1.5); 3.3407 (0.2); 3.3222 (73.9); 2.6183 (0.2); 2.6153 (0.3); 2.6123 (0.2); 2.5243 (0.8); 2.5212 (1.0); 2.5181 (0.9); 2.5093 (15.4); 2.5063 (34.4); 2.5032 (48.9); 2.5002 (36.0); 2.4972 (17.1); 2.3933 (0.1); 2.3903 (0.2); 2.3871 (0.3); 2.3841 (0.2); 1.3590 (3.6); 1.3467 (8.1); 1.3343 (3.6); 1.2346 (0.3); -0.0001 (2.2) I-49 1H-NMR(600.1 MHz, d6-DMSO): δ= 8.7395 (5.4); 8.1340 (0.2); 7.9484 (1.3); 7.9452 (1.3); 7.9318 (1.3); 7.9285 (1.3); 7.8725 (1.1); 7.8590 (2.0); 7.8457 (1.4); 7.7272 (1.2); 7.7247 (1.2); 7.7143 (1.0); 7.7133 (1.0); 7.7109 u_ (1.0); 5.7538 (3.2); 4.2830 (0.1); 4.1800 (0.1); 4.1207 (16.0); 3.9984 (15.1); 3.8593 (0.9); 3.8470 (3.3); 3.8347 (3.3); 3.8223 (1.0); 3.5687 (0.4); 3.3481 (0.1); 3.3215 (89.2); 2.6210 (0.1); a 2.6180 (0.3); 2.6149 (0.4); 2.6118 (0.3); 2.6089 (0.1); 2.5239 (0.9); 2.5208 (1.1); 2.5177 (1.0); 2.5090 (17.2); 2.5059 (38.7); 2.5029 (55.0); 2.4998 (40.4); 2.4968 (19.3); 2.3925 (0.1); 2.3898 (0.3); 2.3868 (0.4); 2.3837 (0.3); 2.3806 (0.1); 2.0742 (0.4); 2.0103 (0.1); 1.3579 (3.6); 1.3456 (8.2); 1.3332 (3.6); 1.2345 (0.7); 0.8538 (0.2); -0.0001 (2.6); -0.0057 (0.1) BCS233014 FC-Text - 95 - I-50 0 1 - O H-NMR(600.1 MHz, d6-DMSO): 1 , . δ= 8.7469 (6.2); 8.3193 (0.2); 7.8944 (0.1); 7.8900 (0.2); 7.8819 Z (1.2); 7.8707 (1.5); 7.8683 (1.5); 7.8570 (1.2); 7.8493 (0.2); 5.7597 (3.0); 4.1272 (16.0); 4.0054 (0.2); 3.9930 (14.6); 3.8722 u (0.9); 3.8599 (3.0); 3.8475 (3.1); 3.8352 (0.9); 3.5744 (0.6); Z z _ -- 3.3242 (88.5); 2.6262 (0.2); 2.6231 (0.4); 2.6201 (0.6); 2.6171 "-- (0.4); 2.6139 (0.2); 2.5291 (1.4); 2.5260 (1.7); 2.5229 (1.6); u_ 2.5142 (29.6); 2.5111 (66.7); 2.5081 (94.8); 2.5050 (68.4); 2.5019 u (31.5); 2.4807 (0.2); 2.4771 (0.1); 2.3981 (0.2); 2.3950 (0.4); _ 2.3919 (0.6); 2.3888 (0.4); 2.3859 (0.2); 2.0797 (1.1); 1.3651 (3.3); 1.3528 (7.7); 1.3404 (3.3); 1.2410 (0.6); 0.8604 (0.2); 0.0060 (0.3) I-51 . 1 . O H-NMR(600.1 MHz, d6-DMSO): --.v ., δ= 8.7474 (6.0); 8.3184 (0.1); 7.8697 (0.4); 7.8656 (0.8); 7.8617 \ Z (3.2); 7.8492 (3.1); 7.8453 (0.7); 7.8414 (0.3); 5.7586 (0.8); 4.1284 (16.0); 4.0160 (14.6); 3.9990 (0.1); 3.8719 (0.9); 3.8596 * u_ (3.1); 3.8472 (3.1); 3.8349 (0.9); 3.3248 (53.8); 2.6263 (0.1); z 2.6232 (0.3); 2.6201 (0.4); 2.6170 (0.3); 2.6140 (0.1); 2.5291 (0.9); 2.5260 (1.1); 2.5229 (1.0); 2.5141 (19.9); 2.5111 (44.2); 5 2.5080 (62.1); 2.5049 (44.4); 2.5019 (20.2); 2.3979 (0.1); 2.3950 u_ (0.3); 2.3919 (0.4); 2.3889 (0.3); 2.3859 (0.1); 2.0157 (0.1); 1.3657 (3.4); 1.3534 (7.8); 1.3411 (3.4); 1.2399 (0.6); 0.8593 (0.2); 0.8474 (0.1); 0.0052 (0.2) I-52 0 1H-NMR(600.1 MHz, d6-DMSO): ‘, δ= 8.7484 (1.8); 8.3202 (0.9); 7.8047 (1.0); 5.3314 (1.2); 4.4357 Z \ (0.9); 4.1285 (5.2); 4.0009 (4.9); 3.8521 (1.1); 3.8397 (1.1); 3.3244 (888.0); 2.6206 (5.8); 2.5295 (10.8); 2.5265 (15.3); 2.5235 \ * u_ (15.0); 2.5115 (626.7); 2.5085 (915.2); 2.5056 (752.5); 2.3924 (6.1); 2.0280 (1.4); 2.0154 (2.5); 2.0028 (2.0); 1.9927 (1.4); 1.4628 (1.1); 1.3655 (1.3); 1.3532 (2.8); 1.3411 (1.3); 1.2423 (16.0); 0.8731 (1.7); 0.8617 (4.3); 0.8499 (2.0); 0.0073 (2.2) _ I-53 1H-N \ 0 MR(400.2 MHz, d6-DMSO): \ . δ= 8.7497 (5.6); 7.8930 (0.5); 7.8867 (3.8); 7.8820 (1.3); 7.8703 (1.4); 7.8653 (5.1); 7.8593 (0.6); 7.7159 (0.6); 7.7099 (5.0); •N 7.7050 (1.5); 7.6933 (1.3); 7.6884 (4.0); 7.6825 (0.4); 4.5246 Z"- \ (0.9); 4.1215 (16.0); 3.9832 (14.0); 3.8690 (0.9); 3.8506 (3.1); ---- 3.8321 (3.2); 3.8137 (0.9); 3.3255 (23.9); 2.6840 (0.4); 2.6795 -. (0.9); 2.6750 (1.2); 2.6704 (0.9); 2.6658 (0.4); 2.5284 (4.5); 5 2.5236 (7.2); 2.5150 (76.7); 2.5106 (154.4); 2.5061 (201.7); 2.5015 (142.0); 2.4970 (66.6); 2.3420 (0.4); 2.3374 (0.8); 2.3328 (1.2); 2.3283 (0.9); 2.3237 (0.4); 2.0795 (2.3); 1.3634 (3.5); 1.3450 (8.0); 1.3265 (3.4); 0.0044 (0.4 I-54 ° ) 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.2025 (2.4); 9.1988 (2.4); 9.1973 (2.3); 8.7563 (5.7); 8.7429 NN (1.7); 8.5574 (1.6); 8.5519 (1.5); 8.5371 (1.9); 8.5317 (1.9); 11 z 8.3259 (2.5); 8.3158 (0.8); 8.3056 (2.2); 5.7561 (1.4); 4.2141 (0.6); 4.1267 (16.0); 4.0621 (5.0); 4.0333 (14.4); 3.9859 (0.7); 3.9396 (4.5); 3.8880 (1.0); 3.8697 (3.2); 3.8512 (3.3); 3.8329 (1.0); 3.8054 (0.3); 3.7867 (1.0); 3.7681 (1.1); 3.7494 (0.3); 3.3234 (206.2); 2.6753 (1.3); 2.6708 (1.8); 2.6665 (1.4); 2.5243 (5.3); 2.5107 (108.3); 2.5064 (222.0); 2.5019 (295.1); 2.4974 (214.6); 2.4931 (105.2); 2.3376 (0.6); 2.3333 (1.3); 2.3287 (1.7); 2.3242 (1.3); 1.3731 (3.6); 1.3547 (8.1); 1.3363 (3.5); 1.3077 (1.2); 1.2893 (2.5); 1.2708 (1.1); 0.0079 (1.0); -0.0002 (30.8); - 0.0085 (1.1) I-55 z NN N 1 , H-NMR(400.2 MHz, d6-DMSO): CO N . .. z δ= 9.2847 (3.2); 9.2796 (3.2); 9.2565 (3.1); 9.2515 (3.2); 8.8358 N (2.0); 8.8306 (3.6); 8.8255 (1.9); 8.7552 (5.9); 8.3154 (2.1); \ N 4.4543 (0.4); 4.2169 (0.4); 4.1372 (16.0); 4.0289 (14.2); 3.9830 z z (0.4); 3.8950 (1.0); 3.8762 (3.3); 3.8576 (3.4); 3.8396 (1.0); / 3.5898 (0.3); 3.4748 (0.3); 3.4319 (0.5); 3.3239 (1177.5); 2.9443 (1.6); 2.6751 (5.8); 2.6705 (7.9); 2.6660 (5.9); 2.6431 (0.5); 2.5729 (1.0); 2.5239 (22.0); 2.5104 (468.7); 2.5061 (965.2); 2.5016 (1283.4); 2.4971 (934.6); 2.4928 (458.1); 2.3930 (0.4); 2.3329 (5.5); 2.3284 (7.8); 2.3239 (5.7); 1.3759 (3.5); 1.3575 (8.0); 1.3390 (3.4); 1.2379 (0.4); 0.1458 (0.5); 0.0079 (4.1); - 0.0002 (133.8); -0.0085 (4.9); -0.1493 (0.5) BCS233014 FC-Text - 96 - I-56 1H-NMR(400.2 MHz, d6-DMSO): 3 δ= 8.7703 (5.7); 8.4661 (3.4); 8.4436 (4.2); 8.2007 (3.8); 8.1782 (3.4); 5.7557 (0.4); 4.3744 (14.7); 4.1245 (16.0); 3.8862 (0.9); 3.8678 (3.1); 3.8493 (3.1); 3.8309 (0.9); 3.3225 (39.5); 2.6758 (0.4); 2.6712 (0.6); 2.6667 (0.4); 2.5249 (1.7); 2.5201 (2.6); 2.5114 (35.0); 2.5069 (72.4); 2.5024 (95.8); 2.4978 (67.5); 2.4932 (31.3); 2.3338 (0.4); 2.3292 (0.6); 2.3246 (0.4); 1.9890 (0.3); 1.3555 (3.5); 1.3371 (8.2); 1.3186 (3.4); 1.1753 (0.5); 1.1661 (0.4); 0.0080 (0.4); -0.0002 (14.1); -0.0085 (0.4) I-57 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7391 (5.0); 8.6444 (2.2); 8.6383 (2.2); 8.3156 (0.6); 8.1730 (1.4); 8.1669 (1.3); 8.1514 (1.5); 8.1452 (1.4); 7.0697 (2.2); 7.0482 (2.1); 4.1212 (13.0); 3.9805 (11.8); 3.9617 (16.0); 3.8663 (0.8); 3.8479 (2.8); 3.8295 (2.8); 3.8109 (0.9); 3.3237 (399.0); ) 2.6755 (2.2); 2.6712 (2.8); 2.6668 (2.0); 2.5066 (350.0); 2.5022 \ (432.2); 2.4977 (313.5); 2.3334 (2.2); 2.3291 (2.8); 2.3246 (2.0); 1.3604 (3.0); 1.3419 (6.6); 1.3235 (2.9); 0.1465 (0.9); 0.0082 (11.2); 0.0002 (211.0); -0.0080 (9.8); -0.1490 (0.9) I-58 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.1533 (0.3); 8.8776 (2.4); 8.8713 (2.3); 8.8296 (0.6); 8.8236 (0.6); 8.7559 (0.9); 8.7487 (5.6); 8.3630 (0.4); 8.3495 (1.7); 8.3433 (1.8); 8.3287 (1.8); 8.3225 (1.8); 8.3155 (0.8); 8.2788 (0.5); 8.2721 (0.4); 8.2579 (0.5); 8.2513 (0.5); 7.8125 (2.5); 7.7915 (2.3); 7.7338 (0.3); 7.6867 (0.7); 7.6650 (0.7); 4.1476 ) (2.0); 4.1218 (16.0); 4.0605 (2.0); 4.0022 (14.2); 3.9396 (0.8); 3.8788 (0.5); 3.8721 (1.0); 3.8537 (3.2); 3.8352 (3.2); 3.8166 (1.0); 3.3239 (353.2); 2.6754 (1.8); 2.6707 (2.5); 2.6663 (1.8); 2.6621 (0.9); 2.5242 (6.3); 2.5195 (9.6); 2.5107 (149.4); 2.5064 (311.0); 2.5018 (413.9); 2.4973 (297.6); 2.4929 (142.9); 2.3332 (1.8); 2.3287 (2.5); 2.3241 (1.8); 2.0743 (0.8); 1.3831 (0.5); 1.3661 (4.0); 1.3479 (8.2); 1.3294 (3.4); 1.2890 (0.5); 0.0080 (1.0); -0.0002 (35.8); -0.0085 (1.3) I-59 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.9852 (3.2); 8.9807 (3.2); 8.8833 (3.0); 8.8775 (3.1); 8.7509 (5.7); 8.4522 (1.9); 8.4467 (3.0); 8.4417 (1.8); 4.1316 (16.0); / 4.0554 (0.4); 4.0377 (1.2); 4.0172 (14.5); 4.0022 (0.5); 3.8834 (0.9); 3.8650 (3.2); 3.8465 (3.2); 3.8281 (1.0); 3.3228 (81.4); 2.6754 (0.7); 2.6708 (1.0); 2.6664 (0.8); 2.6618 (0.4); 2.5243 ) (2.8); 2.5108 (60.6); 2.5064 (124.5); 2.5019 (165.0); 2.4974 (118.6); 2.4930 (57.1); 2.3332 (0.7); 2.3287 (1.0); 2.3242 (0.7); 1.9888 (4.6); 1.3723 (3.5); 1.3539 (8.0); 1.3354 (3.5); 1.1927 (1.3); 1.1750 (2.5); 1.1572 (1.2); 0.0079 (1.5); -0.0002 (47.8); - 0.0085 (1.8) I-60 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.3435 (0.4); 9.3379 (0.4); 9.2252 (3.2); 9.2200 (3.3); 9.1525 (3.3); 9.1472 (3.3); 9.1308 (0.3); 9.1261 (0.3); 8.8567 (0.4); 8.7518 (6.4); 8.6467 (1.9); 8.6414 (3.4); 8.6361 (1.8); 8.3390 (1.3); 8.3147 (0.7); 7.7970 (1.3); 4.1335 (16.0); 4.0281 (13.8); 3.8757 (0.8); 3.8571 (3.1); 3.8386 (3.1); 3.8201 (0.9); 3.3255 ) \ (325.0); 2.6802 (0.5); 2.6756 (1.0); 2.6711 (1.5); 2.6664 (1.1); 2.6621 (0.5); 2.5246 (3.8); 2.5199 (5.6); 2.5112 (84.5); 2.5067 (177.1); 2.5021 (235.8); 2.4975 (166.8); 2.4930 (78.0); 2.3380 (0.5); 2.3336 (1.0); 2.3289 (1.5); 2.3243 (1.0); 2.3199 (0.5); 1.3714 (3.4); 1.3530 (8.0); 1.3345 (3.3); 0.0079 (0.5); -0.0002 (19.5); -0.0086 (0.6) I-61 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.0686 (2.5); 9.0650 (2.4); 9.0634 (2.2); 8.7549 (5.9); 8.7092 (0.5); 8.4727 (1.6); 8.4672 (1.5); 8.4523 (1.9); 8.4469 (1.9); 8.3730 (0.5); 8.3156 (0.8); 8.2814 (1.3); 8.2531 (2.5); 8.2326 (2.2); 7.8322 (1.2); 4.1333 (16.0); 4.1147 (1.7); 4.0348 (14.4); ) 3.9863 (1.6); 3.8845 (0.9); 3.8661 (3.2); 3.8476 (3.2); 3.8291 (1.0); 3.3235 (309.7); 2.6797 (0.9); 2.6752 (1.8); 2.6708 (2.5); 2.6663 (1.8); 2.6617 (0.9); 2.5242 (7.0); 2.5193 (11.1); 2.5107 (149.7); 2.5064 (306.2); 2.5018 (404.2); 2.4973 (290.0); 2.4928 (138.6); 2.3377 (0.8); 2.3332 (1.8); 2.3287 (2.5); 2.3241 (1.8); 1.3747 (3.6); 1.3564 (8.2); 1.3379 (3.5); 1.3027 (0.4); 1.2845 (0.9); 1.2660 (0.4); 0.0081 (1.4); -0.0001 (45.0); -0.0084 (1.6) BCS233014 FC-Text - 97 - 0 I-62 0 / 1 )/ c \ s , H-NMR(400.2 MHz, d6-DMSO): o z δ= 8.9525 (2.1); 8.9505 (2.3); 8.9469 (2.2); 8.9448 (2.1); 8.7458 — N .. i z ( _ \ -- i (6.3); 8.3213 (1.8); 8.3157 (1.8); 8.3007 (1.9); 8.2949 (1.9); z --- N 7.7882 (2.1); 7.7863 (2.1); 7.7676 (2.1); 7.7655 (2.1); 7.6641 u_ u _ ••.c,. .. (0.4); 7.6622 (0.3); 4.4430 (0.4); 4.1298 (1.0); 4.1205 (16.0); u „ _ ..,s • ..., -• / "- 4.0281 (0.6); 3.9947 (13.9); 3.8802 (0.8); 3.8617 (3.1); 3.8432 u_ u z _ 1 1.z (3.1); 3.8249 (0.9); 3.6779 (0.3); 3.3277 (78.6); 2.6765 (0.4); 2.6718 (0.5); 2.6672 (0.3); 2.5254 (1.2); 2.5207 (1.9); 2.5120 (27.5); 2.5075 (56.9); 2.5029 (75.0); 2.4983 (52.5); 2.4937 (24.0); 2.3343 (0.3); 2.3297 (0.5); 2.3251 (0.3); 2.0754 (2.8); 1.9504 (1.0); 1.9376 (2.3); 1.9290 (3.2); 1.9198 (1.4); 1.8668 (0.4); 1.8581 (0.5); 1.8325 (1.5); 1.8226 (3.2); 1.8140 (2.4); 1.8009 (1.0); 1.7516 (0.5); 1.7431 (0.4); 1.3671 (3.4); 1.3487 (8.0); 1.3302 (3.2); -0.0002 (7.7) I-63 0 0 1H-NMR(400 6 )/ / ‘ c, .2 MHz, d -DMSO): o.• δ= 8.7484 (6.1); 8.7205 (2.7); 8.4936 (0.8); 8.4880 (0.8); 8.4731 — _ N - (1.5); 8.4678 (1.4); 8.4527 (0.9); 8.4470 (0.8); 8.3163 (0.8); _ N N -"- \ z 7.4909 (1.5); 7.4847 (1.5); 7.4696 (1.5); 7.4631 (1.5); 4.1254 / z u _ u z _/ u _ (16.0); 4.0622 (1.9); 3.9908 (14.8); 3.9398 (1.7); 3.8775 (1.1); .... ... u_ \ .„„.. . z . ,. 3.8594 (3.6); 3.8410 (3.7); 3.8218 (1.2); . . .. " \/ 3.7867 (0.5); 3.7681 .. u .. (0.4); 3.3230 (212.5); 2.6709 (4.3); 2.5019 (709.6); 2.3282 (4.3); _ u , _ z1 1 z 1.3689 (3.8); 1.3507 (8.2); 1.3321 (3.8); 1.3072 (0.5); 1.2889 (1.0); 1.2720 (0.5); 0.1458 (2.8); -0.0001 (529.3); -0.1493 (2.9) I-64 u _ 0 1H-NMR(400.2 MHz, d6-DMSO): u_ \ u _ \ δ= 8.7822 (6.3); 8.3181 (1.2); 8.2805 (6.0); 7.2030 (0.3); 5.3244 u_ (0.5); 4.3104 (15.0); 4.0691 (16.0); 3.8434 (1.2); 3.8255 (3 \ z \ .6); . z u 3.8068 (3.8); 3.7888 (1.2); 3.4479 (0.3); 3.3883 (0.5); 3.38 _ . 03 . z N \ (0.5); 3.3307 (590.5); 2.6710 (6.2); 2.6107 (0.4); 2.5021 (942.0); /7K z. z z C . \ . 2.4266 (0.7); 2.3495 (0.4); 2.3289 (5.9); 2.0265 (0.6); 2.0064 - ) ---- (1.2); 1.9878 (1.0); 1.4761 (0.4); 1.4689 (0.5); 1.4557 (0.5); z 1.3236 (4.1); 1.3051 (8.7); 1.2866 (4.6); 1.2342 (9.6); 1.1837 (0.4); 1.1590 (0.3); 0.8538 (1.7); 0.8361 (0.8); 0.1453 (0.5); - 0.0002 (87.6); -0.1498 (0.4) I-65 . 0.: u . 0 1 _ .. H-NMR(400.2 MHz, d6 . -DMSO): LL u _ 7.--u ) δ= 9.2226 (4.2); 9.2192 (4.3); 9.0365 (4.4); 9.0331 (4.2); 8.7658 z \ (6.7); 8.3157 (1.6); 4.3068 (14.4); 4.1301 (16.0); 3.8721 (0.9); u_ \ . 3.8536 (3.1); 3.8352 (3.2); 3.8168 (0.9); 3.3708 (0.4); 3.3613 u_ _( . z N \ (0.5); 3.3251 (347.0); 3.2940 (0.3); 3.2178 (0.8); 2.6800 (1.3); /z . / z z - 2.6756 (2.7); 2.6710 (3.8); 2.6664 (2.7); 2.6618 (1.3); 2.5245 --- - - - (11.7); 2.5198 (16.8); 2.5111 (219.6); 2.5066 (453.8); 2.5021 - zi (594.4); 2.4974 (413.2); 2.4929 (188.6); 2.3380 (1.1); 2.3335 5 (2.5); 2.3289 (3.5); 2.3243 (2.5); 2.3197 (1.1); 1.3508 (0.6); 1.3432 (3.6); 1.3248 (8.4); 1.3063 (3.4); 1.2585 (0.4); 1.2345 (1.6); 0.9494 (0.5); 0.8536 (0.4); 0.1459 (2.7); 0.0360 (0.5); 0.0080 (23.2); -0.0001 (704.7); -0.0085 (21.6); -0.1496 (2.7) I-66 0 u 0 1 _ : H-NMR(400.2 MHz, d6 : .. -DMSO): LL u „.- _ /-\ u \ ) δ= 9.3572 (5.5); 9.0098 (5.4); 8.7682 (6.1); 8.3151 (1.4); 4.3122 z \ (14.4); 4.1285 (16.0); 3.8719 (0.9); 3.8532 (3.2); 3.8348 (3.2); u_ \ - . 3.8164 (1.0); 3.3791 (0.6); 3.3303 (781.8); 3.2593 (0.6); 2.6802 u_ ( z - N (1.3); 2.6758 (2.7); 2.6712 (3.7); 2.6666 (2.7); 2.6623 (1.3); /7 z z z 5 . •- 2.5246 (11.6); 2.5112 (240.1); 2.5068 (479.0); 2.5023 (616.8); - 2.4977 (434.4); 2.4932 (204.2); 2.4316 (0.3); 2.3380 (1.3); 2.3335 \ z (2.7); 2.3291 (3.6); 2.3245 (2.6); 2.3202 (1.2); 1.3433 (3.5); 1.3249 (7.9); 1.3064 (3.4); 0.0079 (2.7); -0.0002 (74.8); -0.0085 (2.6) 0 I-67 1 u -. H-NMR(400.2 MHz, d6-DMSO): L _ L -.. u . _ -.c \ o\ 0 δ= 9.0655 (3.8); 9.0520 (3.9); 8.7721 (6.9); 8.3160 (2.1); 7.9391 \ \ ,z (4.2); 7.9257 (4.0); 4.3173 (14.6); 4.1450 (0.3); 4.0849 (16.0); u_ u_ 3.8551 (1.0); 3.8362 (3.4); 3.8177 (3.4); 3.7991 (1.1); 3.3843 z / \ z (0.5); 3.3267 (711.2); 2.6754 (4.6); 2.6709 (6.2); 2.6664 (4.6 / z z 5 ); / 2.5242 (26.1); 2.5108 (407.1); 2.5065 (802.0); 2.5020 (1033.6); z \ 2.4975 (738.5); 2.4931 (358.1); 2.3333 (4.5); 2.3288 (6.2); 2.3243 (4.5); 1.3352 (3.6); 1.3168 (8.0); 1.2983 (3.4); 0.1459 (2.7); 0.0078 (25.8); -0.0002 (609.2); -0.0084 (24.7); -0.1496 (2.7) BCS233014 FC-Text - 98 - I-68 0- 1 - H-NMR(400.2 MHz, d6-DMSO): -\ δ= 10.2042 (0.4); 8.7781 (6.0); 8.7710 (0.8); 8.6700 (2.7); 8.6479 (5.4); 8.6032 (5.1); 8.5811 (2.9); 8.4660 (0.4); 8.4435 (0.6); n 8.3157 (1.7); 8.2011 (0.5); 8.1785 (0.5); 4.4173 (14.2); 4.3739 - (1.8); 4.1293 (16.0); 4.1241 (2.9); 3.9019 (0.8); 3.8835 (3.0); 3.8650 (3.1); 3.8468 (1.0); 3.3265 (158.2); 2.6803 (0.6); 2.6758 (1.4); 2.6712 (2.0); 2.6665 (1.4); 2.6619 (0.6); 2.5416 (67.2); 2.5247 (5.7); 2.5201 (8.3); 2.5113 (112.3); 2.5068 (235.1); 2.5022 //z (311.2); 2.4976 (216.5); 2.4930 (98.8); 2.3382 (0.7); 2.3336 (1.4); 2.3291 (2.0); 2.3245 (1.4); 2.3199 (0.7); 1.7421 (2.0); 1.3611 (3.3); 1.3552 (0.7); 1.3427 (8.0); 1.3368 (1.4); 1.3242 (3.3); 1.3185 (0.6); 0.1459 (1.3); 0.0080 (11.1); -0.0002 (366.0); -0.0086 (11.1); -0.1496 (1.3) I-69 O C--- 1 - H-NMR(400.2 MHz, d6-DMSO): δ= 9.6228 (5.4); 8.7766 (6.3); 5.7575 (3.1); 4.3166 (14.8); 4.0829 (16.0); 3.8636 (1.0); 3.8453 (3.4); 3.8269 (3.5); 3.8085 (1.1); 3.3295 (72.0); 2.6720 (0.5); 2.5252 (1.1); 2.5074 (60.3); 2.5031 r,- (79.8); 2.4988 (58.6); 2.3298 (0.5); 2.3254 (0.4); 1.3367 (3.8); ,r- 1.3183 (8.4); 1.2999 (3.8); 1.2352 (0.4); 0.0079 (0.4); -0.0002 (12.7) I-70 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.8188 (11.4); 8.7653 (4.9); 8.3183 (2.2); 7.5971 (0.5); 7.5505 (0.4); 4.2545 (11.1); 4.1121 (0.4); 4.0982 (12.1); 4.0341 (15.4); 4.0214 (0.5); 3.8667 (0.8); 3.8480 (2.6); 3.8296 (2.4); 3.8111 n- (0.9); 3.5843 (0.4); 3.5258 (0.4); 3.5066 (0.6); 3.4507 (0.6); 3.4216 (0.8); 3.3940 (1.1); 3.3312 (1911.9); 2.6755 (11.8); 2.6710 (16.0); 2.6664 (11.6); 2.6340 (0.7); 2.5716 (2.1); 2.5245 (56.5); 2.5197 (88.6); 2.5110 (988.2); 2.5066 (1936.0); 2.5020 (2511.1); 0 2.4974 (1828.8); 2.4929 (883.3); 2.3586 (0.4); 2.3378 (5.4); — 2.3334 (11.4); 2.3288 (15.5); 2.3243 (11.1); 2.3198 (5.2); 1.3415 (2.6); 1.3230 (5.9); 1.3042 (2.6); 1.2582 (0.4); 1.2354 (0.8); 0.0080 (2.0); -0.0001 (65.5); -0.0085 (2.2) I-71 1H-NMR(400.2 MHz, d6-DMSO): δ= 20.0048 (0.4); 8.9587 (3.1); 8.9539 (3.3); 8.8121 (3.0); 8.8064 (3.2); 8.7492 (6.2); 8.3149 (1.8); 8.1732 (1.8); 8.1680 (3.2); 8.1625 (1.9); 7.6427 (0.4); 7.6263 (0.7); 7.6135 (0.6); 7.5963 (0.7); 7.5733 (0.6); 7.5669 (0.5); 7.5474 (0.5); 4.1174 (16.0); 3.9891 (14.1); 3.9508 (0.3); 3.8705 (1.0); 3.8521 (3.3); 3.8337 4 (3.4); 3.8151 (1.1); 3.3226 (732.0); 2.8913 (1.1); 2.7315 (0.9); 2.6748 (5.0); 2.6706 (6.8); 2.6661 (5.2); 2.5238 (25.2); 2.5103 (449.6); 2.5062 (896.3); 2.5017 (1171.2); 2.4973 (848.3); 2.3331 (5.0); 2.3285 (7.0); 2.3242 (5.3); 2.0739 (5.3); 1.9113 (1.1); 1.8970 (3.1); 1.8898 (3.5); 1.8785 (1.6); 1.7621 (1.7); 1.7495 (3.3); 1.7424 (3.2); 1.7281 (1.1); 1.3714 (3.6); 1.3528 (8.0); 1.3344 (3.5); 1.2373 (0.5); 0.1464 (0.7); 0.0079 (5.8); -0.0002 (161.0); -0.0084 (6.4); -0.1501 (0.8) I-72 1H-NMR(400.2 MHz, d6-DMSO): n- δ= 9.2860 (15.9); 8.7729 (6.9); 8.3187 (1.1); 4.2957 (14.4); 4.0964 (16.0); 3.8749 (1.0); 3.8562 (3.3); 3.8379 (3.4); 3.8195 (1.0); 3.3678 (0.5); 3.3320 (693.4); 3.3031 (0.9); 3.2925 (0.4); 3.2805 (0.4); 2.6799 (2.1); 2.6756 (4.6); 2.6711 (6.3); 2.6665 (4.6); 2.6620 (2.1); 2.5844 (0.3); 2.5246 (17.6); 2.5200 (24.7); 2.5111 (347.8); 2.5067 (731.4); 2.5021 (970.6); 2.4976 (682.7); c 2.4931 (312.8); 2.3683 (0.3); 2.3377 (2.1); 2.3335 (4.5); 2 o_ .3290 (6.2); 2.3244 (4.5); 2.3200 (2.0); 2.0757 (1.0); 1.3421 (3.6); 1.3237 (8.2); 1.3052 (3.4); 1.2630 (0.6); 1.2479 (0.7); 0.0079 (0.4); -0.0002 (13.7); -0.0088 (0.4) I-73 -0-:- 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.5588 (7.2); 9.5568 (6.7); 8.7824 (7.4); 8.1539 (0.8); 4.3547 (14.3); 4.1086 (16.0); 3.8978 (0.9); 3.8794 (3.2); 3.8609 (3.2); 3.8425 (0.9); 3.3333 (10.8); 2.6763 (0.5); 2.6717 (0.7); 2.6671 (0.5); 2.5253 (2.2); 2.5205 (3.5); 2.5118 (42.8); 2.5073 (84.0); 2.5027 (108.3); 2.4981 (78.3); 2.4936 (37.2); 2.3342 (0.5); 2.3295 r (0.7); 2.3250 (0.5); 2.0763 (1.6); 1.3543 (3.4); 1.3359 (8.0); ,- 1.3174 (3.3); -0.0002 (2.1) ,r- BCS233014 FC-Text - 99 - I-74 . u_ . 0 -- 0 1H-NMR(400.2 MHz, d6-DMS u - O): _ - -% u _ -1 V / , c 1) δ= 9.1931 (9.5); 9.1918 (9.7); 9.1800 (0.4); 8.7732 (6.8); 8.1557 u_ (4.5); 7.6477 (0.5); 7.6277 (0.8); 7.6222 (0.6); 7.6182 (0.7); \ z u - 7 7.6010 (0.8); 7.5809 (0.6); 7.5726 (0.7); 7.5629 (0.5); 7.5547 _ - . z (0.6); 5.7595 (0.8); 4.2991 (0.3); 4.2781 (14.6); 4.2588 (0.3); li ( z z z * 4.1861 (0.4); 4.1012 (16.0); 3.8785 (1.0); 3.8600 (3.4); 3.8415 " " . (3.5); 3.8233 (1.2); 3.3718 (398.9); 2.6814 (1.5); 2.6769 (2.0); z 2.6723 (1.5); 2.5302 (7.0); 2.5254 (11.0); 2.5168 (120.6); 2.5124 u_ (236.7); 2.5079 (307.8); 2.5033 (226.8); 2.4989 (111.4); 2.3393 (1.4); 2.3346 (1.9); 2.3301 (1.4); 1.3478 (3.6); 1.3294 (8.1); 0 1.3109 (3.4) I-75 u - 1H-NMR(400.2 MHz, d6-DMSO): u _ _ - u_ --\ \ 0 δ= 9.5602 (14.0); 9.2205 (0.9); 8.7725 (6.2); 8.7659 (0.6); 8.3155 z \ u_ \ z (0.6); 4.3503 (13.8); 4.2996 (0.9); 4.0986 (16.0); 3.8834 (0.9); u_ V . 3.8649 (3.1); 3.8464 (3.2); 3.8389 (0.6); 3.8279 (1.0); 3.3246 z // z z (257.7); 2.6755 (1.4); 2.6710 (1.9); 2.6665 (1.3); 2.6620 (0.6); 2.5244 (5.9); 2.5111 (116.4); 2.5067 (229.7); 2.5021 (295.6); z \ 2.4976 (210.0); 2.4931 (99.9); 2.3381 (0.7); 2.3335 (1.4); 2.3290 (1.8); 2.3244 (1.4); 2.3199 (0.6); 1.3466 (3.5); 1.3282 (8.1); z 1.3097 (3.5); 1.2982 (1.6); 1.2589 (2.1); 1.2352 (0.9); 0.1460 (0.9); 0.0080 (8.7); -0.0001 (216.3); -0.0084 (7.9); -0.1495 (0.9) 0 I-76 1 u H-NMR(400.2 MHz, d6-DMSO): u _ _ \ 0 u _ \ δ= 9.2200 (14.2); 8.7652 (6.6); 8.3148 (0.6); 4.2994 (14.7); \ \ ,z u 4.2795 (0.4); 4.0986 (16.0); 3.8747 (1.0); 3.8564 (3.3); 3.8379 _ u_ (3.3); 3.8196 (1.0); 3.3250 (403.9); 2.6798 (0.8); 2.6754 (1.5); z / \ z 2.6709 (2.0); 2.6664 (1.5); 2.6619 (0.7); 2.5242 (6.5); 2.5108 / z z z (126.0); 2.5065 (245.9); 2.5019 (316.6); 2.4974 (225.6); 2.4929 z \ (108.6); 2.3379 (0.7); 2.3331 (1.5); 2.3287 (2.0); 2.3242 (1.4); 5 2.3197 (0.7); 1.3443 (3.6); 1.3259 (8.2); 1.3074 (3.5); -0.0002 (1.7) I-77 0 u - 0 1H-NMR(400.2 MHz, d6-DMSO): u _ _ u - v _ , δ= 10.2093 (0.6); 9.2634 (2.2); 9.2600 (2.1); 8.7626 (6.3); 8.6402 z, \ u_ \ (1.4); 8.6349 (1.4); 8.6197 (1.6); 8.6144 (1.6); 8.3178 (0.4); u_ _ _ 8.2455 (2.2); 8.2259 (2.0); 4.1380 (16.0); 4.0478 (14.4); 3.9056 z /z/ . \ ( z \ - (1.0); 3.8871 (3.2); 3.8686 (3.3); 3.8501 (1.0); 3.3322 (283.8); --- _ - / u _ 2.6762 (1.3); 2.6716 (1.7); 2.6671 (1.3); 2.5250 (5.7); 2.5202 (8.8); 2.5115 (97.5); 2.5072 (195.6); 2.5026 (256.1); 2.4981 / u_ / z (186.9); 2.4937 (91.2); 2.3387 (0.6); 2.3340 (1.2); 2.3294 (1.7); 2.3249 (1.2); 2.0755 (3.4); 1.3833 (3.5); 1.3649 (8.1); 1.3464 (3.5); 0.1459 (0.8); 0.0080 (6.5); -0.0002 (185.9); -0.0085 (6.9); - 0.1496 (0.8) 0 I-78 u _ 1 - H-NMR(400.2 MHz, d6-DMSO): u_ - _ -- 0 u \ \ δ= 8.8720 (1.1); 8.8704 (1.1); 8.8594 (1.2); 8.8577 (1.2); 8.7498 u_ \ \ z, (3.5); 8.1387 (3.5); 7.9985 (1.6); 7.9973 (1.6); 7.9952 (1.3); u_ - 7.8666 (1.0); 7.8629 (1.0); 7.8540 (1.0); 7.8502 (1.0); 5.7471 z - \ / (2.4); 4.1051 (8.8); 4.0382 (7.6); 3.8586 (0.6); 3.8403 (1.8); / z K z - \ - 3.8218 (1.8); 3.8034 (0.6); 3.4225 (176.4); 3.1715 (0.4); 2.6778 ---. / (0.4); 2.5312 (1.1); 2.5264 (1.6); 2.5179 (21.8); 2.5134 (44.2); z 2.5088 (58.2); 2.5042 (42.4); 2.4997 (20.6); 2.3355 (0.4); 1.7892 (16.0); 1.3659 (1.9); 1.3475 (4.4); 1.3290 (1.8); 0.0080 (0.7); - / 0.0002 (22.4); -0.0085 (0.7) / z I-79 0 0 1 / . . . H-NMR(400.2 MHz, d6-DMSO): , u .N . 5 ) z δ= 8.7550 (5.9); 8.6844 (2.4); 8.6715 (2.5); 7.9987 (3.0); 7.8990 N (2.0); 7.8954 (1.8); 7.8862 (1.9); 7.8826 (1.8); 4.1226 (16.0); z \ . z 4.0473 (14.2); 3.8796 (0.9); 3.8613 (3.2); 3.8428 (3.3); 3.8243 z u _ u _ (1.0); 3.3260 (46.4); 2.6720 (0.4); 2.5253 (1.2); 2.5119 (24.5); ...„..i 1 2.5075 (49.2); 2.5029 (64.9); 2.4984 (47.6); 2.4939 (23.2); 2.3298 u_ .. . . ...5.. . / „.... (0.4); 2.0867 (2.5); 1.3675 (3.5); 1.3 . . 491 (8.0); 1.3306 (3.4); ,.. u z . _ u _ I z 0.1459 (0.4); 0.0078 (2.9); -0.0002 (75.8); -0.0086 (2.7); -0.1495 (0.4) BCS233014 FC-Text - 100 - I-80 - 0 1H-NMR(400.2 MHz, d6-DMSO): u_ u - _ - 0 - u_ J " --ci \ -• , δ= 9.2770 (4.7); 9.0745 (3.3); 9.0619 (3.5); 8.7598 (6.5); 8.2021 (2.6); 8.1894 (2.5); 7.6438 (0.4); 7.6270 (0.8); 7.6147 (0.6); u z \ _ \ 7.5974 (0.7); 7.5744 (0.5); 7.5665 (0.6); 7.5569 (0.5); 7.5509 u_ - (0.6); 7.5486 (0.5); 5.7560 (1.9); 4.1761 (16.0); 4.0090 (14.4); z// ( 3.9626 (1.0); 3.9443 (3.4); 3.9258 (3.4); 3.9072 (1.0); 3.3279 z z z --- z (189.6); 2.6758 (0.8); 2.6714 (1.0); 2.6671 (0.8); 2.5069 (126.8); --- 2.5024 (164.8); 2.4980 (125.7); 2.3335 (0.8); 2.3293 (1.0); 2.3249 \ (0.8); 1.4091 (3.6); 1.3907 (8.0); 1.3722 (3.5); 0.0078 (2.4); - z\ 0.0002 (56.7); -0.0084 (2.5) o I-81 o// s. u , - 1H-NMR(400.2 MHz, d6-DMSO) )) -- : - - / / . . δ= 9.2299 (2.4); 9.2247 (2.4); 9.2234 (2.4); 9.1606 (2.2); 9.1589 N „ . „ .. „ (7 z z ) z (2.3); 9.1551 (2.3); 9.1532 (2.2); 8.7531 (7.1); 8.6439 (1.8); 8.6375 (1.7); 8.6229 (1.8); 8.6165 (1.9); 8.4433 (1.3); 8.4377 u_ ... / (1.3); 8.4225 (2.1); 8.4169 (2.2); 8.3625 (2.3); 8.3609 (2.4); u_ „ , z u_ u _ I T 8.3418 (1.5); 8.3400 (1.5); 7.7320 (2.6); 7.7122 (2.4); 7.7109 (2.5); 4.1492 (16.0); 4.0621 (14.0); 3.8984 (0.9); 3.8799 (3.2); 3.8614 (3.2); 3.8429 (0.9); 3.3205 (29.0); 2.6760 (0.4); 2.6715 (0.6); 2.6668 (0.5); 2.5250 (1.9); 2.5203 (2.7); 2.5116 (34.4); 2.5070 (70.1); 2.5024 (94.3); 2.4978 (69.9); 2.4933 (34.2); 2.3339 (0.4); 2.3293 (0.6); 2.3249 (0.4); 1.3846 (3.5); 1.3662 (8.2); 1.3477 (3.4); 0.0080 (1.8); -0.0002 (67.4); -0.0085 (2.4) z I-82 1H-NMR(400.2 MHz, d6-DMSO): )o o - /' ( - N (7) δ= 9.0160 (2.5); 9.0036 (2.5); 8.7671 (7.3); 8.6084 (3 ,) •:- -- - . .0); 8.5954 -- - „ -z (5.8); 8.3161 (1.1); 8.2727 (3.5); 8.2704 (3.2); 8.2142 (2.5); — N `N. z 8.2105 (2.0); 8.2011 (2.2); 8.1974 (1.7); 7.9777 (2.2); 7.9741 z u _ u _ ,,,, (1.9); 7.9653 (2.1); 7.9615 (1.7); 4.1408 (16.0); 4.0938 (14.0); 1 . . . ..... / 3.9065 (1.0); 3.8880 ( .\ 3.4); 3.8694 (3.3); 3.8513 (1.0); 3.6560 u_ -..„. . . (0.5); 3.3238 (335.6); 2.6756 (3.4); 2.6710 (4.0); 2.6663 (2.8); u_ zI. z ._ 2.6620 (1.2); 2.5108 (330.2); 2.5064 (540.3); 2.5019 (628.7); 2.4974 (431.9); 2.4930 (194.3); 2.3375 (2.0); 2.3334 (3.3); 2.3289 (3.9); 2.3243 (2.7); 2.0744 (1.2); 1.3880 (3.8); 1.3695 (8.2); 1.3512 (3.5); 1.2376 (0.4); 0.1461 (3.0); 0.0078 (60.9); -0.0001 (700.3); -0.0085 (24.8); -0.1494 (3.0) I-83 u . u _ .. 0 - 1H-NMR(400.2 MH - 0 z, d6-DMSO): _ u - _ - ---7N s , . δ= 8.7290 (5.4); 8.3105 (0.6); 7.9652 (1.6); 7.9616 (1.8); 7.9449 u (2.0); 7.9414 (2.0); 7.8020 (1.5); 7.7984 (1.6); 7.7828 (2.2); _ z \ / •• N 7.7791 (2.0); 7.6515 (2.0); 7.6318 (2.9); 7.6121 (1.5); 5.7506 u_ _ , „ (0.8); 4.1305 (16.0); 4.1143 (0. / zN .. 9); 4.0385 (0.9); 4.0208 (0.9); z z z 4 4.0031 (0.4); 3.9429 (1.0); 3.9248 (3.3); 3.9063 (3.4); 3.8877 .--- (1.2); 3.7767 (14.6); 3.7607 (0.9); 3.5681 (2.6); 3.3108 (189.3); -- 3.2937 (11.8); 2.6747 (0.9); 2.6701 (1.2); 2.6658 (1.0); 2.5098 (.7.) (77.0); 2.5056 (154.5); 2.5012 (208.2); 2.4967 (159.1); 2.3324 c. 7 (0.9); 2.3280 (1.3); 2.3234 (1.0); 1.9878 (3.7); 1.3700 (3.6); ) 1.3515 (8.3); 1.3331 (3.9); 1.2358 (1.6); 1.1933 (1.1); 1.1755 (2.1); 1.1577 (1.1); 0.0078 (0.8); -0.0002 (18.8); -0.0079 (1.8); - 0.0169 (0.8) I-84 u . u _ .. 0 - 1 - 0 H-NMR(600.1 MHz, d6-DMSO): _ u - _ -j ---7N s , . δ= 8.7469 (7.0); 7.7853 (0.4); 7.7715 (0.9); 7.7569 (0.8); 7.7432 u (0.4); 7.6363 (0.7); 7.6235 (1.2); 7.6132 (0.8); 7.4996 (0.5); _ z \ / •• 7.4912 (0.6); 7.4862 (0.9); 7.4784 (0.9); 7.4645 (0.4); 5.7553 u_ — N N , „. (2.5); 4.1275 (16.0); 4.0065 (0.1); 3.9249 (1.0); 3.9127 (3.4); z/ z . z z 4 3.9003 (3.6); 3.8902 (10.2); 3.7678 (0.1); 3.5686 (0.4); 3.3367 .--- (7.8); 3.3330 (15.4); 3.3294 (25.6); 3.3264 (23.2); 3.3237 (40.5); -- 3.3212 (56.6); 2.6178 (0.2); 2.6148 (0.4); 2.6115 (0.2); 2.5238 (0.5); 2.5207 (0.6); 2.5176 (0.6); 2.5087 (17.8); 2.5057 (39.8); u_ 2.5027 (56.4); 2.4997 (41.7); 2.4967 (19.9); 2.3895 (0.2); 2.3868 (0.4); 2.3834 (0.3); 1.9892 (0.2); 1.3618 (3.9); 1.3495 (8.4); 1.3372 (3.9); 1.2345 (0.4); 1.1759 (0.2); -0.0001 (2.4); -0.0052 (0.1) BCS233014 FC-Text - 101 - I-85 .. 0 .- 1 - O - - . . H-NMR(600.1 MHz, d6-DMSO): -j -v , I. δ= 8.7388 (6.2); 7.9769 (2.5); 7.9733 (2.6); 7.8002 (0.7); 7.7856 \ (4.8); 7.7841 (4.5); 7.7802 (3.1); 7.7657 (0.5); 5.7555 (2.1); . N z • . 4.1310 (16.0); 4.1213 (1.3); 3.9842 (1.2); 3.9218 (0.9); 3.9099 N' 5 (3.0); 3.8976 (3.1); 3.8853 (0.9); 3.8436 (0.2); 3.8311 (0.2); • - 3.7874 (15.8); 3.3393 (55.9); 3.3346 (94.2); 3.3321 (105.5); •' 3.3276 (169.4); 3.3262 (252.9); 3.3228 (428.7); 2.6169 (1.1); 5 2.6138 (1.7); 2.6107 (1.2); 2.5228 (2.3); 2.5197 (3.0); 2.5166 (2.8); 2.5078 (85.3); 2.5048 (194.7); 2.5018 (278.4); 2.4987 (203.4); 2.4957 (95.7); 2.3887 (1.2); 2.3856 (1.7); 2.3826 (1.3); 2.0738 (0.8); 1.3593 (3.7); 1.3470 (8.3); 1.3347 (3.8); 1.2354 (2.2); 0.8540 (0.4); -0.0001 (3.5); -0.0643 (0.6) z I-86 0 0 1 . H-NMR(400.2 MHz, d6-DMSO): / N . /u . ) . • • '' ' ' 'z / u δ= 8.7507 (5.9); 8.0697 (0.5); 8.0551 (0.6); 8.04 * _ 99 (1.0); 8.0352 (1.0); 8.0289 (0.9); 8.0142 (0.8); 7.9080 (2.2); 7.8903 (1.6); \ 7.8885 (1.6); 7.8495 (1.0); 7.8278 (1.7); 7.8065 (0.8); 7.8047 (0.8); 4.1699 (16.0); 3.9623 (14.1); 3.9523 (1.2); 3.9335 (3.2); 3.9151 (3.2); 3.8967 (1.0); 3.3113 (69.3); 2.6743 (0.4); 2.6697 (0.6); 2.6652 (0.5); 2.5232 (1.3); 2.5185 (1.9); 2.5098 (37.0); 2.5054 (79.2); 2.5008 (108.2); 2.4962 (77.0); 2.4917 (35.8); 2.3323 (0.5); 2.3277 (0.6); 2.3231 (0.5); 1.4000 (3.4); 1.3816 (8.0); 1.3631 (3.4); 0.1458 (0.5); 0.0080 (3.8); -0.0002 (123.8); - 0.0085 (3.9); -0.1496 (0.5) o I-87 ' 1 c i ' H-NMR(400.2 MHz, d6-DMSO ): -,. ): .„ * u _ δ= 8.7514 (5.6); 7.9592 (3.6); 7.9380 (3.5); 5.7541 (1.3); 4.1213 \ (16.0); 4.0262 (14.1); 3.8882 (0.9); 3.8698 (3.1); 3.8513 (3.2); i1 z 3.8328 (0.9); 3.3129 (67.4); 2.6702 (0.4); 2.5237 (0.7); 2.5190 (1.1); 2.5102 (20.5); 2.5058 (44.1); 2.5012 (60.4); 2.4966 (43.0); / u _ 2.4921 (20.1); 2.3280 (0.4); 1.3689 (3.5); 1.3505 (8.0); 1.3320 (3.4); 0.0080 (0.8); -0.0002 (27.7); -0.0085 (0.8) 0 I-88 - . 1 .- H-NMR(400.2 MHz, d6-DMSO): - )) \ \ 0 ( J δ= 8.7476 (6.0); 8.2839 (0.6); 8.2681 (0.7); 8.2626 (1.0); 8.2468 \ (1.0); 8.2413 (0.7); 8.2252 (0.6); 7.7357 (0.9); 7.7142 (1.6); N • u _ 7.6923 (0.8); 4.1203 (16.0); 4.1068 (0.4); 3.9285 (0.9); 3.9100 \\ z (3.3); 3.8893 (9.1); 3.8862 (8.0); 3.8733 (1.1); 3.3146 (407.0); 2.6787 (0.5); 2.6744 (1.0); 2.6697 (1.4); 2.6651 (1.0); 2.5231 (3.4); 2.5098 (83.6); 2.5053 (172.9); 2.5008 (231.7); 2.4962 u_ (163.0); 2.4917 (75.0); 2.3366 (0.5); 2.3321 (1.0); 2.3277 (1.4); 2.3231 (1.0); 1.3661 (3.6); 1.3478 (8.1); 1.3293 (3.5); 0.0079 0 (0.5); -0.0002 (15.9); -0.0085 (0.5) I-89 1 % 0 H-NMR(600.1 MHz, d6-DMSO): \ ) \ δ= 8.7570 (4.4); 8.7555 (3.2); 8.2275 (9.6); 8.2269 (9.8); 8.2257 \ (7.1); 4.1281 (14.4); 4.0189 (16.0); 4.0072 (0.2); 3.8718 (0.8); N • . 3.8598 (2.6); 3.8474 (2.6); 3.8350 (0.8); 3.3520 (18.9); 3.3496 6 (18.0); 3.3475 (18.3); 3.3455 (15.5); 3.3447 (15.3); 3.3401 (21.4); 3.3365 (19.6); 3.3347 (15.5); 3.3324 (26.5); 3.3306 (23.7); 2.6232 (0.1); 2.6200 (0.2); 2.6169 (0.2); 2.5291 (0.3); 2.5260 (0.4); // 2.5229 (0.4); 2.5141 (10.2); 2.5111 (22.6); 2.5080 (31.9); 2.5049 z (23.1); 2.5019 (10.7); 2.3950 (0.1); 2.3919 (0.2); 2.3888 (0.1); 2.0797 (0.4); 1.3686 (3.6); 1.3563 (7.8); 1.3440 (3.6); 0.0043 (0.2) 0 I-90 , 1H-NMR(400.2 MHz, d6-DMSO): z * δ= 8.7410 (6.5); 7.7373 (0.4); 7.7313 (0.6); 7.7227 (3.9); 7.7016 N (3.8); 7.6930 (0.6); 4.1191 (16.0); 4.0082 (14.0); 3.8903 (1.0); . 1 3.8718 (3.3); 3.8533 (3.4); 3.8349 (1.0); 3.3127 (59.8); 2.6 --P -P 703 - (0.4); 2.5233 (0.9); 2.5101 (22.6); 2.5058 (45.9); _ .z- 2.5013 (61.2); u -..--. . . 2.4968 (43.5); 2.4924 (20.4); 2.3281 (0.3); 2.0733 (0.6); 1.9057 (1.0); 1.8925 (2.7); 1.8857 (2.9); 1.8734 (1.1); 1.5628 (1.1); 1.5502 (2.7); 1.5435 (2.8); 1.5300 (1.0); 1.3698 (3.6); 1.3514 (8.0); 1.3329 (3.5); 0.0080 (0.5); -0.0002 (15.4); -0.0084 (0.5) BCS233014 FC-Text - 102 - I-91 F F 1H-NMR(600.1 MHz, d6-DMSO): F δ= 8.7631 (6.3); 8.2877 (1.1); 8.2748 (2.8); 8.2616 (2.3); 8.2443 O O // / (2.3); 8.2431 (2.4); 8.2316 (1.3); 8.2302 (1.1); 7.5207 (2.0); S O N N 7.5193 (1.9); 7.5074 (2.0); 7.5060 (1.9); 4.3280 (14.5); 4.1051 (16.0); 3.8320 (0.9); 3.8197 (3.2); 3.8074 (3.2); 3.7951 (0.9); N \ 3.3446 (0.2); 3.3407 (0.2); 3.3198 (174.1); 3.2892 (0.2); 2.6167 N F F (0.4); 2.6137 (0.6); 2.6105 (0.4); 2.6076 (0.2); 2.5226 (1.0); F N 2.5196 (1.3); 2.5165 (1.2); 2.5077 (31.5); 2.5047 (70.4); 2.5016 ) \ (99.3); 2.4985 (72.0); 2.4955 (33.7); 2.4731 (0.2); 2.4705 (0.2); F F N N 2.3915 (0.2); 2.3886 (0.4); 2.3854 (0.6); 2.3825 (0.4); 1.3286 (3.5); 1.3163 (8.0); 1.3040 (3.5); -0.0001 (2.2) I-92 1H-NMR(600.1 MHz, d6-DMSO): δ= 3.3251 (16.0); 2.5074 (3.7); 2.5045 (7.4); 2.5014 (9.6); 2.4984 (7.1); 2.4954 (3.5); -0.0001 (0.5) ) I-93 1H-NMR(600.4 MHz, d6-DMSO): δ= 8.7237 (5.7); 7.9392 (2.7); 7.9354 (2.6); 7.3087 (0.6); 6.8764 (3.4); 6.8726 (3.4); 4.2964 (14.8); 4.0832 (16.0); 4.0498 (0.3); 4.0028 (14.5); 3.8381 (0.4); 3.7822 (1.0); 3.7699 (3.3); 3.7576 (3.2); 3.7452 (0.9); 3.3340 (0.4); 3.3085 (317.0); 3.2855 (0.4); \ 2.6159 (0.6); 2.6128 (0.9); 2.6097 (0.7); 2.5219 (2.0); 2.5188 ) (2.4); 2.5157 (2.3); 2.5069 (45.2); 2.5039 (99.6); 2.5009 (139.9); 2.4978 (100.5); 2.4948 (46.5); 2.3878 (0.7); 2.3848 (1.0); 2.3817 (0.7); 1.3021 (3.6); 1.2898 (8.0); 1.2775 (3.5); 0.0967 (0.5); 0.0053 (3.9); -0.0002 (133.9); -0.0057 (4.3); -0.1004 (0.5) I-94 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7281 (6.3); 8.4339 (4.6); 8.3158 (0.4); 8.0283 (5.0); 4.1150 (0.7); 4.0892 (16.0); 4.0388 (14.6); 3.9939 (0.5); 3.9870 (0.6); 3.9629 (15.2); 3.8597 (0.5); 3.7935 (1.0); 3.7752 (3.4); 3.7568 (3.4); 3.7385 (1.1); 3.3238 (195.6); 2.6754 (1.2); 2.6710 (1.6); \ 2.6666 (1.2); 2.5065 (201.9); 2.5021 (257.6); 2.4976 (189.3); ) 2.3333 (1.2); 2.3288 (1.6); 2.3245 (1.2); 1.3181 (3.7); 1.2997 (8.2); 1.2812 (3.7); 0.1462 (0.5); 0.0081 (5.5); 0.0000 (124.4); - 0.0082 (6.2); -0.1493 (0.6) I-95 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7766 (5.4); 8.6912 (1.7); 8.6870 (1.7); 8.3157 (0.6); 7.2344 (2.3); 7.2278 (2.3); 4.1149 (16.0); 3.9759 (14.7); 3.8897 (0.9); 3.8713 (3.1); 3.8528 (3.2); 3.8344 (0.9); 3.3218 (116.7); 2.6793 (0.8); 2.6751 (1.7); 2.6705 (2.4); 2.6660 (1.8); 2.6613 (0.8); 2.5240 (7.1); 2.5193 (10.5); 2.5105 (137.3); 2.5061 (284.7); 2.5016 (377.2); 2.4970 (270.3); 2.4925 (129.5); 2.3374 (0.7); 2.3329 (1.6); 2.3284 (2.3); 2.3239 (1.7); 2.3194 (0.8); 1.3976 (8.7); 1.3598 (3.5); 1.3414 (8.1); 1.3229 (3.4); 0.1456 (0.4); 0.0079 (3.3); -0.0003 (108.5); -0.0086 (3.5); -0.1500 (0.4) I-96 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7675 (5.6); 8.5178 (3.6); 8.5111 (3.6); 6.8536 (3.5); 6.8469 (3.5); 4.1054 (16.0); 4.0002 (14.6); 3.8698 (0.9); 3.8514 (3.1); 1 3.8330 (3.2); 3.8146 (0.9); 3.3241 (99.3); 2.6756 (0.7); 2.6709 (1.0); 2.6665 (0.7); 2.6619 (0.4); 2.5244 (3.1); 2.5197 (4.8); 2.5110 (60.8); 2.5066 (124.7); 2.5020 (164.3); 2.4974 (117.2); ) 2.4929 (56.0); 2.3377 (0.3); 2.3334 (0.7); 2.3288 (1.0); 2.3242 (0.7); 2.3198 (0.3); 2.0746 (1.0); 1.3485 (3.5); 1.3301 (8.0); 1.3116 (3.4); -0.0002 (5.3) I-97 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7667 (6.0); 8.4616 (3.8); 8.4549 (3.8); 8.3157 (0.5); 6.9006 (3.7); 6.8940 (3.8); 5.7561 (0.4); 4.1039 (16.0); 3.9955 (14.4); I 3.9760 (0.4); 3.8696 (0.9); 3.8512 (3.2); 3.8327 (3.2); 3.8142 (1.0); 3.3231 (150.4); 2.6755 (1.3); 2.6708 (1.8); 2.6663 (1.3); 2.5243 (5.6); 2.5195 (9.1); 2.5109 (106.7); 2.5065 (214.7); 2.5019 (278.9); 2.4974 (198.2); 2.4929 (94.2); 2.3333 (1.2); 2.3288 (1.7); 2.3242 (1.2); 2.0744 (0.5); 1.3485 (3.6); 1.3301 (8.1); 1.3116 (3.4); 1.2337 (0.4); 0.0080 (0.4); -0.0001 (9.5) BCS233014 FC-Text - 103 - I-98 1H-NMR(400.2 MHz, d6-DMSO): x# δ= 8.7670 (5.7); 8.7267 (4.8); 8.3157 (0.6); 8.1808 (4.7); 4.1191 (16.0); 4.0000 (14.8); 3.8939 (0.9); 3.8754 (3.1); 3.8569 (3.1); I 3.8385 (0.9); 3.3235 (226.2); 2.6795 (0.8); 2.6752 (1.7); 2.6706 (2.3); 2.6660 (1.8); 2.6617 (0.8); 2.5239 (10.0); 2.5192 (15.4); 2.5106 (144.0); 2.5062 (289.6); 2.5017 (379.8); 2.4971 (271.0); ) 2.4926 (129.9); 2.3375 (0.8); 2.3330 (1.7); 2.3285 (2.3); 2.3239 (1.7); 2.3195 (0.8); 2.0743 (1.0); 1.3556 (3.5); 1.3372 (8.1); 1.3187 (3.4); 0.0079 (0.4); -0.0003 (13.2); -0.0085 (0.5) I-99 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7674 (5.7); 8.7341 (4.5); 8.3155 (1.4); 8.1863 (4.4); 4.1164 (16.0); 4.0045 (14.6); 3.8890 (0.9); 3.8706 (3.1); 3.8520 (3.1); 3.8336 (1.0); 3.3940 (0.3); 3.3822 (0.4); 3.3694 (0.5); 3.3235 (594.1); 2.6796 (1.8); 2.6751 (4.0); 2.6705 (5.6); 2.6659 (4.0); 2.6614 (1.9); 2.5240 (17.0); 2.5193 (26.6); 2.5106 (333.0); 2.5061 ) (682.7); 2.5015 (898.0); 2.4970 (636.4); 2.4924 (300.9); 2.3375 (1.9); 2.3329 (4.0); 2.3283 (5.5); 2.3239 (4.0); 2.3192 (1.9); 1.3542 (3.5); 1.3358 (8.0); 1.3173 (3.4); 0.0079 (0.4); -0.0003 (14.4); -0.0086 (0.4) I-100 1H-NMR(400.2 MHz, d6-DMSO): N δ= 9.0024 (0.7); 8.9905 (0.7); 8.7772 (5.8); 8.7429 (0.6); 8.7384 / (3.8); 8.7316 (3.8); 8.3154 (6.8); 8.0965 (0.5); 7.6344 (0.4); I 7.4255 (3.7); 7.4187 (3.7); 4.1990 (0.4); 4.1099 (16.0); 4.0617 (1.1); 4.0437 (0.6); 4.0282 (0.3); 3.9934 (14.2); 3.9736 (0.5); 3.9391 (1.0); 3.8895 (1.0); 3.8709 (3.1); 3.8523 (3.2); 3.8341 ) \ (0.9); 3.4237 (0.3); 3.3256 (1204.8); 3.3017 (3.8); 2.6798 (2.4); 2.6753 (5.1); 2.6708 (7.1); 2.6662 (5.2); 2.6618 (2.4); 2.6188 (0.4); 2.6066 (0.4); 2.5243 (21.6); 2.5195 (32.8); 2.5109 (426.0); 2.5064 (872.6); 2.5018 (1144.8); 2.4972 (808.6); 2.4927 (380.2); 2.4449 (0.8); 2.3379 (2.4); 2.3332 (5.1); 2.3286 (6.9); 2.3241 (5.0); 2.3199 (2.4); 2.0741 (0.5); 1.4160 (1.0); 1.3993 (1.0); 1.3740 (0.4); 1.3581 (3.6); 1.3398 (8.1); 1.3213 (3.4); 1.3081 (0.4); 1.2891 (0.7); 1.2697 (0.6); 0.0079 (0.5); -0.0002 (17.8); - 0.0086 (0.6) I-101 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.3239 (5.4); 9.3230 (5.5); 8.7751 (6.7); 8.7428 (1.4); 8.7289 (0.8); 8.6184 (5.3); 8.3157 (0.6); 7.7944 (0.4); 6.2963 (0.4); i 5.7560 (0.4); 4.1162 (16.0); 4.0623 (3.6); 4.0445 (2.0); 3.9906 (14.8); 3.9395 (3.8); 3.8996 (1.2); 3.8813 (3.5); 3.8628 (3.6); 3.8445 (1.1); 3.8058 (0.3); 3.7869 (0.8); 3.7684 (0.9); 3.7630 ) \ (0.6); 3.7444 (0.5); 3.3239 (254.0); 2.7450 (0.6); 2.6709 (2.2); 2.5063 (279.7); 2.5020 (357.3); 2.4980 (273.6); 2.3289 (2.1); 1.3597 (3.8); 1.3413 (8.2); 1.3228 (3.7); 1.3079 (1.0); 1.2893 (2.2); 1.2704 (1.8); 1.2510 (0.6); 1.2369 (0.5); 0.0078 (3.6); - 0.0001 (58.1) I-102 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7636 (6.5); 8.3307 (4.5); 8.3241 (4.6); 8.3154 (1.8); 6.9311 (4.5); 6.9246 (4.5); 4.0986 (16.0); 3.9897 (14.2); 3.9714 (0.3); 3.8642 (0.8); 3.8459 (3.0); 3.8274 (3.0); 3.8091 (0.9); 3.3241 (682.5); 3.3012 (0.7); 2.6799 (1.6); 2.6753 (3.5); 2.6706 (4.9); 2.6661 (3.5); 2.6614 (1.6); 2.5243 (14.0); 2.5196 (19.6); 2.5109 ) (281.7); 2.5063 (593.4); 2.5017 (785.7); 2.4971 (546.8); 2.4925 (250.6); 2.4274 (0.4); 2.3377 (1.6); 2.3332 (3.5); 2.3285 (4.9); 2.3239 (3.5); 2.3193 (1.6); 1.3457 (3.4); 1.3272 (8.0); 1.3088 (3.4); 1.2333 (0.4); 0.1459 (0.5); 0.0081 (4.1); -0.0002 (156.3); - 0.0085 (4.4); -0.1495 (0.5) I-103 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7638 (5.7); 8.6356 (4.9); 8.6345 (5.0); 8.3160 (1.2); 8.1282 (4.9); 8.1271 (4.8); 4.3487 (0.3); 4.3374 (0.3); 4.1197 (16.0); 3.9938 (14.5); 3.8947 (0.9); 3.8765 (3.0); 3.8580 (3.1); 3.8397 (0.9); 3.3225 (132.4); 2.6798 (1.0); 2.6753 (2.2); 2.6707 (3.0); 2.6661 (2.2); 2.6614 (1.0); 2.5242 (7.5); 2.5195 (11.5); 2.5108 (171.2); 2.5063 (353.8); 2.5017 (468.6); 2.4971 (334.4); 2.4926 (157.5); 2.3376 (0.9); 2.3332 (2.0); 2.3285 (2.8); 2.3239 (2.0); 2.3195 (1.0); 1.3548 (3.4); 1.3364 (8.0); 1.3179 (3.3); 1.0446 (1.3); 1.0294 (1.3); 0.1459 (1.1); 0.0080 (9.1); -0.0002 (291.4); - 0.0085 (9.0); -0.0196 (0.4); -0.1496 (1.1) BCS233014 FC-Text - 104 - I-104 1H-NMR(400.2 MHz, d6-DMSO): δ= 19.9804 (0.4); 8.7654 (3.9); 8.7315 (5.0); 8.4281 (3.2); 8.3155 (6.9); 8.1993 (3.9); 4.0891 (12.9); 4.0569 (11.4); 3.8032 (0.9); / 3.7857 (2.8); 3.7667 (2.8); 3.7485 (1.0); 3.7388 (0.4); 3.6764 (0.5); 3.6539 (0.4); 3.6279 (0.4); 3.5940 (0.4); 3.5265 (0.5); 3.3206 (123.2); 3.2206 (1.1); 3.1586 (0.6); 3.1368 (0.5); 3.0903 (0.5); 2.9917 (0.4); 2.9543 (0.4); 2.9247 (0.4); 2.8985 (0.4); _ 2.8755 (0.5); 2.8526 (0.5); 2.8197 (0.6); 2.7971 (0.6); 2.7441 (0.7); 2.7053 (0.9); 2.6793 (5.8); 2.6750 (11.6); 2.6705 (16.0); 2.6659 (12.0); 2.6395 (1.1); 2.6191 (1.4); 2.5239 (51.4); 2.5191 (76.8); 2.5105 (938.2); 2.5061 (1877.7); 2.5015 (2451.9); 2.4970 (1777.5); 2.4925 (866.8); 2.4270 (0.5); 2.3329 (10.8); 2.3284 (15.0); 2.3238 (10.8); 2.3193 (5.0); 2.2895 (2.1); 2.2735 (2.6); 2.0154 (0.5); 1.9872 (2.1); 1.9793 (2.2); 1.9547 (2.5); 1.9458 (2.0); 1.9396 (1.7); 1.9187 (0.7); 1.6827 (0.4); 1.6684 (0.4); 1.5096 (0.4); 1.4969 (0.4); 1.4935 (0.4); 1.4634 (0.4); 1.3184 (3.0); 1.2999 (6.7); 1.2813 (3.1); 1.2485 (0.6); 1.2349 (0.7); 1.1649 (0.4); 0.9699 (0.8); 0.9524 (0.7); 0.9392 (7.6); 0.9224 (7.4); 0.8765 (2.4); 0.8599 (2.3); 0.8372 (0.4); 0.1459 (9.0); 0.0080 (70.7); -0.0001 (2064.3); -0.0085 (75.5); -0.0392 (0.5); - 0.1496 (9.0) I-105 1H-NMR(400.2 MHz, d6-DMSO): δ= 8.7409 (6.4); 8.3152 (1.5); 7.6853 (3.1); 7.6755 (3.3); 7.2836 (3.4); 7.2738 (3.2); 4.1127 (14.5); 4.0851 (16.0); 3.8187 (1.0); Z 3.8005 (3.4); 3.7820 (3.5); 3.7642 (1.1); 3.3795 (0.4); 3.3226 (560.0); 2.6750 (4.5); 2.6707 (6.3); 2.6662 (4.6); 2.6438 (0.3); 2.6388 (0.4); 2.5236 (24.6); 2.5061 (805.0); 2.5017 (1049.7); 2.4973 (765.3); 2.3330 (4.5); 2.3284 (6.2); 2.3243 (4.5); 1.9390 (1.3); 1.9255 (3.8); 1.9181 (4.0); 1.9063 (1.6); 1.6585 (1.6); 1.6465 (3.8); 1.6389 (4.0); 1.6256 (1.2); 1.3307 (3.6); 1.3123 (8.1); 1.2939 (3.6); 0.1464 (0.7); 0.0079 (4.9); -0.0002 (145.1); - 0.0082 (6.0); -0.1500 (0.7) I-106 1H-NMR(600.4 MHz, d6-DMSO): δ= 8.7564 (6.2); 8.7347 (0.4); 8.4441 (2.3); 8.4433 (2.3); 8.4398 (2.4); 8.4390 (2.2); 8.0244 (2.2); 8.0236 (2.3); 8.0215 (2.3); 8.0206 (2.1); 6.7036 (2.0); 6.7006 (2.1); 6.6993 (2.1); 6.6963 (1.9); 4.3469 (0.6); 4.2902 (0.9); 4.1110 (16.0); 4.0602 (0.9); 4.0360 (15.1); 3.9399 (0.8); 3.8534 (0.9); 3.8411 (3.2); 3.8288 (3.2); 3.8165 (1.0); 3.5628 (0.6); 3.4736 (0.8); 3.3323 (0.5); \ 3.3092 (732.7); 3.2899 (0.9); 3.2878 (0.8); 2.6185 (0.8); 2.6154 (1.7); 2.6124 (2.4); 2.6093 (1.7); 2.6063 (0.7); 2.5366 (0.4); 2.5214 (6.0); 2.5183 (7.9); 2.5152 (9.2); 2.5065 (138.7); 2.5035 (283.1); 2.5004 (384.6); 2.4973 (276.0); 2.4943 (127.0); 2.3904 (0.9); 2.3874 (1.8); 2.3843 (2.4); 2.3813 (1.7); 2.3783 (0.8); 1.9876 (1.1); 1.3442 (3.4); 1.3319 (7.9); 1.3196 (3.4); 1.2885 (0.5); 1.1748 (0.6); 0.0053 (3.1); -0.0001 (82.2); -0.0057 (2.4) I-107 1H-NMR(400.2 MHz, d6-DMSO): , δ= 8.7613 (6.1); 8.2181 (6.2); 5.7569 (0.6); 4.3895 (14.9); 4.0859 ' (16.0); 3.8201 (1.1); 3.8017 (3.6); 3.7832 (3.6); 3.7650 (1.1); Z / 3.3284 (163.2); 2.6714 (1.2); 2.5064 (153.7); 2.5026 (197.5); 2.4986 (155.0); 2.3293 (1.2); 1.3210 (3.8); 1.3027 (8.2); 1.2842 (3.7); 0.0000 (23.5) ) - I-108 1 \ q H-NMR(400.2 MHz, d6-DMSO): δ= 8.7637 (6.3); 8.3163 (0.8); 8.1816 (7.9); 7.6260 (0.4); 7.6141 ) , (0.4); 7.5968 (0.4); 7.5658 (0.4); 7.5493 (0.3); 4.3928 (14.6); 4.1153 (0.6); 4.0851 (16.0); 3.9868 (0.4); 3.8155 (0.9); 3.7969 (3.1); 3.7784 (3.2); 3.7600 (1.0); 3.3257 (229.3); 2.6802 (0.9); 2.6756 (1.9); 2.6710 (2.7); 2.6665 (2.0); 2.6619 (1.0); 2.5245 (7.8); 2.5198 (12.0); 2.5110 (161.2); 2.5066 (333.5); 2.5021 \ (440.3); 2.4975 (320.6); 2.4930 (157.2); 2.3335 (1.9); 2.3289 (2.7); 2.3243 (2.0); 1.3195 (3.5); 1.3011 (8.1); 1.2827 (3.5); 1.2347 (0.4); 0.1458 (0.4); 0.0081 (3.2); -0.0001 (110.7); -0.0084 (4.3); -0.1496 (0.4) BCS233014 FC-Text - 105 - I-109 1H-NMR(400.2 MHz, d6-DMSO): δ= 9.1297 (7.2); 8.7703 (6.7); 8.3156 (0.6); 4.4051 (14.4); 4.0929 (16.0); 4.0556 (0.4); 4.0377 (1.0); 4.0200 (1.1); 4.0022 (0.4); 3.8327 (0.9); 3.8142 (3.3); 3.7957 (3.3); 3.7773 (1.0); 3.3261 (249.2); 2.6800 (0.6); 2.6757 (1.2); 2.6712 (1.8); 2.6666 (1.3); 2.6622 (0.6); 2.5246 (5.4); 2.5198 (8.4); 2.5112 (103.0); 2.5068 (209.6); 2.5023 (274.2); 2.4977 (195.5); 2.4932 (93.6); 2.3381 (0.6); 2.3336 (1.3); 2.3291 (1.7); 2.3246 (1.3); 2.3201 (0.6); 1.9890 (4.6); 1.3978 (0.6); 1.3270 (3.6); 1.3086 (8.1); 1.2902 (3.5); 1.2353 (0.4); 1.1930 (1.2); 1.1752 (2.5); 1.1574 (1.2); - 0.0001 (2.2) Use examples Diabrotica balteata – spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Soaked wheat seeds (Triticum aestivum) are placed in a multiple well plate filled with agar and some water and are incubated for 1 day to germinate (5 seeds per well). The germinated wheat seeds are sprayed with a test solution containing the desired concentration of the active ingredient. Afterwards each unit is infected with 10-20 larvae of the banded cucumber beetle (Diabrotica balteata). After 7 days efficacy in % is determined. 100 % means all the seedlings have grown up like in the untreated, uninfected control; 0 % means none of the seedlings have grown. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 500 g/ha (= 160 µg/well): I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-17, I-19, I-21, I-22, I-23, I-24, I-54, I-55, I-56, I-57, I-58, I-59, I-60, I-61, I-62, I-63, I-71, I-80, I-81, I-92, I-93, I-94, I- 95, I-96, I-97, I-99, I-100, I-101, I-102, I-103, I-104, I-105, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 125 g/ha (= 40 µg/well): I-1, I-2, I-3, I-4, I-5, I-54, I-55, I-56, I-57, I-58, I-59, I-60, I-61, I-62, I-63, I-92, I-93, I-94, I-95, I-96, I-97, I-98, I-99, I-100, I-101, I-102, I-103. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha (= 32 µg/well): I-6, I-7, I-8, I-9, I-10, I-11, I-12, I-13, I-14, I- 15, I-16, I-17, I-19, I-22, I-23, I-24, I-25, I-26, I-27, I-28, I-29, I-30, I-31, I-32, I-33, I-34, I-35, I-36, I-37, BCS233014 FC-Text - 106 - I-38, I-39, I-40, I-41, I-42, I-43, I-45, I-46, I-47, I-48, I-49, I-50, I-51, I-52, I-65, I-68, I-71, I-72, I-74, I- 75, I-76, I-78, I-79, I-80, I-81, I-82, I-83, I-84, I-85, I-86, I-87, I-89, I-90, I-91, I-105, I-106, I-107, I-108, I-109. In this test, for example, the following compounds from the preparation examples showed good activity of 80 % at an application rate of 100 g/ha (= 32 µg/well): I-73, I-104. Frankliniella occidentalis – spray test Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Common bean (Phaseolus vulgaris) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration and infected with all instars of the western flower thrips (Frankliniella occidentalis) afterwards. After 7 days leaf protection efficacy is determined in %.100 % means no visible leaf damage (very good protection) and 0 % means a complete damaged leaf disk (no protection). In this test, for example, the following compounds from the preparation examples showed a very good leaf protection of 90 % at an application rate of 500 g/ha: I-13, I-84. Meloidogyne incognita - test Solvent: 125.0 parts by weight of acetone To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water to the desired concentration. Vessels are filled with sand, a solution of the active ingredient, a suspension containing eggs and larvae of the southern root-knot nematode (Meloidogyne incognita) and lettuce seeds. The lettuce seeds germinate and the seedlings grow. Galls develop in the roots. After 14 days the nematicidal effect in percent is determined by the formation of galls. 100 % means no galls were found and 0 % means the number of galls found on the roots of the treated plants was equal to that in untreated control plants. BCS233014 FC-Text - 107 - In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 20 ppm: I-27, I-28, I-30, I-37, I-38, I-57, I-61, I-62, I-92, I-93, I-94, I- 102. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 20 ppm: I-2, I-6, I-29, I-41, I-53, I-58, I-59, I-63, I-79, I-82, I-101, I-104. Myzus persicae – oral test Solvent: 100 parts by weight acetone To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water to the desired concentration. 50 µL compound solution is filled in microtiter plates and 150 µL IPL41 insect medium (33 % + 15 % sugar) is added to obtain a total volume of 200 µL per well. Afterwards the plates are sealed with parafilm through which a mixed population of the green peach aphid (Myzus persicae) can suck on the compound preparation. After 5 days mortality in % is determined.100 % means all aphids have been killed and 0 % means none of the aphids have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 4 ppm: I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-17, I-19, I-20, I-21, I-22, I-23, I- 24, I-53, I-54, I-55, I-56, I-57, I-58, I-59, I-60, I-61, I-62, I-63, I-71, I-80, I-81, I-92, I-93, I-94, I-95, I-96, I-97, I-98, I-99, I-100, I-101, I-102, I-103, I-104, I-105, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 0.8 ppm: I-1, I-2, I-3, I-4, I-5, I-7, I-17, I-20, I-23, I-24, I-26, I-28, I-29, I-31, I-54, I-55, I-56, I-57, I-58, I-59, I-61, I-62, I-63, I-79, I-80, I-92, I-93, I-94, I-95, I-96, I-97, I-98, I- 99, I-100, I-101, I-103, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 0.8 ppm: I-19, I-21, I-22, I-30, I-78, I-82, I-102, I-104, I-108. Myzus persicae – spray test Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 BCS233014 FC-Text - 108 - ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Chinese cabbage (Brassica pekinensis) leaf disks infected with all instars of the green peach aphid (Myzus persicae), are sprayed with a preparation of the active ingredient of the desired concentration. After 5 days mortality in % is determined.100 % means all aphids have been killed and 0 % means none of the aphids have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-6, I-9, I-10, I-53, I-57, I-79, I-95, I-96, I-98, I-103. In this test, for example, the following compounds from the preparation examples showed good activity of 95 % at an application rate of 100 g/ha: I-84. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 100 g/ha: I-8, I-11, I-20, I-22, I-23, I-24, I-26, I-28, I-30, I-38, I-45, I-48, I-49, I-50, I-51, I-55, I-59, I-62, I-63, I-69, I-71, I-72, I-76, I-80, I-92, I-93, I-97, I-99, I-101, I-104, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 85 % at an application rate of 100 g/ha: I-14, I-89. In this test, for example, the following compounds from the preparation examples showed good activity of 80 % at an application rate of 100 g/ha: I-83. In this test, for example, the following compounds from the preparation examples showed good activity of 70 % at an application rate of 100 g/ha: I-4, I-27, I-37, I-40, I-54, I-58, I-61, I-70, I-78, I-94, I-102. Nezara viridula – spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Barley plants (Hordeum vulgare) are sprayed with a test solution containing the desired concentration of the active ingredient and are infested with larvae of the southern green stink bug (Nezara viridula). After 4 days mortality in % is determined. 100 % means all the stink bugs have been killed; 0 % means none of the stink bugs have been killed. BCS233014 FC-Text - 109 - In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 500 g/ha: I-10, I-11, I-12, I-13, I-14, I-27, I-28, I-30, I-33, I-36, I-38, I- 40, I-41, I-42, I-45, I-48, I-49, I-50, I-51, I-66, I-70, I-72, I-73, I-74, I-76, I-84, I-89, I-90. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 500 g/ha: I-25, I-29, I-39, I-47, I-86. Nilaparvata lugens – spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Rice plants (Oryza sativa) are sprayed with a preparation of the active ingredient of the desired concentration and the plants are infested with the brown planthopper (Nilaparvata lugens). After 4 days mortality in % is determined.100 % means all planthoppers have been killed and 0 % means none of the planthoppers have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 500 g/ha: I-10, I-27, I-28, I-30, I-36, I-40, I-41, I-48, I-49, I-51, I-70, I- 72, I-73, I-74, I-76. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 500 g/ha: I-25, I-29, I-45, I-75. Phaedon cochleariae – spray test Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. BCS233014 FC-Text - 110 - Chinese cabbage (Brassica pekinensis) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf disks are infested with mustard beetle larvae (Phaedon cochleariae). After 7 days mortality in % is determined.100 % means all beetle larvae have been killed and 0 % means none of the beetle larvae have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-53. Spodoptera frugiperda – spray test Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Maize (Zea mays) leaf sections are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf sections are infested with fall armyworm larvae (Spodoptera frugiperda). After 7 days mortality in % is determined. 100 % means all caterpillars have been killed and 0 % means none of the caterpillars have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8, I-9, I-10, I-11, I-12, I-13, I- 14, I-15, I-16, I-17, I-19, I-20, I-21, I-22, I-24, I-25, I-27, I-28, I-29, I-30, I-31, I-32, I-33, I-34, I-35, I-36, I-37, I-38, I-39, I-40, I-41, I-42, I-43, I-45, I-46, I-47, I-48, I-49, I-50, I-51, I-52, I-53, I-57, I-58, I-59, I- 62, I-63, I-65, I-66, I-70, I-72, I-73, I-74, I-75, I-76, I-78, I-79, I-81, I-82, I-83, I-84, I-89, I-90, I-91, I-92, I-93,I-95, I-96, I-97, I-98, I-99, I-100, I-102, I-103, I-105, I-107, I-108, I-109. In this test, for example, the following compounds from the preparation examples showed good activity of 83 % at an application rate of 100 g/ha: I-64, I-94, I-101. Nezara viridula – spray test Solvent: 52.5 parts by weight of acetone 7 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycolether BCS233014 FC-Text - 111 - To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration if necessary. Barley plants (Hordeum vulgare) are sprayed with a test solution containing the desired concentration of the active ingredient and are infested with larvae of the southern green stink bug (Nezara viridula). After 4 days mortality in % is determined. 100 % means all the stink bugs have been killed; 0 % means none of the stink bugs have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-1, I-2, I-3, I-6, I-7, I-17, I-19, I-20, I-23, I-24, I-53, I-54, I- 55, I-57, I-58, I-62, I-63, I-78, I-79, I-92, I-93, I-94, I-95, I-97, I-98, I-99, I-100, I-101, I-102, I-103, I- 104, I-105, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 90 % at an application rate of 100 g/ha: I-4, I-22, I-61, I-82, I-96. In this test, for example, the following compounds from the preparation examples showed good activity of 80 % at an application rate of 100 g/ha: I-5. Nilaparvata lugens – spray test Solvent: 52.5 parts by weight of acetone 7 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycolether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration if necessary. Rice plants (Oryza sativa) are treated by being sprayed with the desired concentration of the active compound and are infested with larvae of the brown planthopper (Nilaparvata lugens). After 4 days mortality in % is determined.100 % means all planthoppers have been killed and 0 % means none of the planthoppers have been killed. In this test, for example, the following compounds from the preparation examples showed good activity of 100 % at an application rate of 100 g/ha: I-1, I-4, I-6, I-7, I-19, I-22, I-24, I-53, I-54, I-55, I-57, I-58, I- BCS233014 FC-Text - 112 - 59, I-61, I-62, I-63, I-71, I-78, I-79, I-92, I-93, I-94, I-95, I-96, I-97, I-98, I-99, I-100, I-101, I-102, I-103, I-104, I-106. In this test, for example, the following compounds from the preparation examples showed good activity of 80 % at an application rate of 100 g/ha: I-82. Comparative experiments Phaedon cochleariae – spray test (PHAECO) Solvent: 78.0 parts by weight of acetone 1.5 parts by weight of dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Chinese cabbage (Brassica pekinensis) leaf disks are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf disks are infested with mustard beetle larvae (Phaedon cochleariae). After the specified period of time mortality in % is determined. 100 % means all beetle larvae have been killed and 0 % means none of the beetle larvae have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table Spodoptera frugiperda – spray test (SPODFR) Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide Emulsifier: alkylarylpolyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvents and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Maize (Zea mays) leaf sections are sprayed with a preparation of the active ingredient of the desired concentration. Once dry, the leaf sections are infested with fall armyworm larvae (Spodoptera frugiperda). BCS233014 FC-Text - 113 - After the specified period of time mortality in % is determined. 100 % means all caterpillars have been killed and 0 % means none of the caterpillars have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table Meloidogyne incognita – test (MELGIN) Solvent: 125.0 parts by weight of acetone To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with water to the desired concentration. Vessels are filled with sand, a solution of the active ingredient, a suspension containing eggs and larvae of the southern root-knot nematode (Meloidogyne incognita) and lettuce seeds. The lettuce seeds germinate and the seedlings grow. Galls develop in the roots. After 14 days the nematicidal effect in percent is determined by the formation of galls.100 % means no galls were found and 0 % means the number of galls found on the roots of the treated plants was equal to that in untreated control plants. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table Plutella xylostella – spray test (PLUTMA) Solvent: 14 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration. Cabbage leaves (Brassica oleracea) are treated by being sprayed with the preparation of the active compound of the desired concentration and are infested with larvae of the diamondback moth (Plutella xylostella). After the specified period of time mortality in % is determined.100 % means all the caterpillars have been killed and 0 % means none of the caterpillars have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table BCS233014 FC-Text - 114 - Aphis gossypii – spray test (APHIGO) Solvent: 14 parts by weight of dimethylformamide Emulsifier: alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and is diluted with water, containing an emulsifier concentration of 1000 ppm, to the desired concentration. Further test concentrations are prepared by dilution with emulsifier containing water. Ammonium salt and/or penetration enhancer in a dosage of 1000 ppm are added to the desired concentration. Cotton plants (Gossypium hirsutum), which are heavily infested with the cotton aphid (Aphis gossypii), are treated by being sprayed with the preparation of the active compound of the desired concentration. After the specicifed period of time mortality in % is determined. 100 % means all the aphids have been killed and 0 % means none of the aphids have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table Spodoptera frugiperda – drench test (SPODFR D) Solvent: 7 parts by weight of dimethylformamide Emulsifier: 2 parts by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and emulsifier and is diluted with water to the desired concentration. In the calculation of the concentration the soil volume has to be included. Care has to be taken that the emulsifier concentration in the soil does not exceed 40 ppm. Further test concentrations are prepared by dilution with water. Corn plant leaves (Zea mays) in pots filled with soil, are treated by being drenched with the preparation of the active compound of the desired concentration and are infested with caterpillars of the fall army worm (Spodoptera frugiperda). After the specicifed period of time mortality in % is determined. 100 % means all the caterpillars have been killed and 0 % means none of the caterpillars have been killed. In this test, for example, the following compound from the preparation examples shows a superior level of activity compared to the prior state of the art: see table BCS233014 FC-Text - 115 - Table: Substance Structure Object Concentration % Efficacy dat* Example No. I-063 o ,0_ , . . • SPODFR 4 g ai/ha 100 7 dat State of the art z _\ ( 0.8 g ai/ha 17 7 dat WO2018/130443 r1 ) , / PHAECO 4 g ai/ha 100 7 dat 0.8 g ai/ha 0 7 dat MELGIN 20 ppm 0 14 dat PLUTMA 4 ppm 100 7 dat 0.8 ppm 55 7 dat SPODFR D 4 ppm 100 14 dat 0.8 ppm 60 14 dat 0.16 ppm 0 14 dat APHIGO 4 ppm 20 6 dat Example No. I-53 o °\.,- SPODFR 4 g ai/ha 100 7 dat \ According to the ,s \ _ invention / 7 . * 0.8 g ai/ha 100 7 dat — PHAECO 4 g ai/ha 100 7 dat 0.8 g ai/ha 100 7 dat MELGIN 20 ppm 90 14 dat PLUTMA 4 ppm 100 7 dat 0.8 ppm 100 7 dat SPODFR D 4 ppm 100 14 dat 0.8 ppm 100 14 dat 0.16 ppm 85 14 dat APHIGO 4 ppm 95 6 dat *dat = days after treatment

Claims

BCS233014 FC-Text - 116 - Claims 1. Compounds of the formula (I)
Figure imgf000117_0001
in which R1 represents aryl or 5 to 6 membered hetaryl, each of which is optionally mono- or polysubstituted by identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, acetyl, SCN, SF5, tri(C1-C4)alkylsilyl, (C3-C6)cycloalkyl, (C3- C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3- C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C1-C4)hydroxyalkyl, hydroxycarbonyl-(C1- C4)alkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3-C6)cycloalkyl-(C2)alkenyl, (C2-C4)alkynyl, (C2- C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkoxy, (C1-C4)alkoxy-(C1-C4)alkoxy, (C1-C4)alkoxyimino, (C1- C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkoxy-(C1-C4)alkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkoxy-(C1- C4)alkylsulfinyl, (C1-C4)alkylsulfinyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyl, (C1- C4)haloalkylsulfonyl, (C1-C4)alkoxy-(C1-C4)alkylsulfonyl, (C1-C4)alkylsulfonyl-(C1-C4)alkyl, (C1-C4)alkylsulfonyloxy, (C1-C4)haloalkylsulfonyloxy, (C1-C4)alkylcarbonyl, (C1- C4)haloalkylcarbonyl, (C1-C4)alkylcarbonyloxy, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di(C1-C4)alkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1-C4)alkylsulfonylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1- C4)alkylsulfoximino, aminothiocarbonyl, (C1-C4)alkylaminothiocarbonyl, di(C1- C4)alkylaminothiocarbonyl, (C1-C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3- C6)cycloalkylcarbonylamino, aryl, haloaryl, cyanoaryl, (C1-C6)haloalkylaryl or hetaryl, oxohetaryl, halohetaryl, halooxohetaryl, cyanohetaryl, cyanooxohetaryl, (C1-C4)haloalkylhetaryl or (C1-C4)haloalkyloxohetaryl. 2. Compounds of the formula (I) according to Claim 1, in which R1 represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, furanyl, pyrazolyl, thiazolyl, oxazolyl or imidazolyl, each of which is optionally mono- or polysubstituted by BCS233014 FC-Text - 117 - identical or different substituents, where (in the case of hetaryl) at least one carbonyl group may optionally be present and where possible substituents in each case are as follows: cyano, halogen, nitro, (C3-C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1- C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C1-C4)hydroxyalkyl, hydroxycarbonyl-(C1-C4)alkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkyl, (C1-C4)alkoxy-(C1- C4)alkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3-C6)cycloalkyl- (C2)alkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C2-C4)cyanoalkynyl, (C1-C4)alkoxy, (C1- C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxycarbonyl-(C1-C4)alkoxy, (C1-C4)alkoxy-(C1- C4)alkoxy, (C1-C4)alkoxyimino, (C1-C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkoxy-(C1-C4)alkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (C1- C4)haloalkylsulfinyl, (C1-C4)alkoxy-(C1-C4)alkylsulfinyl, (C1-C4)alkylsulfinyl-(C1-C4)alkyl, (C1- C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl, (C1-C4)alkylcarbonyl, (C1-C4)haloalkylcarbonyl, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di(C1-C4)alkylaminocarbonyl, (C3- C6)cycloalkylaminocarbonyl, (C1-C4)alkylsulfonylamino, aminosulfonyl, (C1- C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1-C4)alkylsulfoximino, aminothiocarbonyl, (C1-C4)alkylaminothiocarbonyl, di(C1-C4)alkylaminothiocarbonyl, (C1- C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3-C6)cycloalkylcarbonylamino, phenyl which is optionally substituted by halogen, cyano or (C1-C6)haloalkyl or 5 to 6 membered hetaryl which is optionally substituted by halogen, cyano or (C1-C6)haloalkyl. 3. Compounds of the formula (I) according to Claim 1, in which R1 represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl or thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents, where possible substituents in each case are as follows: cyano, halogen, nitro, (C3- C6)cycloalkyl, (C3-C6)cycloalkyl-(C3-C6)cycloalkyl, (C1-C4)alkyl-(C3-C6)cycloalkyl, (C1- C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3-C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1-C4)cyanohaloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C2-C4)cyanoalkenyl, (C3-C6)cycloalkyl-(C2)alkenyl, (C2-C4)alkynyl, (C2-C4)haloalkynyl, (C2- C4)cyanoalkynyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)cyanoalkoxy, (C1-C4)alkoxyimino, (C1-C4)haloalkoxyimino, (C1-C4)alkylthio, (C1-C4)haloalkylthio, (C1-C4)alkylthio-(C1-C4)alkyl, (C1-C4)alkylsulfinyl, (C1-C4)haloalkylsulfinyl, (C1-C4)alkylsulfonyl, (C1-C4)haloalkylsulfonyl, (C1-C4)alkylcarbonyl, (C1-C4)haloalkylcarbonyl, aminocarbonyl, (C1-C4)alkylaminocarbonyl, di(C1-C4)alkylaminocarbonyl, (C3-C6)cycloalkylaminocarbonyl, (C1-C4)alkylsulfonylamino, aminosulfonyl, (C1-C4)alkylaminosulfonyl, di(C1-C4)alkylaminosulfonyl, (C1- C4)alkylsulfoximino, (C1-C4)alkylcarbonylamino, (C1-C4)haloalkylcarbonylamino, (C3- C6)cycloalkylcarbonylamino, phenyl, halophenyl, pyridyl or halopyridyl. BCS233014 FC-Text - 118 - 4. Compounds of the formula (I) according to Claim 1, in which R1 represents phenyl, pyridyl, pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, halogen, (C3-C6)cycloalkyl, (C1-C4)haloalkyl-(C3-C6)cycloalkyl, halo(C3- C6)cycloalkyl, cyano(C3-C6)cycloalkyl, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)cyanoalkyl, (C1- C4)cyanohaloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkoxyimino, aminocarbonyl, phenyl which is optionally monosubstituted by chlorine or pyridyl which is optionally monosubstituted by chlorine, or pyrazolyl which is optionally monosubstituted by cyano, halogen or (C1-C4)haloalkyl – bridged via a nitrogen atom to the rest of the molecule. 5. Compounds of the formula (I) according to Claim 1, in which R1 represents phenyl, pyridyl (pyridinyl), pyrimidyl, pyridazinyl, pyrazinyl, thienyl, pyrazolyl, thiazolyl, each of which is optionally mono-, di- or trisubstituted by identical or different substituents – bridged via a carbon atom to the rest of the molecule – where possible substituents in each case are as follows: cyano, fluorine, bromine, chlorine, methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyclopropyl, 1-cyanocyclopropyl, 1- trifluoromethylcyclopropyl, 1-fluorocyclopropyl, 2-cyanopropan-2-yl, cyano(difluoro)methyl, methoxyimino, ethoxyimino, aminocarbonyl, chlorophenyl or chloropyridyl, or pyrazolyl which is optionally monosubstituted by cyano, bromine, chlorine, iodine or trifluoromethyl – bridged via a nitrogen atom to the rest of the molecule. 6. Compounds of the formula (I) according to Claim 1, in which R1 represents phenyl, which is mono-, di- or trisubstituted identically or differently by fluorine, bromine, chlorine, cyano, methyl, 1-cyanocyclopropyl, 1-trifluoromethylcyclopropyl, 1- fluorocyclopropyl, aminocarbonyl, methoxyimino, ethoxyimino or chlorophenyl, or pyridin-2-yl which is optionally mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl, trifluoromethoxy or 1-cyanocyclopropyl, or pyridin-3-yl which is monosubstituted by fluorine, chlorine, cyano, cyano(difluoro)methyl (-CF2CN), methoxy, aminocarbonyl, 1-cyanocyclopropyl or chloropyridin-3-yl, or pyridin-4-yl which is monosubstituted by chlorine, 2-cyanopropan-2-yl (-C(CH3)2CN) or chloropyridin-4-yl, BCS233014 FC-Text - 119 - or pyridazin-3-yl which is monosubstituted by chlorine or cyano, or pyrimidin-2-yl which is mono- or disubstituted identically or differently by fluorine, bromine, chlorine, cyano, trifluoromethyl or methoxy, or pyrazin-2-yl which is monosubstituted by chlorine, or 1H-pyrazol-4-yl which is monosubstituted by methyl, cyclopropyl or 1-cyanocyclopropyl, or 1H-pyrazol-3-yl which is monosubstituted by methyl, or 1H-pyrazol-1-yl which is optionally monosuhstituted by bromine, chlorine, iodine, cyano or trifluoromethyl, or thien-2-yl which is monosubstituted by 1-cyanocyclopropyl, or 1,3-thiazol-2-yl which is monosubstituted by bromine, chlorine or cyano. 7. Compounds of the formula (I) according to Claim 1, having the structures according to Examples I-1 to I-109. 8. Agrochemical formulation comprising compounds of the formula (I) according to Claim 1 and also extenders and/or surfactants. 9. Agrochemical formulation according to Claim 8, additionally comprising a further agrochemical active ingredient. 10. Method for controlling animal pests, characterized in that a compound of the formula (I) according to Claim 1 or an agrochemical formulation according to Claim 8 or 9 is allowed to act on the animal pests and/or their habitat. 11. Use of compounds of the formula (I) according to Claim 1 or of agrochemical formulations according to Claim 8 or 9 for controlling animal pests.
PCT/EP2024/070220 2023-07-31 2024-07-17 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides WO2025026738A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23188625 2023-07-31
EP23188625.0 2023-07-31

Publications (1)

Publication Number Publication Date
WO2025026738A1 true WO2025026738A1 (en) 2025-02-06

Family

ID=87551064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2024/070220 WO2025026738A1 (en) 2023-07-31 2024-07-17 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides

Country Status (1)

Country Link
WO (1) WO2025026738A1 (en)

Citations (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010A (en) 1841-03-18 Machine foe
US2009A (en) 1841-03-18 Improvement in machines for boring war-rockets
US24077A (en) 1859-05-17 Window-sash supporter
US137395A (en) 1873-04-01 Improvement in nuts
US4125726A (en) 1977-03-11 1978-11-14 Hoffmann-La Roche Inc. Imidazo[1,5-a][1,4]benzodiazepines
WO1997017432A1 (en) 1995-11-06 1997-05-15 Wisconsin Alumni Research Foundation Insecticidal protein toxins from photorhabdus
WO1998008932A1 (en) 1996-08-29 1998-03-05 Dow Agrosciences Llc Insecticidal protein toxins from $i(photorhabdus)
WO1998044140A1 (en) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Glyphosate resistant maize lines
WO1998050427A1 (en) 1997-05-05 1998-11-12 Dow Agrosciences Llc INSECTICIDAL PROTEIN TOXINS FROM $i(XENORHABDUS)
WO2000026356A1 (en) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Glufosinate tolerant rice
WO2000026345A1 (en) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Glufosinate tolerant rice
WO2001031042A2 (en) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Male-sterile brassica plants and methods for producing same
WO2001041558A1 (en) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Hybrid winter oilseed rape and methods for producing same
WO2001047952A2 (en) 1999-12-28 2001-07-05 Bayer Cropscience N.V. Insecticidal proteins from bacillus thuringiensis
WO2001051654A2 (en) 2000-01-11 2001-07-19 Bayer Cropscience N.V. Methods and kits for identifying elite event gat-zm1 in biological samples
WO2002027004A2 (en) 2000-09-29 2002-04-04 Monsanto Technology Llc Glyphosate tolerant wheat plant 33391 and compositions and methods for detection thereof
WO2002034946A2 (en) 2000-10-25 2002-05-02 Monsanto Technology Llc Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
WO2002036831A2 (en) 2000-10-30 2002-05-10 Monsanto Technology Llc Canola event pv-bngt04(rt73) and compositions and methods for detection thereof
WO2002040677A2 (en) 2000-11-20 2002-05-23 Monsanto Technology Llc Cotton event pv-ghbk04 (531) and compositions and methods for detection thereof
WO2002044407A2 (en) 2000-11-30 2002-06-06 Ses Europe N.V. Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
WO2002100163A2 (en) 2001-06-11 2002-12-19 Monsanto Technology Llc Cotton event moni5985 and compositions and methods for detection
WO2003013224A2 (en) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Herbicide tolerant cotton plants and methods for producing and identifying same
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
WO2004011601A2 (en) 2002-07-29 2004-02-05 Monsanto Technology, Llc Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
WO2004039986A1 (en) 2002-10-29 2004-05-13 Syngenta Participations Ag Cot102 insecticidal cotton
WO2004053062A2 (en) 2002-12-05 2004-06-24 Monsanto Technology Llc Bentgrass event asr-368 and compositions and methods for detection thereof
WO2004072235A2 (en) 2003-02-12 2004-08-26 Monsanto Technology Llc Cotton event mon 88913 and compositions and methods for detection thereof
WO2004074492A1 (en) 2003-02-20 2004-09-02 Kws Saat Ag Glyphosate tolerant sugar beet
US20040172669A1 (en) 2003-02-28 2004-09-02 Josef Kraus Glyphosate tolerant sugar beet
WO2004099177A1 (en) 2003-05-09 2004-11-18 Merck Sharp & Dohme Limited Substituted-1-phthalazinamines as vr-1 antagonists
WO2004099447A2 (en) 2003-05-02 2004-11-18 Dow Agrosciences Llc Corn event tc1507 and methods for detection thereof
US6855533B2 (en) 1995-04-20 2005-02-15 Basf Corporation Structure-based designed herbicide resistant products
WO2005054480A2 (en) 2003-12-01 2005-06-16 Syngenta Participations Ag Insect resistant cotton plants and methods of detecting the same
WO2005054479A1 (en) 2003-12-01 2005-06-16 Syngenta Participations Ag Insect resistant cotton plants and methods of detecting the same
WO2005058898A2 (en) 2003-12-16 2005-06-30 Ranbaxy Laboratories Limited Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
WO2005059103A2 (en) 2003-12-15 2005-06-30 Monsanto Technology Llc Corn plant mon88017 and compositions and methods for detection thereof
WO2005061720A2 (en) 2003-12-11 2005-07-07 Monsanto Technology Llc High lysine maize compositions and methods for detection thereof
WO2005074671A1 (en) 2004-01-30 2005-08-18 Syngenta Participations Ag Improved fertility restoration for ogura cytoplasmic male sterile brassica and method
US20050216969A1 (en) 2004-03-26 2005-09-29 Dow Agrosciences Llc Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof
WO2005103301A2 (en) 2004-03-25 2005-11-03 Syngenta Participations Ag Corn event mir604
WO2006003494A2 (en) 2004-06-28 2006-01-12 Syngenta Participations Ag Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides
US20060070139A1 (en) 2004-09-29 2006-03-30 Pioneer Hi-Bred International, Inc. Corn event DAS-59122-7 and methods for detection thereof
WO2006043635A1 (en) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematicide containing the same as active ingredient
WO2006098952A2 (en) 2005-03-16 2006-09-21 Syngenta Participations Ag Corn event 3272 and methods of detection thereof
WO2006108675A2 (en) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Elite event a5547-127 and methods and kits for identifying such event in biological samples
WO2006108674A2 (en) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Elite event a2704-12 and methods and kits for identifying such event in biological samples
WO2006128571A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce44-69d , insecticidal transgenic cotton expressing cry1ab
WO2006128569A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-14a, insecticidal transgenic cotton expressing cry1ab
WO2006128570A1 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-51b insecticidal cotton
WO2006128568A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag T342-142, insecticidal transgenic cotton expressing cry1ab
WO2006130436A2 (en) 2005-05-27 2006-12-07 Monsanto Technology Llc Soybean event mon89788 and methods for detection thereof
WO2006128573A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce43- 67b, insecticidal transgenic cotton expressing cry1ab
WO2006128572A1 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce46-02a insecticidal cotton
WO2007017186A1 (en) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Herbicide tolerant cotton plants and methods for identifying same
WO2007024782A2 (en) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions providing tolerance to multiple herbicides and methods of use thereof
WO2007040280A1 (en) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
WO2007091277A2 (en) 2006-02-10 2007-08-16 Maharashtra Hybrid Seeds Company Limited (Mahyco) TRANSGENIC BRINJAL (SOLANUM MELONGENA) EXPRESSING THE CRYlAC GENE
WO2007140256A1 (en) 2006-05-26 2007-12-06 Monsanto Technology, Llc Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof
WO2007142840A2 (en) 2006-06-03 2007-12-13 Syngenta Participations Ag Corn event mir162
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
WO2007148093A1 (en) 2006-06-22 2007-12-27 Prolysis Ltd. Antibacterial compositions
WO2008002872A2 (en) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and/or detection thereof
US20080064032A1 (en) 2006-09-13 2008-03-13 Syngenta Participations Ag Polynucleotides and uses thereof
WO2008054747A2 (en) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
WO2008112019A2 (en) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof
WO2008114282A2 (en) 2007-03-19 2008-09-25 Maharashtra Hybrid Seeds Company Limited Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof
WO2008122406A1 (en) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Insect resistant cotton plants and methods for identifying same
US20080289060A1 (en) 2006-08-24 2008-11-20 Bayer Bioscience N.V. Herbicide tolerant rice plants and methods for identifying same
WO2008151780A1 (en) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Insect resistant cotton plants comprising elite event ee-gh6 and methods for identifying same
CN101337940A (en) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity
CN101337937A (en) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 N-benz-3-substituted amino pyrazoles compounds with insecticidal activity
US20090130071A1 (en) 2007-11-15 2009-05-21 Ai-Guo Gao Soybean Plant And Seed Corresponding To Transgenic Event MON87701 And Methods For Detection Thereof
WO2009100188A2 (en) 2008-02-08 2009-08-13 Dow Agrosciences Llc Methods for detection of corn event das-59132
US20090210970A1 (en) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Plant Genomic DNA Flanking SPT Event and Methods for Identifying SPT Event
WO2009102873A1 (en) 2008-02-15 2009-08-20 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof
WO2009111263A1 (en) 2008-02-29 2009-09-11 Monsanto Technology Llc Corn plant event mon87460 and compositions and methods for detection thereof
WO2009152359A2 (en) 2008-06-11 2009-12-17 Dow Agrosciences Llc Constructs for expressing herbicide tolerance genes, related plants, and related trait combinations
JP2010018586A (en) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Substance pf1364, its manufacturing method, producing strain and agricultural/horticultural insecticide having the substance as active ingredient
WO2010024976A1 (en) 2008-08-29 2010-03-04 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87754 and methods for detection thereof
US20100080887A1 (en) 2008-09-29 2010-04-01 Monsanto Technology Llc Soybean Transgenic Event MON87705 and Methods for Detection Thereof
WO2010052161A2 (en) 2008-11-06 2010-05-14 Syngenta Participations Ag Herbicidal compositions
WO2010051926A2 (en) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft New halogen-substituted bonds
CN101715774A (en) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 Preparation and use of compound having insecticidal activity
WO2010066780A1 (en) 2008-12-12 2010-06-17 Syngenta Participations Ag Spiroheterocyclic n-oxypiperidines as pesticides
WO2010076212A1 (en) 2008-12-19 2010-07-08 Syngenta Participations Ag Transgenic sugar beet event gm rz13
WO2010077816A1 (en) 2008-12-16 2010-07-08 Syngenta Participations Ag Corn event 5307
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
WO2010117735A1 (en) 2009-03-30 2010-10-14 Monsanto Technology Llc Transgenic rice event17314 and methods of use thereof
WO2010117737A1 (en) 2009-03-30 2010-10-14 Monsanto Technology Llc Rice transgenic event17053 and methods of use thereof
WO2010125985A1 (en) 2009-04-28 2010-11-04 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use thereof
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
WO2011034704A1 (en) 2009-09-17 2011-03-24 Monsanto Technology Llc Soybean transgenic event mon 87708 and methods of use thereof
WO2011062904A1 (en) 2009-11-23 2011-05-26 Monsanto Technology Llc Transgenic maize event mon 87427 and the relative development scale
WO2011063413A2 (en) 2009-11-23 2011-05-26 Bayer Bioscience N.V. Herbicide tolerant soybean plants and methods for identifying same
WO2011066360A1 (en) 2009-11-24 2011-06-03 Dow Agrosciences Llc Detection of aad-12 soybean event 416
WO2011066384A1 (en) 2009-11-24 2011-06-03 Dow Agrosciences Llc Aad-12 event 416, related transgenic soybean lines, and event-specific identification thereof
WO2011075595A1 (en) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maize event dp-043a47-3 and methods for detection thereof
WO2011075593A1 (en) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maize event dp-040416-8 and methods for detection thereof
WO2011084632A1 (en) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Maize event dp-032316-8 and methods for detection thereof
WO2011084621A1 (en) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Maize event dp-004114-3 and methods for detection thereof
WO2011085575A1 (en) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Ortho-heterocyclyl formanilide compounds, their synthesis methods and use
WO2011151146A1 (en) 2010-05-31 2011-12-08 Syngenta Participations Ag Method of crop enhancement
WO2011153186A1 (en) 2010-06-04 2011-12-08 Monsanto Technology Llc Transgenic brassica event mon 88302 and methods of use thereof
WO2012033794A2 (en) 2010-09-08 2012-03-15 Dow Agrosciences Llc Aad-12 event 1606 and related transgenic soybean lines
WO2012034403A1 (en) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof
CN102391261A (en) 2011-10-14 2012-03-28 上海交通大学 N-substituted dioxazine compound as well as preparation method and application thereof
WO2012051199A2 (en) 2010-10-12 2012-04-19 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87712 and methods for detection thereof
US20120131692A1 (en) 2010-11-24 2012-05-24 Pioneer Hi-Bred International, Inc. Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
WO2012071039A1 (en) 2010-11-24 2012-05-31 Pioner Hi-Bred International, Inc. Brassica gat event dp-061061-7 and compositions and methods for the identification and/or detection thereof
WO2012075429A1 (en) 2010-12-03 2012-06-07 Dow Agrosciences Llc Stacked herbicide tolerance event 8291.45.36.2, related transgenic soybean lines, and detection thereof
WO2012075426A1 (en) 2010-12-03 2012-06-07 Dow Agrosciences Llc Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof
WO2012074135A1 (en) 2010-12-01 2012-06-07 Sumitomo Chemical Company, Limited Pyrimidine compound and use for pest control thereof
WO2012082548A2 (en) 2010-12-15 2012-06-21 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
WO2012086848A1 (en) 2010-12-24 2012-06-28 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use for pest control thereof
WO2012134808A1 (en) 2011-03-30 2012-10-04 Monsanto Technology Llc Cotton transgenic event mon 88701 and methods of use thereof
WO2012143599A1 (en) 2011-04-21 2012-10-26 Orion Corporation Androgen receptor modulating carboxamides
WO2013003558A1 (en) 2011-06-30 2013-01-03 Monsanto Technology Llc Alfalfa plant and seed corresponding to transgenic event kk 179-2 and methods for detection thereof
WO2013010094A1 (en) 2011-07-13 2013-01-17 Dow Agrosciences Llc Stacked herbicide tolerance event 8264.42.32.1, related transgenic soybean lines, and detection thereof
WO2013012775A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Corn event mzdt09y
WO2013018928A1 (en) 2011-08-04 2013-02-07 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use thereof for pest control
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN103109816A (en) 2013-01-25 2013-05-22 青岛科技大学 Thiobenzamide compounds and application thereof
CN103232431A (en) 2013-01-25 2013-08-07 青岛科技大学 Dihalogenated pyrazole amide compound and its use
CN103265527A (en) 2013-06-07 2013-08-28 江苏省农用激素工程技术研究中心有限公司 Anthranilamide compound as well as preparation method and application thereof
WO2013144213A1 (en) 2012-03-30 2013-10-03 Basf Se N-substituted pyridinylidene compounds and derivatives for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
US20130281433A1 (en) 2012-04-20 2013-10-24 Gilead Sciences, Inc. Therapeutic compounds
WO2013162715A2 (en) 2012-04-27 2013-10-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2013180193A1 (en) 2012-05-31 2013-12-05 住友化学株式会社 Fused heterocyclic compound
WO2013191113A1 (en) 2012-06-18 2013-12-27 住友化学株式会社 Fused heterocyclic compound
CN103524422A (en) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
WO2014053450A1 (en) 2012-10-02 2014-04-10 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US20140243316A1 (en) 2013-02-28 2014-08-28 Eisai R&D Management Co., Ltd. Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative
WO2014142292A1 (en) 2013-03-15 2014-09-18 日本農薬株式会社 Fused heterocyclic compound or salt thereof, agricultural and horticultural insecticide containing fused heterocyclic compound, and method for using agricultural and horticultural insecticide
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
WO2014148451A1 (en) 2013-03-19 2014-09-25 日本農薬株式会社 Fused heterocyclic compound or salt thereof, pesticide for agricultural and horticultural use containing said compound, and usage method therefor
WO2014187846A1 (en) 2013-05-23 2014-11-27 Syngenta Participations Ag Tank-mix formulations
WO2015002211A1 (en) 2013-07-01 2015-01-08 住友化学株式会社 Fused heterocyclic compound and pest control use thereof
WO2015000715A1 (en) 2013-07-02 2015-01-08 Syngenta Participations Ag Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
WO2015071180A1 (en) 2013-11-13 2015-05-21 Syngenta Participations Ag Pesticidally active bicyclic heterocycles with sulphur containing substituents
WO2015091945A1 (en) 2013-12-20 2015-06-25 Syngenta Participations Ag Pesticidally active substituted 5,5-bicyclic heterocycles with sulphur containing substituents
WO2015121136A1 (en) 2014-02-17 2015-08-20 Bayer Cropscience Ag 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2015133603A1 (en) 2014-03-07 2015-09-11 住友化学株式会社 Fused heterocyclic compound and pest control application thereof
US20150284358A1 (en) 2012-11-14 2015-10-08 Teijin Pharma Limited Pyridine derivative
WO2015198859A1 (en) 2014-06-26 2015-12-30 住友化学株式会社 Condensed heterocyclic compound
WO2015198817A1 (en) 2014-06-26 2015-12-30 Sumitomo Chemical Company, Limited Method for producing fused heterocyclic compound
WO2016005263A1 (en) 2014-07-08 2016-01-14 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016020286A1 (en) 2014-08-07 2016-02-11 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016023954A2 (en) 2014-08-12 2016-02-18 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016026848A1 (en) 2014-08-21 2016-02-25 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016039444A1 (en) 2014-09-12 2016-03-17 日本農薬株式会社 Imidazopyridazine compound or salts thereof, agricultural and horticultural insecticide containing said compound, and use of same
WO2016039441A1 (en) 2014-09-12 2016-03-17 日本農薬株式会社 Imidazopyridazine compound or salts thereof and agricultural and horticultural insecticide containing said compound and method of using same
WO2016041819A1 (en) 2014-09-16 2016-03-24 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulphur containing substituents
WO2016046071A1 (en) 2014-09-25 2016-03-31 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016058928A1 (en) 2014-10-14 2016-04-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016059145A1 (en) 2014-10-16 2016-04-21 Syngenta Participations Ag Pesticidally active tetracyclic heterocyclic derivatives with sulphur containing substituents
WO2016071214A1 (en) 2014-11-07 2016-05-12 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016091731A1 (en) 2014-12-11 2016-06-16 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016096584A1 (en) 2014-12-17 2016-06-23 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016107742A1 (en) 2014-12-29 2016-07-07 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016107831A1 (en) 2014-12-31 2016-07-07 Syngenta Crop Protection Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016109559A2 (en) 2014-12-29 2016-07-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
WO2016113155A1 (en) 2015-01-13 2016-07-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016116338A1 (en) 2015-01-19 2016-07-28 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016121997A1 (en) 2015-01-29 2016-08-04 日本農薬株式会社 Fused heterocyclic compound having cycloalkylpyridyl group or salt thereof, and agricultural or horticultural insecticide containing said compound and use method therefor
WO2016125621A1 (en) 2015-02-03 2016-08-11 住友化学株式会社 Benzimidazole compound, and use thereof for noxious arthropod control
WO2016124557A1 (en) 2015-02-05 2016-08-11 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2016125622A1 (en) 2015-02-03 2016-08-11 住友化学株式会社 Benzoxazole compound, and use thereof for noxious arthropod control
WO2016124563A1 (en) 2015-02-05 2016-08-11 Bayer Cropscience Aktiengesellschsaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2016129684A1 (en) 2015-02-12 2016-08-18 日産化学工業株式会社 Condensed heterocyclic compound and noxious organism control agent
WO2016142326A1 (en) 2015-03-12 2016-09-15 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016142327A1 (en) 2015-03-12 2016-09-15 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016169886A1 (en) 2015-04-24 2016-10-27 Syngenta Crop Protection Ag Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocyles
WO2016169882A1 (en) 2015-04-24 2016-10-27 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur substituted five membered ring heterocyles
WO2017065228A1 (en) 2015-10-16 2017-04-20 住友化学株式会社 Pyrazine compound and arthropod pest control agent containing same
WO2017146226A1 (en) 2016-02-26 2017-08-31 日本農薬株式会社 Benzoxazole compound or salt thereof, agricultural/horticultural insecticide containing said compound, and method for using same
WO2018130443A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2018130437A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2019059412A1 (en) 2017-09-20 2019-03-28 Mitsui Chemicals Agro, Inc. Prolonged ectoparasite-controlling agent for animal
US20190202829A1 (en) 2016-08-16 2019-07-04 Bayer Cropscience Aktiengesellschaft Process for preparing halogenated pyridine derivatives
WO2019236274A1 (en) 2018-06-08 2019-12-12 Dow Agrosciences Llc Molecule having pesticidal utility, and compositions, and processes, related thereto
WO2020002082A1 (en) 2018-06-26 2020-01-02 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2020013147A1 (en) 2018-07-10 2020-01-16 日本農薬株式会社 Benzimidazole compound having alkylenedioxy group which may be halogenated or salt thereof, agricultural and horticultural pesticide containing said compound, and method of using same
WO2020074560A1 (en) 2018-10-11 2020-04-16 Bayer Aktiengesellschaft Process for preparing substituted imidazole derivatives
WO2020074558A1 (en) 2018-10-11 2020-04-16 Bayer Aktiengesellschaft Process for preparing imidazole derivatives
US20200146293A1 (en) 2017-05-02 2020-05-14 Bayer Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
WO2022002818A1 (en) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents

Patent Citations (232)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009A (en) 1841-03-18 Improvement in machines for boring war-rockets
US24077A (en) 1859-05-17 Window-sash supporter
US137395A (en) 1873-04-01 Improvement in nuts
US2010A (en) 1841-03-18 Machine foe
US4125726A (en) 1977-03-11 1978-11-14 Hoffmann-La Roche Inc. Imidazo[1,5-a][1,4]benzodiazepines
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
US6855533B2 (en) 1995-04-20 2005-02-15 Basf Corporation Structure-based designed herbicide resistant products
WO1997017432A1 (en) 1995-11-06 1997-05-15 Wisconsin Alumni Research Foundation Insecticidal protein toxins from photorhabdus
WO1998008932A1 (en) 1996-08-29 1998-03-05 Dow Agrosciences Llc Insecticidal protein toxins from $i(photorhabdus)
US20050086719A1 (en) 1997-04-03 2005-04-21 Michael Spencer Glyphosate resistant maize lines
US20050188434A1 (en) 1997-04-03 2005-08-25 Michael Spencer Method for plant breeding
US20060059581A1 (en) 1997-04-03 2006-03-16 Dekalb Genetics Corporation Method of breeding glyphosate resistant plants
WO1998044140A1 (en) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Glyphosate resistant maize lines
WO1998050427A1 (en) 1997-05-05 1998-11-12 Dow Agrosciences Llc INSECTICIDAL PROTEIN TOXINS FROM $i(XENORHABDUS)
WO2000026345A1 (en) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Glufosinate tolerant rice
US6468747B1 (en) 1998-11-03 2002-10-22 Plant Genetic System, N.V. Glufosinate tolerant rice
WO2000026356A1 (en) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Glufosinate tolerant rice
WO2001031042A2 (en) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Male-sterile brassica plants and methods for producing same
US20030188347A1 (en) 1999-12-08 2003-10-02 Both Greta De Hybrid winter oilseed rape and methods for producing same
WO2001041558A1 (en) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Hybrid winter oilseed rape and methods for producing same
WO2001047952A2 (en) 1999-12-28 2001-07-05 Bayer Cropscience N.V. Insecticidal proteins from bacillus thuringiensis
WO2001051654A2 (en) 2000-01-11 2001-07-19 Bayer Cropscience N.V. Methods and kits for identifying elite event gat-zm1 in biological samples
US20010029014A1 (en) 2000-01-11 2001-10-11 Beuckeleer Marc De Methods and kits for identifying elite event GAT-ZM1 in biological samples
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
WO2002027004A2 (en) 2000-09-29 2002-04-04 Monsanto Technology Llc Glyphosate tolerant wheat plant 33391 and compositions and methods for detection thereof
US20020120964A1 (en) 2000-10-25 2002-08-29 Rangwala Tasneem S. Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof
WO2002034946A2 (en) 2000-10-25 2002-05-02 Monsanto Technology Llc Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
WO2002036831A2 (en) 2000-10-30 2002-05-10 Monsanto Technology Llc Canola event pv-bngt04(rt73) and compositions and methods for detection thereof
US20080070260A1 (en) 2000-10-30 2008-03-20 Rachel Krieb Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
WO2002040677A2 (en) 2000-11-20 2002-05-23 Monsanto Technology Llc Cotton event pv-ghbk04 (531) and compositions and methods for detection thereof
WO2002044407A2 (en) 2000-11-30 2002-06-06 Ses Europe N.V. Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion
US20090265817A1 (en) 2000-11-30 2009-10-22 Ses Europe N.V./S.A. T227-1 flanking sequence
US20040250317A1 (en) 2001-06-11 2004-12-09 Huber Scott A Cotton event moni5985 and compositions and methods for detection thereof
WO2002100163A2 (en) 2001-06-11 2002-12-19 Monsanto Technology Llc Cotton event moni5985 and compositions and methods for detection
US20030097687A1 (en) 2001-08-06 2003-05-22 Linda Trolinder Herbicide tolerant cotton plants and methods for producing and identifying same
WO2003013224A2 (en) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Herbicide tolerant cotton plants and methods for producing and identifying same
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004011601A2 (en) 2002-07-29 2004-02-05 Monsanto Technology, Llc Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
US20060095986A1 (en) 2002-07-29 2006-05-04 Cavato Tracey A Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
US20060130175A1 (en) 2002-10-29 2006-06-15 Ellis Daniel M Cot102 insecticidal cotton
WO2004039986A1 (en) 2002-10-29 2004-05-13 Syngenta Participations Ag Cot102 insecticidal cotton
WO2004053062A2 (en) 2002-12-05 2004-06-24 Monsanto Technology Llc Bentgrass event asr-368 and compositions and methods for detection thereof
US20060162007A1 (en) 2002-12-05 2006-07-20 Monsanto Technology Llc Bentgrass event asr-368 and compositions and methods for detection thereof
US20060059590A1 (en) 2003-02-12 2006-03-16 Monsanto Technology Llc Cotton event mon 88913 and compositions and methods for detection thereof
WO2004072235A2 (en) 2003-02-12 2004-08-26 Monsanto Technology Llc Cotton event mon 88913 and compositions and methods for detection thereof
WO2004074492A1 (en) 2003-02-20 2004-09-02 Kws Saat Ag Glyphosate tolerant sugar beet
US20040172669A1 (en) 2003-02-28 2004-09-02 Josef Kraus Glyphosate tolerant sugar beet
WO2004099447A2 (en) 2003-05-02 2004-11-18 Dow Agrosciences Llc Corn event tc1507 and methods for detection thereof
US20050039226A1 (en) 2003-05-02 2005-02-17 Dow Agrosciences Llc Corn event TC1507 and methods for detection thereof
WO2004099177A1 (en) 2003-05-09 2004-11-18 Merck Sharp & Dohme Limited Substituted-1-phthalazinamines as vr-1 antagonists
US20070067868A1 (en) 2003-12-01 2007-03-22 Negrotto David V Insect resistant cotton plants and methods of detecting the same
WO2005054480A2 (en) 2003-12-01 2005-06-16 Syngenta Participations Ag Insect resistant cotton plants and methods of detecting the same
WO2005054479A1 (en) 2003-12-01 2005-06-16 Syngenta Participations Ag Insect resistant cotton plants and methods of detecting the same
WO2005061720A2 (en) 2003-12-11 2005-07-07 Monsanto Technology Llc High lysine maize compositions and methods for detection thereof
US20070028322A1 (en) 2003-12-11 2007-02-01 Dizigan Mark A High lysine maize compositions and methods for detection thereof
WO2005059103A2 (en) 2003-12-15 2005-06-30 Monsanto Technology Llc Corn plant mon88017 and compositions and methods for detection thereof
US20080028482A1 (en) 2003-12-15 2008-01-31 Beazley Kim A Corn Plant Mon88017 and Compositions and Methods for Detection Thereof
WO2005058898A2 (en) 2003-12-16 2005-06-30 Ranbaxy Laboratories Limited Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
WO2005074671A1 (en) 2004-01-30 2005-08-18 Syngenta Participations Ag Improved fertility restoration for ogura cytoplasmic male sterile brassica and method
WO2005103301A2 (en) 2004-03-25 2005-11-03 Syngenta Participations Ag Corn event mir604
US20080167456A1 (en) 2004-03-25 2008-07-10 Syngenta Participations Ag Corn Event MIR604
WO2005103266A1 (en) 2004-03-26 2005-11-03 Dow Agrosciences Llc Cry1f and cry1ac transgenic cotton lines and event-specific identification thereof
US20050216969A1 (en) 2004-03-26 2005-09-29 Dow Agrosciences Llc Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof
US20070143876A1 (en) 2004-03-26 2007-06-21 Dow Agrosciences Llc Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof
WO2006003494A2 (en) 2004-06-28 2006-01-12 Syngenta Participations Ag Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides
US20060070139A1 (en) 2004-09-29 2006-03-30 Pioneer Hi-Bred International, Inc. Corn event DAS-59122-7 and methods for detection thereof
WO2006043635A1 (en) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematicide containing the same as active ingredient
US20060230473A1 (en) 2005-03-16 2006-10-12 Syngenta Participations Ag Corn event 3272 and methods for detection thereof
WO2006098952A2 (en) 2005-03-16 2006-09-21 Syngenta Participations Ag Corn event 3272 and methods of detection thereof
WO2006108674A2 (en) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Elite event a2704-12 and methods and kits for identifying such event in biological samples
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
WO2006108675A2 (en) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Elite event a5547-127 and methods and kits for identifying such event in biological samples
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
WO2006130436A2 (en) 2005-05-27 2006-12-07 Monsanto Technology Llc Soybean event mon89788 and methods for detection thereof
US20060282915A1 (en) 2005-05-27 2006-12-14 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
WO2006128568A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag T342-142, insecticidal transgenic cotton expressing cry1ab
WO2006128573A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce43- 67b, insecticidal transgenic cotton expressing cry1ab
WO2006128570A1 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-51b insecticidal cotton
WO2006128569A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-14a, insecticidal transgenic cotton expressing cry1ab
US20090217423A1 (en) 2005-06-02 2009-08-27 Cayley Patricia J Ce43-67b insecticidal cotton
WO2006128571A2 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce44-69d , insecticidal transgenic cotton expressing cry1ab
WO2006128572A1 (en) 2005-06-02 2006-12-07 Syngenta Participations Ag Ce46-02a insecticidal cotton
US20100050282A1 (en) 2005-08-08 2010-02-25 Bayer Bioscience N.V. Herbicide Tolerant Cotton Plants and Methods for Identifying the Same
WO2007017186A1 (en) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Herbicide tolerant cotton plants and methods for identifying same
WO2007024782A2 (en) 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions providing tolerance to multiple herbicides and methods of use thereof
WO2007040282A1 (en) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Bridged cyclic amine compound and pest control agent
WO2007040280A1 (en) 2005-10-06 2007-04-12 Nippon Soda Co., Ltd. Cyclic amine compound and pest control agent
WO2007091277A2 (en) 2006-02-10 2007-08-16 Maharashtra Hybrid Seeds Company Limited (Mahyco) TRANSGENIC BRINJAL (SOLANUM MELONGENA) EXPRESSING THE CRYlAC GENE
WO2007140256A1 (en) 2006-05-26 2007-12-06 Monsanto Technology, Llc Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof
US20080260932A1 (en) 2006-05-26 2008-10-23 Anderson Heather M Corn Plant and Seed Corresponding to Transgenic Event MON89034 and Methods For Detection and Use Thereof
US20090300784A1 (en) 2006-06-03 2009-12-03 Syngenta Participations Ag Corn event mir162
WO2007142840A2 (en) 2006-06-03 2007-12-13 Syngenta Participations Ag Corn event mir162
WO2007148093A1 (en) 2006-06-22 2007-12-27 Prolysis Ltd. Antibacterial compositions
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
WO2008002872A2 (en) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and/or detection thereof
US20080289060A1 (en) 2006-08-24 2008-11-20 Bayer Bioscience N.V. Herbicide tolerant rice plants and methods for identifying same
US20080064032A1 (en) 2006-09-13 2008-03-13 Syngenta Participations Ag Polynucleotides and uses thereof
WO2008112019A2 (en) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
WO2008054747A2 (en) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
WO2008114282A2 (en) 2007-03-19 2008-09-25 Maharashtra Hybrid Seeds Company Limited Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof
WO2008122406A1 (en) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Insect resistant cotton plants and methods for identifying same
US20100077501A1 (en) 2007-04-05 2010-03-25 Bayer Bioscience N.V. Insect resistant cotton plants and methods for identifying same
WO2008151780A1 (en) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Insect resistant cotton plants comprising elite event ee-gh6 and methods for identifying same
US20090130071A1 (en) 2007-11-15 2009-05-21 Ai-Guo Gao Soybean Plant And Seed Corresponding To Transgenic Event MON87701 And Methods For Detection Thereof
WO2009064652A1 (en) 2007-11-15 2009-05-22 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87701 and methods for detection thereof
WO2009100188A2 (en) 2008-02-08 2009-08-13 Dow Agrosciences Llc Methods for detection of corn event das-59132
US20090210970A1 (en) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Plant Genomic DNA Flanking SPT Event and Methods for Identifying SPT Event
WO2009103049A2 (en) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Plant genomic dna flanking spt event and methods for identifying spt event
WO2009102873A1 (en) 2008-02-15 2009-08-20 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof
US20110067141A1 (en) 2008-02-15 2011-03-17 Byron Froman Soybean plant and seed corresponding to transgenic event mon87769 and methods for detection thereof
WO2009111263A1 (en) 2008-02-29 2009-09-11 Monsanto Technology Llc Corn plant event mon87460 and compositions and methods for detection thereof
US20110138504A1 (en) 2008-02-29 2011-06-09 Monsanto Technology Llc Corn plant event mon87460 and compositions and methods for detection thereof
WO2009152359A2 (en) 2008-06-11 2009-12-17 Dow Agrosciences Llc Constructs for expressing herbicide tolerance genes, related plants, and related trait combinations
JP2010018586A (en) 2008-07-14 2010-01-28 Meiji Seika Kaisha Ltd Substance pf1364, its manufacturing method, producing strain and agricultural/horticultural insecticide having the substance as active ingredient
CN101337937A (en) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 N-benz-3-substituted amino pyrazoles compounds with insecticidal activity
CN101337940A (en) 2008-08-12 2009-01-07 国家农药创制工程技术研究中心 Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity
WO2010024976A1 (en) 2008-08-29 2010-03-04 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87754 and methods for detection thereof
US20100080887A1 (en) 2008-09-29 2010-04-01 Monsanto Technology Llc Soybean Transgenic Event MON87705 and Methods for Detection Thereof
WO2010037016A1 (en) 2008-09-29 2010-04-01 Monsanto Technology Llc Soybean transgenic event mon87705 and methods for detection thereof
CN101715774A (en) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 Preparation and use of compound having insecticidal activity
WO2010051926A2 (en) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft New halogen-substituted bonds
WO2010052161A2 (en) 2008-11-06 2010-05-14 Syngenta Participations Ag Herbicidal compositions
WO2010066780A1 (en) 2008-12-12 2010-06-17 Syngenta Participations Ag Spiroheterocyclic n-oxypiperidines as pesticides
WO2010077816A1 (en) 2008-12-16 2010-07-08 Syngenta Participations Ag Corn event 5307
WO2010076212A1 (en) 2008-12-19 2010-07-08 Syngenta Participations Ag Transgenic sugar beet event gm rz13
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
WO2010117735A1 (en) 2009-03-30 2010-10-14 Monsanto Technology Llc Transgenic rice event17314 and methods of use thereof
WO2010117737A1 (en) 2009-03-30 2010-10-14 Monsanto Technology Llc Rice transgenic event17053 and methods of use thereof
WO2010125985A1 (en) 2009-04-28 2010-11-04 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use thereof
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
WO2011034704A1 (en) 2009-09-17 2011-03-24 Monsanto Technology Llc Soybean transgenic event mon 87708 and methods of use thereof
WO2011062904A1 (en) 2009-11-23 2011-05-26 Monsanto Technology Llc Transgenic maize event mon 87427 and the relative development scale
WO2011063413A2 (en) 2009-11-23 2011-05-26 Bayer Bioscience N.V. Herbicide tolerant soybean plants and methods for identifying same
WO2011066360A1 (en) 2009-11-24 2011-06-03 Dow Agrosciences Llc Detection of aad-12 soybean event 416
WO2011066384A1 (en) 2009-11-24 2011-06-03 Dow Agrosciences Llc Aad-12 event 416, related transgenic soybean lines, and event-specific identification thereof
WO2011075595A1 (en) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maize event dp-043a47-3 and methods for detection thereof
WO2011075593A1 (en) 2009-12-17 2011-06-23 Pioneer Hi-Bred International, Inc. Maize event dp-040416-8 and methods for detection thereof
WO2011084632A1 (en) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Maize event dp-032316-8 and methods for detection thereof
WO2011084621A1 (en) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Maize event dp-004114-3 and methods for detection thereof
WO2011085575A1 (en) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Ortho-heterocyclyl formanilide compounds, their synthesis methods and use
WO2011151146A1 (en) 2010-05-31 2011-12-08 Syngenta Participations Ag Method of crop enhancement
WO2011153186A1 (en) 2010-06-04 2011-12-08 Monsanto Technology Llc Transgenic brassica event mon 88302 and methods of use thereof
WO2012033794A2 (en) 2010-09-08 2012-03-15 Dow Agrosciences Llc Aad-12 event 1606 and related transgenic soybean lines
WO2012034403A1 (en) 2010-09-14 2012-03-22 中化蓝天集团有限公司 Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof
WO2012051199A2 (en) 2010-10-12 2012-04-19 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event mon87712 and methods for detection thereof
US20120131692A1 (en) 2010-11-24 2012-05-24 Pioneer Hi-Bred International, Inc. Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
WO2012071039A1 (en) 2010-11-24 2012-05-31 Pioner Hi-Bred International, Inc. Brassica gat event dp-061061-7 and compositions and methods for the identification and/or detection thereof
WO2012074135A1 (en) 2010-12-01 2012-06-07 Sumitomo Chemical Company, Limited Pyrimidine compound and use for pest control thereof
WO2012075429A1 (en) 2010-12-03 2012-06-07 Dow Agrosciences Llc Stacked herbicide tolerance event 8291.45.36.2, related transgenic soybean lines, and detection thereof
WO2012075426A1 (en) 2010-12-03 2012-06-07 Dow Agrosciences Llc Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof
WO2012082548A2 (en) 2010-12-15 2012-06-21 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
WO2012086848A1 (en) 2010-12-24 2012-06-28 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use for pest control thereof
WO2012134808A1 (en) 2011-03-30 2012-10-04 Monsanto Technology Llc Cotton transgenic event mon 88701 and methods of use thereof
US20140094474A1 (en) 2011-04-21 2014-04-03 Orion Corporation Androgen receptor modulating carboxamides
WO2012143599A1 (en) 2011-04-21 2012-10-26 Orion Corporation Androgen receptor modulating carboxamides
WO2013003558A1 (en) 2011-06-30 2013-01-03 Monsanto Technology Llc Alfalfa plant and seed corresponding to transgenic event kk 179-2 and methods for detection thereof
WO2013010094A1 (en) 2011-07-13 2013-01-17 Dow Agrosciences Llc Stacked herbicide tolerance event 8264.42.32.1, related transgenic soybean lines, and detection thereof
WO2013012775A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Corn event mzdt09y
WO2013018928A1 (en) 2011-08-04 2013-02-07 Sumitomo Chemical Company, Limited Fused heterocyclic compound and use thereof for pest control
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (en) 2011-10-14 2012-03-28 上海交通大学 N-substituted dioxazine compound as well as preparation method and application thereof
WO2013144213A1 (en) 2012-03-30 2013-10-03 Basf Se N-substituted pyridinylidene compounds and derivatives for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
US20130281433A1 (en) 2012-04-20 2013-10-24 Gilead Sciences, Inc. Therapeutic compounds
WO2013162715A2 (en) 2012-04-27 2013-10-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2013162716A2 (en) 2012-04-27 2013-10-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US20140213448A1 (en) 2012-04-27 2014-07-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2013180193A1 (en) 2012-05-31 2013-12-05 住友化学株式会社 Fused heterocyclic compound
WO2013191113A1 (en) 2012-06-18 2013-12-27 住友化学株式会社 Fused heterocyclic compound
WO2014053450A1 (en) 2012-10-02 2014-04-10 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US20150284358A1 (en) 2012-11-14 2015-10-08 Teijin Pharma Limited Pyridine derivative
CN103109816A (en) 2013-01-25 2013-05-22 青岛科技大学 Thiobenzamide compounds and application thereof
CN103232431A (en) 2013-01-25 2013-08-07 青岛科技大学 Dihalogenated pyrazole amide compound and its use
US20140243316A1 (en) 2013-02-28 2014-08-28 Eisai R&D Management Co., Ltd. Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
WO2014142292A1 (en) 2013-03-15 2014-09-18 日本農薬株式会社 Fused heterocyclic compound or salt thereof, agricultural and horticultural insecticide containing fused heterocyclic compound, and method for using agricultural and horticultural insecticide
WO2014148451A1 (en) 2013-03-19 2014-09-25 日本農薬株式会社 Fused heterocyclic compound or salt thereof, pesticide for agricultural and horticultural use containing said compound, and usage method therefor
WO2014187846A1 (en) 2013-05-23 2014-11-27 Syngenta Participations Ag Tank-mix formulations
CN103265527A (en) 2013-06-07 2013-08-28 江苏省农用激素工程技术研究中心有限公司 Anthranilamide compound as well as preparation method and application thereof
WO2015002211A1 (en) 2013-07-01 2015-01-08 住友化学株式会社 Fused heterocyclic compound and pest control use thereof
WO2015000715A1 (en) 2013-07-02 2015-01-08 Syngenta Participations Ag Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
CN103524422A (en) 2013-10-11 2014-01-22 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
WO2015071180A1 (en) 2013-11-13 2015-05-21 Syngenta Participations Ag Pesticidally active bicyclic heterocycles with sulphur containing substituents
WO2015091945A1 (en) 2013-12-20 2015-06-25 Syngenta Participations Ag Pesticidally active substituted 5,5-bicyclic heterocycles with sulphur containing substituents
WO2015121136A1 (en) 2014-02-17 2015-08-20 Bayer Cropscience Ag 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2015133603A1 (en) 2014-03-07 2015-09-11 住友化学株式会社 Fused heterocyclic compound and pest control application thereof
WO2015198859A1 (en) 2014-06-26 2015-12-30 住友化学株式会社 Condensed heterocyclic compound
WO2015198817A1 (en) 2014-06-26 2015-12-30 Sumitomo Chemical Company, Limited Method for producing fused heterocyclic compound
WO2016005263A1 (en) 2014-07-08 2016-01-14 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016020286A1 (en) 2014-08-07 2016-02-11 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016023954A2 (en) 2014-08-12 2016-02-18 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016026848A1 (en) 2014-08-21 2016-02-25 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016039444A1 (en) 2014-09-12 2016-03-17 日本農薬株式会社 Imidazopyridazine compound or salts thereof, agricultural and horticultural insecticide containing said compound, and use of same
WO2016039441A1 (en) 2014-09-12 2016-03-17 日本農薬株式会社 Imidazopyridazine compound or salts thereof and agricultural and horticultural insecticide containing said compound and method of using same
WO2016041819A1 (en) 2014-09-16 2016-03-24 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulphur containing substituents
WO2016046071A1 (en) 2014-09-25 2016-03-31 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016058928A1 (en) 2014-10-14 2016-04-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016059145A1 (en) 2014-10-16 2016-04-21 Syngenta Participations Ag Pesticidally active tetracyclic heterocyclic derivatives with sulphur containing substituents
WO2016071214A1 (en) 2014-11-07 2016-05-12 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016091731A1 (en) 2014-12-11 2016-06-16 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016096584A1 (en) 2014-12-17 2016-06-23 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016109559A2 (en) 2014-12-29 2016-07-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
WO2016107742A1 (en) 2014-12-29 2016-07-07 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016107831A1 (en) 2014-12-31 2016-07-07 Syngenta Crop Protection Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016113155A1 (en) 2015-01-13 2016-07-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016116338A1 (en) 2015-01-19 2016-07-28 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
WO2016121997A1 (en) 2015-01-29 2016-08-04 日本農薬株式会社 Fused heterocyclic compound having cycloalkylpyridyl group or salt thereof, and agricultural or horticultural insecticide containing said compound and use method therefor
WO2016125622A1 (en) 2015-02-03 2016-08-11 住友化学株式会社 Benzoxazole compound, and use thereof for noxious arthropod control
WO2016125621A1 (en) 2015-02-03 2016-08-11 住友化学株式会社 Benzimidazole compound, and use thereof for noxious arthropod control
WO2016124557A1 (en) 2015-02-05 2016-08-11 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2016124563A1 (en) 2015-02-05 2016-08-11 Bayer Cropscience Aktiengesellschsaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2016129684A1 (en) 2015-02-12 2016-08-18 日産化学工業株式会社 Condensed heterocyclic compound and noxious organism control agent
WO2016142326A1 (en) 2015-03-12 2016-09-15 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016142327A1 (en) 2015-03-12 2016-09-15 Syngenta Participations Ag Pesticidally active tetracyclic derivatives with sulfur containing substituents
WO2016169886A1 (en) 2015-04-24 2016-10-27 Syngenta Crop Protection Ag Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocyles
WO2016169882A1 (en) 2015-04-24 2016-10-27 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur substituted five membered ring heterocyles
WO2017065228A1 (en) 2015-10-16 2017-04-20 住友化学株式会社 Pyrazine compound and arthropod pest control agent containing same
WO2017146226A1 (en) 2016-02-26 2017-08-31 日本農薬株式会社 Benzoxazole compound or salt thereof, agricultural/horticultural insecticide containing said compound, and method for using same
US20190202829A1 (en) 2016-08-16 2019-07-04 Bayer Cropscience Aktiengesellschaft Process for preparing halogenated pyridine derivatives
WO2018130443A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2018130437A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
US20200146293A1 (en) 2017-05-02 2020-05-14 Bayer Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
WO2019059412A1 (en) 2017-09-20 2019-03-28 Mitsui Chemicals Agro, Inc. Prolonged ectoparasite-controlling agent for animal
WO2019236274A1 (en) 2018-06-08 2019-12-12 Dow Agrosciences Llc Molecule having pesticidal utility, and compositions, and processes, related thereto
WO2020002082A1 (en) 2018-06-26 2020-01-02 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2020013147A1 (en) 2018-07-10 2020-01-16 日本農薬株式会社 Benzimidazole compound having alkylenedioxy group which may be halogenated or salt thereof, agricultural and horticultural pesticide containing said compound, and method of using same
WO2020074560A1 (en) 2018-10-11 2020-04-16 Bayer Aktiengesellschaft Process for preparing substituted imidazole derivatives
WO2020074558A1 (en) 2018-10-11 2020-04-16 Bayer Aktiengesellschaft Process for preparing imidazole derivatives
US20220009930A1 (en) 2018-10-11 2022-01-13 Bayer Aktiengesellschaft Process for preparing imidazole derivatives
WO2022002818A1 (en) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"Bioorganic and Medicinal Chemistry Letters", vol. 17, 2007, pages: 5825 - 5830
"Boronic Acids", 2011, WILEY-VCH
"Technical Monograph", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system"
"The Pesticide Manual", 2012, BRITISH CROP PROTECTION COUNCIL
CHEM. REV., vol. 95, 1995, pages 2457 - 2483
ESTRUCH ET AL., PROC NATL ACAD SCI US A., vol. 93, no. 2408220-94-8, 1996, pages 5389 - 94
JOURNAL OF ORGANIC CHEMISTRY, vol. 69, 2004, pages 8829 - 8835
R. WEGLER: "Chemie der Pflanzenschutz- and Schädlingsbekämpfungsmittel", vol. 2, 1970, SPRINGER VERLAG, pages: 401 - 412
TETRAHEDRON, vol. 58, 2002, pages 9633 - 9695

Similar Documents

Publication Publication Date Title
EP4003973B1 (en) Novel heteroaryl-triazole compounds as pesticides
US20230148601A1 (en) Novel heteroaryl-triazole compounds as pesticides
US20230242513A1 (en) Novel heteroaryl-substituted pyrazine derivatives as pesticides
US11083199B2 (en) Heterocycle derivatives as pesticides
US20220264880A1 (en) Novel heteroaryl-triazole compounds as pesticides
US11926623B2 (en) Heterocycle derivatives as pesticides
US20230058623A1 (en) Novel heteroaryl-triazole compounds as pesticides
EP4041721B1 (en) Novel heteroaryl-triazole compounds as pesticides
US11089783B2 (en) 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
AU2020228119A1 (en) Condensed bicyclic heterocyclic derivatives as pest control agents
AU2021260029A1 (en) 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
US20220403410A1 (en) Rnai-mediated pest control
US20220289691A1 (en) 5-amino-substituted pyrazoles and triazoles as pest control agents
US20230247994A1 (en) Heterocyclene derivatives as pest control agents
US20240294533A1 (en) 2-(het)aryl-substituted condensed heterocycle derivatives as pest control agents
EP4334315A1 (en) Alkylamide substituted, annulated imidazoles and use thereof as insecticides
US20220380318A1 (en) Substituted sulfonyl amides for controlling animal pests
WO2025026738A1 (en) 6-[5-(ethylsulfonyl)-1-methyl-1h-imidazol-4-yl]-7-methyl-3-(pentafluoroethyl)-7h-imidazo[4,5-c]pyridazine derivatives as pesticides
AU2022335669A1 (en) Novel pyrazinyl-triazole compounds as pesticides